15th Annual Scientific Meeting - Heart Failure Society of America
15th Annual Scientific Meeting - Heart Failure Society of America
15th Annual Scientific Meeting - Heart Failure Society of America
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>15th</strong> <strong>Annual</strong><br />
<strong>Scientific</strong> <strong>Meeting</strong><br />
2011 Program<br />
September 18 – 21, 2011<br />
Hynes Convention Center<br />
Boston, MA<br />
www.hfsa.org
Table <strong>of</strong> Contents<br />
President’s Message. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2<br />
About the HFSA .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3<br />
<strong>Society</strong> Officers and Council. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4<br />
<strong>Scientific</strong> Program Committee. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5<br />
<strong>Meeting</strong> Content .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5<br />
General <strong>Meeting</strong> Information .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6<br />
Complimentary Food Events.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8<br />
2011 HFSA Satellite/<strong>Scientific</strong> Program Activity Supporters.. . . . . . 9<br />
2011 HFSA Corporate Members.. . . . . . . . . . . . . . . . . . . . . . . . . . . . 9<br />
Liability Statement .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9<br />
CME Information .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10<br />
Disclosure Information .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11<br />
<strong>Scientific</strong> Program Learning Objectives .. . . . . . . . . . . . . . . . . . . . . 11<br />
2011 Abstract Reviewers.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12<br />
2011 HFSA Faculty.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14<br />
Program-at-a-Glance.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23<br />
September 18: (Sunday)<br />
<strong>Scientific</strong> Session .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30<br />
Satellite Symposium .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31<br />
<strong>Scientific</strong> Sessions.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32<br />
Satellite Symposia.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34<br />
September 19: (Monday)<br />
Satellite Symposia.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36<br />
Morning <strong>Scientific</strong> Program .. . . . . . . . . . . . . . . . . . . . . . . . . . . . 37<br />
How To Sessions.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43<br />
Oral Abstract Session (Rapid Fire) .. . . . . . . . . . . . . . . . . . . . . . . 44<br />
Afternoon <strong>Scientific</strong> Program.. . . . . . . . . . . . . . . . . . . . . . . . . . . 46<br />
Monday Posters.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58<br />
September 20: (Tuesday)<br />
Morning <strong>Scientific</strong> Program .. . . . . . . . . . . . . . . . . . . . . . . . . . . . 86<br />
How To Sessions.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100<br />
Oral Abstract Session (Rapid Fire) .. . . . . . . . . . . . . . . . . . . . . . 101<br />
Award Presentations .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103<br />
Afternoon <strong>Scientific</strong> Program.. . . . . . . . . . . . . . . . . . . . . . . . . . 103<br />
Tuesday Posters .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110<br />
September 21: (Wednesday)<br />
Morning <strong>Scientific</strong> Program .. . . . . . . . . . . . . . . . . . . . . . . . . . . 138<br />
Exhibit Hall<br />
Hands-on Workshop (September 19).. . . . . . . . . . . . . . . . . . . . . . . 148<br />
Product Theater (September 20) .. . . . . . . . . . . . . . . . . . . . . . . . . . 149<br />
Exhibitors and Exhibit Floor Plan.. . . . . . . . . . . . . . . . . . . . . . . . . 150<br />
Clinical Trial Row.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152<br />
Exhibitor Descriptions.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153<br />
Author Index.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164<br />
Hynes Convention Center Floor Plans. . . . . . . . . . . . . . . . . . . . . . 202<br />
Notes.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 204<br />
1
President’s Message<br />
On behalf <strong>of</strong> the Executive<br />
Council and the Program<br />
Committee <strong>of</strong> the <strong>Heart</strong> <strong>Failure</strong><br />
<strong>Society</strong> <strong>of</strong> <strong>America</strong> it is my<br />
pleasure to welcome you to the<br />
<strong>15th</strong> <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong>.<br />
The Program Committee, led<br />
by Lynne W. Stevenson, Steven<br />
Houser, and Barbara Riegel,<br />
has put together a very exciting<br />
and truly novel program, which<br />
includes content that should<br />
be <strong>of</strong> great interest to the<br />
wide spectrum <strong>of</strong> attendees.<br />
Whether you are a clinician or<br />
researcher, physician, nurse,<br />
pharmacist, or a trainee, this program will cover topics that will be<br />
useful in your practice and work.<br />
The program has been carefully planned to provide state-<strong>of</strong>-the-art<br />
information about heart failure for the expert covering the entire field<br />
from basic science to clinical practice. This year’s program includes<br />
sessions on fundamental clinical topics, simultaneous symposia,<br />
how-to sessions, rapid fire abstract sessions, debates, poster sessions,<br />
and late-breaking clinical trials. Areas where there have been new<br />
advances and topics, including controversial issues, are highlighted<br />
as part <strong>of</strong> the program. Some <strong>of</strong> the sessions will focus on a benchto-bedside<br />
approach; it is our hope that you will choose to attend<br />
sessions out <strong>of</strong> your main areas <strong>of</strong> interest and benefit from this unique<br />
aspect <strong>of</strong> our meeting which <strong>of</strong>fers a broad view <strong>of</strong> what is happening<br />
in heart failure. The Hyde Park session, an HFSA tradition, gives<br />
the audience an opportunity sit back, relax, enjoy and laugh a little<br />
while the presenters provide novel insights into important issues and<br />
controversies in the care <strong>of</strong> heart failure patients.<br />
We view our meeting’s success not only by the knowledge gained, but<br />
also by the enjoyment that attendees have in gaining it. We hope you<br />
find this year’s program to be informative and rewarding. As always<br />
we welcome and encourage your feedback.<br />
I hope you enjoy Boston, leave energized, and take home new ideas<br />
that will enhance your pr<strong>of</strong>essional goals. The 2012 <strong>Annual</strong> <strong>Scientific</strong><br />
<strong>Meeting</strong> will be held in Seattle, and we look forward to seeing you<br />
again.<br />
Barry M. Massie, MD<br />
President<br />
<strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong><br />
2010-2012<br />
About the HFSA<br />
The <strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong> (HFSA) represents the first<br />
organized effort by heart failure experts from the <strong>America</strong>s to provide<br />
a forum for all those interested in heart failure research and patient care.<br />
The HFSA is dedicated to:<br />
Promoting research related to all aspects <strong>of</strong> heart failure and to provide<br />
a forum for presentation <strong>of</strong> basic, clinical, and population-based research.<br />
Educating health care pr<strong>of</strong>essionals through programs, publications<br />
and other media in the areas <strong>of</strong> basic science, clinical medicine, patient<br />
management, and social, ethical and economic issues to enable them to<br />
diagnose and treat heart failure and concomitant medical conditions more<br />
effectively.<br />
Encouraging primary and secondary preventive measures to reduce the<br />
incidence <strong>of</strong> heart failure; to serve as a resource for government, private<br />
industry, and health care providers to facilitate the establishment <strong>of</strong><br />
programs and policies that will better serve the patient.<br />
Enhancing quality and duration <strong>of</strong> life in those with heart failure.<br />
Promoting and facilitating the formal training <strong>of</strong> physicians, scientists,<br />
and allied health care providers in the field <strong>of</strong> heart failure.<br />
<strong>Society</strong> Membership Information<br />
Membership in the <strong>Society</strong> is open to all health care pr<strong>of</strong>essionals<br />
with an interest in cardiovascular medicine. For information about the<br />
HFSA or to become a member, call or write:<br />
<strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong>, Inc.<br />
Court International<br />
Suite 240 South<br />
2550 University Avenue West<br />
St. Paul, MN 55114<br />
phone: 651-642-1633<br />
fax: 651-642-1502<br />
e-mail: info@hfsa.org<br />
Interested participants can also visit the HFSA exhibit booth (#2906)<br />
or visit the HFSA web site at www.hfsa.org.<br />
2 3
Officers:<br />
President:<br />
Vice-President:<br />
Secretary:<br />
Treasurer:<br />
Immediate Past President:<br />
Members:<br />
Ex Officio Members:<br />
Executive Council<br />
Barry M. Massie, MD<br />
San Francisco, CA<br />
Thomas Force, MD<br />
Philadelphia, PA<br />
Hani N. Sabbah, PhD<br />
Detroit, MI<br />
Mandeep R. Mehra, MD<br />
Baltimore, MD<br />
Douglas L. Mann, MD<br />
St. Louis, MO<br />
John C. Burnett, Jr., MD<br />
Rochester, MN<br />
John Chin, MD<br />
Sacramento, CA<br />
Steven R. Houser, PhD<br />
Philadelphia, PA<br />
Sharon A. Hunt, MD<br />
Stanford, CA<br />
Mariell L. Jessup, MD<br />
Philadelphia, PA<br />
JoAnn Lindenfeld, MD<br />
Denver, CO<br />
Sara C. Paul, RN, MSN, DNP<br />
Hickory, NC<br />
Mariann R. Piano, RN, PhD<br />
Chicago, IL<br />
Randall C. Starling, MD, MPH<br />
Cleveland, OH<br />
James E. Udelson, MD<br />
Boston, MA<br />
Michael R. Zile, MD<br />
Charlotte, SC<br />
Jay N. Cohn, MD<br />
Minneapolis, MN<br />
Allen Farber, Esq<br />
Washington, DC<br />
Gary S. Francis, MD<br />
Minneapolis, MN<br />
David A. Lathrop, PhD<br />
Bethesda, MD<br />
Isabella Liang, PhD<br />
Bethesda, MD<br />
2011 <strong>Scientific</strong> Program Committee<br />
Lynne Warner Stevenson, MD (Co-Chair)<br />
Steven R. Houser, PhD (Co-Chair)<br />
Barbara J. Riegel, RN, DNSc (Co-Chair)<br />
Nancy M. Albert, RN, PhD<br />
Mark E. Anderson, MD, PhD<br />
Wilson S. Colucci, MD<br />
James P. Daubert, MD<br />
Akshay M. Desai, MD<br />
Justin A. Ezekowitz, MB, BCh<br />
J. Thomas Heywood, MD<br />
Corrine Y. Jurgens, RN, PhD<br />
Annarosa Leri, MD<br />
Douglas W. Losordo, MD<br />
Carmelo A. Milano, MD<br />
Leslie W. Miller, MD<br />
Mark A. Munger, PharmD<br />
Ayan R. Patel, MD<br />
Peipei Ping, PhD<br />
Stuart D. Russell, MD<br />
Douglas D. Schocken, MD<br />
Randall C. Starling, MD, MPH<br />
Mark A. Sussman, PhD<br />
Mary N. Walsh, MD<br />
Matthew J. Wolf, MD, PhD<br />
<strong>Meeting</strong> Content:<br />
The 2011 HFSA <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong> provides a forum for<br />
the open exchange and discussion <strong>of</strong> research results and scientific<br />
advancements in the field <strong>of</strong> heart failure; however HFSA makes no<br />
representation or warranty as to the truth, originality, or accuracy<br />
<strong>of</strong> the information presented. Nor are the views expressed by the<br />
individual speakers necessarily the views <strong>of</strong> HFSA. HFSA supports<br />
the ACCME’s policy on evidence-based content and encourages<br />
faculty to adhere to these standards when preparing a presentation.<br />
4 5
General <strong>Meeting</strong> Information<br />
Boston, MA<br />
All activities listed in this program book will take place at the Hynes<br />
Convention Center. See pages 203-204 for floor plan <strong>of</strong> meeting<br />
space.<br />
CME Accreditation/Registration<br />
<strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong><br />
Court International, Suite 240 South<br />
2550 University Avenue West<br />
St. Paul, MN 55114<br />
651-642-1633; fax: 651-642-1502<br />
Registration Hours<br />
<strong>Meeting</strong> Registration Desk, Hynes Convention Center (2nd floor).<br />
Saturday, September 17:<br />
9:00 AM-4:00 PM<br />
Sunday, September 18:<br />
9:00 AM-4:00 PM<br />
Monday, September 19:<br />
7:00 AM-5:00 PM<br />
Tuesday, September 20:<br />
7:00 AM-5:00 PM<br />
Wednesday, September 21:<br />
7:00 AM-10:00 AM<br />
What’s Included in Registration Fees<br />
The registration fee includes admittance to satellite programs,<br />
scientific sessions, poster sessions, commercial exhibits and activities,<br />
and the Opening Reception.<br />
<strong>Scientific</strong> <strong>Meeting</strong> Evaluation<br />
There are two ways to complete the scientific meeting evaluation<br />
form: (1) complete the evaluation form found in your congress bag<br />
and return to the Registration Desk (Hynes Convention Center); OR<br />
(2) complete the form on-line after the meeting (information to be sent<br />
to attendees by e-mail after the scientific meeting).<br />
E-Mail From the Exhibit Floor (Booth #2522)<br />
During the meeting e-mail stations will be available in Exhibit Hall D for<br />
attendees to check their e-mail. Please note your e-mail account must be<br />
accessible through a web-based browser, e.g., Internet Explorer.<br />
No Smoking Policy<br />
HFSA prohibits smoking in all areas <strong>of</strong> the meeting and all hotel meeting<br />
rooms hosting HFSA functions. Thank you for your cooperation.<br />
Special Needs<br />
The HFSA strives to hold meetings that are accessible to all.<br />
Please tell us what you require to help make your participation<br />
more enjoyable and meaningful. Contact Gudrun Echterh<strong>of</strong>f, Global<br />
<strong>Meeting</strong>s & Incentives at gudrun@global-mtgs.com (201-850-7607).<br />
Speaker Ready Room – Room 309 (Hynes Convention Center)<br />
Sunday, September 18<br />
8:00 AM-6:00 PM<br />
Monday, September 19<br />
6:30 AM-6:00 PM<br />
Tuesday, September 20<br />
6:30 AM-6:00 PM<br />
Wednesday, September 21<br />
6:30 AM-NOON<br />
Press Room – Room 308 (Hynes Convention Center)<br />
Sunday, September 18<br />
10:00 AM-5:00 PM<br />
Monday, September 19<br />
7:00 AM-5:00 PM<br />
Tuesday, September 20<br />
7:00 AM-5:00 PM<br />
Wednesday, September 21<br />
7:00 AM-NOON<br />
Exhibit Hall Dates and Hours<br />
The exhibits are located in Exhibit Hall C (2nd level) Hynes<br />
Convention Center. See page 151 for list <strong>of</strong> exhibitors and location.<br />
Sunday, September 18<br />
Monday, September 19<br />
Tuesday, September 20<br />
Wednesday, September 21<br />
6:00 PM-8:00 PM<br />
9:30 AM-7:00 PM<br />
9:30 AM-7:00 PM<br />
CLOSED<br />
Clinical Trial Row: Located in Exhibit Hall D. This provides an<br />
opportunity for attendees to learn more about ongoing clinical trials<br />
in heart failure. These boards have been rented by groups supporting<br />
clinical trials. The HFSA assumes no responsibility or liability for<br />
information posted about a clinical trial on these boards.<br />
Hands-on Workshop: Located in Exhibit Hall C. This provides an<br />
opportunity for hands-on user learning to meeting attendees.<br />
Product Theater: Located in Exhibit Hall D. This provides an<br />
opportunity to hold product-related presentations during expo hours.<br />
Poster Sessions<br />
Poster Sessions will be held in the Exhibit Hall C (Hynes Convention<br />
Center) as follows:<br />
Poster Display:<br />
Monday, September 19<br />
9:30 AM-7:00 PM<br />
Tuesday, September 20<br />
Presenters at<br />
their Posters:<br />
5:45 PM-6:45 PM<br />
<strong>Annual</strong> Business <strong>Meeting</strong>:<br />
The <strong>Annual</strong> Business <strong>Meeting</strong> <strong>of</strong> the HFSA will be held on<br />
Wednesday, September 21, 8:15 AM, Room 311.<br />
Questions?<br />
Look for staff wearing golf shirts with the HFSA logo.<br />
6 7
General <strong>Meeting</strong> Information (continued)<br />
Complimentary Food Events<br />
The following complimentary food events will be <strong>of</strong>fered. All food<br />
events will take place in the Hynes Convention Center Exhibit Halls C<br />
and D unless otherwise noted.<br />
SUNDAY, September 18<br />
Opening Reception<br />
(Wine & Hors d’oeuvres)<br />
MONDAY, September 19<br />
Continental Breakfast<br />
<strong>Meeting</strong> area foyers (3rd Floor)<br />
Refreshment Break<br />
Refreshment Break<br />
Poster Session and Reception<br />
(Wine & Hors d’oeuvres)<br />
6:00 PM-8:00 PM<br />
6:30 AM-8:30 AM<br />
10:00 AM-10:30 AM<br />
3:30 PM-4:00 PM<br />
5:30 PM-7:00 PM<br />
2011 HFSA Satellite/<strong>Scientific</strong> Program<br />
Activity Supporters<br />
Actelion<br />
CardioMEMS<br />
Medtronic, Inc.<br />
Otsuka <strong>America</strong> Pharmaceuticals, Inc.<br />
Respicardia<br />
Thoratec Corporation<br />
2011 HFSA Corporate Members<br />
Amgen<br />
Boston <strong>Scientific</strong> Corporation<br />
Janssen Pharmaceuticals<br />
Medtronic, Inc.<br />
Merck & Co., Inc.<br />
Otsuka <strong>America</strong> Pharmaceuticals, Inc.<br />
St. Jude Medical<br />
Thoratec Corporation<br />
TUESDAY, September 20<br />
Continental Breakfast<br />
<strong>Meeting</strong> area foyers (3rd Floor)<br />
Refreshment Break<br />
Refreshment Break<br />
Poster Session and Reception<br />
(Wine & Hors d’oeuvres)<br />
WEDNESDAY, September 21<br />
Continental Breakfast<br />
<strong>Meeting</strong> area foyers (3rd Floor)<br />
Refreshment Break<br />
<strong>Meeting</strong> area foyers (3rd Floor)<br />
6:45 AM-8:30 AM<br />
10:00 AM-10:30 AM<br />
3:30 PM-4:00 PM<br />
5:30 PM-7:00 PM<br />
6:45 AM-8:30 AM<br />
10:00 AM-10:30 AM<br />
Liability Statement<br />
Disclaimer: The <strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong> (HFSA) cannot accept,<br />
and hereby specifically disclaims, any liability for death, injury, any loss,<br />
cost or expense suffered or incurred by any person if such loss is caused<br />
by, arises from or results from the act, default or omission <strong>of</strong> any person<br />
other than an employee or agent <strong>of</strong> HFSA. In particular, neither HFSA<br />
nor its agents can accept, and hereby specifically disclaims, any liability<br />
for losses arising from, caused by, or resulting from, the provision or<br />
non-provision <strong>of</strong> services provided by the hotels, companies, or transport<br />
operators. Neither HFSA nor its agents can accept, and hereby specifically<br />
disclaims, liability for losses suffered by reason <strong>of</strong> war including threat <strong>of</strong><br />
war, riots and civil strife, terrorist activity, natural disaster, weather, fire,<br />
flood, drought, technical, mechanical or electrical breakdown within any<br />
premises visited by delegates and/or participants in connection with the<br />
meeting, industrial disputes, government action, regulations or technical<br />
problems that affect or may affect the services provided in connection<br />
with the meeting. HFSA is not able to warrant and does not warrant<br />
that a particular person will appear as a speaker. As a condition to any<br />
participation in or attendance at the <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong> or any<br />
function associated or affiliated herewith, each attendee and participant<br />
accepts the foregoing disclaimer.<br />
8 9
CREDIT STATEMENTS<br />
<strong>Scientific</strong> Program<br />
Physicians: The <strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong> is accredited by the<br />
Accreditation Council for Continuing Medical Education to provide<br />
continuing medical education for physicians.<br />
The <strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong> designates this live activity for a<br />
maximum <strong>of</strong> 23.5 AMA PRA Category 1 Credits. Physicians should only<br />
claim credit commensurate with the extent <strong>of</strong> their participation in the activity.<br />
Nurses: This program has been approved by the <strong>America</strong>n Association<br />
<strong>of</strong> Critical Care Nurses (AACN) for 23.5 contact hours, Synergy CERP<br />
Category A, File number 00017263.<br />
Satellite Symposia: September 18 (Sunday)<br />
Physicians: The <strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong> (HFSA) is accredited<br />
by the Accreditation Council for Continuing Medical Education to provide<br />
continuing medical education for physicians. The HFSA designates this<br />
live activity for a maximum <strong>of</strong> 2.0 AMA PRA Category 1 Credits.<br />
Physicians should only claim credit commensurate with the extent <strong>of</strong> their<br />
participation in each program.<br />
Nurses: Each program has been designed to meet Minnesota Board <strong>of</strong><br />
Nursing continuing education requirements and is acceptable for 2.0<br />
contact hours <strong>of</strong> continuing education.<br />
Satellite Symposia: September 19 (Monday)<br />
Physicians: The <strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong> (HFSA) is accredited<br />
by the Accreditation Council for Continuing Medical Education to provide<br />
continuing medical education for physicians. The HFSA designates this<br />
live activity for a maximum <strong>of</strong> 1.0 AMA PRA Category 1 Credits.<br />
Physicians should only claim credit commensurate with the extent <strong>of</strong> their<br />
participation in this program.<br />
Nurses: Each program has been designed to meet Minnesota Board <strong>of</strong><br />
Nursing continuing education requirements and is acceptable for 1.0<br />
contact hour <strong>of</strong> continuing education.<br />
CME Certificates Available On-Site<br />
Presenter/Planner Disclosure Information<br />
The <strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong> has a disclosure policy that<br />
requires oral presenters to disclose whether or not they have relevant<br />
financial relationships with any commercial interest and whether or<br />
not <strong>of</strong>f-label or investigational drug/device use will be discussed.<br />
All oral and poster presenters’ disclosure information received is<br />
listed in the HFSA Presenter/Author Disclosure Booklet. A booklet<br />
is in each meeting congress bag. In addition, each oral presenter will<br />
have a disclosure slide at the beginning <strong>of</strong> his/her presentation.<br />
<strong>Scientific</strong> Program Learning Objectives<br />
Following this meeting, participants will be able to:<br />
1. Describe the epidemiology <strong>of</strong> HF, including environmental factors,<br />
and implement strategies for the prevention <strong>of</strong> HF.<br />
2. Describe current knowledge about the scientific basis <strong>of</strong> HF at the<br />
levels <strong>of</strong> cardiovascular physiology, neurohormones, tissue factors,<br />
and molecular biology and genetics.<br />
3. Identify the findings <strong>of</strong> basic science and current clinical trials and<br />
their implications for current and future HF therapy.<br />
4. Implement optimal guideline-based therapeutic options for HF,<br />
including pharmacologic agents, non-pharmacologic options, such<br />
as diet and exercise; and devices.<br />
5. Manage comorbidities including hypertension, diabetes, and<br />
cognitive issues.<br />
6. Demonstrate awareness <strong>of</strong> psychosocial, economic and ethical<br />
issues in the treatment <strong>of</strong> patients with HF.<br />
7. Implement strategies for effective management <strong>of</strong> the patient with<br />
HF, incorporating the family, encouraging self-care, and employing<br />
the medical home model.<br />
8. Outline strategies for transitioning patients from impatient to<br />
outpatient and for reducing hospital readmissions.<br />
9. Engage in performance measurement and other site-based research.<br />
<strong>Scientific</strong> Session and Satellite Symposia learning objectives are<br />
listed at the end <strong>of</strong> each session in the program book.<br />
CME CERTIFICATES (SCIENTIFIC AND SATELLITE<br />
SESSIONS) WILL BE AVAILABLE ON-SITE. PLEASE<br />
VISIT THE CME KIOSK IN REGISTRATION AREA TO<br />
DOWNLOAD AND PRINT YOUR CME CERTIFICATE(S).<br />
All main entrances to meeting rooms for the scientific sessions<br />
and the satellite programs will be “gated” to capture attendee<br />
information. This is the only information that will be used to<br />
verify attendance for credit certificates. Please make sure you<br />
enter each session through a gated entrance.<br />
10 11
Nancy M. Albert, RN, PhD<br />
Cleveland, OH<br />
Inder S. Anand, MD, PhD<br />
Minneapolis, MN<br />
Mark E. Anderson, MD, PhD<br />
Iowa City, IA<br />
Burns C. Blaxall, PhD<br />
Rochester, NY<br />
John P. Boehmer, MD<br />
Hershey, PA<br />
Bikyem Bozkurt, MD<br />
Houston, TX<br />
Javed Butler, MD, MPH<br />
Atlanta, GA<br />
Horng H. Chen, MB, BCh<br />
Rochester, MN<br />
Wilson S. Colucci, MD<br />
Boston, MA<br />
James P. Daubert, MD<br />
Durham, NC<br />
Teresa De Marco, MD<br />
San Francisco, CA<br />
David DeN<strong>of</strong>rio, MD<br />
Boston, MA<br />
Akshay M. Desai, MD<br />
Boston, MA<br />
Anita Deswal, MD, MPH<br />
Houston, TX<br />
Mark H. Drazner, MD<br />
Dallas, TX<br />
Justin A. Ezekowitz, MBBCh, MSc<br />
Edmonton, AB, Canada<br />
James C. Fang, MD<br />
Cleveland, OH<br />
G. Michael Felker, MD<br />
Durham, NC<br />
Gregg C. Fonarow, MD<br />
Los Angeles, CA<br />
Michael M. Givertz, MD<br />
Boston, MA<br />
Steven Goldman, MD<br />
Tucson, AZ<br />
Stephen S. Gottlieb, MD<br />
Baltimore, MD<br />
2011 Abstract Reviewers<br />
Roger J. Hajjar, MD<br />
New York, NY<br />
Joshua Hare, MD<br />
Miami, FL<br />
Paul J. Hauptman, MD<br />
St. Louis, MO<br />
Edward P. Havranek, MD<br />
Denver, CO<br />
Paul A. Heidenreich, MD<br />
Palo Alto, CA<br />
Adrian F. Hernandez, MD<br />
Durham, NC<br />
Ray E. Hershberger, MD<br />
Miami, FL<br />
J. Thomas Heywood, MD<br />
La Jolla, CA<br />
Katherine J. Hoercher, RN<br />
Cleveland, OH<br />
Tamara B. Horwich, MD<br />
Los Angeles, CA<br />
Steven R. Houser, PhD<br />
Philadelphia, PA<br />
Sharon A. Hunt, MD<br />
Stanford, CA<br />
Mariell L. Jessup, MD<br />
Philadelphia, PA<br />
Corrine Y. Jurgens, RN, PhD<br />
Stony Brook, NY<br />
Michelle M. Kittleson, MD, PhD<br />
Beverly Hills, CA<br />
David E. Lanfear, MD<br />
Detroit, MI<br />
Terry A. Lennie, RN, PhD<br />
Lexington, KY<br />
Ronglih Liao, PhD<br />
Boston, MA<br />
JoAnn Lindenfeld, MD<br />
Denver, CO<br />
Kenneth B. Margulies, MD<br />
Philadelphia, PA<br />
Paul J. Mather, MD<br />
Philadelphia, PA<br />
Dennis M. McNamara, MD<br />
Pittsburgh, PA<br />
Alan B. Miller, MD<br />
Jacksonville, FL<br />
Leslie W. Miller, MD<br />
Tampa, FL<br />
Judith E. Mitchell, MD<br />
New York, NY<br />
Mark A. Munger, PharmD<br />
Salt Lake City, UT<br />
Myung H. Park, MD<br />
Baltimore, MD<br />
Soon J. Park, MD<br />
Rochester, MN<br />
Parag C. Patel, MD<br />
Dallas, TX<br />
J. Herbert Patterson, PharmD<br />
Chapel Hill, NC<br />
Peipei Ping, PhD<br />
Los Angeles, CA<br />
Margaret M. Redfield, MD<br />
Rochester, MN<br />
Barbara J. Riegel, RN, DNSc<br />
Philadelphia, PA<br />
Stuart D. Russell, MD<br />
Baltimore, MD<br />
Hani N. Sabbah, PhD<br />
Detroit, MI<br />
Leslie A. Saxon, MD<br />
Los Angeles, CA<br />
Douglas D. Schocken, MD<br />
Durham, NC<br />
Marc A. Silver, MD<br />
Oak Lawn, IL<br />
John A. Spertus, MD, MPH<br />
Kansas City, MO<br />
Francis G. Spinale, MD<br />
Charleston, SC<br />
William G. Stevenson, MD<br />
Boston, MA<br />
Mark A. Sussman, PhD<br />
San Diego, CA<br />
W.H. Wilson Tang, MD<br />
Cleveland, OH<br />
Patricia A. Uber, PharmD<br />
Baltimore, MD<br />
Mary N. Walsh, MD<br />
Indianapolis, IN<br />
Yibin Wang, PhD<br />
Los Angeles, CA<br />
David J. Whellan, MD<br />
Philadelphia, PA<br />
Suzanne J. Wingate, RN, PhD<br />
Gaithersburg, MD<br />
Matthew J. Wolf, MD, PhD<br />
Durham, NC<br />
Michael R. Zile, MD<br />
Charleston, SC<br />
12 13
2011 HFSA Faculty<br />
<strong>15th</strong> <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
Keith D. Aaronson, MD, MS<br />
University <strong>of</strong> Michigan<br />
Ann Arbor, MI<br />
Maha Abdellatif, PhD, MBC<br />
UMDNJ<br />
Newark, NJ<br />
William T. Abraham, MD<br />
The Ohio State University<br />
Columbus, OH<br />
Kirkwood F. Adams, Jr., MD<br />
University <strong>of</strong> North Carolina<br />
Chapel Hill, NC<br />
Sana M. Al-Khatib, MD<br />
Duke University<br />
Durham, NC<br />
Nancy M. Albert, RN, PhD<br />
Cleveland Clinic Foundation<br />
Cleveland, OH<br />
Larry A. Allen, MD, MHS<br />
University <strong>of</strong> Colorado<br />
Denver, CO<br />
Susan E. Ammon, RN, MS, FNP<br />
San Francisco VAMC<br />
San Francisco, CA<br />
Inder S. Anand, MD, PhD<br />
Minneapolis VAMC<br />
Minneapolis, MN<br />
Mark E. Anderson, MD, PhD<br />
University <strong>of</strong> Iowa<br />
Iowa City, IA<br />
Stefan D. Anker, MD, PhD<br />
Charité Hospital<br />
Berlin, Germany<br />
Piero Anversa, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
J. Malcolm O. Arnold, MD<br />
University Hospital<br />
London, ON, Canada<br />
Denise D. Barnard, MD<br />
University <strong>of</strong> California,<br />
San Diego<br />
San Diego, CA<br />
Bradley A. Bart, MD<br />
Hennepin County Medical Center<br />
Minneapolis, MN<br />
Donald M. Bers, PhD<br />
University <strong>of</strong> California, Davis<br />
Davis, CA<br />
Emma J. Birks, MD, PhD<br />
University <strong>of</strong> Louisville<br />
Louisville, KY<br />
Burns C. Blaxall, PhD<br />
University <strong>of</strong> Rochester<br />
Rochester, NY<br />
John P. Boehmer, MD<br />
Penn State University<br />
Hershey, PA<br />
Roberto Bolli, MD<br />
University <strong>of</strong> Louisville<br />
Louisville, KY<br />
Barry A. Borlaug, MD<br />
Mayo Clinic & Foundation<br />
Rochester, MN<br />
Eugene Braunwald, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Michael R. Bristow, MD, PhD<br />
University <strong>of</strong> Colorado<br />
Denver, CO<br />
Harleah G. Buck, RN, PhD, CHPN<br />
The Pennsylvania State University<br />
University Park, PA<br />
John C. Burnett, Jr., MD<br />
Mayo Clinic & Foundation<br />
Rochester, MN<br />
Javed Butler, MD, MPH<br />
Emory University<br />
Atlanta, GA<br />
Alfred E. Buxton, MD<br />
Beth Israel Deaconess<br />
Medical Center<br />
Boston, MA<br />
Peter E. Carson, MD<br />
Washington VAMC<br />
Washington, DC<br />
Horng H. Chen, MB, BCh<br />
Mayo Clinic & Foundation<br />
Rochester, MN<br />
John Chin, MD<br />
Sutter Memorial Hospital<br />
Sacramento, CA<br />
Deepak Chopra, MD<br />
The Chopra Center for Wellbeing<br />
Carlsbad, CA<br />
Jay N. Cohn, MD<br />
University <strong>of</strong> Minnesota<br />
Minneapolis, MN<br />
Henry M. Colecraft, PhD<br />
Columbia University<br />
New York, NY<br />
Wilson S. Colucci, MD<br />
Boston Medical Center<br />
Boston, MA<br />
Gianluigi Condorelli, MD, PhD<br />
National Research Council<br />
Rome, Italy<br />
Maria Rosa Costanzo, MD<br />
Midwest <strong>Heart</strong> Specialists<br />
Naperville, IL<br />
Catherine E. Costello, PhD<br />
Boston University<br />
Boston, MA<br />
Jennifer Cowger, MD<br />
University <strong>of</strong> Michigan<br />
Ann Arbor, MI<br />
Laura A. Coyle, RN, MSN, NP<br />
Advocate Christ Medical Center<br />
Oak Lawn, IL<br />
James P. Daubert, MD<br />
Duke University<br />
Durham, NC<br />
Teresa De Marco, MD<br />
University <strong>of</strong> California,<br />
San Francisco<br />
San Francisco, CA<br />
Prakash C. Deedwania, MD<br />
VA Central California<br />
Health Care System<br />
Fresno, CA<br />
Frederica del Monte, MD, PhD<br />
Beth Israel Deaconess<br />
Medical Center<br />
Boston, MA<br />
David DeN<strong>of</strong>rio, MD<br />
Tufts Medical Center<br />
Boston, MA<br />
Akshay M. Desai, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
14 15<br />
Victoria V. Dickson, PhD, CRNP<br />
New York University<br />
New York, NY<br />
Lynn V. Doering, RN, DNSc<br />
UCLA<br />
Los Angeles, CA<br />
Gerald W. Dorn, II, MD<br />
Washington University<br />
St. Louis, MO<br />
Mark H. Drazner, MD<br />
University <strong>of</strong> Texas Southwestern<br />
Dallas, TX<br />
Samuel C. Dudley, MD, PhD<br />
University <strong>of</strong> Illinois<br />
Chicago, IL<br />
Jean-Bernard Durand, MD<br />
University <strong>of</strong> Texas<br />
Houston, TX<br />
Kenneth A. Ellenbogen, MD<br />
Virginia Commonwealth<br />
University<br />
Richmond, VA<br />
Tonya Elliott, RN, MSN<br />
Inova Fairfax Hospital<br />
Falls Church, VA<br />
Andrew E. Epstein, MD<br />
University <strong>of</strong> Pennsylvania<br />
Philadelphia, PA<br />
Jonathan A. Epstein, MD<br />
University <strong>of</strong> Pennsylvania<br />
Philadelphia, PA<br />
Justin A. Ezekowitz, MB, BCh<br />
University <strong>of</strong> Alberta<br />
Edmonton, AB, Canada<br />
Michael D. Ezekowitz, MB, PhD<br />
Lankenau Institute for<br />
Medical Research<br />
Wynnewood, PA<br />
James C. Fang, MD<br />
Case Western University<br />
Cleveland, OH<br />
Arthur M. Feldman, MD, PhD<br />
Temple University<br />
Philadelphia, PA<br />
G. Michael Felker, MD<br />
Duke University<br />
Durham, NC<br />
Carol Flavell, NP, APRN<br />
Brigham and Women’s Hospital<br />
Boston, MA
John S. Floras, MD, PhD<br />
Mount Sinai Hospital<br />
Toronto, ON, Canada<br />
Joshua I. Goldhaber, MD<br />
Cedars-Sinai <strong>Heart</strong> Institute<br />
Los Angeles, CA<br />
Ray E. Hershberger, MD<br />
University <strong>of</strong> Miami<br />
Miami, FL<br />
Corrine Y. Jurgens, RN, PhD<br />
Stony Brook University<br />
Stony Brook, NY<br />
Gregg C. Fonarow, MD<br />
UCLA<br />
Los Angeles, CA<br />
Samuel Z. Goldhaber, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
J. Thomas Heywood, MD<br />
Scripps Clinic<br />
La Jolla, CA<br />
Jan Kajstura, PhD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Thomas Force, MD<br />
Thomas Jefferson University<br />
Philadelphia, PA<br />
Steven Goldman, MD<br />
VA Medical Center<br />
Tucson, AZ<br />
Joseph A. Hill, MD, PhD<br />
University <strong>of</strong> Texas Southwestern<br />
Dallas, TX<br />
Stuart D. Katz, MD<br />
New York University<br />
New York, NY<br />
Paul R. Forfia, MD<br />
University <strong>of</strong> Pennsylvania<br />
Philadelphia, PA<br />
Steven R. Goldsmith, MD<br />
University <strong>of</strong> Minnesota<br />
Minneapolis, MN<br />
Carolyn Yung Ho, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
James N. Kirkpatrick, MD<br />
University <strong>of</strong> Pennsylvania<br />
Philadelphia, PA<br />
Majid Fotuhi, MD, PhD<br />
Neurology Institute for Brain<br />
Health and Fitness<br />
Lutherville, MD<br />
Michael B. Fowler, MD<br />
Stanford University<br />
Stanford, CA<br />
Gary S. Francis, MD<br />
University <strong>of</strong> Minnesota<br />
Minneapolis, MN<br />
Robert P. Frantz, MD<br />
Mayo Clinic & Foundation<br />
Rochester, MN<br />
Hasan Garan, MD<br />
Columbia University<br />
New York, NY<br />
Carrie A. Geisberg, MD<br />
Vanderbilt University<br />
Nashville, TN<br />
Robert E. Gerszten, MD<br />
Massachusetts General Hospital<br />
Charlestown, MA<br />
Jalal K. Ghali, MD<br />
Harper University Hospital<br />
Detroit, MI<br />
Mihai Gheorghiade, MD<br />
Northwestern University<br />
Chicago, IL<br />
Michele N. Gilbert, RN, MSN<br />
Charity Health Care System<br />
Oakland, NJ<br />
Michael M. Givertz, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Lee R. Goldberg, MD, MPH<br />
University <strong>of</strong> Pennsylvania<br />
Philadelphia, PA<br />
Nathan E. Goldstein, MD<br />
Mount Sinai<br />
New York, NY<br />
John Gorcsan, III, MD<br />
University <strong>of</strong> Pittsburgh<br />
Pittsburgh, PA<br />
Stephen S. Gottlieb, MD<br />
University <strong>of</strong> Maryland<br />
Baltimore, MD<br />
Kathleen L. Grady, RN, PhD, APN<br />
Northwestern University<br />
Chicago, IL<br />
Barry H. Greenberg, MD<br />
University <strong>of</strong> California,<br />
San Diego<br />
San Diego, CA<br />
Jeffrey L. Greenwald, MD<br />
Massachusetts General Hospital<br />
Boston, MA<br />
Roger J. Hajjar, MD<br />
Mount Sinai School <strong>of</strong> Medicine<br />
New York, NY<br />
Michele A. Hamilton, MD<br />
Cedars-Sinai Medical Center<br />
Los Angeles, CA<br />
Joshua M. Hare, MD<br />
University <strong>of</strong> Miami<br />
Miami, FL<br />
Paul J. Hauptman, MD<br />
St. Louis University<br />
St. Louis, MO<br />
Paul A. Heidenreich, MD, MS<br />
VA/Stanford University<br />
Palo Alto, CA<br />
Adrian F. Hernandez, MD<br />
Duke University<br />
Durham, NC<br />
Steven R. Houser, PhD<br />
Temple University<br />
Philadelphia, PA<br />
Jonathan G. Howlett, MD<br />
University <strong>of</strong> Calgary<br />
Calgary, AB, Canada<br />
Sharon A. Hunt, MD<br />
Stanford University<br />
Stanford, CA<br />
Claire Hunter, MD<br />
Creighton University<br />
Omaha, NE<br />
Dennis Irwin, MD<br />
OptumHealth Care Solutions<br />
Minneapolis, MN<br />
Brian Jack, MD<br />
Boston University<br />
Boston, MA<br />
James L. Januzzi, Jr., MD<br />
Massachusetts General Hospital<br />
Boston, MA<br />
Shahrokh Javaheri, MD<br />
Sleepcare Diagnostics<br />
Mason, OH<br />
Mariell L. Jessup, MD<br />
University <strong>of</strong> Pennsylvania<br />
Philadelphia, PA<br />
Roy M. John, PhD, MB<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Jacob Joseph, MD<br />
VA Boston Health Care System<br />
West Roxbury, MA<br />
Karen E. Joynt, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Raj Kishore, PhD<br />
Northwestern University<br />
Chicago, IL<br />
Michelle M. Kittleson, MD, PhD<br />
Cedars-Sinai <strong>Heart</strong> Institute<br />
Los Angeles, CA<br />
Jon A. Kobashigawa, MD<br />
Cedars-Sinai <strong>Heart</strong> Institute<br />
Los Angeles, CA<br />
Walter J. Koch, PhD<br />
Thomas Jefferson University<br />
Philadelphia, PA<br />
Todd M. Koelling, MD<br />
University <strong>of</strong> Michigan<br />
Ann Arbor, MI<br />
Alan T. Kono, MD<br />
Dartmouth University<br />
Lebanon, NH<br />
Marvin A. Konstam, MD<br />
Tufts Medical Center<br />
Boston, MA<br />
Bruce A. Koplan, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Robert L. Kormos, MD<br />
University <strong>of</strong> Pittsburgh<br />
Pittsburgh, PA<br />
Peter R. Kowey, MD<br />
Lankenau Medical Center<br />
Wynnewood, PA<br />
Evangelia G. Kranias, PhD<br />
University <strong>of</strong> Cincinnati<br />
Cincinnati, OH<br />
Raymond Y. Kwong, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
16 17
Bonnie Ky, MD, MSCE<br />
University <strong>of</strong> Pennsylvania<br />
Philadelphia, PA<br />
Edward G. Lakatta, MD<br />
National Institutes <strong>of</strong> Health<br />
Baltimore, MD<br />
Neal Lakdawala, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Michael J. Landzberg, MD<br />
Children’s Hospital<br />
Boston, MA<br />
David E. Lanfear, MD<br />
Henry Ford Health System<br />
Detroit, MI<br />
Carl V. Leier, MD<br />
The Ohio State University<br />
Columbus, OH<br />
Daniel J. Lenihan, MD<br />
Vanderbilt University<br />
Nashville, TN<br />
Terry A. Lennie, RN, MS, PhD<br />
University <strong>of</strong> Kentucky<br />
Lexington, KY<br />
Annarosa Leri, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Bruce B. Lerman, MD<br />
Cornell University<br />
New York, NY<br />
Eldrin F. Lewis, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Gregory D. Lewis, MD<br />
Massachusetts General Hospital<br />
Boston, MA<br />
Ronglih Liao, PhD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Peter Libby, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Katherine Lietz, MD, PhD<br />
Loyola University<br />
Maywood, IL<br />
JoAnn Lindenfeld, MD<br />
University <strong>of</strong> Colorado<br />
Denver, CO<br />
Mark S. Link, MD<br />
Tufts Medical Center<br />
Boston, MA<br />
William C. Little, MD<br />
Wake Forest University<br />
Winston-Salem, NC<br />
Peter P. Liu, MD<br />
University <strong>of</strong> Toronto<br />
Toronto, ON, Canada<br />
Barry London, MD, PhD<br />
University <strong>of</strong> Pittsburgh<br />
Pittsburgh, PA<br />
Joseph Loscalzo, MD, PhD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Douglas W. Losordo, MD<br />
Northwestern University<br />
Chicago, IL<br />
Donna M. Mancini, MD<br />
Columbia University<br />
New York, NY<br />
Brian F. Mandell, MD, PhD<br />
Cleveland Clinic Foundation<br />
Cleveland, OH<br />
Douglas L. Mann, MD<br />
Washington University<br />
St. Louis, MO<br />
Kenneth B. Margulies, MD<br />
University <strong>of</strong> Pennsylvania<br />
Philadelphia, PA<br />
Ali J. Marian, MD<br />
University <strong>of</strong> Texas<br />
Houston, TX<br />
Tony Martin, RN, APRN<br />
Morris Plains, NJ<br />
Frederick A. Masoudi, MD, MSPH<br />
University <strong>of</strong> Colorado<br />
Denver, CO<br />
M. Patricia Massicotte, MD, MHSc<br />
University <strong>of</strong> Alberta<br />
Edmonton, AB, Canada<br />
Barry M. Massie, MD<br />
University <strong>of</strong> California,<br />
San Francisco<br />
San Francisco, CA<br />
Paul J. Mather, MD<br />
Thomas Jefferson University<br />
Philadelphia, PA<br />
Simon Maybaum, MD<br />
Albert Einstein College<br />
New York, NY<br />
Michael A. Mathier, MD<br />
University <strong>of</strong> Pittsburgh<br />
Pittsburgh, PA<br />
Kathleen M. McCauley, RN, PhD<br />
University <strong>of</strong> Pennsylvania<br />
Pennsylvania, PA<br />
Elizabeth M. McNally, MD, PhD<br />
University <strong>of</strong> Chicago<br />
Chicago, IL<br />
Dennis M. McNamara, MD<br />
University <strong>of</strong> Pittsburgh<br />
Pittsburgh, PA<br />
Mandeep R. Mehra, MD<br />
University <strong>of</strong> Maryland<br />
Baltimore, MD<br />
Gregory F. Michaud, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Melissa A. Mikelson, RN, BSN<br />
Marshfield Clinic<br />
Marshfield, WI<br />
Leslie W. Miller, MD<br />
University <strong>of</strong> South Florida<br />
Tampa, FL<br />
Frank Misselwitz, MD, PhD<br />
Bayer Schering Pharma AG<br />
Wuppertal, Germany<br />
Daria Mochly-Rosen, PhD<br />
Stanford University<br />
Stanford, CA<br />
Nicanor Ilie Moldovan, PhD<br />
The Ohio State University<br />
Columbus, OH<br />
Jeffery D. Molkentin, PhD<br />
Cincinnati Children’s<br />
Hospital Medical Center<br />
Cincinnati, OH<br />
Stephanie A. Moore, MD<br />
Massachusetts General Hospital<br />
Boston, MA<br />
Rohinton J. Morris, MD<br />
Abington Memorial Hospital<br />
Abington, PA<br />
Matthew A. Movsesian, MD<br />
VA Healthcare System<br />
Salt Lake City, UT<br />
Debra K. Moser, RN, DNSc<br />
University <strong>of</strong> Kentucky<br />
Lexington, KY<br />
Mark A. Munger, PharmD<br />
University <strong>of</strong> Utah<br />
Salt Lake City, UT<br />
Anju Nohria, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Thomas E. Noonan, MD<br />
CV Institute <strong>of</strong> New England<br />
Pawtucket, RI<br />
John B. O’Connell, MD<br />
St. Joseph’s Hospital<br />
Atlanta, GA<br />
Christopher M. O’Connor, MD<br />
Duke University<br />
Durham, NC<br />
Milton Packer, MD<br />
University <strong>of</strong> Texas Southwestern<br />
Dallas, TX<br />
Robert Lee Page, PharmD, MSPH<br />
University <strong>of</strong> Colorado<br />
Denver, CO<br />
Peter S. Pang, MD<br />
Northwestern University<br />
Chicago, IL<br />
Myung H. Park, MD<br />
University <strong>of</strong> Maryland<br />
Baltimore, MD<br />
Ayan R. Patel, MD<br />
Tufts Medical Center<br />
Boston, MA<br />
J. Herbert Patterson, PharmD<br />
University <strong>of</strong> North Carolina<br />
Chapel Hill, NC<br />
Sara C. Paul, RN, MSN, DNP<br />
Western Piedmont <strong>Heart</strong> Centers<br />
Hickory, NC<br />
Michael G. Petty, CCNS, ACNS<br />
University <strong>of</strong> Minnesota<br />
Minneapolis, MN<br />
Marc A. Pfeffer, MD, PhD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Mariann R. Piano, RN, PhD<br />
University <strong>of</strong> Illinois<br />
Chicago, IL<br />
18 19
Ileana L. Piña, MD<br />
Albert Einstein College<br />
Bronx, NY<br />
Peipei Ping, PhD<br />
UCLA<br />
Los Angeles, CA<br />
Piotr Ponikowski, MD, PhD<br />
Medical University<br />
Wroclaw, Poland<br />
Susan J. Pressler, RN, PhD<br />
University <strong>of</strong> Michigan<br />
Ann Arbor, MI<br />
Martha J. Radford, MA, MD<br />
New York University<br />
New York, NY<br />
Kismet D. Rasmusson, RN, FNP<br />
Intermountain Medical Center<br />
Murray, UT<br />
Lisa D. Rathman, MSN, CRNP<br />
Lancaster General Hospital<br />
Lancaster, PA<br />
Margaret M. Redfield, MD<br />
Mayo Clinic & Foundation<br />
Rochester, MN<br />
Juanita Reigle, RN, MSN, ACNP<br />
University <strong>of</strong> Virginia<br />
Charlottesville, VA<br />
Michael W. Rich, MD<br />
Washington University<br />
St. Louis, MO<br />
Barbara J. Riegel, RN, DNSc<br />
University <strong>of</strong> Pennsylvania<br />
Philadelphia, PA<br />
Richard J. Rodeheffer, MD<br />
Mayo Clinic & Foundation<br />
Rochester, MN<br />
Joseph G. Rogers, MD<br />
Duke University<br />
Durham, NC<br />
Heather J. Ross, MD<br />
The Toronto Hospital<br />
Toronto, ON, Canada<br />
Stuart D. Russell, MD<br />
Johns Hopkins University<br />
Baltimore, MD<br />
Hani N. Sabbah, PhD<br />
Henry Ford Health System<br />
Detroit, MI<br />
20<br />
Junichi Sadoshima, PhD, MD<br />
UMDNJ<br />
Newark, NJ<br />
Jeffrey E. Saffitz, MD, PhD<br />
Beth Israel Deaconess<br />
Medical Center<br />
Boston, MA<br />
Flora Sam, MD<br />
Boston University<br />
Boston, MA<br />
Martin A. Samuels, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Douglas B. Sawyer, MD, PhD<br />
Vanderbilt University<br />
Nashville, TN<br />
Kristen G. Schaefer, MD<br />
Dana-Farber Cancer Institute<br />
Boston, MA<br />
Douglas D. Schocken, MD<br />
Duke University<br />
Durham, NC<br />
Gerilynn M. Schott, MSN, CRNP<br />
University <strong>of</strong> Pennsylvania<br />
Philadelphia, PA<br />
Christine E. Seidman, MD<br />
Harvard University<br />
Boston, MA<br />
Marc J. Semigran, MD<br />
Massachusetts General Hospital<br />
Boston, MA<br />
Monica R. Shah, MD<br />
National <strong>Heart</strong>, Lung and<br />
Blood Institute<br />
Bethesda, MD<br />
Ravi V. Shah, MD<br />
Massachusetts General Hospital<br />
Boston, MA<br />
Julie B. Shea, RNCS, MS, CCDS<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Julie A. Shinn, RN, MA, CCRN<br />
Stanford University<br />
Stanford, CA<br />
Marc A. Silver, MD<br />
Christ Hospital and Medical Center<br />
Oak Lawn, IL<br />
Robert D. Simari, MD<br />
Mayo Clinic & Foundation<br />
Rochester, MN<br />
Jagmeet P. Singh, MD, PhD<br />
Massachusetts General Hospital<br />
Boston, MA<br />
Mark S. Slaughter, MD<br />
University <strong>of</strong> Louisville<br />
Louisville, KY<br />
Mara T. Slawsky, MD, PhD<br />
Baystate Medical Center<br />
Springfield, MA<br />
Andrew L. Smith, MD<br />
Emory University Hospital<br />
Atlanta, GA<br />
Paul A. Sobotka, MD<br />
Medtronic, Inc.<br />
Minneapolis, MN<br />
Virend K. Somers, MD<br />
Mayo Clinic and Foundation<br />
Rochester, MN<br />
Scott D. Solomon, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Pothur R. Srinivas, PhD, MPH<br />
National Institutes <strong>of</strong> Health<br />
Bethesda, MD<br />
Marshall S. Stanton, MD<br />
Medtronic, Inc.<br />
Mounds View, MN<br />
Randall C. Starling, MD, MPH<br />
Cleveland Clinic Foundation<br />
Cleveland, OH<br />
Josef Stehlik, MD, MPH<br />
University <strong>of</strong> Utah<br />
Salt Lake City, UT<br />
Kenneth M. Stein, MD<br />
Boston <strong>Scientific</strong> Corporation<br />
St. Paul, MN<br />
Lynne Warner Stevenson, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Willliam G. Stevenson, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Garrick C. Stewart, MD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Wendy Gattis Stough, PharmD<br />
Campbell University<br />
Cary, NC<br />
Benjamin Sun, MD<br />
Abbott Northwestern Hospital<br />
Minneapolis, MN<br />
Mark A. Sussman, PhD<br />
San Diego State University<br />
San Diego, CA<br />
Karl Swedberg, MD, PhD<br />
Sahlgrenska University<br />
Gothenburg, Sweden<br />
Nancy K. Sweitzer, MD, PhD<br />
University <strong>of</strong> Wisconsin<br />
Madison, WI<br />
W.H. Wilson Tang, MD<br />
Cleveland Clinic Foundation<br />
Cleveland, OH<br />
David O. Taylor, MD<br />
Cleveland Clinic Foundation<br />
Cleveland, OH<br />
Ryan J. Tedford, MD<br />
Johns Hopkins University<br />
Baltimore, MD<br />
John R. Teerlink, MD<br />
San Francisco VAMC<br />
San Francisco, CA<br />
Andre Terzic, MD, PhD<br />
Mayo Clinic & Foundation<br />
Rochester, MN<br />
Jeffrey M. Testani, MD<br />
University <strong>of</strong> Pennsylvania<br />
Philadelphia, PA<br />
Jeffrey J. Teuteberg, MD<br />
University <strong>of</strong> Pittsburgh<br />
Pittsburgh, PA<br />
Jeffrey A. Towbin, MD<br />
Cincinnati Children’s Hospital<br />
Medical Center<br />
Cincinnati, OH<br />
Patricia A. Uber, PharmD<br />
University <strong>of</strong> Maryland<br />
Baltimore, MD<br />
James E. Udelson, MD<br />
Tufts Medical Center<br />
Boston, MA<br />
Anne Marie Valente, MD<br />
Children’s Hospital<br />
Boston, MA<br />
Eva van Rooij, PhD<br />
miRagen Therapeutics<br />
Boulder, CO<br />
21
Dirk J. van Veldhuisen, MD, PhD<br />
University Medical Centre<br />
Groningen, The Netherlands<br />
Hector O. Ventura, MD<br />
Ochsner Medical Center<br />
New Orleans, LA<br />
Joseph G. Verbalis, MD<br />
Georgetown University<br />
Washington, DC<br />
Mary N. Walsh, MD<br />
St. Vincent <strong>Heart</strong> Center <strong>of</strong> Indiana<br />
Indianapolis, IN<br />
Da-Zhi Wang, PhD<br />
Children’s Hospital<br />
Boston, MA<br />
Yibin Wang, PhD<br />
UCLA<br />
Los Angeles, CA<br />
Aaron B. Waxman, MD, PhD<br />
Brigham and Women’s Hospital<br />
Boston, MA<br />
Xander H.T. Wehrens, MD, PhD<br />
Baylor College<br />
Houston, TX<br />
Andrew R. Weintraub, MD<br />
Tufts Medical Center<br />
Boston, MA<br />
David J. Whellan, MD, MHS<br />
Thomas Jefferson University<br />
Philadelphia, PA<br />
Connie L. White-Willliams, RN, PhD<br />
University <strong>of</strong> Alabama<br />
Birmingham, AL<br />
Ronald M. Witteles, MD<br />
Stanford University<br />
Stanford, CA<br />
Kelly Wolf, MSW, LCSW<br />
Newark Beth Israel Medical Center<br />
Newark, NJ<br />
Matthew J. Wolf, MD, PhD<br />
Duke University<br />
Durham, NC<br />
Clyde W. Yancy, MD, MSc<br />
Northwestern University<br />
Chicago, IL<br />
James B. Young, MD<br />
Cleveland Clinic Foundation<br />
Cleveland, OH<br />
Michael R. Zile, MD<br />
Medical University <strong>of</strong><br />
South Carolina<br />
Charleston, SC<br />
Sunday-September 18, 2011 HFSA <strong>15th</strong> <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong> – September 18-21, 2011 – Boston, MA<br />
Ballroom A Room 302 Room 304 Room 311 Room 312<br />
11:00 AM-1:30 PM <strong>Scientific</strong> Session<br />
Clinical Fundamentals:<br />
<strong>Heart</strong> <strong>Failure</strong> Evaluation<br />
and Medical Therapy<br />
1:00-3:00 PM Satellite Symposium<br />
Evaluating the Right<br />
Ventricle: A Practical<br />
Guide for the <strong>Heart</strong> <strong>Failure</strong><br />
Clinician<br />
3:00-4:00 PM<br />
<strong>Scientific</strong> Session<br />
Excellence in Basic Science<br />
(featured speaker: Christine<br />
E. Seidman, MD)<br />
3:30 - 6:00 PM<br />
<strong>Scientific</strong> Session<br />
<strong>Heart</strong> <strong>Failure</strong> and VADs:<br />
Does Extended Support<br />
Change the Game?<br />
(4:30-6:00 PM)<br />
Satellite Symposium<br />
Novel Strategies to Enhance<br />
Response to the Cardiac<br />
Resynchronization Therapy<br />
Patient: A Clinician Update<br />
4:00-6:00 PM Satellite Symposium<br />
Improving Outcomes in<br />
<strong>Heart</strong> <strong>Failure</strong> Complicated<br />
by Hyponatremia<br />
6:00 PM Opening Reception 15 th <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong> - Poster-Exhibit Area (Exhibit Hall D) Hynes Convention Center<br />
22 23
Monday-September 19, 2011 HFSA <strong>15th</strong> <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong> – September 18-21, 2011 – Boston, MA<br />
Ballroom A Ballroom B Ballroom C Room 302 Room 304<br />
6:30 AM Continental Breakfast available in foyer areas<br />
6:45 AM Satellite Symposium<br />
Addressing the Challenge <strong>of</strong><br />
Central Sleep Apnea in <strong>Heart</strong><br />
<strong>Failure</strong><br />
8:00 AM Welcome/Opening Remarks<br />
2011 HFSA Lifetime Achievement Award<br />
8:15 AM Opening Plenary Session<br />
The Brain Connection<br />
10:00 AM C<strong>of</strong>fee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM)<br />
10:30 AM Symposium<br />
Double Trouble:<br />
Comorbidities and Cases in<br />
<strong>Heart</strong> <strong>Failure</strong><br />
Symposium<br />
Where Is the Route to <strong>Heart</strong><br />
<strong>Failure</strong> Recovery?<br />
Symposium<br />
Pills or Power? Treatment <strong>of</strong><br />
Arrhythmias<br />
Satellite Symposium<br />
Update on <strong>Heart</strong> <strong>Failure</strong><br />
Device Diagnostics:<br />
Challenges and Opportunities<br />
Symposium<br />
MicroRNA in Cardiovascular<br />
Disease<br />
Monday-September 19, 2011 HFSA <strong>15th</strong> <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong> – September 18-21, 2011 – Boston, MA<br />
Ballroom A Ballroom B Ballroom C Room 302 Room 304 Room 306 Room 310 Room 312<br />
NOON Lunch Break – Exhibit Hall opens at 9:30 AM; see page 38 for Monday posters; visit posters until 7:00 PM<br />
12:30-1:30 PM How To Sessions<br />
(4) See page 43<br />
for locations<br />
2:00 PM Symposium<br />
Quality <strong>of</strong> Care<br />
and <strong>Heart</strong> <strong>Failure</strong><br />
Guidelines:<br />
Progress and<br />
Controversies<br />
Symposium<br />
Fluid and Flow<br />
3:30 PM C<strong>of</strong>fee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM)<br />
4:00 PM Late Breaking<br />
News<br />
Nursing<br />
Research Award<br />
Symposium<br />
The Problem<br />
with<br />
Readmission<br />
Jay N. Cohn<br />
New Investigator<br />
Award:<br />
Clinical/<br />
Integrative<br />
Physiology<br />
5:30 PM Wine and Hors d’oeuvres in Poster Area Exhibit Hall (presenters at their posters 5:45-6:45 PM)<br />
7:00 PM Exhibits Close (Exhibit Hall re-opens Tuesday 9:30 AM-7:00 PM)<br />
Symposium<br />
Inhibitors <strong>of</strong><br />
Cardiac Kinases<br />
and Phosphatases<br />
To Treat the<br />
Failing <strong>Heart</strong><br />
Jay N. Cohn<br />
New Investigator<br />
Award:<br />
Basic Science<br />
MOC Session<br />
Advanced<br />
<strong>Heart</strong> <strong>Failure</strong><br />
and Transplant<br />
Cardiology Part I<br />
MOC Session<br />
Advanced<br />
<strong>Heart</strong> <strong>Failure</strong><br />
and Transplant<br />
Cardiology<br />
Part II<br />
Rapid Fire Oral<br />
Abstract Session<br />
Symposium<br />
Are We An<br />
Ocean Apart for<br />
Devices?<br />
24<br />
25
Tuesday-September 20, 2011 HFSA <strong>15th</strong> <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong> – September 18-21, 2011 – Boston, MA<br />
Ballroom A Ballroom C Room 302 Room 304 Room 306<br />
6:45 AM Continental Breakfast available in foyer areas<br />
Roundtable<br />
Centers for VAD/Transplant/<br />
<strong>Heart</strong> <strong>Failure</strong>: All or None?<br />
7:00 AM Clinical Fundamentals<br />
Transplantation/Palliative<br />
Care<br />
Symposium<br />
How Can We Improve Stem<br />
Cells for <strong>Heart</strong> <strong>Failure</strong><br />
Therapy?<br />
Symposium<br />
What Works to Decrease<br />
Readmissions?<br />
Symposium<br />
Before and After Cardiac<br />
Transplantation<br />
Symposium<br />
Time To Slow Down<br />
8:30 AM Symposium<br />
Improving Outcomes after<br />
Hospitalization for <strong>Heart</strong><br />
<strong>Failure</strong>: A Call for Action<br />
26<br />
10:00 AM C<strong>of</strong>fee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM)<br />
Symposium<br />
Genes in the <strong>Heart</strong><br />
Symposium<br />
Mechanisms to Prevent<br />
Sudden Death<br />
Symposium<br />
Take a Deep Breath<br />
10:30 AM Case Discussion Symposium<br />
Implantable Pacing/<br />
Defibrillation Devices<br />
Tuesday-September 20, 2011 HFSA <strong>15th</strong> <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong> – September 18-21, 2011 – Boston, MA<br />
Ballroom A Ballroom B Room 302 Room 304 Room 306 Room 312<br />
NOON Lunch Break – Exhibit Hall opens at 9:30 AM; see page 93 for Tuesday posters; visit posters until 7:00 PM<br />
Rapid Fire Oral<br />
Abstract Session<br />
12:30-1:30 PM How To Sessions (3)<br />
See page 100 for<br />
locations<br />
1:45 PM Announcement <strong>of</strong> Awards<br />
Symposium<br />
Patients Ask About<br />
Stem Cells: Are We<br />
Almost There Yet?<br />
2:00 PM Hyde Park Session Symposium<br />
Through Thick<br />
and Thin: Issues in<br />
Anticoagulation<br />
27<br />
3:30 PM C<strong>of</strong>fee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM)<br />
Symposium<br />
Status with Novel<br />
Proteins and<br />
Metabolic Markers in<br />
Characterizing <strong>Heart</strong><br />
<strong>Failure</strong><br />
Symposium<br />
Oxidative Stress and<br />
Uric Acid<br />
Symposium<br />
Paradox on the Right<br />
4:00 PM Debate Session<br />
How Do You Vote: The Weekly <strong>Meeting</strong>;<br />
Risk Stratification Is an Intervention<br />
5:30 PM Wine and Hors d’oeuvres in poster/exhibit area (presenters at their posters 5:45-6:45 PM)<br />
7:00 PM Exhibits Close
Wednesday-September 21, 2011 HFSA <strong>15th</strong> <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong> – September 18-21, 2011 – Boston, MA<br />
Ballroom A Room 302 Room 304 Room 306 Room 311<br />
7:00 AM Continental Breakfast available in foyer areas Clinical Fundamentals<br />
Atrial and Ventricular<br />
Arrhythmias/Troubleshooting<br />
CRT/ICD/Mechanical<br />
Circulatory Support<br />
8:15 AM HFSA <strong>Annual</strong> Business<br />
<strong>Meeting</strong><br />
Symposium<br />
Cancer Chemotherapy and<br />
Cardiotoxicity<br />
Symposium<br />
The Supported Circulation<br />
Symposium<br />
What to Evaluate After the<br />
Office Visit: To Diagnose,<br />
Predict or Guide?<br />
8:30 AM Guideline Session<br />
Guideline Updates<br />
2011: What’s Current,<br />
Controversial, and Coming<br />
Next<br />
28<br />
10:00 AM C<strong>of</strong>fee Break in meeting foyer areas<br />
Symposium<br />
Hope for <strong>Heart</strong> <strong>Failure</strong> with<br />
Preserved Ejection Fraction<br />
Symposium<br />
Making Decisions with Level<br />
<strong>of</strong> Evidence C<br />
10:30 AM Symposium<br />
How Will Therapy Change<br />
This Year?<br />
12:00 PM <strong>Scientific</strong> <strong>Meeting</strong> adjourned. 16 th <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong>: September 9-12, 2012, Seattle, WA
Welcome to the<br />
<strong>15th</strong> <strong>Annual</strong><br />
<strong>Scientific</strong> <strong>Meeting</strong><br />
September 18 – 21, 2011<br />
Hynes Convention Center<br />
Boston, MA<br />
www.hfsa.org<br />
29
Sept. 18<br />
Sunday<br />
AM<br />
SCIENTIFIC SESSION<br />
Sunday, September 18<br />
11:00 AM-1:30 PM<br />
Room 312<br />
SATELLITE SYMPOSIUM<br />
Sunday, September 18<br />
1:00-3:00 PM<br />
Room 302<br />
Sept. 18<br />
Sunday<br />
PM<br />
sundAY<br />
Clinical Fundamentals: <strong>Heart</strong> <strong>Failure</strong><br />
Evaluation and Medical Therapy<br />
Evaluating the Right Ventricle:<br />
A Practical Guide for the <strong>Heart</strong> <strong>Failure</strong> Clinician<br />
SundAY<br />
Moderators: Larry A. Allen, Denver, CO<br />
Akshay M. Desai, Boston, MA<br />
11:00 Introduction to Clinical Fundamental Curriculum<br />
Akshay M. Desai, Boston, MA<br />
11:05 Baseline Evaluation for Etiology <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong><br />
Todd M. Koelling, Ann Arbor, MI<br />
Chair:<br />
Mandeep R. Mehra, Baltimore, MD<br />
1:00 Welcome and Introduction<br />
Mandeep R. Mehra, Baltimore, MD<br />
1:05 Insights into Right Ventricular <strong>Failure</strong>:<br />
A Distinctive Pathophysiology<br />
Paul R. Forfia, Philadelphia, PA<br />
11:15 Use and Limitation <strong>of</strong> Classification Systems <strong>of</strong> Type/<br />
Stage and NYHA Class<br />
Stuart D. Russell, Baltimore, MD<br />
11:25 Initiation and Titration <strong>of</strong> ACEI/ARB/Aldosterone<br />
Antagonists and Beta Blockers<br />
Jonathan G. Howlett, Calgary, AB, Canada<br />
1:25 Question and Answers (ARS)<br />
1:30 Emerging and Establishing Concepts in PAH<br />
Management: Practical Insights<br />
Robert P. Frantz, Rochester, MN<br />
1:50 Question and Answers (ARS)<br />
11:45 Indications for CRT/ICD<br />
Kenneth A. Ellenbogen, Richmond, VA<br />
12:00 Questions and Answers<br />
Faculty<br />
2:00 Adults with Repaired Congenital <strong>Heart</strong> Defect:<br />
Not Everything is Free and Clear<br />
Michael J. Landzberg, Boston, MA<br />
2:20 Question and Answers (ARS)<br />
12:15 Assessment <strong>of</strong> Hemodynamic Status by Clinical<br />
Assessment and Indications for Right <strong>Heart</strong><br />
Catheterization<br />
Mark H. Drazner, Dallas, TX<br />
12:30 Recognition and Approach to Acute Decompensated<br />
<strong>Heart</strong> <strong>Failure</strong><br />
Mara T. Slawsky, Springfield, MA<br />
12:45 Adjunctive Therapies: Aldosterone Antagonists, Nitrates,<br />
Hydralazine Isosorbide Dinitrate<br />
Jacob Joseph, West Roxbury, MA<br />
12:55 Use <strong>of</strong> Diuretics<br />
Javed Butler, Atlanta, GA<br />
2:30 Taking Stock <strong>of</strong> Right and Left Issues:<br />
The “Politics” <strong>of</strong> the Horse and the Cart<br />
Milton Packer, Dallas, TX<br />
2:50 Question and Answers<br />
Learning Objectives:<br />
1. Describe the unique pathology <strong>of</strong> right ventricle (RV) failure<br />
2. Use appropriate hemodynamic assessment <strong>of</strong> the<br />
identification <strong>of</strong> RV failure<br />
3. Describe effective strategies for managing pulmonary<br />
arterial hypertension (PAH)<br />
4. Evaluate and manage adult patients with repaired congenital<br />
heart defects<br />
5. Effectively assess the differences between right and left<br />
ventricular failure<br />
1:10 Questions and Answers<br />
Faculty<br />
Supported by an educational grant from Actelion<br />
Pharmaceuticals<br />
Learning Objective: Describe methods for evaluating acute and<br />
chronic heart failure and standard drug and device therapy.<br />
This program is part <strong>of</strong> the scientific program<br />
as planned by the HFSA <strong>Scientific</strong> Program<br />
Committee.<br />
This program is not part <strong>of</strong> the scientific program<br />
as planned by the HFSA <strong>Scientific</strong> Program<br />
Committee.<br />
30<br />
31
Sept. 18<br />
Sunday<br />
PM<br />
SCIENTIFIC SESSIoN<br />
Sunday, September 18<br />
3:30-6:00 PM<br />
Room 312<br />
SCIENTIFIC SESSIoN<br />
Sunday, September 18<br />
4:30-6:00 PM<br />
Room 311<br />
Sept. 18<br />
Sunday<br />
PM<br />
sundAY<br />
Excellence in Basic Science<br />
Moderators: Steven R. Houser, Philadelphia, PA<br />
Matthew J. Wolf, Durham, NC<br />
3:30* Genetic Bases <strong>of</strong> Dilated Cardiomyopathy<br />
5th Distinguished Lecture in Basic Science<br />
Christine E. Seidman, Boston, MA<br />
(Award to be presented immediately following lecture)<br />
4:30* Developmental Defects and Adult Cardiac Disease<br />
Jonathan A. Epstein, Philadelphia, PA<br />
<strong>Heart</strong> <strong>Failure</strong> and VADs: Does Extended<br />
Support Change the Game?<br />
Joint Session <strong>of</strong> the HFSA and International Consortium <strong>of</strong><br />
Circulatory Assist Clinicians (ICCAC)<br />
Moderators: Keith D. Aaronson, Ann Arbor, MI<br />
Tony Martin, Morris Plains, NJ<br />
4:30* What Role Should Psychosocial Assessment Play in<br />
Patient Selection?<br />
Kelly Wolf, Newark, NJ<br />
SundAY<br />
5:00* Epigenetics and <strong>Heart</strong> <strong>Failure</strong><br />
Gerald W. Dorn, II, St. Louis, MO<br />
5:30* Molecular Genetics and Pathogenesis <strong>of</strong> Arrhythmogenic<br />
Right Ventricular Cardiomyopathy<br />
Ali J. Marian, Houston, TX<br />
*Includes 5 minute audience discussion<br />
Learning Objective: Discuss the genetic bases <strong>of</strong> dilated<br />
cardiomyopathy and cardiac arrhythmias, the role <strong>of</strong><br />
developmental defects in adult cardiac disease, and the role<br />
<strong>of</strong> epigenetics in the study <strong>of</strong> heart failure.<br />
4:45* Enhancing Collaboration with <strong>Heart</strong> <strong>Failure</strong> Programs:<br />
The Right Time for Referral<br />
Maria Rosa Costanzo, Naperville, IL<br />
5:00* Long-Term Management: Caring for Patients to Keep<br />
Them at Home<br />
Laura A. Coyle, Oak Lawn, IL<br />
5:15* Family Caregivers: Supporting the Support System<br />
Michael G. Petty, Minneapolis, MN<br />
5:30* End <strong>of</strong> Life: When the <strong>Heart</strong> is Taken out <strong>of</strong> the<br />
Equation<br />
James N. Kirkpatrick, Philadelphia, PA<br />
5:45 Panel Discussion<br />
*12 minute presentation, 3 minute audience discussion<br />
Learning Objective: Describe the role <strong>of</strong> extended support<br />
options in the care <strong>of</strong> patients with heart failure and VADs<br />
This program is part <strong>of</strong> the scientific program<br />
as planned by the HFSA <strong>Scientific</strong> Program<br />
Committee.<br />
This program is part <strong>of</strong> the scientific program<br />
as planned by the HFSA <strong>Scientific</strong> Program<br />
Committee.<br />
6:00 Opening Reception<br />
2011 HFSA <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
Exhibit Hall D<br />
6:00 Opening Reception<br />
2011 HFSA <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
Exhibit Hall D<br />
32<br />
33
Sept. 18<br />
Sunday<br />
PM<br />
SATELLITE SYMPOSIUM<br />
Sunday, September 18<br />
4:00-6:00 PM<br />
Ballroom A<br />
SATELLITE SYMPOSIUM<br />
Sunday, September 18<br />
4:00-6:00 PM<br />
Room 304<br />
Sept. 18<br />
Sunday<br />
PM<br />
sundAY<br />
Chair:<br />
Improving Outcomes in <strong>Heart</strong> <strong>Failure</strong><br />
Complicated by Hyponatremia<br />
Marvin A. Konstam, Boston, MA<br />
4:00 Welcome and Introduction<br />
Marvin A. Konstam, Boston, MA<br />
4:05 Hyponatremia in <strong>Heart</strong> <strong>Failure</strong>: Vasopressin Release and<br />
Other Mechanisms<br />
Joseph G.Verbalis, Washington, DC<br />
4:25 Questions and Answers (ARS)<br />
4:30 Is Hyponatremia a Marker or Mediator <strong>of</strong> Worsening<br />
Outcomes in <strong>Heart</strong> <strong>Failure</strong>?<br />
Gregg C. Fonarow, Los Angeles, CA<br />
4:50 Questions and Answers (ARS)<br />
4:55 Insights from the Vasopressin Trials<br />
James E. Udelson, Boston, MA<br />
5:15 Questions and Answers (ARS)<br />
5:20 Clinical Implications: Approaches to Managing Patients<br />
with <strong>Heart</strong> <strong>Failure</strong> and Hyponatremia<br />
Barry H. Greenberg, San Diego, CA<br />
5:40 Questions and Answers (ARS)<br />
Learning Objectives:<br />
1. Review the prevalence, pathophysiology and clinical<br />
implications <strong>of</strong> hyponatremia in patients with heart failure<br />
including the relationship between the kidney and heart in<br />
acute decompensated heart failure (ADHF)<br />
2. Discuss most recent data on the clinical consequences <strong>of</strong><br />
hyponatremia in heart failure<br />
3. Identify the role <strong>of</strong> free water clearance and hyponatremia in<br />
ADHF and the renal consequences <strong>of</strong> neurohormonal activation<br />
4. Discuss the current guidelines and emerging therapeutic<br />
options for the prevention and treatment <strong>of</strong> hyponatremia in<br />
patients with heart failure<br />
Supported by an educational grant from Otsuka <strong>America</strong><br />
Pharmaceuticals, Inc.<br />
Chair:<br />
Novel Strategies to Enhance Response to the<br />
Cardiac Resynchronization Therapy Patient: A<br />
Clinician Update<br />
Jagmeet P. Singh, Boston, MA<br />
4:00 Introduction and Overview<br />
Jagmeet P. Singh, Boston, MA<br />
4:05 Cardiac Resynchronization Therapy:<br />
Evidence and Guidelines<br />
Jagmeet P. Singh, Boston, MA<br />
4:25 Questions and Answers<br />
4:30 Imaging <strong>of</strong> the CRT Patient for Patient Selection and<br />
Follow-up: Can this Improve Response?<br />
John Gorcsan, III, Pittsburgh, PA<br />
4:50 Questions and Answers<br />
4:55 Can We Use Device Diagnostic Information to Optimize<br />
Medical Management in the <strong>Heart</strong> <strong>Failure</strong> Patient?<br />
John P. Boehmer, Hershey, PA<br />
5:15 Questions and Answers<br />
5:20 Multidisciplinary Care for the CRT Patient: Will It<br />
Improve Outcomes?<br />
Mariell L. Jessup, Philadelphia, PA<br />
5:40 Questions and Answers<br />
5:45 Panel Discussion<br />
Learning Objectives:<br />
1. Discuss the criteria for selection <strong>of</strong> HF patients suitable for<br />
cardiac resynchronization therapy (CRT)<br />
2. Recognize the challenges in identifying the CRT nonresponder,<br />
and minimizing non-responses through optimal<br />
lead placement and CRT programming<br />
3. Outline the evolving role <strong>of</strong> aggressive HF management<br />
based on physiologic data, and discuss the impact <strong>of</strong><br />
multidisciplinary clinics<br />
4. Review the most recent clinical data regarding the role <strong>of</strong><br />
biventricular (BiV) pacing in improving patient outcomes<br />
Supported by an educational grant from Medtronic, Inc.<br />
SundAY<br />
This program is not part <strong>of</strong> the scientific program<br />
as planned by the HFSA <strong>Scientific</strong> Program<br />
Committee.<br />
This program is not part <strong>of</strong> the scientific program<br />
as planned by the HFSA <strong>Scientific</strong> Program<br />
Committee.<br />
6:00 Opening Reception<br />
2011 HFSA <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
Exhibit Hall D<br />
6:00 Opening Reception<br />
2011 HFSA <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
Exhibit Hall D<br />
34<br />
35
Sept. 19<br />
Monday<br />
AM<br />
SATELLITE SYMPOSIUM<br />
Monday, September 19<br />
6:45-7:45 AM<br />
Room 302<br />
OPENING PLENARY SESSION<br />
Monday, September 19<br />
8:00-10:00 AM<br />
Ballrooms A-B<br />
Sept. 19<br />
Monday<br />
AM<br />
MondAY<br />
Chair:<br />
Addressing the Challenge <strong>of</strong> Central Sleep Apnea<br />
in <strong>Heart</strong> <strong>Failure</strong><br />
William T. Abraham, Columbus, OH<br />
6:45 Welcome and Overview <strong>of</strong> the Role <strong>of</strong> Sleep Apnea<br />
Disorders in <strong>Heart</strong> <strong>Failure</strong><br />
William T. Abraham, Columbus, OH<br />
6:50 Central Sleep Apnea in <strong>Heart</strong> <strong>Failure</strong>: Mechanisms <strong>of</strong><br />
Disease and Clinical Impact<br />
Virend K. Somers, Rochester, MN<br />
8:00 Welcome and Opening Remarks<br />
Lynne Warner Stevenson, Boston, MA<br />
8:05 2011 HFSA Lifetime Achievement Award:<br />
Kathleen A. Dracup<br />
Presented by Barbara J. Riegel, Philadelphia, PA<br />
The Brain Connection<br />
Moderators: Barry M. Massie, San Francisco, CA<br />
Lynne Warner Stevenson, Boston, MA<br />
MondAY<br />
7:10 Treatment Landscape for <strong>Heart</strong> <strong>Failure</strong> Patients with<br />
Central Sleep Apnea: Current and Evolving Therapies<br />
Shahrokh Javaheri, Mason, OH<br />
7:30 Panel Discussion<br />
Learning Objectives:<br />
1. Describe the mechanisms <strong>of</strong> central sleep apnea (CSA)<br />
and identify it’s clinical impact with patients with heart<br />
failure<br />
2. Discuss current therapeutic options and evolving therapies<br />
for CSA in patients with heart failure<br />
Supported by an educational grant from Respicardia<br />
8:15 Memory: Building and Keeping It<br />
Majid Fotuhi, Baltimore, MD<br />
8:40 “Voodoo” Death Revisited: The Modern Lessons <strong>of</strong><br />
Neurocardiology<br />
Martin A. Samuels, Boston, MA<br />
9:05 Mindfulness and the <strong>Heart</strong>/Brain Connection<br />
Deepak Chopra, Carlsbad, CA<br />
Learning Objective: Describe the role <strong>of</strong> the heart/brain<br />
connection in cardiovascular disease and its implication for<br />
clinical practice.<br />
Monday, September 19<br />
6:45-7:45 AM<br />
Room 304<br />
Update on <strong>Heart</strong> <strong>Failure</strong> Device Diagnostics:<br />
Challenges and Opportunities<br />
Chair:<br />
David J. Whellan, Philadelphia, PA<br />
6:45 <strong>Heart</strong> <strong>Failure</strong> Diagnostics and Management:<br />
Framing the Problem<br />
David J. Whellan, Philadelphia, PA<br />
6:55 What’s New in Technology that Might Improve Patient Care<br />
Philip B. Adamson, Oklahoma City, OK<br />
7:15 Data in your Clinical Practice: Obtaining Data,<br />
Managing Data, and Improving Patient Care<br />
Nancy M. Albert, Cleveland, OH<br />
7:35 Questions and Answers<br />
Supported by an educational grant from CardioMEMS<br />
These programs are not part <strong>of</strong> the scientific<br />
program as planned by the HFSA <strong>Scientific</strong><br />
Program Committee.<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
36<br />
37
Sept. 19<br />
Monday<br />
AM<br />
POSTERS DISPLAYED<br />
Monday, September 19<br />
9:30 AM-7:00 PM<br />
Exhibit Hall C<br />
SYMPOSIUM<br />
Monday, September 19<br />
10:30 AM-NOON<br />
Ballroom A<br />
Sept. 19<br />
Monday<br />
AM<br />
PRESENTERS AT POSTERS 5:45 PM-6:45 PM<br />
Double Trouble: Comorbidities and Cases in<br />
<strong>Heart</strong> <strong>Failure</strong><br />
MondAY<br />
Categories Poster #<br />
Cardiovascular Physiology 016-035<br />
Cardiovascular Structure 056-060<br />
Moderators: Barbara J. Riegel, Philadelphia, PA<br />
Douglas D. Schocken, Durham, NC<br />
10:30 Prevalence <strong>of</strong> Major Comorbidities in <strong>Heart</strong> <strong>Failure</strong> Low<br />
Ejection Fraction and <strong>Heart</strong> <strong>Failure</strong> Preserved Ejection<br />
Fraction<br />
Robert Lee Page, II, Denver, CO<br />
MondAY<br />
Neurohormones/Cytokines 066-082<br />
10:40 What Do Patients Face?<br />
Victoria V. Dickson, New York, NY<br />
Molecular Biology and Genetics 099-106<br />
10:50 Writing Guidelines to Include Comorbidities<br />
JoAnn Lindenfeld, Denver, CO<br />
Surgery, Transplantation, Devices 115-137<br />
11:00 Drug Dosing for <strong>Heart</strong> <strong>Failure</strong> with Comorbidities<br />
Mark A. Munger, Salt Lake City, UT<br />
Electrophysiology/Arrhythmias 162-170<br />
11:10 When Depression Prevents Optimal Medical Therapy<br />
Lynn V. Doering, Los Angeles, CA<br />
Clinical Trials 179-187<br />
Cardiovascular Pharmacology 198-205<br />
Epidemiology, Prevention 214-220<br />
Outcomes 228-254<br />
Clinical Care/Management Strategies 282-318<br />
11:20 Case Management Problems Around Comorbidity<br />
Lee R. Goldberg, Philadelphia, PA<br />
Claire Hunter, Omaha, NE<br />
Mark A. Munger, Salt Lake City, UT<br />
Sara C. Paul, Hickory, NC<br />
11:50 Questions and Answers<br />
Faculty<br />
Learning Objective: Describe strategies for treating<br />
comorbidities in patients with heart failure.<br />
Listing for Monday posters begins on page 58<br />
Listing for Tuesday posters begins on page 110<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
38<br />
39
Sept. 19<br />
Monday<br />
AM<br />
SYMPOSIUM<br />
Monday, September 19<br />
10:30 AM-NOON<br />
Ballroom C<br />
SYMPOSIUM<br />
Monday, September 19<br />
10:30 AM-NOON<br />
Room 302<br />
Sept. 19<br />
Monday<br />
AM<br />
Where Is the Route to <strong>Heart</strong> <strong>Failure</strong> Recovery?<br />
Pills or Power? Treatment <strong>of</strong> Arrhythmias<br />
Moderators: Douglas L. Mann, St. Louis, MO<br />
Hani N. Sabbah, Detroit, MI<br />
Moderators: Alfred E. Buxton, Boston, MA<br />
Barry London, Pittsburgh, PA<br />
MondAY<br />
10:30* Is There a “Right” Stem Cell To Repair the<br />
Failing <strong>Heart</strong>?<br />
Mark A. Sussman, San Diego, CA<br />
10:48* Gene Therapy for the Failing <strong>Heart</strong><br />
Roger J. Hajjar, New York, NY<br />
10:30 Arrhythmias in <strong>Heart</strong> <strong>Failure</strong> Low Ejection Fraction<br />
vs. Preserved Ejection Fraction<br />
Alfred E. Buxton, Boston, MA<br />
10:45 Ablation vs. Drug Suppression <strong>of</strong> Atrial Fibrillation<br />
Gregory F. Michaud, Boston, MA<br />
MondAY<br />
11:06* How Can We Recognize Recovery?<br />
Scott D. Solomon, Boston, MA<br />
11:24* Ventricular Assist Devices to Support Recovery<br />
Emma J. Birks, Louisville, KY<br />
11:42* Inducing Stem Cells to the Cardiovascular Lineage with<br />
Biomaterials<br />
Nicanor I. Moldovan, Columbus, OH<br />
*15 minute presentation, 3 minute audience discussion<br />
Learning Objective: Describe emerging methods for<br />
promoting heart failure recovery.<br />
11:00 AV Node Ablation for Atrial Fibrillation:<br />
When and How to Pace<br />
James P. Daubert, Durham, NC<br />
11:15 Panel Discussion<br />
Alfred E. Buxton, Boston, MA<br />
Gregory F. Michaud, Boston, MA<br />
James P. Daubert, Durham, NC<br />
11:30* Current State <strong>of</strong> Drugs vs. Ablation for<br />
Ventricular Tachycardia<br />
William G. Stevenson, Boston, MA<br />
11:45* Ventricular Arrhythmias Before and After<br />
Ventricular Assist Devices<br />
Hasan Garan, New York, NY<br />
*12 minute presentation, 3 minute audience discussion<br />
Learning Objective: Assess options for the treatment <strong>of</strong><br />
arrhythmias in patients with heart failure.<br />
40<br />
41
Sept. 19<br />
Monday<br />
AM<br />
MondAY<br />
SYMPOSIUM<br />
Monday, September 19<br />
10:30 AM-NOON<br />
Room 304<br />
MicroRNA in Cardiovascular Disease<br />
Moderators: Steven Goldman, Tuscon, AZ<br />
Jeffery D. Molkentin, Cincinnati, OH<br />
10:30* MicroRNA and <strong>Heart</strong> <strong>Failure</strong> Diagnosis<br />
Joseph A. Hill, Dallas, TX<br />
10:48* MicroRNA and Cardioprotection<br />
Maha Abdellatif, Newark, NJ<br />
11:06* MicroRNA and Pathological Cardiac Hypertrophy<br />
Gianluigi Condorelli, Rome, Italy<br />
11:24* MicroRNA and Congenital <strong>Heart</strong> Disease<br />
Da-Zhi Wang, Boston, MA<br />
11:42* MicroRNA as Therapeutic Targets in Ischemic<br />
<strong>Heart</strong> Disease<br />
Eva van Rooij, Boulder, CO<br />
*15 minute presentation, 2-3 minute audience discussion<br />
Learning Objective: Describe the role <strong>of</strong> microRNA in<br />
cardiovascular disease and its implications for heart failure<br />
therapy.<br />
HOW TO SESSIONS<br />
Monday, September 19<br />
12:30-1:30 PM<br />
Location<br />
1. Tools for End-<strong>of</strong>-Life Discussion: Finding the Words, Room 302<br />
Dosing the Drugs<br />
Nathan E. Goldstein, New York, NY<br />
Juanita Reigle, Charlottesville, VA<br />
Kristen G. Schaefer, Boston, MA<br />
Learning Objective: Describe strategies for effective<br />
end-<strong>of</strong>-life discussion with heart failure patients and<br />
their families.<br />
2. Don’t Miss Causes <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong> Room 304<br />
Neal Lakdawala, Boston, MA<br />
Dennis M. McNamara, Pittsburgh, PA<br />
Learning Objective: Identify important, but sometimes<br />
overlooked, causes <strong>of</strong> heart failure.<br />
3. What Reviewers Look for in Your Articles Room 306<br />
Gary S. Francis, Minneapolis, MN<br />
Debra K. Moser, Lexington, KY<br />
James E. Udelson, Boston, MA<br />
Learning Objective: Outline the features <strong>of</strong> successful<br />
journal article submissions.<br />
Sept. 19<br />
Monday<br />
PM<br />
4. Reading the ICD Print Out Room 311<br />
Bruce A. Koplan, Boston, MA<br />
Gerilynn M. Schott, Philadelphia, PA<br />
Julie B. Shea, Boston, MA<br />
MondAY<br />
Learning Objective: Describe what to look for in an<br />
ICD print out and what the implications are for treatment.<br />
42<br />
43
Sept. 19<br />
Monday<br />
PM<br />
ORAL ABSTRACT SESSION<br />
Monday, September 19<br />
12:30-1:45 PM<br />
Room 312<br />
ORAL ABSTRACT SESSION<br />
Monday, September 19<br />
12:30-1:45 PM<br />
Room 312<br />
Sept. 19<br />
Monday<br />
PM<br />
Rapid Fire Abstracts<br />
Rapid Fire Abstracts (cont.)<br />
MondAY<br />
Moderators: Carl V. Leier, Columbus, OH<br />
Peter P. Liu, Toronto, ON, Canada<br />
12:30* The Swanz-Ganz Catheter and UNOS IA Patients: 287<br />
The Routine Change Challenge<br />
Jason A. Gluck, Roja Mulamalla, Joseph Radojevic, Justin<br />
Lundbye, Detlef Wencker, Hartford Hospital, Hartford, CT<br />
12:36* Who Wants an LVAD for Ambulatory <strong>Heart</strong> <strong>Failure</strong>? 118<br />
Garrick C. Stewart, Michelle M. Kittleson, Jennifer A.<br />
Cowger, Frances L. Johnson, Chetan B. Patel, Maria M.<br />
Mountis, Parag Patel, Eduardo Rame, Maya E. Guglin,<br />
Jeffrey J. Teuteberg, Lynne W. Stevenson, Brigham and<br />
Women’s Hospital, Boston, MA<br />
12:42* Hemodynamic Predictors <strong>of</strong> Renal Function 122<br />
Following Left Ventricular Assist Device<br />
Implantation<br />
Gabriel T. Sayer, Shiela Sahni, Kimberly Ashley, Rachel<br />
Flynn, Ajith P. Nair, Anelechi C. Anyanwu, Michael J.<br />
Domanski, Sean P. Pinney, Mount Sinai Medical Center,<br />
New York, New York<br />
12:48* A Multimarker Panel lmproves Risk Prediction 066<br />
in Chronic <strong>Heart</strong> <strong>Failure</strong><br />
Bonnie Ky, Benjamin French, James C. Fang, Nancy<br />
K. Sweitzer, Wayne C. Levy, Alan H.B. Wu, Lee R.<br />
Goldberg, Marriel Jessup, Thomas P. Cappola, University<br />
<strong>of</strong> Pennsylvania, Philadelphia, PA<br />
12:54* The Intermountain Risk Score Stratifies Mortality 235<br />
Risk in <strong>Heart</strong> <strong>Failure</strong> Patients Receiving an ICD<br />
Based on Pre-Implant Laboratory Values<br />
Kimberly D. Brunisholz, Benjamin D. Horne, Roberta<br />
James, Kyle D. Balling, Kismet D. Rasmusson, Deborah<br />
Budge, Rami Alharethi, Dylan P. Nelson, Joseph M. Tuinel,<br />
Abdallah G. Kfoury, Intermountain Medical Center, Salt<br />
Lake City, UT<br />
1:00* Development and Prospective Validation <strong>of</strong> 229<br />
Pediatric Heat <strong>Failure</strong> Risk-Prediction Model for<br />
30-Day Mortality in US Children Listed for <strong>Heart</strong><br />
Transplantation<br />
Christopher S. Almond, Kimberlee Guavreau, Charles<br />
E. Canter, Gary E. Piercey, T.P. Singh, Children’s<br />
Hospital, Boston, MA<br />
(continued next page)<br />
*3 minutes to present, 2 minute discussion<br />
1:06* The Impact <strong>of</strong> Prior <strong>Heart</strong> <strong>Failure</strong> Hospitalization 233<br />
on Long-Term Mortality Differs by Baseline Risk<br />
<strong>of</strong> Death<br />
Scott L. Hummel, Naga V.A. Kommuri, Todd M.<br />
Koelling, Detroit Medical Center, Ann Arbor, MI<br />
1:12* Changes in Galectin-3 Levels Over Time Predict 294<br />
Mortality and Morbidity in Chronic HF<br />
Rudolf A. de Boer, Dirk J. van Veldhuisen, Lars Gullestad,<br />
Thor Ueland, Pal Aukrust, Yu Guo, Aram S. Adourian,<br />
Pieter Muntendam, University Medical Center, Groningen,<br />
Netherlands<br />
1:18* Natriuetic Peptide Receptor 3 Genotype is 198<br />
Associated with Altered Pharmacokinetics During<br />
Nesiritide Infusion<br />
David E. Lanfear, James Yang, Karen Leszczynski, Hani N.<br />
Sabbah, Henry Ford Hospital, Detroit, MI<br />
1:24* Treatment with CBA-NP a Novel Chimeric 068<br />
Natruiretic Peptide Attenuates Cardiorenal Fibrosis<br />
and Improves Diastolic Dysfunction in Diabetic Rat<br />
Model<br />
Syed Ameenuddin, Elise A. Oehler, John C. Burnett, Jr.,<br />
Hong H. Chen, Mayo Clinic, Rochester, MN<br />
1:30* Chronic Cardiac Gene Delivery <strong>of</strong> proBNP in 067<br />
Experimental Progressive Hypertensive <strong>Heart</strong><br />
Disease Improves Survival<br />
Alessandro Cataliotti, Jason M. Tonne, Diego Bellavia,<br />
Fernando L. Martin, Sarah Mangiafico, John C. Burnett,<br />
Yasuhiro Ikeda, Mayo Clinic, Rochester MN<br />
1:36* HF Assessment with BNP in the Home: Primary 289<br />
Results <strong>of</strong> the Multicenter HABIT Trial<br />
Alan S. Maisel, Denise Barnard, Brian Jaski, Geir Frivold,<br />
John Marais, Barry H. Greenberg, San Diego VA Medical<br />
Center, San Diego, CA<br />
*3 minutes to present, 2 minute discussion<br />
Learning Objective: Discuss findings from recent clinical<br />
research in heart failure.<br />
To learn more about these studies, visit their posters during<br />
the poster presentation session in the Exhibit Hall this<br />
afternoon.<br />
MondAY<br />
44<br />
45
Sept. 19<br />
Monday<br />
PM<br />
SYMPOSIUM<br />
Monday, September 19<br />
2:00-3:30 PM<br />
Ballroom A<br />
SYMPOSIUM<br />
Monday, September 19<br />
2:00-3:30 PM<br />
Ballroom C<br />
Sept. 19<br />
Monday<br />
PM<br />
MondAY<br />
Quality <strong>of</strong> Care and <strong>Heart</strong> <strong>Failure</strong> Guidelines:<br />
Progress and Controversies<br />
Moderators: Frederick A. Masoudi, Denver, CO<br />
Michael W. Rich, St. Louis, MO<br />
2:00 Quantitating the Improvement in the Use <strong>of</strong> Guideline<br />
Therapies<br />
Gregg C. Fonarow, Los Angeles, CA<br />
2:15 A for One and A for All? Differences in the Level <strong>of</strong><br />
Evidence Between Subgroups<br />
G. Michael Felker, Durham, NC<br />
2:30 Panel Discussion<br />
2:45 Current Status <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong> Quality <strong>of</strong> Care in the<br />
United States<br />
Martha J. Radford, New York, NY<br />
3:00 If We Pay for Performance, What Will We Get?<br />
Jalal K. Ghali, Detroit, MI<br />
3:15 Panel Discussion<br />
Learning Objective: Describe the role <strong>of</strong> guidelines in the<br />
treatment <strong>of</strong> heart failure.<br />
Fluid and Flow<br />
Moderators: John C. Burnett, Jr., Rochester, MN<br />
Steven R. Goldsmith, Minneapolis, MN<br />
2:00 Hormonal Regulation <strong>of</strong> Fluid Balance<br />
Margaret M. Redfield, Rochester, MN<br />
2:10 Kidney Output: Quality as well as Quantity<br />
James E. Udelson, Boston, MA<br />
2:20 Circulating Markers <strong>of</strong> Renal Function and Injury<br />
James L. Januzzi, Jr., Boston, MA<br />
2:30 Venous Pressure and Renal Function<br />
W.H. Wilson Tang, Cleveland, OH<br />
2:40 Hemoconcentration with Diuretics: Good or Bad?<br />
Jeffrey M. Testani, Philadelphia, PA<br />
2:50 Hemoconcentration With Ultrafiltration: Good or Bad?<br />
Bradley A. Bart, Minneapolis, MN<br />
3:00 Limits for Salt and Fluid Intake<br />
Terry A. Lennie, Lexington, KY<br />
3:10 Discussion: Will Diuresis Be Different Next Year?<br />
Faculty<br />
3:20 Release the Kidney: Effects <strong>of</strong> Denervation<br />
Paul A. Sobotka, Minneapolis, MN<br />
Learning Objective: Describe the role <strong>of</strong> the kidney and<br />
contrast differing strategies for fluid management in the care<br />
<strong>of</strong> patients with heart failure.<br />
MondAY<br />
3:30 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
3:30 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
46<br />
47
Sept. 19<br />
Monday<br />
PM<br />
SYMPOSIUM<br />
Monday, September 19<br />
2:00-3:30 PM<br />
Room 304<br />
SYMPOSIUM<br />
Monday, September 19<br />
2:00-3:30 PM<br />
Room 312<br />
Sept. 19<br />
Monday<br />
PM<br />
The Problem with Readmission<br />
Are We An Ocean Apart for Devices?<br />
MondAY<br />
Moderators: Peter E. Carson, Washington, DC<br />
David DeN<strong>of</strong>rio, Boston, MA<br />
2:00 Can We Really Adjust for Risk?<br />
Larry A. Allen, Denver, CO<br />
2:15 Only Half <strong>of</strong> Readmissions Are for <strong>Heart</strong> <strong>Failure</strong><br />
Prakash C. Deedwania, Fresno, CA<br />
2:30 Under-served Populations at Risk<br />
Karen E. Joynt, Boston, MA<br />
2:45 Readmissions Can Be Decreased by Increasing Length <strong>of</strong><br />
Stay or Death<br />
Adrian F. Hernandez, Durham, NC<br />
3:00 Differences Between the USA and Canada<br />
J. Malcolm O. Arnold, London, ON, Canada<br />
3:15 Panel Discussion<br />
Learning Objective: Discuss issues in measurement <strong>of</strong><br />
readmissions and strategies for reducing readmissions<br />
(Joint Session: HFSA and HFA <strong>of</strong> the ESC)<br />
Moderators: Stefan Anker, Berlin, Germany<br />
Barry M. Massie, San Francisco, CA<br />
Challenge Presenter: Piotr Ponikowski, Wroclaw, Poland<br />
Panel:<br />
Karl Swedberg¸ Gothenburg, Sweden<br />
Dirk J. Van Veldhuisen, Groningen, The Netherlands<br />
David Taylor, Cleveland, OH<br />
Sana M. Al-Khatib, Durham, NC<br />
2:00 Case 1: ICD in 63 yr old Class II pt with LVED 30,<br />
non-ischemic, 5 yr diagnosis, on good therapy.<br />
Does he need a device?<br />
2:22 Case 2: 82 yr old woman living alone at home with QRS<br />
170 LBBB, Class III HF symptoms, EF 26, LV Dimension<br />
7.2, moderate MR, serumcreatinine 1.9.<br />
Should she have CRT or CRD-D?<br />
2:45 Case 3: 73 yr old male, 5 yr history <strong>of</strong> ischemic HF and<br />
diabetic vascular disease, 5 hospitalizations in past yr, last one<br />
complicated by 2 ICD shocks for PMVT with hypokalemia.<br />
Returns to clinic and wants ICD turned <strong>of</strong>f.<br />
What happens now?<br />
3:08 Case 4: 68 yr old with new diagnosis HF w/o obvious<br />
etiology, LVEF 27, LVD 6.2, LBBB QRS 125, presented<br />
with orthopnea resolved on furosemide.<br />
How long to wait before considering a device?<br />
Learning Objective: Discuss the use <strong>of</strong> devices in selected<br />
heart failure patients from the European and North <strong>America</strong>n<br />
perspective.<br />
MondAY<br />
3:30 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
3:30 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
48<br />
49
Sept. 19<br />
Monday<br />
PM<br />
MOC SESSION<br />
Monday, September 19<br />
2:00-3:30 PM<br />
Room 310<br />
SYMPOSIUM<br />
Monday, September 19<br />
2:00-3:30 PM<br />
Room 306<br />
Sept. 19<br />
Monday<br />
PM<br />
MondAY<br />
HFSA Study Session for MOC: Advanced <strong>Heart</strong><br />
<strong>Failure</strong> and Transplant Cardiology Part I<br />
(10 Knowledge Points: Must attend both sessions to earn points)<br />
Moderators: Ileana L. Piña, Bronx, NY<br />
Marc J. Semigran, Boston, MA<br />
HFSA has developed an ABIM-approved Self-Evaluation<br />
<strong>of</strong> Medical Knowledge Module on Advanced <strong>Heart</strong> <strong>Failure</strong><br />
and Transplant Cardiology worth 10 points towards<br />
Maintenance <strong>of</strong> Certification (MOC). This two-part<br />
session will review the 25 questions in that module.<br />
In order to receive MOC points, the module must be<br />
purchased at www.hfsa.org and successfully completed<br />
online. CME credit is also granted upon completion <strong>of</strong> the<br />
module. There is no CME credit for the review sessions.<br />
It is not necessary to be board certified in Advanced <strong>Heart</strong><br />
<strong>Failure</strong> and Transplant Cardiology to complete the module<br />
or attend these sessions.<br />
Although there is no additional registration fee to attend<br />
this session, attendee must be preregistered in order to<br />
enter the session.<br />
Learning Objective: Discuss key questions in the<br />
epidemiology, pathophysiology, and treatment <strong>of</strong> patients<br />
with advanced heart failure.<br />
Inhibitors <strong>of</strong> Cardiac Kinases and Phosphatases<br />
To Treat the Failing <strong>Heart</strong><br />
Moderators: Michael R. Bristow, Denver, CO<br />
Jeffery D. Molkentin, Cincinnati, OH<br />
2:00* Inhibiting Phosphatases in the Failing <strong>Heart</strong><br />
Yibin Wang, Los Angeles, CA<br />
2:18* CamKII Inhibition to Improve Cardiac Function<br />
Mark E. Anderson, Iowa City, IA<br />
2:36* Phosphatase Inhibition to Improve Myocyte Calcium<br />
Handling<br />
Evangelia G. Kranias, Cincinnati, OH<br />
2:54* PKC Inhibition to Protect the <strong>Heart</strong><br />
Daria Mochly-Rosen, Stanford, CA<br />
3:12* GRK2 Is More than a Target: An Emerging Clinical<br />
Biomarker for <strong>Heart</strong> <strong>Failure</strong><br />
Walter J. Koch, Philadelphia, PA<br />
*15 minute presentation, 3 minute audience discussion<br />
Learning Objective: Describe the role <strong>of</strong> inhibitors <strong>of</strong><br />
cardiac kinases and phosphatases in treating the failing<br />
heart.<br />
MondAY<br />
3:30 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
3:30 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
50<br />
51
Sept. 19<br />
Monday<br />
PM<br />
LATE BREAKING NEWS<br />
Monday, September 19<br />
4:00-5:30 PM<br />
Ballroom B<br />
LATE BREAKING NEWS<br />
Monday, September 19<br />
4:00-5:30 PM<br />
Ballroom B<br />
Sept. 19<br />
Monday<br />
PM<br />
Late Breaking News<br />
Late Breaking News (cont.)<br />
Moderators: Eugene Braunwald, Boston, MA<br />
Jay N. Cohn, Minneapolis, MN<br />
5:04* Details for this clinical trial where not available at the time<br />
<strong>of</strong> printing. Information will be provided on-site.<br />
MondAY<br />
4:00* Treatment <strong>of</strong> ADHF with Soluble Guanylate Cyclase<br />
Activator Cinaciguat: The COMPOSE Program: Three<br />
Randomized, Controlled, Phase IIb Studies<br />
Mihai Gheorghiade, Erland Erdmann, Roberto Ferrari,<br />
Gerasimos Filippatos, Philip D. Levy, Aldo Maggioni,<br />
Alexandre Mebazaa, Christina Nowack, Northwestern<br />
University, Chicago, IL<br />
4:10 Commentary:<br />
John C. Burnett, Jr., Rochester, MN<br />
5:14 Commentary<br />
5:19 Audience Questions<br />
*22 minutes allotted: 10 minute presentation, 5 minute<br />
commentary, 7 minute audience questions<br />
Learning Objective: Describe the results <strong>of</strong> recent trials and<br />
discuss their implications for the care <strong>of</strong> patients with heart<br />
failure.<br />
MondAY<br />
4:15 Audience Questions<br />
4:22* Clinical Outcomes at 180 Days in the ASCEND-HF Trial:<br />
Double-Blind, Placebo-Controlled, Multicenter Acute<br />
Study <strong>of</strong> Clinical Effectiveness <strong>of</strong> Nesiritide in Subjects<br />
with Decompensated HF<br />
Randall C. Starling, Adrian F. Hernandez, Christopher M.<br />
O’Connor, Paul W. Armstrong, Kenneth Dickstein, Daniel<br />
Gennivois, Vic Hasselblad, Gretchen M. Heizer, Michel<br />
Komajda, Barry M. Massie, John JV McMurray, Markku<br />
Nieminen, Karl Swedberg, Robert M. Califf, Cleveland Clinic,<br />
Cleveland, OH<br />
4:32 Commentary<br />
William C. Little, Winston-Salem, NC<br />
4:37 Audience Questions<br />
4:42 Surgical Treatment <strong>of</strong> Ischemic HF Trial (STICH)<br />
Daniel Mark, J. David Knight, Eric J. Velazquez, Jaroslaw<br />
Wasilewski, Jonathan G. Howlett, Peter K. Smith, Miroslaw<br />
Rajda, Rakesh Yadav, Baron L. Hamman, Marcin Malinowski,<br />
Ajay Naik, Gena Rankin, Tina M. Harding, Laura A. Drew,<br />
Patrice Desvigne-Nickens, Kevin J. Anstrom for the STICH<br />
Investigators, Duke University, Durham, NC<br />
4:52 Commentary<br />
Paul A. Heidenreich, Stanford, CA<br />
4:57 Audience Questions<br />
(continued next page)<br />
5:30 Poster Session and Reception<br />
Exhibit Halls C and D<br />
Presenters at their Posters 5:45-6:45 PM<br />
Refreshments and Hors d’oeuvres served<br />
5:30 Poster Session and Reception<br />
Exhibit Halls C and D<br />
Presenters at their Posters 5:45-6:45 PM<br />
Refreshments and Hors d’oeuvres served<br />
52<br />
53
Sept. 19<br />
Monday<br />
PM<br />
NURSING INVESTIGATOR AWARD<br />
Monday, September 19<br />
4:00-5:30 PM<br />
Room 302<br />
JNC NEW INVESTIGATOR SESSION<br />
Monday, September 19<br />
4:00-5:30 PM<br />
Room 304<br />
Sept. 19<br />
Monday<br />
PM<br />
MondAY<br />
Nursing Research Award<br />
Moderators: Mariann R. Piano, Chicago, IL<br />
Susan J. Pressler, Ann Arbor, MI<br />
4:00* Regular Monitoring <strong>of</strong> Lower Extremity Edema 011<br />
Predicts Cardiac Event-Free Survival in Patients<br />
with <strong>Heart</strong> <strong>Failure</strong><br />
Kyoung Suk Lee, Terry A. Lennie, Sandra B. Dunbar, Susan<br />
J. Pressler, Seongkum Heo, Debra K. Moser, University <strong>of</strong><br />
Kenntucky, Lexington, KY<br />
4:18* Comfort and Symptom Burden Associated with 012<br />
Health-Related Quality <strong>of</strong> Life in Older Women<br />
with Advanced <strong>Heart</strong> <strong>Failure</strong> and Preserved<br />
Systolic Function<br />
Bonita L. Huiskes, J. Thomas Heywood, Kathleen Dracup,<br />
Azusa Pacific University, Azusa, CA<br />
4:36* “I Just Can’t Do It Anymore”: Patterns <strong>of</strong> Physical 013<br />
Activity and Cardiac Rehabilitation Referral in<br />
African <strong>America</strong>ns with <strong>Heart</strong> <strong>Failure</strong><br />
Margaret M. McCarthy, Alexandra Howe, Judith Schipper,<br />
Jaime Gonzalez, Stuart Katz, Victoria V. Dickson, New<br />
York University, New York, NY<br />
4:54* Is Cognitive Impairment Associated with Medication 014<br />
Adherence in Outpatients with <strong>Heart</strong> <strong>Failure</strong>?<br />
Lee Ann Hawkins, Shirley Kilian, Michael Kashner,<br />
Anthony Firek, Christopher J. Firek, Elena V. Perez, Helme<br />
Silvet, VA Loma Linda Healthcare System, Loma Linda,<br />
CA<br />
5:12* Bio-Feedback Relaxation Intervention Improve 015<br />
<strong>Heart</strong> <strong>Failure</strong> Patients’ Long-Term Disease Outcomes<br />
Tsuey-Yuan Huang, Shiow-Li Hwang, Terry A. Lennie,<br />
Ming-Feng Tsai, Debra K. Moser, Chang Gung Institute <strong>of</strong><br />
Technology, Taoyuan, Taiwan<br />
*10 minute presentation, 8 minute audience discussion<br />
Learning Objective: Discuss results <strong>of</strong> recent nursing<br />
research and its implications for the care <strong>of</strong> patients with<br />
heart failure.<br />
5:30 Poster Session and Reception<br />
Exhibit Halls C and D<br />
Presenters at their Posters 5:45-6:45 PM<br />
Refreshments and Hors d’oeuvres served<br />
54<br />
Jay N. Cohn New Investigator Award:<br />
Clinical/Integrative Physiology<br />
Moderators: Justin A. Ezekowitz, Edmonton, AB, Canada<br />
Marc A. Pfeffer, Boston, MA<br />
4:00* Increase in Left Ventricular Pro-Fibrotic Genes with 006<br />
LVAD Therapy and Potential Anti-Fibrotic Therapeutic<br />
Properties <strong>of</strong> the Novel Designer Natriuretic Peptide<br />
CD-NP in Cultural Human Cardiac Fibroblasts<br />
Tomoko Ichiki, John A. Shirger, Frank C. Brozovich, Brenda<br />
K. Huntley, S. Jeson Sangaralingham, Paul M. McKie, Soon<br />
J. Park, John C. Burnett, Jr., Mayo Clinic, Rochester, MN<br />
4:18* Ventricular Assist Device Implantation Corrects 007<br />
Skeletal Muscle Function, Oxidative Capacity and<br />
Local Expression <strong>of</strong> Insulin-Like Growth Factor-1 in<br />
Patients with Advanced <strong>Heart</strong> <strong>Failure</strong><br />
Tuba Khawaja, Tomoko Kato, Aalap Chokshi, Michael<br />
Chew, Hirokazu Akashi, Raffay Khan, Faisal Cheema,<br />
Meaghan Jones, Ulrich Jorde, Daniel Forman, Hiroo<br />
Takayama, Yoshifumi Naka, Donna Mancini, P. Christian<br />
Schulze, Columbia University New York, NY<br />
4:36* Elevated Mid-Region Pro-Adrenomedullin is 008<br />
Associated with Increased Mortality in Stable<br />
Outpatients with Diastolic Dysfunction<br />
Yang Xue, Pam Taub, Navaid Iqbal, Hugh Nguyen,<br />
Paul Clopton, Lori Daniels, Alan Maisel, VA San Diego<br />
Healthcare System, San Diego, CA<br />
4:54* Effects <strong>of</strong> the Sodium-Restricted DASH Diet 009<br />
in Hypertensive <strong>Heart</strong> <strong>Failure</strong> with Preserved<br />
Ejection Fraction<br />
Scott L. Hummel, E. Mitchell Seymour, Samar S. Sheth,<br />
Hannah R. Rosenblum, Robert D. Brook, Joanna M. Wells,<br />
Alan B. Weder, University <strong>of</strong> Michigan, Ann Arbor, MI<br />
5:12* Single Breath Exhaled Gas Analysis by Selected 010<br />
Ion-Flow Tube Mass-Specrometry (SIFT-MS) in<br />
Patients with Acute Decompensated <strong>Heart</strong> <strong>Failure</strong><br />
Michael A. Samara, Kelly M. Paschke, W.H. Wilson Tang,<br />
Raed A. Dweik, Cleveland Clinic, Cleveland, OH<br />
*10 minute presentation, 8 minute audience discussion<br />
Learning Objective: Discuss results <strong>of</strong> recent research and<br />
their implications for the treatment <strong>of</strong> heart failure.<br />
5:30 Poster Session and Reception<br />
Exhibit Halls C and D<br />
Presenters at their Posters 5:45-6:45 PM<br />
Refreshments and Hors d’oeuvres served<br />
55<br />
MondAY
Sept. 19<br />
Monday<br />
PM<br />
JNC NEW INVESTIGATOR SESSION<br />
Monday, September 19<br />
4:00-5:30 PM<br />
Room 306<br />
MOC SESSION<br />
Monday, September 19<br />
4:00-5:30 PM<br />
Room 310<br />
Sept. 19<br />
Monday<br />
PM<br />
MondAY<br />
Jay N. Cohn New Investigator Award:<br />
Basic Science<br />
Moderators: Burns C. Blaxall, Rochester, NY<br />
Michael R. Zile, Charleston, SC<br />
4:00* Ca2+ Oscillations Regulate Growth and 001<br />
Commitment <strong>of</strong> Stem Cells in the Developing <strong>Heart</strong><br />
Joao Ferreira-Martins, Sergio Signore, Francesco Cappetta,<br />
Barbara Ogorek, Elisabeth Steadman, Justin A. Korn,<br />
Noriko Ide-Iwata, Claudia Fiorini, Fumihiro Sanada,<br />
Hanqiao Zheng, Toru Hosoda, Annarosa Leri, Piero<br />
Anversa, Jan Kajstura, Marcello Rota, Brigham & Women’s<br />
Hospital, Boston, MA<br />
4:18* Presenilin Mediated Ca2+ Changes and 002<br />
Protein Quality Control in <strong>Heart</strong> <strong>Failure</strong><br />
Cristina Balla, Davide Gianni, Khaushik Subramanian,<br />
Bernhard Haring, Nicole Koulisis, Eduward Goihberg,<br />
Massimo Volpe, Federica del Monte, Beth Israel Deaconess<br />
Medical Center, Boston, MA<br />
4:36* Role <strong>of</strong> Cardiac mTOR in Ischemic Injury 003<br />
Toshinori Aoyagi, Yuichiro Kusakari, Chunyang Xiao,<br />
Brendan T. Inouye, Anthony Rosenzweig, Takashi Matsui,<br />
University <strong>of</strong> Hawaii, Honolulu, HI<br />
4:54* Cardiomyocyte Autophagy: Therapeutic 004<br />
Titration in Pathological Cardiac Remodeling<br />
Dian J. Cao, Wang V. Zhao, Pavan K. Battiprolua,<br />
Thomas G. Gillette, Joseph A. Hill, University <strong>of</strong> Texas<br />
Southwestern, Dallas, TX<br />
HFSA Study Session for MOC: Advanced <strong>Heart</strong><br />
<strong>Failure</strong> and Transplant Cardiology Part II<br />
(10 Knowledge Points: Must attend both sessions to earn points)<br />
Moderators: Ileana L. Piña, Bronx, NY<br />
Marc J. Semigran, Boston, MA<br />
HFSA has developed an ABIM-approved Self-Evaluation<br />
<strong>of</strong> Medical Knowledge Module on Advanced <strong>Heart</strong> <strong>Failure</strong><br />
and Transplant Cardiology worth 10 points towards<br />
Maintenance <strong>of</strong> Certification (MOC). This two-part<br />
session will review the 25 questions in that module.<br />
In order to receive MOC points, the module must be<br />
purchased at www.hfsa.org and successfully completed<br />
online. CME credit is also granted upon completion <strong>of</strong> the<br />
module. There is no CME credit for the review sessions.<br />
It is not necessary to be board certified in Advanced <strong>Heart</strong><br />
<strong>Failure</strong> and Transplant Cardiology to complete the module<br />
or attend these sessions.<br />
Although there is no additional registration fee to attend<br />
this session, attendee must be preregistered in order to<br />
enter the session.<br />
Learning Objective: Discuss key questions in the<br />
epidemiology, pathophysiology, and treatment <strong>of</strong> patients<br />
with advanced heart failure.<br />
MondAY<br />
5:12* Intact T and B Cell Responses are Required 005<br />
for Full Expression <strong>of</strong> Acute Non-Ischemic<br />
Cardiomyopathy<br />
Andrea Cordero-Reyes, Keith A. Youker, Jose Flores-<br />
Arredondo, Alejandro Trevino, Jerry D. Estep, Carlos M.<br />
Orrego, Guillermo Torre-Amione, The Methodist Hospital,<br />
Houston, TX<br />
*10 minute presentation, 8 minute audience discussion<br />
Learning Objective: Discuss the results and implications <strong>of</strong><br />
basic science research in heart failure.<br />
5:30 Poster Session and Reception<br />
Exhibit Halls C and D<br />
Presenters at their Posters 5:45-6:45 PM<br />
Refreshments and Hors d’oeuvres served<br />
56<br />
5:30 Poster Session and Reception<br />
Exhibit Halls C and D<br />
Presenters at their Posters 5:45-6:45 PM<br />
Refreshments and Hors d’oeuvres served<br />
57
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Cardiovascular Physiology<br />
Posters<br />
Cardiovascular Physiology<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
016 Interferon Regulatory Factor-3 (IRF-3) as a Potential<br />
Therapeutic Target To Prevent Myocyte Apoptosis and<br />
Promote Angiogenesis in Post-Myocardial Infarction<br />
Remodeling<br />
Ge<strong>of</strong>frey de Couto 1 , William Stanford 1 , Scott Heximer 1 , Jeffrey<br />
Medin 1 , Peter Liu 1 ; 1 University <strong>of</strong> Toronto, Toronto, ON, Canada<br />
017 Impaired Dobutamine Augmentation <strong>of</strong> Early Diastolic<br />
Suction in Diastolic Dysfunction<br />
Takahiro Ohara 1 , Cassie L. Niebel 2 , Kelley C. Stewart 2 , John J.<br />
Charonko 2 , Pamela R. Burgess 1 , Min Pu 1 , Pavlos P. Vlachos 2 ,<br />
William C. Little 1 ; 1 Cardiology Section, Wake Forest University<br />
School <strong>of</strong> Medicine, Winston-Salem, NC; 2 Department <strong>of</strong><br />
Mechanical Engineering, Virginia Tech, Blacksburg, VA<br />
018 The GRK2 Inhibitor βARKct Enhances β2-Adrenergic<br />
Receptor-Dependent Cardiac Contractility In Vivo by<br />
Opposing Receptor Interaction with Phosphodiesterase<br />
Type 4D<br />
Anastasios Lymperopoulos 1,2 , Giuseppe Rengo 2,3 , Erhe Gao 2 ,<br />
Walter J. Koch 2 ; 1 Pharmaceutical Sciences/College <strong>of</strong> Pharmacy,<br />
Nova Southeastern University, Fort Lauderdale, FL; 2 Center<br />
for Translational Medicine, Thomas Jefferson University,<br />
Philadelphia, PA; 3 University Federico II, Naples, Italy<br />
019 Diminished Global Arginine Bioavailability as a<br />
Metabolic Defect in Chronic <strong>Heart</strong> <strong>Failure</strong> in the Setting<br />
<strong>of</strong> Preserved Renal Function<br />
Kevin Shrestha 1 , Zhili Shao 1 , Allen G. Borowski 1 , Richard W.<br />
Troughton 2 , Allan L. Klein 2 , W.H. Wilson Tang 1 ; 1 Cleveland<br />
Clinic, Cleveland, OH; 2 Christchurch School <strong>of</strong> Medicine and<br />
Health Sciences, Christchurch, New Zealand<br />
020 TWIST-1 and Its Target, the miR 199/214 Cluster, Are<br />
Down-Regulated in Dilated Cardiomyopathy Resulting<br />
in Increased Proteasome Activity in Human Myocardium<br />
Anna Baumgarten 1 , Claudia Bang 2 , Reinhard Pregla 3 , Anika<br />
Tschirner 1 , Volker Adams 4 , Rudolf Meyer 3 , Thomas Thum 2 ,<br />
Roland Hetzer 3 , Stefan D. Anker 1 , Jochen Springer 1 ; 1 Applied<br />
Cachexia Research, CCR, Charite Medical School, Berlin,<br />
Germany; 2 Institute for Molecular and Translational Therapeutic<br />
Strategies, Medical School Hannover, Hannover, Germany;<br />
3<br />
DHZB, Berlin, Germany; 4 <strong>Heart</strong> Center Leipzig, Leipzig,<br />
Germany<br />
021 Nebulette Mutations Augment Cardiomyocyte Calcium<br />
Signaling through Modification <strong>of</strong> the Thin Filament in<br />
Preclinical Inherited Dilated Cardiomyopathy<br />
Kathryn M. Rafferty 1 , Evangalia G. Kranias 2 , Jeanne James 1 ,<br />
Jeffrey A. Towbin 1 , Enkhsaikhan Purevjav 1 ; 1 The <strong>Heart</strong> Institute,<br />
Cincinnati Childrens Hospital Medical Center, Cincinnati, OH;<br />
2<br />
Department <strong>of</strong> Pharmacology Cell Biophysics, University <strong>of</strong><br />
Cincinnati, Cincinnati, OH<br />
58<br />
022 Association between VE-VCO2 Slope and Resting<br />
Hemodynamic Measurements in Ambulatory <strong>Heart</strong><br />
<strong>Failure</strong> (HF) Patients: An Analysis from the Duke<br />
Advanced HF Database<br />
C. Patel 1 , R.J. Mentz 1 , J. Suarez 1 , A.F. Hernandez 1 , G.M. Felker 1 ,<br />
C.M. O’Connor 1 , J.G. Rogers 1 ; 1 Duke University, Durham, NC<br />
023 Obese Patients with Equivalent NYHA Have Less<br />
Cardiac Impairment Than Non-Obese Counterparts<br />
Shanmugakumar Chinnappa 1 , Nigel Lewis 1 , David Goldspink 2 ,<br />
Diane Barker 1 , Lip-Bun Tan 1 ; 1 Leeds Teaching Hospitals NHS<br />
Trust, Leeds, United Kingdom; 2 University <strong>of</strong> Leeds, Leeds,<br />
United Kingdom<br />
024 Fat Measurement and Functional Characteristics in<br />
<strong>Heart</strong> <strong>Failure</strong> Patients<br />
A. Zavin 1 , K. Allsup 1 , D.R. Gagnon 6,7 , R. Arena 4 , S. Davis 1 , J.<br />
Joseph 1,2 , S. Lecker 2 , A. Lazzari 1,3 , P.C. Schulze 5 , D.E. Forman 1,2 ;<br />
1<br />
VA Boston Healthcare System, Boston; 2 Harvard Medical<br />
School, Boston, MA; 3 Boston University School <strong>of</strong> Medicine,<br />
Boston, MA; 4 University <strong>of</strong> New Mexico, Albuquerque,<br />
NM; 5 Columbia University Medical Center, New York, NY;<br />
6<br />
Boston University SPH, Boston, MA; 7 VA Cooperative Studies<br />
Program, Boston, MA<br />
025 Pacing from a Novel Quadripolar LV Lead Improves LV<br />
Synchrony in CRT Patients<br />
Gery F. Tomassoni 1 , Melody Muir 1 , Erin O’Brien 2 , Kyungmoo<br />
Ryu 2 , Aaron Hesselson 1 ; 1 Lexington Cardiology Consultants,<br />
Lexington, KY; 2 St. Jude Medical, Sylmar, CA<br />
026 Hematological Malignancies Are Associated with<br />
Significant Elevations in N-Terminal Pro Brain<br />
Natriuretic Peptide<br />
Jesal Popat 1 , Abel Rivero 1 , Maya Guglin 1 ; 1 Department <strong>of</strong><br />
Cardiovascular Medicine, University <strong>of</strong> South Florida, Tampa,<br />
FL<br />
027 In Vitro and In Vivo Actions <strong>of</strong> a Novel ANP Genetic<br />
Variant: Unique Actions on Human Endothelial Cells<br />
Valentina Cannone 1 , Brenda K. Huntley 1 , Guido Boerrigter 1 ,<br />
Alessandro Cataliotti 1 , Denise M. Heublein 1 , John C. Burnett,<br />
Jr. 1 ; 1 Cardiorenal Research Laboratory, Mayo Clinic, Rochester,<br />
MN<br />
028 Left Atrial Diastolic Dysfunction, an Underappreciated<br />
Cause <strong>of</strong> Pulmonary Venous Hypertension and<br />
Decompensated <strong>Heart</strong> <strong>Failure</strong><br />
Hemal H. Kadakia 1 , Soheni Channah 1 , James T. Heywood 1 ,<br />
Allen D. Johnson 1 , Douglas N. Gibson 1 , Michael R. Smith 1 ,<br />
Tariq Khan 1 ; 1 Cardiology, Scripps Clinic, San Diego, CA<br />
59<br />
MondAY
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Cardiovascular Physiology<br />
Posters<br />
Cardiovascular Structure<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
029 Cardiac Wasting in Experimental Cancer Cachexia:<br />
Prevention by Bisoprolol and Spironolactone<br />
Jochen Springer 1 , Anika Tschirner 1 , Arash Haghika 2 , Aleksandra<br />
Grzesiak 3 , Elena Kaschina 3 , Hind Lal 4 , Stefan von Haehling 1 ,<br />
Denise Hilfiker-Kleiner 2 , Thomas Force 4 , Stefan D. Anker 1 ;<br />
1<br />
Cachexia Research, Charite Medical School, Berlin,<br />
Germany; 2 Dept <strong>of</strong> Cardiology and Angiology, Medical School<br />
Hannover, Hannover, Germany; 3 Institute <strong>of</strong> Pharmacology,<br />
Charite Medical School, Berlin, Germany; 4 Thomas Jefferson<br />
University, Philadelphia, PA<br />
030 Effects <strong>of</strong> Left Ventricular Stimulation Site on Diastolic<br />
Function in Cardiac Resynchronization Therapy<br />
Dusan Z. Kocovic, Scott Cox, Nancy Britton, Mark Heimann;<br />
Cardiology/Electrophysiology, Lankenau Hospital, Wynnewood,<br />
PA<br />
031 The Right Ventricular Contractile Pattern Is Markedly<br />
Different in Transplanted Compared to Normal <strong>Heart</strong>s.<br />
Implications for RV Function Assessment Post Cardiac<br />
Transplant<br />
Anjali V. Fields 1 , Amresh Raina 1 , Susan V. Chambers 1 , Paul<br />
R. Forfia 1 ; 1 Medicine/Cardiology, University <strong>of</strong> Pennsylvania,<br />
Philadelphia, PA<br />
032 Echocardiographic Estimation <strong>of</strong> the Left Ventricular<br />
End Diastolic Pressure Volume Relationship Predicts<br />
Survival in Congestive <strong>Heart</strong> <strong>Failure</strong><br />
Justin A. Karl 1 , Daniel Spevack 1 , Neeraja Yedlapati 2 , Mario<br />
J. Garcia 1 , Ythan Goldberg 1 ; 1 Medicine, Montefiore Medical<br />
Center, Bronx, NY; 2 Medicine, North Central Bronx Hospital,<br />
Bronx, NY<br />
033 Hemodynamic and Neurochemical Determinates <strong>of</strong><br />
Renal Function in <strong>Heart</strong> <strong>Failure</strong><br />
John D. Parker 1 , Cameron Gilbert; 1 Medicine, University <strong>of</strong><br />
Toronto, Toronto, ON, Canada<br />
034 Ejection Fraction: A Predictor for Types <strong>of</strong> Cognitive<br />
Deficit in HF Patients<br />
Ponrathi R. Athilingam 1 ; 1 College <strong>of</strong> Nursing, University <strong>of</strong><br />
South Florida, Tampa, FL<br />
035 Withdrawn<br />
056 Role <strong>of</strong> T Lymphocytes in Leptin-Mediated Myocardial<br />
Fibrosis<br />
Sherma Zibadi 1,2 , Douglas F. Larson 1 , Ronald R. Watson 1,2 ;<br />
1<br />
Sarver <strong>Heart</strong> Center, The University <strong>of</strong> Arizona, Tucson, AZ;<br />
2<br />
College <strong>of</strong> Public Health, The University <strong>of</strong> Arizona, Tucson,<br />
AZ<br />
057 Renal Remodeling Post Myocardial Infarction: The<br />
Modulating Actions <strong>of</strong> Aging<br />
S. Jeson Sangaralingham 1 , Tomoko Ichiki 1 , Fernando L.<br />
Martin 1 , Paul M. McKie 1 , Horng H. Chen 1 , John C. Burnett, Jr. 1 ;<br />
1<br />
Cardiovascular Diseases, Mayo Clinic, Rochester, MN<br />
058 The Characterization <strong>of</strong> Myocardial Fibrosis by Cardiac<br />
MRI in Association with Renal Dysfunction<br />
Sanjay Dandamudi 1 , James F. Glockner 1 , Joshua P. Slusser 1 ,<br />
David O. Hodge 1 , Horng H. Chen 1 ; 1 Mayo Clinic, Rochester,<br />
MN<br />
059 Echocardiography To Screen for Central Sleep Apnea in<br />
<strong>Heart</strong> <strong>Failure</strong><br />
Andrew D. Calvin 1 , Virend K. Somers 1 , Christelle van der Walt 1 ,<br />
Lyle J. Olson 1 ; 1 Division <strong>of</strong> Cardiovascular Diseases, Mayo<br />
Clinic, Rochester, MN<br />
060 Do Ischemic Cardiomyopathy and Cardiac Allograft<br />
Vasculopathy Have Unique Myocardial Remodeling<br />
Characteristics?<br />
Divya Ratan Verma 1 , Stavros G. Drakos 1 , Monica P. Revelo 1 ,<br />
Abdallah G. Kfoury 1 , Farman Khan 1 , Feras Bader 1 , Deborah<br />
Budge 1 , Rami Alharethi 1 , Craig Selzman 1 , Edward Gilbert 1 ,<br />
Elizabeth Hammond 1 , Dylan Miller 1 , Dean Y. Li 1 , Josef Stehlik 1 ;<br />
1<br />
UTAH Cardiac Transplant Program, Salt Lake City, UT<br />
Neurohormones/Cytokines<br />
066 A Multimarker Panel Improves Risk Prediction in<br />
Chronic <strong>Heart</strong> <strong>Failure</strong><br />
Bonnie Ky 1 , Benjamin French 1 , James C. Fang 2 , Nancy K.<br />
Sweitzer 3 , Wayne C. Levy 4 , Alan H.B. Wu 5 , Lee R. Goldberg 1 ,<br />
Mariell Jessup 1 , Thomas P. Cappola 1 ; 1 Cardiovascular Institute,<br />
University <strong>of</strong> Pennsylvania School <strong>of</strong> Medicine, Philadelphia,<br />
PA; 2 Cardiovascular Medicine, Case Western University,<br />
Cleveland, OH; 3 Cardiovascular Medicine, University <strong>of</strong><br />
Wisconsin, Madison, WI; 4 Cardiovascular Medicine, University<br />
<strong>of</strong> Washington, Seattle, WA; 5 Department <strong>of</strong> Laboratory<br />
Medicine, University <strong>of</strong> California at San Francisco, San<br />
Francisco, CA<br />
MondAY<br />
60<br />
61
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Neurohormones/Cytokines<br />
Posters<br />
Neurohormones/Cytokines<br />
Sept. 19<br />
Monday<br />
Posters<br />
067 Chronic Cardiac Gene Delivery <strong>of</strong> proBNP in<br />
Experimental Progressive Hypertensive <strong>Heart</strong> Disease<br />
Improves Survival<br />
Alessandro Cataliotti 1 , Jason M. Tonne 2 , Diego Bellavia 1 ,<br />
Fernando L. Martin 1 , Sarah Mangiafico 1 , John C. Burnett 1 ,<br />
Yasuhiro Ikeda 2 ; 1 Cardiovascular Diseases, Mayo Clinic,<br />
Rochester, MN; 2 Molecular Medicine, Mayo Clinic, Rochester,<br />
MN<br />
073 Interaction <strong>of</strong> Elevated Copeptin (CT-proVasopressin,<br />
a Surrogate Marker <strong>of</strong> Arginine Vasopressin), B-Type<br />
Natriuretic Peptide, and Hyponatremia in Predicting<br />
Outcome in Chronic <strong>Heart</strong> <strong>Failure</strong><br />
Wayne L. Miller 1 , Diane E. Grill 1 , Mary A. Phelps 1 , Joachim<br />
Struck 2 , Allan S. Jaffe 1 ; 1 Mayo Clinic, Rochester, MN;<br />
2<br />
BRAHMS Aktiengesellschaft (Part <strong>of</strong> ThermoFisher <strong>Scientific</strong>),<br />
Hennigsdorf, Germany<br />
MondAY<br />
068 Treatment with CBA-NP a Novel Chimeric Natriuretic<br />
Peptide Attenuates Cardiorenal Fibrosis and Improves<br />
Diastolic Dysfunction in Diabetic Rat Model<br />
Syed Ameenuddin 1 , Elise A. Oehler 1 , John C. Burnett, Jr. 1 ,<br />
Horng H. Chen 1 ; 1 Division <strong>of</strong> Cardiovascular Diseases, Mayo<br />
Clinic, Rochester, MN<br />
074 NGAL Is Independently Associated with Cardiovascular<br />
Death and All-Cause Mortality in Community-Dwelling<br />
Older Adults with Stage A <strong>Heart</strong> <strong>Failure</strong><br />
Lori B. Daniels 1 , Paul Clopton 2 , Elizabeth Barrett-Connor 1 , Alan<br />
S. Maisel 2 ; 1 University <strong>of</strong> California, San Diego, La Jolla, CA;<br />
2<br />
VA San Diego Healthcare System, La Jolla, CA<br />
MondAY<br />
069 Validation <strong>of</strong> a Formula Combining ST2 and NT-proBNP<br />
Enhancing Prognostic Accuracy in Patients with <strong>Heart</strong><br />
<strong>Failure</strong><br />
J. Snider 1 , T. Breidthardt 2 , M. Noveanu 2 , M. Potocki 2 , T.<br />
Socrates 2 , N. Arenja 2 , C. Heinisch 2 , B. Drexler 2 , C. Mueller 2 ;<br />
1<br />
Critical Diagnostics, San Diego, CA; 2 Departement Innere<br />
Medizin, Universitätsspital Basel, Basel, Switzerland<br />
070 The Prohormone <strong>of</strong> B-Type Natriuretic Peptide,<br />
proBNP1-108, Is Secreted by the Failing and Non-Failing<br />
Human <strong>Heart</strong><br />
Elizabeth C. Costello 1 , Harald Lapp 2 , Amir Lerman 1 , Guido<br />
Boerrigter 1 , Fima Macheret 1 , Fernando Martin 1 , Alexander Bufe 3 ,<br />
Catherine Larue 4 , Denise M. Heublein 1 , John C. Burnett, Jr. 1 ;<br />
1<br />
Cardiovascular Research, Mayo Clinic, Rochester, MN; 2 Helios<br />
Clinic, Erfurt, Germany; 3 Helios Clinic, Wuppertal, Germany;<br />
4<br />
BioRad, Marnes-la-Coquette, France<br />
071 Prognostic Value <strong>of</strong> Natriuretic Peptide in <strong>Heart</strong> <strong>Failure</strong><br />
with Atrial Fibrillation<br />
Jin-Oh Choi 1 , Sung-Ji Park 1 , Jae-Joong Kim 2 , Eun-Seok Jeon 1 ,<br />
Sang Hoon Lee 1 ; 1 Internal Medicine, Samsung Medical Center,<br />
Sungkyunkwan University School <strong>of</strong> Medicine, Seoul, Korea;<br />
2<br />
Internal Medicine, Asan Medical Center, University <strong>of</strong> Ulsan<br />
College <strong>of</strong> Medicine, Seoul, Korea<br />
072 Elevated Cystatin C Predicts Long-Term Adverse<br />
Cardiac Events in Patients with <strong>Heart</strong> <strong>Failure</strong><br />
Independent <strong>of</strong> Natriuretic Peptide Levels and<br />
Creatinine Clearance<br />
Matthias Dupont 1 , Earl B. Britt, Jr. 2 , Yuping Wu 3 , Stanley L.<br />
Hazen 2 , Wilson W.H. Tang 1 ; 1 Department <strong>of</strong> Cardiovascular<br />
Medicine, <strong>Heart</strong> and Vascular Institute, Cleveland Clinic<br />
Foundation, Cleveland, OH; 2 Center for Cardiovascular<br />
Diagnostics and Prevention, Cleveland Clinic Foundation,<br />
Cleveland, OH; 3 Department <strong>of</strong> Mathematics, Cleveland State<br />
University, Cleveland, OH<br />
62<br />
075 Impaired HDL Function Predicts Subclinical Myocardial<br />
Necrosis in Patients at Risk <strong>of</strong> Developing <strong>Heart</strong> <strong>Failure</strong><br />
Zhili Shao 1 , Yuping Wu 2 , Yi Lu 1 , Stanley L. Hazen 1 , W.H.<br />
Wilson Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Cleveland<br />
State University, Cleveland, OH<br />
076 Soluble Angiotensin Converting Enzyme 2 Activity<br />
Levels Is Associated with Cardiopulmonary Functional<br />
Impairment in Chronic Systolic <strong>Heart</strong> <strong>Failure</strong><br />
Andres Schuster 1 , Zhili Shao 1 , Allen G. Borowski 1 , Akanksha<br />
Thakur 2 , W.H. Wilson Tang 1 ; 1 Department <strong>of</strong> Cardiovascular<br />
Medicine, <strong>Heart</strong> and Vascular Institute, Cleveland Clinic<br />
Foundation, Cleveland, OH; 2 Case Western Reserve School <strong>of</strong><br />
Medicine, Case Western Reserve University, Cleveland, OH<br />
077 Rise in Urinary Neutrophil Gelatinase-Associated<br />
Lipocalin (NGAL) Following Intravenous Diuretic<br />
Therapy Predicts Development <strong>of</strong> Worsening Renal<br />
Function in Acute Decompensated <strong>Heart</strong> <strong>Failure</strong><br />
Matthias Dupont 1 , Adiveh Awad 1 , Mario Scarcipino 1 , Cynthia<br />
Kovach 1 , Anjli P. Maroo 1 , Wilson W.H. Tang 1 ; 1 Department<br />
<strong>of</strong> Cardiovascular Medicine, <strong>Heart</strong> and Vascular Institute,<br />
Cleveland Clinic Foundation, Cleveland, OH<br />
078 Heterogeneity <strong>of</strong> ProBNP1-108 to BNP and ProBNP1-108<br />
to Nt-proBNP Ratios in Congestive <strong>Heart</strong> <strong>Failure</strong><br />
Damien Gruson 1 , Sylvie A. Ahn 1 , Jean-Marie Ketelslegers 1 ,<br />
Michel F. Rousseau 1 ; 1 Division <strong>of</strong> Cardiology Dept <strong>of</strong><br />
Laboratory Medicine, University <strong>of</strong> Louvain, Brussels, Belgium<br />
079 Galectin-3 as a New Remodeling Marker in <strong>Heart</strong><br />
<strong>Failure</strong>: Comparison to Other Neurohumoral<br />
Biomarkers<br />
Damien Gruson 1 , Sylvie A. Ahn 1 , Jean-Marie Ketelslegers 1 ,<br />
Michel F. Rousseau 1 ; 1 Division <strong>of</strong> Cardiology Dept <strong>of</strong><br />
Laboratory Medicine, University <strong>of</strong> Louvain, Brussels, Belgium<br />
63
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Neurohormones/Cytokines<br />
Posters<br />
Molecular Biology and Genetics<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
080 Predicting Cardiac Dysfunction during Breast Cancer<br />
Chemotherapy<br />
Carrie Geisberg 1 , Amy Dickey 1 , Holly M. Smith 1 , Brenda White 1 ,<br />
Darla Freehardt 1 , Sawyer Douglas 1 ; 1 Cardiovascular Medicine,<br />
Vanderbilt University, Nashville, TN<br />
081 Plasma Renin Activity (PRA) Predicts Diuretic<br />
Resistance in Acute <strong>Heart</strong> <strong>Failure</strong> Patients: An Ancillary<br />
Study <strong>of</strong> the Diuretic Optimization Strategies Evaluation<br />
in Acute <strong>Heart</strong> <strong>Failure</strong> (DOSE-AHF)<br />
Tomohito Ohtani 1 , G. Michael Felker 2 , Steven E. McNulty 2 ,<br />
Martin M. LeWinter 3 , Eugene Braunwald 4 , Margaret M.<br />
Redfield 1 ; 1 Mayo Clinic, Rochester, MN; 2 Duke University,<br />
Durham, NC; 3 Univ <strong>of</strong> Vermont, Burlington, VT; 4 Brigham and<br />
Women’s Hospital, Boston, MA<br />
082 Italian RED Study Sub-Analysis: 30-Day Post-Discharge<br />
BNP Levels Predict 6-Month All-Cause Mortality and<br />
Cardiac Events<br />
Giorgio Zampini 1 , Kevin S. Shah 2 , Laura Magrini 1 , Alan<br />
S. Maisel 2 , Salvatore DiSomma 1 ; 1 Emergency Medicine<br />
Department, Medical School University La Sapienza,<br />
Sant’Andrea Hospital, Rome, Via di Grottarossa, Italy;<br />
2<br />
Cardiology, Veterans Affairs San Diego Healthcare System, San<br />
Diego, CA<br />
Molecular Biology and Genetics<br />
099 Isolation <strong>of</strong> Cardiovascular Progenitors from Human<br />
Embryonic Stem Cells Capable <strong>of</strong> Integration into<br />
Human Fetal <strong>Heart</strong>s<br />
Reza Ardehali 1,2 , Shah R. Ali 2 , Micha Drukker 2 , Irvig L.<br />
Weissman 2 ; 1 Division <strong>of</strong> Cardiovascular Medicine, Stanford<br />
University School <strong>of</strong> Medicine, Stanford, CA; 2 Institute for Stem<br />
Cell Biology and Regenerative Medicine, Stanford University<br />
School <strong>of</strong> Medicine, Stanford, CA<br />
100 Placental Growth Factor (PlGF) and Soluble fms-Like<br />
Tyrosine Kinase-1 (SFLT-1) Predict Mortality in Stable<br />
Patients with <strong>Heart</strong> <strong>Failure</strong> with Preserved Ejection<br />
Fraction<br />
Michael A. Samara 1 , Stanley L. Hazen 2 , W.H. Wilson Tang 1 ;<br />
1<br />
Cardiovascular Medicine, <strong>Heart</strong> and Vascular Institute,<br />
Cleveland Clinic, Cleveland, OH; 2 Center for Cardiovascular<br />
Diagnostics and Therapy, Lerner Research Institute, Cleveland<br />
Clinic, Cleveland, OH<br />
101 Ca2+/Calmodulin Dependent Protein Kinase II<br />
Phosphorylation <strong>of</strong> RyR2 Alters the Force-Frequency<br />
Relationship in Mice<br />
Mark D. McCauley 1,2 , Tiannan Wang 1 , Sameer Ather 1 , Na Li 1 ,<br />
Biykem Bozkurt 1 , Xander Wehrens 1 ; 1 Department <strong>of</strong> Medicine<br />
(Cardiology), Baylor College <strong>of</strong> Medicine, Houston, TX;<br />
2<br />
Department <strong>of</strong> Cardiology, Texas <strong>Heart</strong> Institute, St. Luke’s<br />
Episcopal Hospital, Houston, TX<br />
102 Beta-Adrenergic Receptor Polymorphisms in<br />
Susceptibility, Response to Treatment and Prognosis in<br />
<strong>Heart</strong> <strong>Failure</strong><br />
Sabrina B. Pereira 1 , Monica W. Veloso 1 , Sergio Chermont 1 ,<br />
Monica Quintao 1 , Wolney Andrade 1 , Humberto Villacorta 1 ,<br />
Luiza Contarato 1 , Maria Luiza G. Rosa 1 , Antonio Claudio L.<br />
Nobrega 1 , Evandro T. Mesquita 1 , Georgina S. Ribeiro 1 ; 1 Federal<br />
Fluminense University, Niterói, Brazil<br />
103 Chronic Treatment with Mineralocorticoid Receptor<br />
Antagonists Reverses Salt-Induced Transcriptional<br />
Effects in Aorta <strong>of</strong> Dahl Salt Sensitive Rats<br />
Sheng Gao 1 , Jun Li 1 , Xiaoyan Zhou 1 , Patricia Brown 1 , Oscar<br />
Puig 1 , Maarten Hoek 1 , Michael Forrest 1 , Sophie Roy 1 , Martin<br />
Crook 1 ; 1 Cardiovascular Diseases, MRL, Merck Co., Rahway,<br />
NJ<br />
104 The Natriuretic Peptide Receptors NPR-A and NPR-B<br />
Are Differentially Regulation by Extracellular Matrix<br />
Proteins<br />
Brenda K. Huntley 1 , Tomoko Ichiki 1 , John C. Burnett, Jr. 1 ;<br />
1<br />
Cardiorenal Research, Mayo Clinic, Rochester, MN<br />
105 NGAL Lacks Specificity for Acute Kidney Injury in<br />
Acute <strong>Heart</strong> <strong>Failure</strong> Syndrome<br />
Mridula Rai 1,2 , Cara Statz 1 , Aleksandra Ras 1 , Jennifer Rahn 1 ,<br />
Lynn O’Bara 1 , Faisal Zaeem 1 , Roja Mulamalla 1 , Jonathan<br />
Hammond 1 , Detlef Wencker 1 ; 1 <strong>Heart</strong> <strong>Failure</strong> and Transplant<br />
Center, Hartford Hospital, Hartford, CT; 2 University <strong>of</strong><br />
Connecticut Health Center, Farmington, CT<br />
106 Circulating microRNA Patterns in Ischemic and<br />
Idiopathic <strong>Heart</strong> <strong>Failure</strong><br />
Oxana Galenko 1 , Samin Panahi 1 , Staci Gunter 1 , Kimberly D.<br />
Brunisholz 1 , Benjamin D. Horne 1,2 , John Carlquist 1,3 , Jeffrey L.<br />
Anderson 1,3 ; 1 Cardiology, Intermountain Medical Center, Murray,<br />
UT; 2 Genetic Epidemiology, University <strong>of</strong> Utah, Salt Lake City,<br />
UT; 3 Cardiology, University <strong>of</strong> Utah, Salt Lake City, UT<br />
MondAY<br />
64<br />
65
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Surgery, Transplantation, Devices<br />
Posters<br />
Surgery, Transplantation, Devices<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
115 Assessment <strong>of</strong> Intrinsic Cardiac Function, Myocardial<br />
Blood Flow and Metabolism in Patients Supported on<br />
Mechanical Circulatory Assist Devices<br />
Patricia Campbell 1 , Hicham Skali 1 , Leslie Griffin 1 , Colleen<br />
Smith 1 , Michael M. Givertz 1 , Marc A. Pfeffer 1 , Scott D.<br />
Solomon 1 , Marcelo F. Di Carli 1 ; 1 Cardiovascular Division,<br />
Brigham and Women’s Hospital, Boston, MA<br />
116 Aortic Valve Opening at Hospital Discharge<br />
after <strong>Heart</strong>Mate II Left Ventricular Assist Device<br />
Implantation Is Associated with Improved Renal<br />
Function at 3 Months<br />
David R. Fermin 1 , Soon J. Park 2 , Yan Topilsky 1 , John C. Burnett,<br />
Jr. 1 , Tal Hasin 1 , Sudhir S. Kushwaha 1 , Brooks S. Edwards 1 ,<br />
Horng H. Chen 1 , Tomoko Ichiki 1 , Barry A. Boilson 1 , Lyle Joyce 2 ,<br />
Richard Daly 2 , John A. Schirger 1 ; 1 Cardiovascular Diseases,<br />
Mayo Clinic, Rochester, MN; 2 Cardiovascular Surgery, Mayo<br />
Clinic, Rochester, MN<br />
117 Mechanical Unloading Via Left Ventricular Assist Device<br />
Implantation Ameliorates Adipose Tissue Inflammation<br />
and Increases Adipocyte Size in Patients with Advanced<br />
<strong>Heart</strong> <strong>Failure</strong><br />
Raffay S. Khan 2 , Aalap Chokshi 1 , Collette R. Harris 1 , Shuiqing<br />
Yu 1 , Gissette Reyes-S<strong>of</strong>fer 2 , Daniel E. Forman 1 , Yoshifumi<br />
Naka 3 , Donna Mancini 1 , P. Christian Schulze 1 ; 1 Division <strong>of</strong><br />
Cardiology, Columbia University, New York, NY; 2 Division<br />
<strong>of</strong> Preventive Medicine Nutrition, Columbia University, New<br />
York, NY; 3 Division <strong>of</strong> Cardiothoracic Surgery, Columbia<br />
University, New York, NY<br />
118 Who Wants an LVAD for Ambulatory <strong>Heart</strong> <strong>Failure</strong>?<br />
Garrick C. Stewart 1 , Michelle M. Kittleson 2 , Jennifer A.<br />
Cowger 3 , Frances L. Johnson 4 , Chetan B. Patel 5 , Maria M.<br />
Mountis 6 , Parag Patel 7 , J. Eduardo Rame 8 , Maya E. Guglin 9 ,<br />
Jeffrey J. Teuteberg 10 , Lynne W. Stevenson 1 ; 1 Brigham and<br />
Women’s Hospital, Boston, MA; 2 Cedars-Sinai <strong>Heart</strong> Institute,<br />
Los Angeles, CA; 3 University <strong>of</strong> Michigan, Ann Arbor, MI;<br />
4<br />
University <strong>of</strong> Iowa, Iowa City, IA; 5 Duke University, Durham,<br />
NC; 6 Cleveland Clinic, Cleveland, OH; 7 University <strong>of</strong> Texas<br />
Southwestern, Dallas, TX; 8 University <strong>of</strong> Pennsylvania,<br />
Philadelphia, PA; 9 University <strong>of</strong> South Florida, Tampa, FL; 10 ,<br />
University <strong>of</strong> Pittsburgh, Pittsburgh, PA<br />
119 Are LVAD Support and Cardiac Transplantation<br />
Approaching Equipoise?<br />
Robert M. Adamson 1 , Brian Jaski 2 , Peter Hoagland 2 , Joseph<br />
Chammas 1 , Sam Baradarian 1 , Vanjah Norman 1 , Walter P.<br />
Dembitsky 1 ; 1 Cardiothoracic Surgery, Sharp Memorial Hospital,<br />
San Diego, CA; 2 Cardiology, Sharp Memorial Hospital, San<br />
Diego, CA<br />
120 Scaffold Delivery <strong>of</strong> Neonatal Cardiomyocyte Results in<br />
Prolonged Cellular Survival and Improvements in Left<br />
Ventricular Function in Rats with Chronic <strong>Heart</strong> <strong>Failure</strong><br />
Jordan J. Lancaster 1 , Elizabeth Juneman 1 , Nicholle M. Johnson 1 ,<br />
Joseph J. Bahl 1 , Steven Goldman 1 ; 1 Cardiology, Southern<br />
Arizona VA Health Care System, Tucson, AZ<br />
121 Survival <strong>of</strong> INTERMACS Pr<strong>of</strong>ile 4-6 Patients after<br />
Left Ventricular Assist Device Implant Is Improved<br />
Compared to Seattle <strong>Heart</strong> <strong>Failure</strong> Model Estimated<br />
Survival<br />
Peter Eckman 1 , Andrew Rosenbaum 1 , Haree Vongooru 2 ,<br />
Jagroop Basraon 3 , Forum Kamdar 1 , Ranjit John 1 , Wayne Levy 4 ;<br />
1<br />
University <strong>of</strong> Minnesota, Minneapolis, MN; 2 University<br />
<strong>of</strong> Louisville, Louisville, KY; 3 UCSF-Fresno, Fresno, CA;<br />
4<br />
University <strong>of</strong> Washington, Seattle, WA<br />
122 Hemodynamic Predictors <strong>of</strong> Renal Function Following<br />
Left Ventricular Assist Device Implantation<br />
Gabriel T. Sayer 1 , Sheila Sahni 2 , Kimberly Ashley 1 , Rachel<br />
Flynn 1 , Ajith P. Nair 1 , Anelechi C. Anyanwu 3 , Michael J.<br />
Domanski 1 , Sean P. Pinney 1 ; 1 Cardiology, Mount Sinai Medical<br />
Center, New York, NY; 2 Medicine, Mount Sinai Medical Center,<br />
New York, NY; 3 Cardiothoracic Surgery, Mount Sinai Medical<br />
Center, New York, NY<br />
123 Use <strong>of</strong> Antigen Microarrays To Detect Non-HLA<br />
Antibodies in Patients with <strong>Heart</strong> Transplant Rejection<br />
Andrzej Chruscinski 1 , Jongsung Lim-Shon 1 , Vivek Rao 1 , Gary<br />
Levy 1 , Heather Ross 1 ; 1 Multi-Organ Transplant, Toronto General<br />
Research Institute, Toronto, ON, Canada<br />
124 Reliability <strong>of</strong> a Novel Slow Cuff-Deflation System for<br />
Non-Invasive Blood Pressure Monitor in Out-Patients<br />
with Continuous-Flow Left Ventricular Assist Devices<br />
Gregg Lanier 1 , Khristine Orlanes 2 , Ryan T. Demmer 1 , Yacki<br />
Hayashi 1 , Jennifer Murphy 2 , Margaret Flannery 2 , Rosie Te-Frey 2 ,<br />
Nir Uriel 1 , Donna M. Mancini 1 , Yoshifumi Naka 2 , Hiroo<br />
Takayama 2 , Ulrich P. Jorde 1 , Paolo C. Colombo 1 ; 1 Department <strong>of</strong><br />
Medicine, Columbia University, New York, NY; 2 Department <strong>of</strong><br />
Surgery, Columbia University, New York, NY<br />
125 Reverse Remodeling with Combined Maximal Medical<br />
Therapy and Continuous Flow LVAD Support<br />
Snehal R. Patel 1 , Vivek Bhatia 1 , Pauline Edwards 1 , Cecelia<br />
Nucci 1 , David Dallesandro 1 , Daniel Goldstein 1 , Simon<br />
Maybaum 1 ; 1 Center for Advanced Cardiac Therapy, Montefiore<br />
Medical Center, Albert Einstein College <strong>of</strong> Medicine, Bronx,<br />
NY<br />
MondAY<br />
66<br />
67
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Surgery, Transplantation, Devices<br />
Posters<br />
Surgery, Transplantation, Devices<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
126 Pilot Evaluation <strong>of</strong> a Novel Intra-Atrial Valved-Shunt<br />
(V-Wave Device) for Pressure-Dependent Cardiac<br />
Unloading in a Chronic Model <strong>of</strong> Ischemic <strong>Heart</strong> <strong>Failure</strong><br />
Patrick I. McConnell 1 , Carlos L. del Rio 2 , Yaacov Nitzan 3 , Yukie<br />
Ueyama 2 , Pedro Vargas 2 , Adriana Pedraza 2 , Meni Jacoby 3 , Robert<br />
L. Hamlin 2,4 , Gad Keren 3 , William T. Abraham 4 , Stefan Verheye 3 ;<br />
1<br />
Nationwide Children’s Hospital, Columbus, OH; 2 QTest Labs,<br />
Columbus, OH; 3 V-Wave, Hod Hasahron, Israel; 4 The Ohio State<br />
University, Columbus, OH<br />
127 Left Ventricular Assist Devices Improve Functional Class<br />
but Fail To Normalize Peak Oxygen Consumption<br />
Casey R. Benton 1 , Gabriel Sayer 2 , Kimberly Ashley 2 , Rachel<br />
Flynn 2 , Ajith P. Nair 2 , Michael J. Domanski 2 , Anelechi C.<br />
Anyanwu 3 , Sean P. Pinney 2 ; 1 Medicine, The Mount Sinai<br />
Medical Center, New York, NY; 2 Cardiology, The Mount Sinai<br />
Medical Center, New York, NY; 3 Cardiothoracic Surgery, The<br />
Mount Sinai Medical Center, New York, NY<br />
128 Use <strong>of</strong> Luminex Antibody Testing and Virtual<br />
Crossmatching To Enhance Donor <strong>Heart</strong> Availability for<br />
Sensitized <strong>Heart</strong> Transplant Candidates: A Single Center<br />
Experience<br />
Robert L. Scott 1 , Diane L. Kasper 1 , Riccardo Valdez 1 , Francisco<br />
A. Arabia 1 , Carol S. Bachtel 1 , Patrick A. DeValeria 1 , D. Eric<br />
Steidley 1 , Louis A. Lanza 1 , Dawn E. Jaroszewski 1 , Radha<br />
S. Gopalan 1 , Anantharam V. Kalya 1 , Scott T. Stoll 1 , Octavio<br />
E. Pajaro 1 , Stacie M. Attig 1 ; 1 <strong>Heart</strong> <strong>Failure</strong> and Cardiac<br />
Transplantation, Mayo Clinic Arizona, Phoenix, AZ<br />
129 Development <strong>of</strong> a Long-Term Superficial Device for<br />
Partial Circulatory Support<br />
R. Dowling 1 , P. Spence 1 , S. Warren 1 , L. Tompkins 1 , M.<br />
Sandoval 1 , G. Giridharan 2 , L. Sherwood 2 , E. Gratz 4 , G.<br />
Spanier 4 , C. Lederer 5 , S. Bruck 5 , M. Slaughter 3 , S. Koenig 2 ;<br />
1<br />
SCR, Inc, Louisville, KY; 2 Bioengineering and Surgery,<br />
Cardiovascular Innovation Institute, Louisville, KY; 3 Thoracic<br />
and Cardiovascular Surgery, U Louisville, Louisville, KY;<br />
4<br />
Abiomed, Danvers, MA; 5 LB Technology, Louisville, KY<br />
130 Increased Levels <strong>of</strong> Osteopontin Are Associated<br />
with Development <strong>of</strong> Right Ventricular <strong>Failure</strong> after<br />
Ventricular Assist Device Implantation in Patients with<br />
Advanced <strong>Heart</strong> <strong>Failure</strong><br />
Tomoko S. Kato 1 , Aalap Chokshi 1 , Tuba Khawaja 1 , Faisal H.<br />
Cheema 1 , Hirokazu Akashi 1 , Jonathan Yang 2 , Hiroo Takayama 2 ,<br />
Yoshifumi Naka 2 , MaryJane Farr 1 , Donna Mancini 1 , P. Christian<br />
Schulze 1 ; 1 Department <strong>of</strong> Medicine, Division <strong>of</strong> Cardiology,<br />
Columbia University Medical Center, New York, NY;<br />
2<br />
Department <strong>of</strong> Surgery, Division <strong>of</strong> Cardiothoracic Surgery,<br />
Columbia University Medical Center, New York, NY<br />
131 Total Depletion and Abnormal Composition <strong>of</strong><br />
Myocardial Free Fatty Acid Stores in Patients with<br />
Advanced <strong>Heart</strong> <strong>Failure</strong><br />
Ruiping Ji 1 , Tuba Khawaja 1 , Hongfeng Jiang 2 , Shuiqing<br />
Yu 1 , Raffay Khan 2 , Donna Mancini 1 , P. Christian Schulze 1 ;<br />
1<br />
Cardiology, Columbia University, New York, NY; 2 Preventive<br />
Medicine & Nutrition, Columbia University, New York, NY<br />
132 Ventricular Restraint Improves Outcomes in HF Patients<br />
with CRT<br />
Russell J. Ivanhoe 1 , Maria Rosa Costanza 2 , William T. Abraham 3 ,<br />
PEERLESS HF Investigators, Barry K. Rayburn 4 ; 1 Paracor<br />
Medical, Inc., Sunnyvale, CA; 2 <strong>Heart</strong> <strong>Failure</strong> Program, Midwest<br />
<strong>Heart</strong> Foundation, Naperville, IL; 3 Cardiovascular Medicine,<br />
The Ohio State University, Columbus, OH; 4 Cardiovascular<br />
Partners, Birmingham, AL<br />
133 The Impact <strong>of</strong> Technology Dependency on Device<br />
Acceptance and Quality <strong>of</strong> Life in Persons with<br />
Implantable Cardioverter Defibrillators<br />
Kimberly A. Udlis 1 ; 1 College <strong>of</strong> Nursing, University <strong>of</strong><br />
Wisconsin Oshkosh, Oshkosh, WI<br />
134 Persistent Anemia in Patients Supported with the<br />
Total Artificial <strong>Heart</strong>: Hemolysis and Ineffective<br />
Erythropoiesis<br />
Anit K. Mankad 1 , Maureen Flattery 1 , Daniel G. Tang 1 , William<br />
Clark 1 , Suzanne Harton 1 , Gundars J. Katlaps 2 , Michael L. Hess 1 ,<br />
Vigneshwar Kasirajan 1 , Keyur B. Shah 1 ; 1 Internal Medicine,<br />
Division <strong>of</strong> Cardiovascular Disease, Virginia Commonwealth<br />
University/Medical College <strong>of</strong> Virginia, Richmond, VA;<br />
2<br />
Cardiothoracic Surgery, Hunter Holmes Mcguire Veterans<br />
Hospital, Richmond, VA<br />
135 Predictors <strong>of</strong> Worsening Renal Function in Patients<br />
with Decompensated <strong>Heart</strong> <strong>Failure</strong> Treated with<br />
Ultrafiltration<br />
Nicholas Haglund 1 , Joan Mack 2 , Melissa Lederer 2 , Ioana<br />
Dumitru 1 , John Windle 1 , Eugenia Raichlin 1 ; 1 Cardiology,<br />
University <strong>of</strong> Nebraska Medical Center, Omaha, NE; 2 Nursing,<br />
Nebraska Medical Center, Omaha, NE<br />
136 Powering a Ventricular Assist Device over Meter<br />
Distances Wirelessly: The Free-Range Resonant<br />
Electrical Energy Delivery (FREE-D) System<br />
Benjamin Waters 1 , Alanson Sample 1 , Robert Kormos 3 , Joshua<br />
Smith 1,2 , Pramod Bonde 3 ; 1 Department <strong>of</strong> Electrical Engineering,<br />
University <strong>of</strong> Washington, Seattle, WA; 2 Department <strong>of</strong><br />
Computer Science and Engineering, University <strong>of</strong> Washington,<br />
Seattle, WA; 3 Cardiothoracic Surgery, University <strong>of</strong> Pittsburgh<br />
Medical Center, Pittsburgh, PA<br />
MondAY<br />
68<br />
69
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Surgery, Transplantation, Devices<br />
Posters<br />
Electrophysiology/Arrhythmias<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
137 Predicting Acute Cardiac Allograft Rejection Using<br />
Donor and Recipient Gene Expression<br />
Zsuzsanna Hollander 1,2 , Virginia Chen 2 , David Lin 1 , Raymond T.<br />
Ng 2,3 , Robert Balshaw 2,4 , Andrew Ignaszewski 5 , Gabriela Cohen<br />
Freue 2,4 , Janet Wilson-McManus 2 , Robert W. McMaster 2,6 , Paul<br />
Keown 1,2,5 , Bruce M. McManus 1,2,5 ; 1 Pathology and Laboratory<br />
Medicine, The University <strong>of</strong> British Columbia, Vancouver,<br />
Canada; 2 NCE CECR PROOF Centre <strong>of</strong> Excellence, Vancouver,<br />
Canada; 3 Computer Science, The University <strong>of</strong> British<br />
Columbia, Vancouver, Canada; 4 Statistics, The University<br />
<strong>of</strong> British Columbia, Vancouver, Canada; 5 Medicine, The<br />
University <strong>of</strong> British Columbia, Vancouver, Canada; 6 Medical<br />
Genetics, The University <strong>of</strong> British Columbia, Vancouver,<br />
Canada<br />
Electrophysiology/Arrhythmias<br />
162 Temporal Association between Fluid Accumulation and<br />
Atrial and Ventricular Tachyarrhythmias: An Analysis <strong>of</strong><br />
46,696 CRT-D and ICD Patients<br />
John Andriulli 1 , Hans J. Moore 2 , James Johnson 3 , Vinod Sharma 3 ,<br />
Douglas A. Hettrick 3 , Steven M. Markowitz 4 ; 1 Cooper University<br />
Hospital, Camden, NJ; 2 Washington Veterans Affairs Medical<br />
Center, Washington, DC; 3 Medtronic, Inc., Minneapolis, MN;<br />
4<br />
Cornell University Medical Center, New York, NY<br />
163 ICD and CRT-D <strong>Heart</strong> <strong>Failure</strong> Patients with an<br />
Intrathoracic Impedance Fluid Index Threshold<br />
Crossing Have Significantly Increased Risk <strong>of</strong><br />
Ventricular Tachyarrhythmias<br />
John A. Andriulli 1 , J. Thomas Heywood 2 , Roy Small 3 , Wilson<br />
Tang 4 , Douglas Hettrick 5 , Clayton T. Miller 6 ; 1 Cooper University<br />
Hospital, Camden, NJ; 2 Scripps Clinic, La Jolla, CA; 3 Lancaster<br />
Medical Center, Lancaster, PA; 4 Cleveland Clinic, Cleveland,<br />
OH; 5 Medtronic Inc., Medtronic Inc., MN; 6 Medtronic Inc.,<br />
Medtronic Inc., MN<br />
164 Clinical Predictors <strong>of</strong> Chronic Cardiac<br />
Resynchronization Pacing Efficacy in the Failing<br />
Congenital <strong>Heart</strong><br />
Yamuna Sanil 1 , Lakshmi Nagaraju 1 , Kathleen Zelin 1 , Harinder<br />
R. Singh 1 , Peter P. Karpawich 1 ; 1 Section <strong>of</strong> Pediatric Cardiology,<br />
The Children’s Hospital <strong>of</strong> Michigan, Detroit Medical Center,<br />
Detroit, MI<br />
165 Clinical Predictors <strong>of</strong> Early Adverse Outcomes Recieving<br />
Cardiac Resynchronization Therapy: Large Scale Single<br />
Center Experience<br />
Clay A. Cauthen 1 , John Rickard 1 , Bruce L. Wilk<strong>of</strong>f 1 , W.H.<br />
Wilson Tang 1 ; 1 Departmenmt <strong>of</strong> Cardiovascular Medicine,<br />
Cleveland Clinic Foundation, Cleveland, OH<br />
70<br />
166 Extending Wearable Cardiac Defibrillator Use in <strong>Heart</strong><br />
<strong>Failure</strong> Patients beyond the ICD Waiting Period<br />
Nicole R. Bianco 1 , Steven J. Szymkiewicz 1 ; 1 Zoll, Pittsburgh, PA<br />
167 Increased Durability <strong>of</strong> Fidelis Leads in<br />
Resynchronization Systems<br />
Susan R. Vishneski 2 , Ashley C. Branch 1 , James F. Paulson 2 ,<br />
Linette R. Klevan 1 , John M. Herre 1 ; 1 Sentara Cardiovascular<br />
Research Institute, Norfolk, VA; 2 Eastern Virginia Medical<br />
School, Norfolk, VA<br />
168 Characteristics <strong>of</strong> Implantable Cardioverter-<br />
Defibrillator Recipients for the Primary and Secondary<br />
Prevention <strong>of</strong> Sudden Cardiac Death in the Outcomes<br />
among Veterans with Implantable Defibrillators (OVID)<br />
Registry<br />
David F. Katz 1 , Ryan G. Aleong 1 , Lauren Pointer 2 , Cara N.<br />
Pelligrini 4 , William H. Sauer 1 , Russell R. Heath 1 , Joseph<br />
Schuller 1 , Duy T. Nguyen 1 , Paul A. Heidenreich 5 , Barry M.<br />
Massie 4 , Paul D. Varosy 1,2,3 ; 1 Division <strong>of</strong> Cardiology, University<br />
<strong>of</strong> Colorado, Aurora, CO; 2 Division <strong>of</strong> Cardiology, VA Eastern<br />
Colorado Health Care System, Denver, CO; 3 Colorado<br />
Cardiovascular Outcomes Research, Denver, CO; 4 Division <strong>of</strong><br />
Cardiology, San Francisco VA Medical Center, San Francisco,<br />
CA; 5 Division <strong>of</strong> Cardiology, Palo Alto VA Medical Center, Palo<br />
Alto, CA<br />
169 Impact <strong>of</strong> Scar Burden on Outcomes <strong>of</strong> Cardiac<br />
Resynchronization Therapy<br />
Kelly L. Brooke 1 , Tracy L. Webster 1 , Yi-Zhou Xu 1 , Panithaya<br />
Chareonthaitawee 1 , Yong-Mei Cha 1 ; 1 Cardiovascular Diseases,<br />
Mayo Clinic, Rochester, MN<br />
170 Chronic Follow-Up <strong>of</strong> Comprehensive Pacemaker<br />
Optimization: LV-Only Pacing as an Available Option<br />
Ryan M. Gage 1 , Kevin V. Burns 1 , Daniel B. Vatterott 1 , Spencer<br />
H. Kubo 1 , Alan J. Bank 1 ; 1 Research Division, United <strong>Heart</strong> <br />
Vascular Clinic, St. Paul, MN<br />
Clinical Trials<br />
179 Effects <strong>of</strong> CRT Interval Optimization on Continuous<br />
Left Atrial Pressure Waveforms in Ambulant <strong>Heart</strong><br />
<strong>Failure</strong> Patients and Inter-Patient Repeatability<br />
Wandy Chan 1 , Richard Troughton 1 , Andreas Blomqvist 2 , Iain<br />
Melton 1 , Ian Crozier 1 , Kjell Noren 2 ; 1 Christchurch Hospital,<br />
Christchurch, New Zealand; 2 St Jude Medical AB, Sweden<br />
71<br />
MondAY
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Clinical Trials<br />
Posters<br />
Clinical Trials<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
180 Tafamidis Stabilizes Transthyretin and Improves Clinical<br />
Outcomes in Transthyretin Amyloid Cardiomyopathy<br />
Rodney Falk 1 , Matthew Maurer 2 , Savitri Fedson 3 , Daniel<br />
Judge 4 , Steven Zeldenrust 5 , Arshed Quyyumi 6 , Arian Pano 7 ,<br />
Jeff Packman 7 , Donna Grogan 7 ; 1 Harvard Vanguard Medical<br />
Associates, Boston, MA; 2 Columbia University College <strong>of</strong><br />
Physicians and Surgeons, New York, NY; 3 University <strong>of</strong><br />
Chicago Hospital, Chicago, IL; 4 Johns Hopkins University,<br />
Baltimore, MD; 5 Mayo Clinic College School <strong>of</strong> Medicine,<br />
Rochester, MN; 6 Emory University School <strong>of</strong> Medicine, Atlanta,<br />
GA; 7 FoldRx Pharmaceuticals, Inc., Cambridge, MA<br />
181 NT-proBNP-Guided Preemptive Treatment <strong>of</strong><br />
Outpatients with Chronic <strong>Heart</strong> <strong>Failure</strong> Followed in a<br />
Out Hospital Clinic<br />
Michael Shochat 1 , Avraham Shotan 1 , Iris Dahan 1 , Ilia Shochat 1 ,<br />
Yaniv Levy 1 , Aya Asif 1 , Mark Kazatsker 1 , David Blondheim 1 ,<br />
Simcha Meisel 1 ; 1 Cardiology, Hillel Yaffe, Hadera, Israel<br />
182 Shock Reduction Remains an Opportunity in Current<br />
Practice for ICD and CRT-D Patients<br />
Brett J. Peterson 1 , Grant Simons 4 , Scott Sakaguchi 3 , Christian<br />
Machado 5 , Michael O. Sweeney 2 , Fang Yang 1 ; 1 Medtronic,<br />
Mounds View, MN; 2 Brigham and Women’s Hospital, Boston,<br />
MA; 3 University <strong>of</strong> Minnesota, Minneapolis, MN; 4 Englewood<br />
Hospital and Medical Center, Englewood, NJ; 5 Providence<br />
Hospital and Medical Centers, Southfield, MI<br />
183 Relationship between Change in Ventricular Size<br />
and Function and BNP in Patients Undergoing CRT<br />
Therapy: MADIT-CRT<br />
Patricia Campbell 1 , Madoka Takeuchi 1 , Mikhail Bourgoun 1 , Scott<br />
McNitt 2 , Ilan Goldenberg 2 , Wojciech Zareba 2 , Arthur J. Moss 2 ,<br />
Marc A. Pfeffer 1 , Scott D. Solomon 1 ; 1 Cardiovascular Division,<br />
Brigham and Women’s Hospital, Boston, MA; 2 Cardiology<br />
Division, University <strong>of</strong> Rochester, Rochester, NY<br />
184 A Novel Method Using the Valsalvagram in the Diagnosis<br />
<strong>of</strong> <strong>Heart</strong> <strong>Failure</strong><br />
Herbert J. Semler 1 , Barry A. Borlaug 2 ; 1 Cardiovascular Medicine,<br />
Oregon Health Science University, Portland, OR; 2 Cardiology,<br />
Mayo Clinic, Rochester, MN<br />
185 Elevated Troponin Is Associated with Increased<br />
Mortality in Patients with Acute Dyspnea<br />
Yang Xue 1 , Paul Clopton 1 , Alan Maisel 1 ; 1 Cardiology, VA San<br />
Diego Healthcare System, San Diego, CA<br />
186 Safety and Efficacy <strong>of</strong> Ixmyelocel-T, an Expanded<br />
Patient-Specific Mixed Cell Product, in Dilated<br />
Cardiomyopathy (IMPACT-DCM)<br />
Amit N. Patel 1 , Baron L. Hamman 2 , Brian Bruckner 3 , Omar<br />
M. Lattouf 4 , Nicholas G. Smedira 5 , Cara East 2 , David A. Bull 1 ;<br />
1<br />
University <strong>of</strong> Utah, Salt Lake City, UT; 2 Baylor University<br />
Medical Center, Dallas, TX; 3 Methodist DeBakey <strong>Heart</strong> Center,<br />
Houston, TX; 4 Emory Crawford Long Hospital, Atlanta, GA;<br />
5<br />
Cleveland Clinic Foundation, Cleveland, OH<br />
187 Cystatin C as a Biomarker <strong>of</strong> Worsening Renal Function<br />
in Acute <strong>Heart</strong> <strong>Failure</strong>: Insights from the DOSE Study<br />
Raquel L. Bennett-Gittens 1,2 , Javed Butler 2 , Steve E. McNulty 3 ,<br />
Anekwe Onwuanyi 1 , Adefisayo Oduwole 1 , Mike Felker 3 , Adrian<br />
F. Hernandez 3 , Kerry L. Lee 3 , Brenda Lankford 1 , Elizabeth O.<br />
Ofili 1 ; 1 Internal Medicine-Cardiology Division, Morehouse<br />
School <strong>of</strong> Medicine, Atlanta, GA; 2 Internal Medicine-Cardiology<br />
Division, Emory University, Atlanta, GA; 3 Data Coordinating<br />
Center, Duke University, Durham, NC<br />
Cardiovascular Pharmacology<br />
198 Natriuretic Peptide Receptor 3 Genotype Is Associated<br />
with Altered Pharmacokinetics during Nesiritide<br />
Infusion<br />
David E. Lanfear 1 , James Yang 2 , Karen Leszczynski 1 , Hani N.<br />
Sabbah 1 ; 1 <strong>Heart</strong> and Vascular Institute, Henry Ford Hospital,<br />
Detroit, MI; 2 Public Health Sciences, Henry Ford Hospital,<br />
Detroit, MI<br />
199 Cellular Basis for Angiotensin-(1-7)-Induced Positive<br />
Modulation on Cardiac Contractile Performance in<br />
<strong>Heart</strong> <strong>Failure</strong><br />
Che Ping Cheng 1 , Peng Zhou 1 , Heng-Jie Cheng 1 ; 1 Internal<br />
Medicine-Cardiology, Wake Forest University School <strong>of</strong><br />
Medicine, Winston-Salem, NC<br />
200 Cardiorenal Actions <strong>of</strong> the Designer Natriuretic Peptide,<br />
CD-NP, in a Severe <strong>Heart</strong> <strong>Failure</strong> Model Treated with<br />
Furosemide<br />
Elizabeth C. Costello 1 , Guido Boerrigter 1 , Sarah Mangiafico 1 ,<br />
Alessandro Cataliotti 1 , John C. Burnett, Jr. 1 ; 1 Cardiovascular<br />
Research, Rochester, MN<br />
201 Atorvastatin Attenuates Atrial Remodeling by Its Anti-<br />
Oxidant and Anti-Inflammatory Action<br />
Y. Li, J. Shi, W.M. Li, Y.T. Gong, N. Yang; Harbin Medical<br />
University, Harbin, China; Harbin Medical University, Harbin,<br />
China; Harbin Medical University, Harbin, China; Harbin<br />
Medical University, Harbin, China; Harbin Medical University,<br />
Harbin, China<br />
MondAY<br />
72<br />
73
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Cardiovascular Pharmacology<br />
Posters<br />
Epidemiology/Prevention<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
202 Therapeutic Window for Cardioprotection by<br />
Recombinant Human Erythropoietin (rhEPO) in the Rat<br />
Model <strong>of</strong> Ischemia-Reperfusion: Implications for Clinical<br />
Trial Design<br />
Ismayil Ahmet 1 , Edward G. Lakatta 1 , Mark I. Talan 1 ; 1 Labratory<br />
<strong>of</strong> Cardiovascular Sciences, NIA/NIH, Baltimore, MD<br />
203 Biological Membrane Sealant Poloxamer 188 Improves<br />
Left Ventricular Function in Rats with Chronic <strong>Heart</strong><br />
<strong>Failure</strong><br />
Elizabeth Juneman 1 , Laith Saleh 1 , Tariq Niazi 1 , Jordan J.<br />
Lancaster 1 , Hoang Thai 1 , Bruce Markham 2 , Steven Goldman 1 ;<br />
1<br />
Cardiology, Southern Arizona VA Health Care System, Tucson,<br />
AZ; 2 University <strong>of</strong> Michigan, Ann Arbor, MI<br />
204 TRV120027, a Novel Beta-Arrestin Biased Ligand at the<br />
Angiotensin II Type I Receptor, Unloads the <strong>Heart</strong> and<br />
Maintains Renal Function When Added to Furosemide<br />
in Experimental <strong>Heart</strong> <strong>Failure</strong><br />
Guido Boerrigter 1 , David G. Soergel 2 , Michael W. Lark 2 , John C.<br />
Burnett, Jr. 1 ; 1 Mayo Clinic, Rochester, MN; 2 Trevena, Inc., King<br />
<strong>of</strong> Prussia, PA<br />
205 Discharge Prescription <strong>of</strong> Angiotensin II Receptor<br />
Blockers and All-Cause Mortality in Hospitalized<br />
Medicare Beneficiaries with <strong>Heart</strong> <strong>Failure</strong> and Preserved<br />
Ejection Fraction: A Propensity-Matched Study <strong>of</strong> the<br />
OPTIMIZE-HF<br />
Ali Ahmed 1,2 , Yan Zhang 1 , Marjan Mujib 1 , Pushkar P. Pawar 1 ,<br />
Tarun Arora 1 , Meredith Kilgore 1 , Inmaculada Aban 1 , Thomas<br />
Love 3 , Richard Allman 2,1 , Gregg Fonarow 4 ; 1 UAB, Birmingham,<br />
AL; 2 VA Medical Center, Birmingham, AL; 3 Case Western<br />
Reserve University, Cleveland, OH; 4 Cardiology, UCLA, Los<br />
Angeles, CA<br />
Epidemiology/Prevention<br />
214 Crystal Methamphetamine Associated <strong>Heart</strong> <strong>Failure</strong><br />
among Native Hawaiians and Pacific Islanders<br />
Ann E. Leonard 1 , Beth Blackburn 1 , Marjorie K. Mau 2 , May<br />
Vawer 1 , Todd B. Seto 1 ; 1 The Queen’s Medical Center, Honolulu,<br />
HI; 2 Native Hawaiian Health, John A. Burns School <strong>of</strong><br />
Medicine, Honolulu, HI<br />
215 Vaccination Rates in <strong>Heart</strong> <strong>Failure</strong>: Are We Missing the<br />
Target?<br />
Imran Khan 1 , Kiran Anna 1 , Mark E. Dunlap 2 ; 1 Medicine,<br />
MetroHealth Campus <strong>of</strong> Case Western Reserve, Cleveland, OH;<br />
2<br />
Cardiology, MetroHealth Campus <strong>of</strong> Case Western Reserve,<br />
Cleveland, OH<br />
216 The Prevalence and Predictors <strong>of</strong> Left Ventricular<br />
Systolic Dysfunction in Patients with Renal Artery<br />
Stenosis<br />
Eric E. Morgan 1,2 , Mujeeb Sheikh 2 , Christopher Cooper 2 ,<br />
Samer Khouri 2 ; 1 Department <strong>of</strong> Physiology and Pharmacology,<br />
University <strong>of</strong> Toledo College <strong>of</strong> Medicine, Toledo, OH;<br />
2<br />
Department <strong>of</strong> Medicine, University <strong>of</strong> Toledo Medical Center,<br />
Toledo, OH<br />
217 Anger Proneness Increases Risk <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong><br />
Anna Kucharska-Newton 1 , Patricia Chang 1 , Carla Dupree 1 ,<br />
Janice Williams 1 , Thomas Mosley 2 , Saul Blecker 3 , Sally Stearns 1 ;<br />
1<br />
University <strong>of</strong> North Carolina, Chapel Hill, NC; 2 University<br />
<strong>of</strong> Mississippi, Jackson, MS; 3 Johns Hopkins University,<br />
Baltimore, MD<br />
218 Ethnic Differences in Risk Prediction for <strong>Heart</strong> <strong>Failure</strong><br />
Rehospitalization<br />
Ma Wai Wai Zaw 1 , Shaw Yang Chia 2 , Ling Ling Sim 2 , Bernard<br />
Kwok 2 , Carolyn Lam 1 ; 1 National University Health System<br />
(NUHS), Singapore, Singapore; 2 National <strong>Heart</strong> Centre (NHC),<br />
Singapore, Singapore<br />
219 Post Traumatic Stress Disorder Is Associated with<br />
Increased Mortality in Stable Outpatients with Elevated<br />
B-Type Natriuretic Peptide<br />
Yang Xue 1 , Laura Redwine 2 , Pam Taub 1 , Paul Clopton 1 , Navaid<br />
Iqbal 1 , Arrash Fard 1 , Murray Stein 2 , Alan Maisel 1 ; 1 Cardiology,<br />
VA San Diego Healthcare System, San Diego, CA; 2 Psychiatry,<br />
VA San Diego Healthcare System, San Diego, CA<br />
220 The Value <strong>of</strong> Optimal Blood Pressure Control in<br />
Reducing Functional and Structural Cardiovascular<br />
Abnormalities<br />
Mahfouz El Shahawy 1 , Miglena Entcheva 1 ; 1 Cardiovascular<br />
Disease Assessment Center, Sarasota Memorial Hospital,<br />
Sarasota, FL<br />
Outcomes<br />
228 Consequences <strong>of</strong> Hyponatremia on Intensive Care Unit<br />
Cost and Length <strong>of</strong> Stay in <strong>Heart</strong> <strong>Failure</strong> Patients<br />
Alpesh Amin 1 , Steven Deitelzweig 2 , Jay Lin 3 , Kathy Belk 4 ,<br />
Dorothy Baumer 4 , Timothy Lowe 4 ; 1 University <strong>of</strong> California,<br />
Irvine, Irvine, CA; 2 Ochsner Health System, New Orleans, LA;<br />
3<br />
Novosyshealth, Flemington, NJ; 4 Premier, Inc., Charlotte, NC<br />
MondAY<br />
74<br />
75
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Outcomes<br />
Posters<br />
Outcomes<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
229 Development and Prospective Validation <strong>of</strong> a<br />
Pediatric <strong>Heart</strong> <strong>Failure</strong> Risk-Prediction Model for<br />
30-Day Mortality in US Children Listed for <strong>Heart</strong><br />
Transplantation<br />
Christopher S. Almond 1 , Kimberlee Gauvreau 1 , Charles E.<br />
Canter 2 , Gary E. Piercey 1 , T.P. Singh 1 ; 1 Children’s Hospital<br />
Boston, Boston, MA; 2 Pediatric Cardiology, St. Louis Children’s<br />
Hospital, St. Louis, MO<br />
230 International Variation in Use <strong>of</strong> Anticoagulation among<br />
<strong>Heart</strong> <strong>Failure</strong> Patients with Atrial Fibrillation<br />
Jorge Suarez 1 , Jonathan P. Piccini 1 , Li Liang 1 , John J. Atherton 2 ,<br />
Christopher S. Haywood 3 , Renato D. Lopes 1 , Adrian F.<br />
Hernandez 1 ; 1 Cardiology, Duke Clinical Research Institute,<br />
Durham, NC; 2 Cardiology, Royal Brisbane and Women’s<br />
Hospital, Brisbane, Queensland, Australia; 3 Cardiology, St<br />
Vincent’s Hospital, Sydney, New South Wales, Australia<br />
231 Serum Sodium Levels Have Strong Prognostic Value in<br />
Patients Admitted for <strong>Heart</strong> <strong>Failure</strong> and a Preserved<br />
Ejection Fraction<br />
Noah Moss 1 , Ronald Zolty 1 ; 1 Cardiology, Montefiore Medical<br />
Center, Bronx, NY<br />
232 Mortality in Pulmonary Hypertension Stratified by<br />
Sedimentation Rate<br />
Baruch Popovtzer 1 , Jason N. Salamon 1 , Jeremy Mazurek 1 ,<br />
Muhammad Sardar 1 , Ronald Zolty 1 ; 1 Cardiology, Montefiore<br />
Medical Center, Bronx, NY<br />
233 The Impact <strong>of</strong> Prior <strong>Heart</strong> <strong>Failure</strong> Hospitalizations on<br />
Long-Term Mortality Differs by Baseline Risk <strong>of</strong> Death<br />
Naga V.A. Kommuri 1 , Todd M. Koelling 2 , Scott L. Hummel 2,3 ;<br />
1<br />
Department <strong>of</strong> Internal Medicine, Detroit Medical Center:<br />
Sinai-Grace Hospital, Detroit, MI; 2 Division <strong>of</strong> Cardiovascular<br />
Medicine, University <strong>of</strong> Michigan, Ann Arbor, MI; 3 Staff<br />
Cardiologist, Ann Arbor Veterans’ Affairs Medical Center, Ann<br />
Arbor, MI<br />
234 Hemodynamic and Laboratory Correlations <strong>of</strong><br />
Symptoms in Patients with <strong>Heart</strong> <strong>Failure</strong><br />
Maya Guglin 1 , Catherine Law 1 ; 1 Cardiology, University <strong>of</strong> South<br />
Florida, Tampa, FL<br />
235 The Intermountain Risk Score Stratifies Mortality Risk<br />
in <strong>Heart</strong> <strong>Failure</strong> Patients Receiving an ICD Based on<br />
Pre-Implant Laboratory Values<br />
Kimberly D. Brunisholz 1 , Benjamin D. Horne 1 , Roberta James 1 ,<br />
Kyle D. Balling 1 , Kismet D. Rasmusson 1 , Deborah Budge 1 ,<br />
Rami Alharethi 1 , Dylan P. Nelson 1 , Joseph M. Tuinei 1 , Abdallah<br />
G. Kfoury 1 ; 1 <strong>Heart</strong> <strong>Failure</strong> Prevention and Treatment Program,<br />
Intermountain Medical Center, Salt Lake City, UT<br />
236 Do Doppler/Echo Variables Improve the Performance <strong>of</strong><br />
the Seattle <strong>Heart</strong> <strong>Failure</strong> Model in Predicting Outcomes?<br />
Omar F. Abouezzeddine 1 , Sultan A. Mirzoyev 1 , Wayne C.<br />
Levy 2 , Margaret M. Redfield 1 ; 1 Mayo Clinic, Rochester, MN;<br />
2<br />
University <strong>of</strong> Washington, Seattle, WA<br />
237 Severity <strong>of</strong> Left Atrial Enlargement Does Not Predict<br />
Mortality in <strong>Heart</strong> <strong>Failure</strong> Patients<br />
Ramesh Chandra 1 , Daniel Spevack 1 ; 1 Division <strong>of</strong> Cardiology,<br />
Montefiore Medical Center, Albert Einstein College <strong>of</strong><br />
Medicine, Bronx, NY<br />
238 Right Bundle Branch Block Is a Prognostic Marker for<br />
Cardiovascular Events in Patients Hospitalized with<br />
Acute <strong>Heart</strong> <strong>Failure</strong>: Data from KorHFR (Korean Acute<br />
<strong>Heart</strong> <strong>Failure</strong> Registry)<br />
Jaewon Oh 1 , Seok-Min Kang 1 , Sung Jin Hong 1 , Namki Hong 1 ,<br />
Hoyoun Won 1 , Sungha Park 1 , Yangsoo Jang 1 ; 1 Cardiology, Yonsei<br />
University Medical College, Seoul, Korea<br />
239 Alcohol Cardiomyopathy Is Associated with Worse Graft<br />
Survival after Cardiac Transplant<br />
Douglas M. Brinkley 1 , Edward M. Geltman 1 ; 1 Medicine,<br />
Washington University School <strong>of</strong> Medicine, St. Louis, MO<br />
240 Barriers and Facilitators to Implementing the 2010<br />
Veteran’s Administration (VA) CHF QUERI Hospital to<br />
Home (H2H) Initiative<br />
Nancy L. Oliva 1,2 , Anju Sahay 1 , Parisa Gholami 1 , Paul A.<br />
Heidenreich 1,3 ; 1 VA Chronic <strong>Heart</strong> <strong>Failure</strong> QUERI Center,<br />
VA Palo Alto Health Care System, Palo Alto, CA; 2 Geriatric<br />
Research, Education Clinical Center (GRECC), VA Palo Alto<br />
Health Care System, Palo Alto, CA; 3 Center for Primary Care <br />
Outcomes Research, Stanford University, Stanford, CA<br />
241 MELD Score at the Time <strong>of</strong> Surgery Does Not Predict<br />
Post-Operative Outcomes in Orthotopic <strong>Heart</strong><br />
Transplant<br />
Maria M. Patarroyo 1 , Cesar A. Simbaqueba 1 , W.H. Wilson<br />
Tang 2 , Randall Starling 2 , David O. Taylor 2 ; 1 Internal Medicine,<br />
Cleveland Clinic Foundation, Cleveland, OH; 2 Cardiovascular<br />
Medicine, Cleveland Clinic Foundation, Cleveland, OH<br />
242 Symptom Pr<strong>of</strong>iles in Advanced <strong>Heart</strong> <strong>Failure</strong> with<br />
Marked Differences in Quality-<strong>of</strong>-Life<br />
Christopher S. Lee 1 , Antony Y. Kim 1 , Jennifer Green 1 , Anne<br />
Rosenfeld 1 ; 1 Oregon Health Science Univ., Portland, OR<br />
MondAY<br />
76<br />
77
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Outcomes<br />
Posters<br />
Outcomes<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
243 Impact <strong>of</strong> Hyponatremia on Inpatient Mortality and<br />
Hospital Readmission Rates in Hospitalized Patients<br />
with <strong>Heart</strong> <strong>Failure</strong><br />
Steven Deitelzweig 1 , Alpesh Amin 2 , Jay Lin 3 , Kathy Belk 4 ,<br />
Dorothy Baumer 4 , Timothy Lowe 4 ; 1 Ochsner Health System,<br />
New Orleans, LA; 2 University <strong>of</strong> California, Irvine, Irvine, CA;<br />
3<br />
Novosyshealth, Flemington, NJ; 4 Premier, Inc., Charlotte, NC<br />
244 Red Blood Cell Distribution Width Predicts In-Hospital<br />
Mortality in Acute Dyspnea Patients with or without<br />
Acute <strong>Heart</strong> <strong>Failure</strong>: Data from YONDER (YONsei<br />
Dyspnea on Emergency Department Registry) Study<br />
Namki Hong 1 , Seok-Min Kang 1 , Jaewon Oh 1 , Soo-Young Kim 1 ,<br />
Hoyoun Won 1 , Sungha Park 1 , Yangsoo Jang 1 ; 1 Cardiology, Yonsei<br />
University Medical College, Seoul, Korea<br />
245 The PROTECT In-Hospital Risk Model: 7-Day Outcome<br />
in Patients Hospitalized with Acute <strong>Heart</strong> <strong>Failure</strong> (AHF)<br />
and Renal Dysfunction<br />
R.J. Mentz 1 , M. Fiuzat 1 , K. Chiswell 1 , D. Wojdyla 1 , B. Davison 2 ,<br />
J. Cleland 3 , H.C. Dittrich 4 , M.M. Givertz 5 , G. Mansoor 4 , P.<br />
Ponikowski 6 , J.R. Teerlink 7 , A.A. Voors 8 , G. Cotter 2 , M. Metra 9 ,<br />
B.M. Massie 7 , C.M. O’Connor 1 ; 1 Duke, Durham; 2 Momentum<br />
Res, Durham; 3 Univ <strong>of</strong> Hull, Hull, United Kingdom; 4 Merck<br />
Res, Rahway; 5 BWH, Boston; 6 Med Univ, Wroclaw, Poland;<br />
7<br />
UCSF SF VAMC, San Francisco; 8 Univ Med Ctr, Groningen,<br />
Netherlands; 9 Univ Brescia, Brescia, Italy<br />
246 A Blended Facilitation To Implement the VA Hospital-to-<br />
Home (H2H) Initiative: CHF QUERI<br />
Anju Sahay 1 , Paul A. Heidenreich 1 ; 1 CHF QUERI, Dept <strong>of</strong><br />
Veterans Affairs, Palo Alto, CA<br />
247 Association <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong> Symptoms Identified by<br />
Home Monitoring with Long-Term Mortality and Shock<br />
Incidence<br />
Paul A. Heidenreich 1 , John P. Boehmer 2 , David L. Hayes 3 , F.R.<br />
Gilliam 4 , John D. Day 5 , Milan Seth 6 , Leslie A. Saxon 7 ; 1 VA Palo<br />
Alto Health Care System, Palo Alto, CA; 2 Penn State, Hershey,<br />
PA; 3 Mayo Clinic, Rochester, MN; 4 Cardiology Associates <strong>of</strong><br />
NE Arkansas, Jonesboro, AR; 5 Intermountain Health System,<br />
Salt Lake City, UT; 6 Boston <strong>Scientific</strong>, St. Paul, MN; 7 USC, Los<br />
Angeles, CA<br />
248 True Biventricular Pacing Favors Outcomes <strong>of</strong> Cardiac<br />
Resynchronization<br />
Kelly L. Brooke 1 , Tracy A. Webster, Heather Wiste, Samuel J.<br />
Asirvatham, David L. Hayes, Yong-Mei Cha; 1 Cardiovascular<br />
Diseases, Mayo Clinic, Rochester, MN<br />
249 Peripartum Cardiomyopathy – Is the Current Definition<br />
Too Restrictive?<br />
Kismet Rasmusson 1 , Kim Brunisholz 1 , Deborah Budge 1 , Rami<br />
Alharethi 1 , Jenny Connolly 1 , Benjamin Horne 1 , Kurt Jensen 1 ,<br />
Josef Stehlik 2 , Abdallah Kfoury 1 ; 1 <strong>Heart</strong> <strong>Failure</strong> Prevention and<br />
Treatment Program, Intermountain Medical Center, Salt Lake<br />
City, UT; 2 <strong>Heart</strong> <strong>Failure</strong> and Transplant, University Hospital,<br />
Salt Lake City, UT<br />
250 Resource Use and Medical Costs by Cause <strong>of</strong> Death in<br />
HF-ACTION<br />
Yanhong Li 1 , David J. Whellan 2 , Mark E. Dunlap 3 , William<br />
E. Kraus 1 , Gregory Samsa 1 , Kevin A. Schulman 1 , Michael<br />
Zile 4 , Shelby D. Reed 1 ; 1 Duke Clinical Research Institute,<br />
Duke University, Durham, NC; 2 Jefferson Medical Center,<br />
Philadelphia, PA; 3 Case Western Reserve University, Cleveland,<br />
OH; 4 Medical University <strong>of</strong> South Carolina, Charleston, OH<br />
251 Regadenoson Stress SPECT MPI for Prediction <strong>of</strong><br />
Outcomes in Patients with Impaired Left Ventricular<br />
Function: A Comparison with Adenosine Stress<br />
Salvador Borges-Neto 1 , Linda K. Shaw 1 , Mona Fiuzat 1 , Robert<br />
Pagnanelli 1 , Christopher M. O’Connor 1 ; 1 Medicine/Cardiology,<br />
Duke University, Durham, NC<br />
252 Aggressive Diuresis as a Predictor <strong>of</strong> Hospital<br />
Readmission Due to Acute <strong>Heart</strong> <strong>Failure</strong> Exacerbations<br />
in Elderly Patients<br />
Shirley Wong 1 , Norela Ocampo 1 , Rebecca Cheung 1 , Jun Chiong 1 ;<br />
1<br />
Department <strong>of</strong> Pharmacotherapy and Outcomes Science, Loma<br />
Linda University, Loma Linda, CA<br />
253 Improved <strong>Heart</strong> <strong>Failure</strong> Outcomes through Family<br />
Involvement<br />
Patricia E. Briggs 1 ; 1 Nursing, Christiana Care Health Services,<br />
Newark, DE<br />
254 Risk Scoring in Cardiac <strong>Failure</strong> and eCPR Patients<br />
Requiring ECMO Support<br />
Richard K. Cheng 1 , Chi-hong Tseng 2 , Richard Shemin 3 , W. Robb<br />
MacLellan 1 ; 1 Cardiology, UCLA, Los Angeles, CA; 2 General<br />
Internal Medicine, UCLA, Los Angeles, CA; 3 Cardiothoracic<br />
Surgery, UCLA, Los Angeles, CA<br />
Clinical Care/Management Strategies<br />
282 Pulse Pressure Widening Is a Determinant <strong>of</strong> Diastolic<br />
Dysfunction<br />
Mahazarin Ginwalla 1 , Florian Rader 1 , Tilak Pasala 1 , Jeremy<br />
Johnson 1 , Mark Dunlap 1 ; 1 Cardiology, Metrohealth Medical<br />
Center/CWRU, Cleveland, OH<br />
MondAY<br />
78<br />
79
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Clinical Care/Management Strategies<br />
Posters<br />
Clinical Care/Management Strategies<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
283 Impact <strong>of</strong> a <strong>Heart</strong> <strong>Failure</strong> “Teach to Goal” Intervention<br />
in Low Literacy Patients<br />
Aurelia Macabasco-O’Connell 1 , Adriana Mendez 1 , Michael<br />
Pignone 2 ; 1 School <strong>of</strong> Nursing, University <strong>of</strong> California Los<br />
Angeles, Los Angeles, CA; 2 Department <strong>of</strong> Medicine, University<br />
<strong>of</strong> North Carolina-Chapel Hill, Chapel Hill, NC<br />
284 Different Features <strong>of</strong> the Apical and Non-Apical Types <strong>of</strong><br />
Stress-Induced Cardiomyopathy<br />
Sun Hwa Lee 1 , Won Ho Kim 1 , Jae Ki Ko 1 , Yun Ji Park 1 , Lae<br />
Young Jung 1 , Min Ju Song 1 , Hae Eun Yun 1 ; 1 Cardiology,<br />
Chonbuk National University Medical School, Jeonju, Korea<br />
285 Significant Barriers Exist in the Appropriate Utilization<br />
<strong>of</strong> Echo Contrast Agents in the <strong>Heart</strong> <strong>Failure</strong> Population<br />
Sara L. Partington 1 , Shelley Hurwitz 1 , Judy R. Mangion 1 ;<br />
1<br />
Non-Invasive Cardiovascular Imaging, Brigham and Women’s<br />
Hospital, Boston, MA<br />
286 Ketamine-Induced Ventricular Remodeling: Pathological<br />
Consequences and Protective Effects <strong>of</strong> Metoprolol<br />
Y. Li, J. Shi, B.F. Yang, Z.H. Gong, W.M. Li; Harbin Medical<br />
University, Harbin, China; Harbin Medical University, Harbin,<br />
China; Harbin Medical University, Harbin, China; Harbin<br />
Medical University, Harbin, China; Harbin Medical University,<br />
Harbin, China<br />
287 The Swan-Ganz Catheter and UNOS IA Patients: The<br />
Routine Change Challange<br />
Jason A. Gluck 1 , Roja Mulamalla 1 , Joseph Radojevic 1 , Justin<br />
Lundbye 1 , Detlef Wencker 1 ; 1 Cardiology, Hartford Hosptial,<br />
Hartford, CT<br />
288 Are Telemonitoring and Structured Telephone Support<br />
More Effective in Younger or Older <strong>Heart</strong> <strong>Failure</strong><br />
Patients? A Sensitivity Analysis from a Cochrane Review<br />
Sally C. Inglis 1 , Robyn A. Clark 2 , Simon Stewart 3 , Finlay A.<br />
McAlister 4 , John G.F. Cleland 5 ; 1 University <strong>of</strong> Technology,<br />
Sydney, Australia; 2 Queensland University <strong>of</strong> Technology,<br />
Brisbane, Australia; 3 Baker IDI <strong>Heart</strong> and Diabetes Institute,<br />
Melbourne, Australia; 4 University <strong>of</strong> Alberta, Edmonton,<br />
Canada; 5 Castle Hill Hospital, East Yorkshire, United Kingdom<br />
289 HF Assessment with BNP in the Home: Primary Results<br />
<strong>of</strong> the Mulitcenter HABIT Trial<br />
Alan S. Maisel 1 , Denise Banard 2 , Brian Jaski 3 , Geir Frivold 4 ,<br />
John Marais 5 , Barry Greenberg 2 ; 1 Medicine, San Diego VA<br />
Medical Center, San Diego, CA; 2 University <strong>of</strong> California San<br />
Diego, San Diego, CA; 3 San Diego Sharp Medical Center, San<br />
Diego, CA; 4 Loma Linda Medical Center, Loma Linda, CA<br />
290 Fatigue Correlates to Functional Status Better Than<br />
Dyspnea or Orthopnea<br />
Jesal Popat 1 , Maya Guglin 1 ; 1 Department <strong>of</strong> Cardiovascular<br />
Medicine, University <strong>of</strong> South Florida, Tampa, FL<br />
291 Utilisation <strong>of</strong> Telehome Monitoring in Patients over the<br />
Age <strong>of</strong> 75 with Complex <strong>Heart</strong> <strong>Failure</strong>; Does Age Make<br />
Any Difference?<br />
Genevieve Lemay 1 , Nahid Azad 2 , Christine Struthers 3 ; 1 Internal<br />
Medicine, University <strong>of</strong> Ottawa, Ottawa, Canada; 2 Geriatric<br />
Medicine, The Ottawa Hospital, Ottawa, Canada; 3 The <strong>Heart</strong><br />
Institute, Ottawa, Canada<br />
292 Bi<strong>of</strong>eedback Training in Patients with Advanced <strong>Heart</strong><br />
<strong>Failure</strong><br />
Dana L. Frank 1 , Matthew Baumann 1 , Michael Liebenstein 1 ,<br />
Lamees Khorshid 1 , Gregory J. Bolwell 1 , Jerome Kiffer 1 , W.H.<br />
Wilson Tang 1 , James B. Young 1 , Randall C. Starling 1 , Michael G.<br />
McKee 1 , Christine S. Moravec 1 ; 1 Cleveland Clinic, Cleveland,<br />
OH<br />
293 Lack <strong>of</strong> Association <strong>of</strong> Changes in BNP with Cardiorenal<br />
Syndrome during Treatment <strong>of</strong> Acute Decompensated<br />
<strong>Heart</strong> <strong>Failure</strong><br />
Sameer Ather 1 , Mark D. McCauley 1 , Amandeep Dhaliwal 1 , Anita<br />
Deswal 1,2 , Wenyaw Chan 3 , David Aguilar 1,2 , Allison M. Pritchett 1 ,<br />
Kumudha Ramasubbu 1,2 , Xander H.T. Wehrens 1 , Biykem<br />
Bozkurt 1,2 ; 1 Baylor College <strong>of</strong> Medicine, Houston, TX; 2 Michael<br />
E DeBakey VA Hospital, Houston, TX; 3 UT School <strong>of</strong> Public<br />
Health, Houston, TX<br />
294 Changes in Galectin-3 Levels over Time Predict<br />
Mortality and Morbidity in Chronic HF<br />
Rudolf A. de Boer 2 , Dirk J. van Veldhuisen 2 , Lars Gullestad 3 ,<br />
Thor Ueland 3 , Pal Aukrust 3 , Yu Guo 1 , Aram S. Adourian 1 ,<br />
Pieter Muntendam 1 ; 1 BG Medicine Inc., Waltham, MA;<br />
2<br />
University Medical Centre Groningen, Groningen, Netherlands;<br />
3<br />
Rikshospitalet University Hospital, Oslo, Norway<br />
295 Emergency Department Diuretic Dosing in Acute<br />
Decompensated <strong>Heart</strong> <strong>Failure</strong> and Its Effect on Length<br />
<strong>of</strong> Stay and Re-Admission Rate<br />
Jacqueline Fearon-Clarke 1 , Simarta Brennan 1 , Rami Bustami 1 ,<br />
Betty Merveil-Ceneus 1 , Bernardo Vargas 1 , Rosmery Montesino 1 ,<br />
Steven Sheris 1 ; 1 Cardiology, Gagnon Cardiovascular Institute at<br />
Overlook Hospital, Atlantic Health, Summit, NJ<br />
296 A Multi-Disciplinary Hospital to Home Initiative To<br />
Reduce <strong>Heart</strong> <strong>Failure</strong> Readmissions<br />
Zachary L. Cox 1,2 , Brittany L. Cunningham 1 , Thomas DiSalvo 1 ;<br />
1<br />
Vanderbilt University Medical Center, Nashville, TN;<br />
2<br />
Lipscomb University College <strong>of</strong> Pharmacy, Nashville, TN<br />
MondAY<br />
80<br />
81
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Clinical Care/Management Strategies<br />
Posters<br />
Clinical Care/Management Strategies<br />
Sept. 19<br />
Monday<br />
Posters<br />
MondAY<br />
297 Plasma Galectin-3 Is Associated with Near-Term<br />
Rehospitalization in <strong>Heart</strong> <strong>Failure</strong>: A Meta-Analysis<br />
Rudolf A. de Boer 1 , Dirk J. van Veldhuisen 1 , Christopher<br />
deFilippi 2 , Pieter Muntendam 3 , Aram S. Adourian 3 , Yu Guo 3 ,<br />
James L. Januzzi 4 ; 1 University Medical Centre Groningen,<br />
Groningen, Netherlands; 2 Division <strong>of</strong> Cardiology, University<br />
<strong>of</strong> Maryland, Baltimore, MD; 3 BG Medicine Inc., Waltham,<br />
MA; 4 Division <strong>of</strong> Cardiology, Massachusetts General Hospital,<br />
Boston, MA<br />
298 Design, Feasibility, and Clinical Characteristics <strong>of</strong> a<br />
Novel <strong>Heart</strong> <strong>Failure</strong> with Preserved Ejection Fraction<br />
Program<br />
Sanjiv J. Shah 1 , Michael A. Burke 1 , Deepak Gupta 1 , Venkatesh<br />
Anjan 1 , John B. O’Connell 1 , Mihai Gheorghiade 1 , Robert O.<br />
Bonow 1 ; 1 Medicine, Northwestern University Feinberg School <strong>of</strong><br />
Medicine, Chicago, IL<br />
299 Medical Management Guided by Pulmonary Artery<br />
Pressures in NYHA Functional Class III <strong>Heart</strong> <strong>Failure</strong><br />
Patients<br />
Maria Rosa Costanzo 1 , William T. Abraham 2 , Philip B.<br />
Adamson 3 , Pam A. Cowart 4 , Kevin M. Corcoran 4 , Greg L.<br />
Ginn 4 ; 1 Cardiology, Midwest <strong>Heart</strong> Foundation, Naperville, IL;<br />
2<br />
Cardiology, Ohio State University, Columbus, OH; 3 Cardiology,<br />
Oklahoma Foundation for Cardiovascular Research, Oklahoma<br />
City, OK; 4 CardioMEMS Inc, Atlanta, GA<br />
300 Medication Management Strategies <strong>of</strong> Community <strong>Heart</strong><br />
<strong>Failure</strong> Programs in Australia<br />
Alexandra A. Bennett 1,2 , Deborah Tong 1 , Patricia M. Davidson 3 ,<br />
Andrew M. McLachlan 1,2 ; 1 Faculty <strong>of</strong> Pharmacy, The University<br />
<strong>of</strong> Sydney, Sydney, NSW, Australia; 2 Centre for Education and<br />
Research on Ageing, The University <strong>of</strong> Sydney and Concord<br />
General Repatriation Hospital, Sydney, NSW, Australia; 3 Curtin<br />
Health Innovation Research Institute, Curtin University, Sydney,<br />
NSW, Australia<br />
301 Does the Interpretation <strong>of</strong> Fluid Threshold Crossings<br />
Differ between <strong>Heart</strong> <strong>Failure</strong> and Non <strong>Heart</strong> <strong>Failure</strong><br />
Centers? Analysis from the OptiVol Care Pathway Study<br />
Roy S. Small 1 , John Andriulli 2 , W.H. Wilson Tang 3 , J. Thomas<br />
Heywood 4 , Clayton Miller 5 ; 1 Cardiology, The <strong>Heart</strong> Group<br />
<strong>of</strong> Lancaster General Health, Lancaster, PA; 2 Cardiology,<br />
University <strong>of</strong> Medicine and Dentistry New Jersey, Voorhees,<br />
NJ; 3 Cardiovascular Medicine, Cleveland Clinic, Cleveland,<br />
OH; 4 Cardiology, Scripps Clinic Torrey Pines, La Jolla, CA;<br />
5<br />
Research, Medtronic, Mounds View, MN<br />
302 Total Body Water Measured with BIVA (Bioelectrical<br />
Impedance Vector Analysis) Predicts Outcome in<br />
Patients Hospitalized with Acute <strong>Heart</strong> <strong>Failure</strong><br />
Carolyn Haunschild 1 , Paul Clopton 2 , Yang Xue 1 , Alan S. Maisel 1 ;<br />
1<br />
Cardiology, University <strong>of</strong> California San Diego, San Diego,<br />
CA; 2 Cardiology, San Diego Veteran Affairs Healthcare System,<br />
San Diego, CA<br />
303 NT-proBNP Guided Therapy Improves the Quality <strong>of</strong><br />
Life in Patients with Chronic <strong>Heart</strong> <strong>Failure</strong>. Results<br />
from the ProBNP Outpatient Tailored Chronic <strong>Heart</strong><br />
<strong>Failure</strong> Therapy Study<br />
Anju Bhardwaj 1 , Shafiq U. Rehman 1 , Asim A. Mohammed 1 ,<br />
Han-na Kim 1 , Linda Barajas 1 , Justine Barajas 1 , Stephanie A.<br />
Moore 1 , Dorothy Sullivan 1 , James L. Januzzi 1 ; 1 Cardiology,<br />
Massachusetts General Hospital, Boston, MA<br />
304 Cardiomyopathy Characterized by Normal<br />
Interventricular Septal Thickness in Amyloidosis:<br />
Description <strong>of</strong> a New Entity<br />
Rahul Suresh 1 , Patricia A. Pellikka 2 , Angela Dispenzieri 2 ,<br />
Naveen L. Pereira 2 ; 1 Mayo Medical School, Mayo Clinic,<br />
Rochester, MN; 2 Medicine, Mayo Clinic, Rochester, MN<br />
305 H1N1 and De Novo Cardiac Dysfunction or<br />
Exacerbation <strong>of</strong> Existing Cardiac Disease in Patients<br />
Admitted to Hospital<br />
Courtney A. Young, Sayeh Zielke, Debra L. Isaac; University <strong>of</strong><br />
Calgary, Calgary, AB<br />
306 Correlation <strong>of</strong> Weight Change and Net Fluid Status as<br />
Markers <strong>of</strong> Diuretic Efficacy<br />
Zachary Cox 1,2 , Thomas DiSalvo 1 ; 1 Vanderbilt University<br />
Medical Center, Nashville, TN; 2 Lipscomb University College<br />
<strong>of</strong> Pharmacy, Nashville, TN<br />
307 Symptom-Monitoring and Treatment-Seeking Behaviors<br />
in Japanese Patients with <strong>Heart</strong> <strong>Failure</strong>: A Multicenter<br />
Study<br />
Naoko Kato 1 , Koichiro Kinugawa 1 , Etsuko Nakayama 2 ,<br />
Akiko Hatakeyama 2 , Yumiko Kumagai 2 , Taro Shiga 1 , Masaru<br />
Hatano 1 , Atsushi Yao 1 , Chikako Miura 2 , Masayoshi Nagayama 3 ,<br />
Tetsuya Sumiyoshi 3 , Ryozo Nagai 1 ; 1 Cardiovascular Medicine,<br />
The University <strong>of</strong> Tokyo Hospital, Tokyo, Japan; 2 Nursing,<br />
Sakakibara <strong>Heart</strong> Institute, Tokyo, Japan; 3 Cardiology,<br />
Sakakibara <strong>Heart</strong> Institute, Tokyo, Japan<br />
MondAY<br />
82<br />
83
Sept. 19<br />
Monday<br />
Posters<br />
Posters<br />
Clinical Care/Management Strategies<br />
Posters<br />
Clinical Care/Management Strategies<br />
Sept. 19<br />
Monday<br />
Posters<br />
308 Ultrafiltration Is Associated with Worsening Renal<br />
Function, and Electrolyte Abnormalities in Patients<br />
with Diuretic Refractory <strong>Heart</strong> <strong>Failure</strong> and Renal<br />
Dysfunction<br />
Shailesh C. Shirolkar 1 , G. Michael Felker 1 , Susanna R. Stevens 1 ,<br />
Minnie P. Blackwell 1 , Shelley L. Thompson 1 , Joseph G. Rogers 1 ,<br />
Christopher M. O’Connor 1 , Sandesh Dev 1 ; 1 Duke Clinical<br />
Research Institute, Durham, NC<br />
315 Nutritional Supplementation with Amino Acids<br />
in Ambulatory Patients with Idiophatic Dilatated<br />
Cardiomyophaty<br />
Carlo Lombardi 1 , Metra Marco 1 , Maiandi Cristian 1 , Filippo<br />
Quinzani 1 , Giovanni Cuminetti 1 , Anna Isotta Castriani 1 , Federica<br />
Guidetti 1 , Nodari Savina 1 , M. Gheorghiade 2 , Dei Cas Livio 1 ;<br />
1<br />
Cardiology, University <strong>of</strong> Brescia, Brescia, Italy; 2 Northwestern<br />
University, Chicago, IL<br />
MondAY<br />
309 Mortality in Primary Pulmonary Arterial Hypertension<br />
Stratified by Hemoglobin Levels<br />
Baruch Popovtzer 1 , Jason N. Salamon 1 , Jeremy Mazurek 1 ,<br />
Muhammad Sardar 1 , Ronald Zolty 1 ; 1 Cardiology, Montefiore<br />
Medical Center, Bronx, NY<br />
316 <strong>Heart</strong> <strong>Failure</strong> in Cancer: Is Interactive Voice Response<br />
System (IVRS) Feasible for Symptom Management?<br />
Anecita P. Fadol, Tito Mendoza, Pankil Shah, Charles Cleeland;<br />
Cardiology, MD Anderson Cancer Center, Houston, TX;<br />
Symptom Research, MD Anderson Cancer Center, Houston, TX<br />
MondAY<br />
310 Racial Disparities in Patients Selected for Advanced<br />
<strong>Heart</strong> <strong>Failure</strong> Therapies<br />
Neelima Nadella 1 , Sevan S. Karadolian 2 , Mohamed Ahmed 2 ,<br />
Celeste Williams 1 , Henry E. Kim 1 ; 1 Cardiovascular Medicine,<br />
Henry Ford Hospital, Detroit, MI; 2 Department <strong>of</strong> Internal<br />
Medicine, Henry Ford Hospital, Detroit, MI<br />
317 Short and Long-Term Outcome <strong>of</strong> Impedance-Guided<br />
Preemptive Therapy Provided To Prevent Acute <strong>Heart</strong><br />
<strong>Failure</strong> in the Course <strong>of</strong> Acute Myocardial Infarction<br />
Michael Shochat 1 , Avraham Shotan 1 , Ilia Shochat 1 , Iris Dahan 1 ,<br />
Aya Asif 1 , David Blomdhaim 1 , Simcha Meisel 1 ; 1 Cardiology,<br />
Hillel Yaffe Medical Center, Hadera, Israel<br />
311 Bioimpedance Improves the Diagnostic Accuracy for<br />
Acute <strong>Heart</strong> <strong>Failure</strong> in the Emergency Department<br />
Tertius Tuy 1 , Lori Fiessinger 2 , Asha Talati 3 , Jieun Kim 1 , W. Frank<br />
Peacock 4 ; 1 Duke-NUS Graduate Medical School, Singapore,<br />
Singapore; 2 Case Western Reserve University SOM, Cleveland,<br />
OH; 3 Cleveland Clinic Lerner College <strong>of</strong> Medicine, Cleveland,<br />
OH; 4 Cleveland Clinic, Cleveland, OH<br />
318 New Discoveries Regarding the Limitations <strong>of</strong><br />
Impedance Monitoring for <strong>Heart</strong> <strong>Failure</strong> Management<br />
Chris Charles 1 , Miriam Rademaker 1 , Iain Melton 1 , Jeff Siou 2 ,<br />
Riddhi Shah 2 , Fujian Qu 2 , Neal Eigler 2 , Dan Gutfinger 2 , Richard<br />
Troughton 1 ; 1 Christchurch Cardioendocrine Research Group,<br />
University <strong>of</strong> Otago, Christchurch, New Zealand; 2 Cardiac<br />
Rhythm Management Division, St Jude Medical, Sylmar, CA<br />
312 Can Echocardiographic Characteristics Help Predict<br />
Response to Echo-Guided Biventricular Pacemaker<br />
Optimization?<br />
Salima Qamruddin 1 , Reza Rafie 1 , Tasneem Z. Naqvi 1 ; 1 Non<br />
Invasive Lab, Division <strong>of</strong> Cardiology, Department <strong>of</strong> Medicine,<br />
University <strong>of</strong> Southern California, Los Angeles, CA<br />
313 History Taking Differences in Acute <strong>Heart</strong> <strong>Failure</strong><br />
Patients by Emergency Medicine and Internal Medicine<br />
Physicians Leads to Differing Initial Management<br />
Ankitkumar K. Patel 1 , Kevin Curl 2 , Sajjad Sabir 1 , Foluso<br />
Fakorede 1 , Walid Saad 1 , Dany Gaspard 1 , Elias Iliadis 1 ;<br />
1<br />
Cardiology, Cooper University Hospital, Robert Wood Johnson<br />
Medical School, Camden, NJ; 2 Penn State College <strong>of</strong> Medicine,<br />
Hershey, PA<br />
314 Clinical Characteristics and Outcomes <strong>of</strong> Patients with<br />
Improvement in Renal Function during the Treatment <strong>of</strong><br />
Decompensated <strong>Heart</strong> <strong>Failure</strong><br />
Jeffrey M. Testani 1 , Brian D. McCauley 1 , Jennifer Chen 1 , Steven<br />
G. Coca 2 , Thomas P. Cappola 1 , Stephen E. Kimmel; 1 Medicine,<br />
University <strong>of</strong> Pennsylvania, Philadelphia, PA; 2 Medicine, Yale<br />
University, New Haven, CT<br />
84<br />
85
Sept. 20<br />
Tuesday<br />
AM<br />
ROUNDTABLE<br />
Tuesday, September 20<br />
7:00-8:15 AM<br />
Room 304<br />
CLINICAL FUNDAMENTALS<br />
Tuesday, September 20<br />
7:00-8:15 AM<br />
Room 302<br />
Sept. 20<br />
Tuesday<br />
AM<br />
Roundtable: Centers for VAD/Transplant/<strong>Heart</strong><br />
<strong>Failure</strong>: All or None?<br />
Clinical Fundamentals: Transplantation/<br />
Palliative Care<br />
TuesdAY<br />
Moderator: Clyde W. Yancy, Chicago, IL<br />
7:00 <strong>Heart</strong> <strong>Failure</strong> Management<br />
John B. O’Connell, Atlanta, GA<br />
7:10 Patient Selection within Centers <strong>of</strong> Excellence<br />
Dennis Irwin, Minneapolis, MN<br />
7:20 Discussion<br />
7:35 VAD Over Transplant<br />
Maria Rosa Costanzo, Naperville, IL<br />
7:45 VAD with Transplant<br />
Robert L. Kormos, Pittsburgh, PA<br />
8:00 Discussion<br />
Learning Objective: Outline the important issues<br />
surrounding certification <strong>of</strong> centers for heart transplantation<br />
<strong>of</strong> VAD implantation.<br />
Moderators: Kismet D. Rasmusson, Murray, UT<br />
Stuart D. Russell, Baltimore, MD<br />
7:00 Identifying Patients Who Have Failed Optimal Medical<br />
Therapy<br />
David J. Whellan, Philadelphia, PA<br />
7:10 Selection, Priority, Early and Late Outcomes with<br />
Transplantation<br />
David O. Taylor, Cleveland, OH<br />
7:20 Current Immunosuppression Regimens and Rejection<br />
John Chin, Sacramento, CA<br />
7:35 The Rest <strong>of</strong> the Regimen and Why<br />
Connie L. White-Williams, Birmingham, AL<br />
7:45 Allograft Vasculopathy<br />
Stephanie A. Moore, Boston, MA<br />
7:55 Changing Goals <strong>of</strong> Care in Advanced Disease<br />
James N. Kirkpatrick, Philadelphia, PA<br />
8:10 Questions and Answers<br />
Faculty<br />
Learning Objective: Describe strategies for identifying and<br />
treating patients with advanced heart failure appropriate for<br />
transplantation or palliative care.<br />
TuesdAY<br />
86<br />
87
Sept. 20<br />
Tuesday<br />
AM<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
8:30-10:00 AM<br />
Ballroom A<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
8:30-10:00 AM<br />
Ballroom C<br />
Sept. 20<br />
Tuesday<br />
AM<br />
TuesdAY<br />
Improving Outcomes after Hospitalization for<br />
<strong>Heart</strong> <strong>Failure</strong>: A Call for Action<br />
Moderators: Mihai Gheorghiade, Chicago, IL<br />
Kenneth M. Stein, St. Paul, MN<br />
8:30 Introduction and Background<br />
Mihai Gheorghiade, Chicago, IL<br />
8:40 NIH View<br />
Monica R. Shah, Bethesda, MD<br />
8:50 View from Pharma<br />
Frank Misselwitz, Wuppertal, Germany<br />
9:00 View from the Device Arena<br />
Marshall S. Stanton, Mounds View, MN<br />
9:10 Measuring Hospital Performance<br />
Frederick A. Masoudi, Denver, CO<br />
9:20 The Hospitalist<br />
Jeffrey L. Greenwald, Boston, MA<br />
9:30 The ED<br />
Peter S. Pang, Chicago, IL<br />
9:40 Panel Discussion<br />
Learning Objective: Outline strategies for improving<br />
outcomes for heart failure patients following hospitalization.<br />
Time To Slow Down<br />
Moderators: Wilson S. Colucci, Boston, MA<br />
David E. Lanfear, Detroit, MI<br />
8:30 To Shift from Beta Blockers<br />
Karl Swedberg, Gothenburg, Sweden<br />
8:50 Calcium Fluxes in the Myocyte<br />
Joshua I. Goldhaber, Los Angeles, CA<br />
9:10 The Biology <strong>of</strong> Cardiac Pacemakers<br />
Edward G. Lakatta, Baltimore, MD<br />
9:30 Cardiomyopathy Related to Tachycardia or PVC Burden<br />
Bruce B. Lerman, New York, NY<br />
9:45 Should Beta Blocker Therapy be Titrated to <strong>Heart</strong> Rate?<br />
Stephen S. Gottlieb, Baltimore, MD<br />
Learning Objective: Describe the role <strong>of</strong> heart rate in the<br />
pathogenesis and treatment <strong>of</strong> heart failure.<br />
TuesdAY<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
88<br />
89
Sept. 20<br />
Tuesday<br />
AM<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
8:30-10:00 AM<br />
Room 302<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
8:30-10:00 AM<br />
Room 304<br />
Sept. 20<br />
Tuesday<br />
AM<br />
Before and After Cardiac Transplantation<br />
What Works to Decrease Readmissions?<br />
Moderators: Michelle M. Kittleson, Los Angeles, CA<br />
Paul J. Mather, Philadelphia, PA<br />
Moderators: Mary N. Walsh, Indianapolis, IN<br />
David J. Whellan, Philadelphia, PA<br />
8:30 Waiting For Better or Worse: Listing and De-Listing<br />
Mariell L. Jessup, Philadelphia, PA<br />
8:30 How Can We Tell What Works?<br />
Andrew R. Weintraub, Boston, MA<br />
TuesdAY<br />
8:45 Impact <strong>of</strong> Priority System on Hospital and Family<br />
Resource Utilization<br />
Julie A. Shinn, Stanford, CA<br />
8:55 Double-Organ Transplantation: Who and Why<br />
Jon A. Kobashigawa, Los Angeles, CA<br />
9:05 Panel Discussion<br />
9:15 Beyond Levels: How Can We Tailor<br />
Immunosuppression?<br />
Josef Stehlik, Salt Lake City, UT<br />
9:25 Timing and Impact <strong>of</strong> Renal Rescue<br />
David O. Taylor, Cleveland, OH<br />
9:35 Panel Discussion<br />
9:40 Graft Arteriosclerosis vs. Native Atherosclerosis:<br />
Contrasts and Commonalities<br />
Peter Libby, Boston, MA<br />
8:45 Education Strategies<br />
Michele N. Gilbert, Oakland, NJ<br />
8:57 Transition <strong>of</strong> Care from Inpatient to Outpatient<br />
Kathleen M. McCauley, Philadelphia, PA<br />
9:09 Value <strong>of</strong> IV Diuretics in Clinic<br />
Lisa D. Rathman, Lancaster, PA<br />
9:21 Project Red<br />
Brian Jack, Boston, MA<br />
9:33 European Approach to Decreasing Readmissions<br />
Stefan D. Anker, Berlin, Germany<br />
9:45 Panel Discussion<br />
Learning Objective: Describe current approaches to<br />
reducing readmissions in heart failure patients.<br />
TuesdAY<br />
Learning Objective: Discuss key clinical issues in pre- and<br />
post-care <strong>of</strong> the transplant patient and identify appropriate<br />
care strategies.<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
90<br />
91
Sept. 20<br />
Tuesday<br />
AM<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
8:30-10:00 AM<br />
Room 306<br />
POSTERS DISPLAYED<br />
Tuesday, September 20<br />
9:30 AM-7:00 PM<br />
Exhibit Hall C<br />
Sept. 20<br />
Tuesday<br />
AM<br />
How Can We Improve Stem Cells for <strong>Heart</strong><br />
<strong>Failure</strong> Therapy?<br />
PRESENTERS AT POSTERS 5:45 PM-6:45 PM<br />
Moderators: Annarosa Leri, Boston, MA<br />
Kenneth B. Margulies, Philadelphia, PA<br />
8:30* Stem Cells and Cardiomyogenesis: Overview <strong>of</strong> Stem<br />
Cell Biology<br />
Piero Anversa, Boston, MA<br />
Categories Poster #<br />
Cardiovascular Physiology 036-055<br />
Cardiovascular Structure 061-065<br />
8:52* Inflammation Modulates Cardiac Repair via Stem Cells<br />
Ronglih Liao, Boston, MA<br />
Neurohormones/Cytokines 083-098<br />
TuesdAY<br />
9:15* Epigenetic Modulation <strong>of</strong> Endothelial Progenitor Cells<br />
for Cardiomyogenesis<br />
Raj Kishore, Chicago, IL<br />
9:37* Directed Differentiation <strong>of</strong> Progenitor Cells<br />
Andre Terzic, Rochester, MN<br />
Molecular Biology and Genetics 107-114<br />
Surgery, Transplantation, Devices 138-161<br />
TuesdAY<br />
*20 minute presentation, 2-3 minute audience discussion<br />
Electrophysiology/Arrhythmias 171-178<br />
Learning Objective: Describe the current and potential role<br />
<strong>of</strong> stem cells in heart failure therapy.<br />
Clinical Trials 188-197<br />
Cardiovascular Pharmacology 206-213<br />
Epidemiology, Prevention 221-227<br />
Outcomes 255-281<br />
Clinical Care/Management Strategies 319-355<br />
Listing for Monday posters begins on page 58<br />
Listing for Tuesday posters begins on page 110<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
92<br />
93
Sept. 20<br />
Tuesday<br />
AM<br />
CASE DISCUSSION<br />
Tuesday, September 20<br />
10:30 AM-NOON<br />
Ballroom A<br />
CASE DISCUSSION<br />
Sept. 20<br />
Tuesday<br />
AM<br />
TuesdAY<br />
Case Presenters: Akshay M. Desai, Boston, MA<br />
James C. Fang, Cleveland, OH<br />
Panelists:<br />
Roy M. John, Boston, MA<br />
Alan T. Kono, Lebanon, NH<br />
Rohinton J. Morris, Abington, PA<br />
J. Herbert Patterson, Chapel Hill, NC<br />
Kismet D. Rasmusson, Murray, UT<br />
10:30 Case 1: A 61 yo diabetic man with a longstanding history <strong>of</strong><br />
atrial fib presents with a 6 mo history <strong>of</strong> progressive lower<br />
extremity edema and exertional dyspnea. His exam is notable<br />
for blood pressure <strong>of</strong> 144/80 mm Hg, irregular pulse <strong>of</strong> 75<br />
beats/min, and prominent temporalis muscle wasting. The<br />
jugular veins are distended to the angle <strong>of</strong> the jaw seated upright<br />
and the lungs are clear to auscultation. The cardiac exam is<br />
notable for a prominent P2 but no gallop, and grade 2/6 systolic<br />
murmurs at both the lower left sternal border and the apex. The<br />
liver edge is firm and palpable four fingerbreadths below the<br />
right costal margin. There is pitting edema to the thighs with<br />
normal muscular strength and bulk in the extremities. ECG is<br />
notable for atrial fib with low limb lead voltage. Echo reveals<br />
concentric LV hypertrophy (posterior wall thickness 18 mm),<br />
marked biatrial enlargement, and moderate tricuspid and mitral<br />
valve regurg. The lateral mitral annular relaxation velocity is 8<br />
cm/s. How would you approach the management <strong>of</strong> this patient<br />
with ‘diastolic’ heart failure?<br />
10:52 Case 2: A 75 yo woman with recurrent episodes <strong>of</strong> ADHF is<br />
referred for management <strong>of</strong> PH. She underwent aortic valve<br />
replacement and coronary artery bypass grafting several yrs ago<br />
for symptomatic aortic stenosis and coronary artery disease.<br />
Her additional history is notable for type 2 diabetes mellitus,<br />
hypertension, and atrial fib. On exam, she weighs 275 lbs and is 55<br />
tall with BP 150/80 and pulse 50 beats/min. She has jugular venous<br />
distention to the jaw, dullness to percussion at both lung bases,<br />
and a stable sternum. There is a prominent RV heave and S3; P2 is<br />
increased and there is a systolic murmur typical <strong>of</strong> tricuspid regurg,<br />
but no diastolic murmur is audible. The abdomen is distended and<br />
obese with 3+ pitting edema <strong>of</strong> the lower extremities with skin<br />
changes <strong>of</strong> venous stasis. Echo reveals mild mitral stenosis, severe<br />
tricuspid regurgitation, and moderate RV enlargement/dysfunction.<br />
The LV EF is normal. Labs reveal creatinine 2.5 mg/dL with BUN<br />
55 mg/dL. Right heart cath reveals right atrial pressure 24 mm Hg,<br />
pulmonary artery pressure <strong>of</strong> 68/24 mm Hg (mean 38 mm Hg) and<br />
pulmonary capillary wedge pressure <strong>of</strong> 20 mm Hg with V-waves<br />
to 26 mm Hg; aortic pressure is 156/72 mm Hg. The pulmonary<br />
artery 02 saturation is 49% and systemic arterial saturation is 90%<br />
generating cardiac index 2.3 L/min/m2, cardiac output <strong>of</strong> 4.7 L/min<br />
by the Fick method; the calculated pulmonary vascular resistance<br />
is 339 dynes/sec/cm5 and systemic vascular resistance is 1256<br />
dynes/sec/cm5. How would you manage this patient with heart<br />
failure, pulmonary hypertension, tricuspid regurgitation, and renal<br />
insufficiency?<br />
11:14 Case 3: A 74 yo man is self referred for consideration <strong>of</strong> ‘stem<br />
cell’ therapy. He suffered an inferior MI over 20 yrs ago and<br />
for the last 5 yrs has been noted to have severe LVdysfunction.<br />
His functional capacity is currently NYHA III and for the<br />
last yr he has noted a left arm ache with exertion. He denies<br />
resting symptoms <strong>of</strong> HF. One year ago, he received a CRT-D<br />
system without clinical improvement. He is currently treated<br />
with losartan 50 mg daily, carvedilol CR 40 mg daily, and<br />
aspirin 325 mg daily. On exam, he is a pleasant elderly man<br />
in no acute distress. He is 5’10” and 197 lbs with body mass<br />
index <strong>of</strong> 28 kg/m2. His BP is 116/61 mm Hg in the right arm<br />
and 110/64 mm Hg in the left, with pulse 50 beats/min. The<br />
head and neck exam are unremarkable and filling pressures<br />
are low. The carotid upstrokes are brisk without bruits. The<br />
lungs are clear to auscultation and percussion bilaterally.<br />
Cardiac auscultation is notable for an S4 gallop, increased P2,<br />
and LV heave, but no murmur. There is no hepatomegaly or<br />
ascites. The distal extremities are warm with good pulses and<br />
no edema. ECG reveals an A-sensed V-paced rhythm with<br />
unclear resynchronization (leftward axis rather than rightward<br />
axis). Labs are notable for creatinine 1.3 mg/dL, NA <strong>of</strong> 136<br />
meq/L, BUN <strong>of</strong> 21 mg/dL, HDL 23 mg/dL, LDL 74 mg/dL,<br />
triglycerides 375 mg/dL, BNP 887 pg/mL, hemoglobin 13 g/dL,<br />
and hemoglobin A1c 6.6%. Echo reveals LV EF 10-15% with<br />
end diastolic dimension 7.7 cm, mild mitral regurg, and normal<br />
RV function w/o minimal tricuspid valve regurg. RV systolic<br />
pressure is estimated at 59 mm Hg based on the tricuspid jet<br />
velocity. MIBI perfusion images reveal an enlarged LV with<br />
inferior scar, but apparent ‘viability’ in the other territories.<br />
What therapies would you <strong>of</strong>fer?<br />
11:36 Case 4: A 60 yr old man with stage III chronic kidney<br />
disease, nonobstructive CAD, and dilated cardiomyopathy with<br />
implanted dual chamber defibrillator presents for evaluation <strong>of</strong><br />
progressive exertional dyspnea (NYHA III). His exam is notable<br />
for BP <strong>of</strong> 100/82 mm Hg, a pulse <strong>of</strong> 75 beats/min, normal<br />
jugular venous pressure, clear lungs, and a paradoxically split<br />
second heart sound with a laterally displaced apical impulse in<br />
the anterior axillary line. There is no hepatomegaly or ascites<br />
and the extremities are well perfused without peripheral edema.<br />
ECG reveals sinus rhythm with left bundle branch block and<br />
QRS duration 192 ms. Echo reveals a markedly dilated LVIDD<br />
10 cm with severely reduced function and estimated EF <strong>of</strong><br />
15-20% with moderate mitral regurg. Adenosine-PET perfusion<br />
study reveals a small region <strong>of</strong> scar in the mid-basal inferior<br />
wall with minimal reversibility. Cardiopulmonary exercise<br />
testing reveals peak VO2 11 cc/kg/min at a RER <strong>of</strong> 1.1. What<br />
would you do next?<br />
Learning Objective: Using practice guidelines, research<br />
findings and clinical experience, make decisions about the<br />
management <strong>of</strong> difficult cases in heart failure.<br />
TuesdAY<br />
(continued next page)<br />
94<br />
95
Sept. 20<br />
Tuesday<br />
AM<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
10:30 AM-NOON<br />
Room 302<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
10:30 AM-NOON<br />
Ballroom C<br />
Sept. 20<br />
Tuesday<br />
AM<br />
Take a Deep Breath<br />
Implantable Pacing/Defibrillation Devices<br />
Moderators: Kirkwood F. Adams, Jr., Chapel Hill, NC<br />
Hector O. Ventura, New Orleans, LA<br />
Moderators: Hasan Garan, New York, NY<br />
William G. Stevenson, Boston, MA<br />
TuesdAY<br />
10:30 Should We Sleep Sitting UP?<br />
John S. Floras, Toronto, ON, Canada<br />
11:00* How Do We Measure Decongestion at Discharge?<br />
J. Thomas Heywood, La Jolla, CA<br />
11:15* Ventilatory Parameters During Exercise<br />
Stuart D. Russell, Baltimore, MD<br />
11:30* Selecting Beta Blockers for Patients with Pulmonary<br />
Disease<br />
Myung H. Park, Baltimore, MD<br />
10:30 Durability <strong>of</strong> Cardiac Resynchronization Therapy<br />
Benefit<br />
Andrew L. Smith, Atlanta, GA<br />
10:45 Who Should NOT Get an ICD?<br />
Andrew E. Epstein, Philadelphia, PA<br />
10:55 Preparing for Death with a Device<br />
Paul J. Hauptman, St. Louis, MO<br />
11:05 Do “Out <strong>of</strong> the Box” Settings Need to Be Changed?<br />
Mark S. Link, Boston, MA<br />
TuesdAY<br />
11:45* Should We Teach Patients How to Breathe?<br />
Patricia A. Uber, Baltimore, MD<br />
11:15 Re-Evaluation after the First Shock<br />
James P. Daubert, Durham, NC<br />
*12 minute presentation, 3 minute audience discussion<br />
Learning Objective: Describe the importance <strong>of</strong> adequate<br />
assessment and control <strong>of</strong> breathing in the therapy <strong>of</strong> heart<br />
failure.<br />
11:25 Future Physiologic <strong>Heart</strong> <strong>Failure</strong> Monitoring<br />
William T. Abraham, Columbus, OH<br />
11:40 Panel Discussion<br />
Learning Objective: Describe the role <strong>of</strong> implantable<br />
pacing and defibrillation devices and monitoring during the<br />
treatment <strong>of</strong> heart failure.<br />
96<br />
97
Sept. 20<br />
Tuesday<br />
AM<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
10:30 AM-NOON<br />
Room 304<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
10:30-NOON<br />
Room 306<br />
Sept. 20<br />
Tuesday<br />
AM<br />
Mechanisms to Prevent Sudden Death<br />
Genes in the <strong>Heart</strong><br />
Moderators: Frederica del Monte, Boston, MA<br />
Joshua I. Goldhaber, Los Angeles, CA<br />
Moderators: Ray E. Hershberger, Miami, FL<br />
Neal Lakdawala, Boston, MA<br />
TuesdAY<br />
10:30* Are There Any Novel Antiarrhythmic Agents on the<br />
Horizon?<br />
Peter R. Kowey, Wynnewood, PA<br />
10:48* Sarcoplasmic Reticulum Calcium Release as a Target for<br />
Ventricular Arrhythmias<br />
Donald M. Bers, Davis, CA<br />
11:06* The Ryanodine Receptor is the Final Common Mediator<br />
<strong>of</strong> Lethal Arrhythmias<br />
Xander H.T. Wehrens, Houston, TX<br />
11:24* Calcium Channels as a Target for Ventricular<br />
Arrhythmias<br />
Henry M. Colecraft, New York, NY<br />
11:42* Device Therapy for Cardiac Arrhythmias: Is the Day <strong>of</strong><br />
Antiarrhythmic Agents Over?<br />
Barry London, Pittsburgh, PA<br />
10:30 Desmosomes<br />
Jeffrey E. Saffitz, Boston, MA<br />
10:50 Dystrophin Defects: Inherited and Acquired<br />
Elizabeth M. McNally, Chicago, IL<br />
11:10 When Are Viral Genomes Pathogenic in the <strong>Heart</strong>?<br />
Jeffrey A. Towbin, Cincinnati, OH<br />
11:30 How Should We Counsel and Follow the Carrier?<br />
Carolyn Yung Ho, Boston, MA<br />
11:45 Panel Discussion<br />
Learning Objective: Describe the role <strong>of</strong> genetics in heart<br />
failure and genetic counseling in the management <strong>of</strong> heart<br />
failure.<br />
TuesdAY<br />
*15 minute presentation, 3 minute audience discussion<br />
Learning Objective: Describe the mechanisms <strong>of</strong> sudden<br />
death and potential interventions to prevent it in heart failure<br />
patients.<br />
98<br />
99
Sept. 20<br />
Tuesday<br />
PM<br />
TuesdAY<br />
HOW TO SESSIONS<br />
Tuesday, September 20<br />
12:30-1:30 PM<br />
Location<br />
5. Clinical Practice Careers in <strong>Heart</strong> <strong>Failure</strong> Room 306<br />
Michele A. Hamilton, Los Angeles, CA<br />
Thomas E. Noonan, Pawtucket, RI<br />
Mary N. Walsh, Indianapolis, IN<br />
Learning Objective: Describe the variety <strong>of</strong> potential<br />
practice opportunities for specialists in heart failure.<br />
6. Following Patients on the Transplant List Room 304<br />
(Frequency, Testing, Re-Evaluation, Status Changes)<br />
Tonya Elliott, Falls Church, VA<br />
Michael B. Fowler, Stanford, CA<br />
Learning Objective: Identify key clinical issues in<br />
following heart failure patients on the transplant list.<br />
7. Select the Test: MRI/Nuclear/Echo Room 302<br />
Raymond Y. Kwong, Boston, MA<br />
Ayan R. Patel, Boston, MA<br />
James E. Udelson, Boston, MA<br />
Learning Objective: Use evaluation methods appropriate<br />
to the diagnostic or treatment situation.<br />
ORAL ABSTRACT SESSION<br />
Tuesday, September 20<br />
12:30-1:30 PM<br />
Room 312<br />
Rapid Fire Abstracts<br />
Moderators: Arthur M. Feldman, Philadelphia, PA<br />
Mark A. Sussman, San Diego, CA<br />
Sept. 20<br />
Tuesday<br />
PM<br />
12:30* Early Enalapril Therapy on Long-Term Mortality 255<br />
in Patients with Asymptomatic Left Ventricular<br />
Systolic Dysfunction: A 22-Year Follow-up <strong>of</strong> SOLVD<br />
in Belgium<br />
Philip Jong, Sylvie A. Ahn, Michel F. Rousseau, University<br />
<strong>of</strong> Louvain, Brussels, Belgium<br />
12:36* Exercise Induced Pulmonary Hypertension: 320<br />
Comparison <strong>of</strong> Stress Echocardiography to Right<br />
<strong>Heart</strong> Catheterization<br />
Karthik Gujia, Deepika Misra, Christine Roncari, Roxana<br />
Sulica, Beth Israel Medical Center, New York, NY<br />
12:42* Comparison <strong>of</strong> Rest and Peak Exercise Exhaled 083<br />
Nitric Oxide in Determining Underlying Pulmonary<br />
Vascular Dysfunction in <strong>Heart</strong> <strong>Failure</strong><br />
Andres Schuster, Allen G. Borowski, Akanksha Thakur,<br />
W.H. Wilson Tang, Cleveland Clinic, Cleveland, OH<br />
TuesdAY<br />
12:48* Fms-Like Tyrosine Kinase 3 Protects Cardiomyocytes 084<br />
Against Oxidative Stress-Induced Apoptosis<br />
Otmar Pfister, Vera Lorenz, Stephanie P. Hauselmann,<br />
Katrin Buhler, Aleksandra Woodnar-Filipowicz, Gabriela<br />
M. Kuster, University <strong>of</strong> Hospital, Basel, Switzerland<br />
12:54* Treatment <strong>of</strong> Functional Mitral Regurgitation 138<br />
by Percutaneous Annuloplasty Results I Durable<br />
Clinical Efficacy Through 18 Months<br />
David G. Reuter, Michael Haude, Tomasz Siminiak, Jezy<br />
Sadowski, Janusz Lipiecki, Jean Fajadet, Uta C. Hoppe,<br />
Seattle Children’s Hospital and Cardiac Dimensions,<br />
Seattle, WA<br />
1:00* Genotype and Phenotypic Characteristics <strong>of</strong> Persons 221<br />
with Cardiac Amyloidosis from the Multinational<br />
Transthyretin Amyloidosis Outcomes Survey<br />
(THAOS) Registry<br />
Kumar Dharmarajan, Say Salomon, Stephen Helmke,<br />
Sergio Tereyua, Claudio Rapezzi, Rodney Falk, Mathew S.<br />
Maurer, Columbia University, New York, NY<br />
(continued next page)<br />
*3 minutes to present, 2 minute discussion<br />
100<br />
101
Sept. 20<br />
Tuesday<br />
PM<br />
ORAL ABSTRACT SESSION<br />
Tuesday, September 20<br />
12:30-1:30 PM<br />
Room 312<br />
HYDE PARK<br />
Tuesday, September 20<br />
2:00-3:30 PM<br />
Ballrooms A-B<br />
Sept. 20<br />
Tuesday<br />
PM<br />
TuesdAY<br />
Rapid Fire Abstracts (cont.)<br />
1:06* Requests for ICD and Pacemaker Deactivation: 171<br />
Characteristics <strong>of</strong> Affected Patients and Outcomes<br />
Tracy L. Webster, Lillian C. Buchhalter, Abigale L.<br />
Ottenberg, Keith M. Swetz, Paul S. Mueller, Mayo Clinic,<br />
Rochester, MN<br />
1:12* Do Advanced Practice Nurses Conform to <strong>Heart</strong> 319<br />
<strong>Failure</strong> Therapies at the Same Rate as Team-Based<br />
Physicians?<br />
Nancy M. Albert, Maureen O’Malley, Benjamin Nutter,<br />
Randall Starling, Cleveland Clinic, Cleveland, OH<br />
1:18* Complex Telemonitoring or a Simple Telephone 321<br />
Call, Which is More Effective in Post-Discharge<br />
<strong>Heart</strong> <strong>Failure</strong> (HF) ]Management?<br />
Robyn A. Clark, Sally C. Inglis, Finlay A. McAllister,<br />
Simon Stewart, John G.F. Cleland, Cochrane <strong>Heart</strong> Group,<br />
Queensland University <strong>of</strong> Technology, Brisbane, Australia<br />
1:24* Effect <strong>of</strong> QRS Morphology on Clinical Event 139<br />
Reduction with Cardiac Resynchronization Therapy:<br />
Meta-Analysis <strong>of</strong> Randomized Controlled Trials<br />
Josephine C. Chou, Iike Sipahi, Marshall Hyden, Daniel I.<br />
Simon, James C. Fang, University Hospitals Case Medical<br />
Center, Cleveland, OH<br />
*3 minutes to present, 2 minute discussion<br />
Learning Objective: Discuss findings from recent research<br />
in heart failure and their implications for heart failure<br />
research and treatment.<br />
To learn more about these studies, visit their posters during<br />
the poster presentation session in the Exhibit Hall this<br />
afternoon.<br />
1:45 Announcement <strong>of</strong> Awards<br />
Jay N. Cohn New Investigator Awards<br />
Nursing Research Award<br />
2011 Nursing Clinical Excellence Award<br />
2011-12 HFSA Research Fellowship Awards<br />
Steven R. Houser, Philadelphia, PA<br />
Corrine Jurgens, Stony Brook, NY<br />
Martin LeWinter, Burington, VT<br />
Barbara J. Riegel, Philadelphia, PA<br />
Lynne Warner Stevenson, Boston, MA<br />
2:00 2012 HFSA Strategic Plan Overview<br />
Barry H. Greenberg, San Diego, CA<br />
Hyde Park Session<br />
Moderators: Michael B. Fowler, Stanford, CA<br />
Douglas D. Schocken, Durham, NC<br />
2:15* It’s Time to Examine Intramural Conflicts <strong>of</strong> Interest<br />
Matthew A. Movsesian, Salt Lake City, Utah<br />
2:30* The Arrogance <strong>of</strong> Statistics<br />
Jay N. Cohn, Minneapolis, MN<br />
2:45* Get Away from the Guidelines (GAFTG)<br />
Ronald M. Witteles, Stanford, CA<br />
3:00* How a Maserati Might Solve the Health Care Problem<br />
Stephen S. Gottlieb, Baltimore, MD<br />
3:15* Move All Our Symptomatic Patients to Tibet:<br />
High Altitude Cures <strong>Heart</strong> <strong>Failure</strong><br />
Simon Maybaum, Bronx, NY<br />
TuesdAY<br />
*10 minute presentation, 5 minute audience discussion<br />
Learning objective: Discuss new insights into heart failure<br />
research, education, and clinical practice.<br />
3:30 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
102<br />
103
Sept. 20<br />
Tuesday<br />
PM<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
2:00-3:30 PM<br />
Room 304<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
2:00-3:30 PM<br />
Room 306<br />
Sept. 20<br />
Tuesday<br />
PM<br />
Through Thick and Thin: Issues in<br />
Anticoagulation<br />
Patients Ask About Stem Cells:<br />
Are We Almost There Yet?<br />
Moderators: Samuel Z. Goldhaber, Boston, MA<br />
Robinton J. Morris, Abington, PA<br />
Moderators: Jan Kajstura, Boston, MA<br />
Ronglih Liao, Boston, MA<br />
TuesdAY<br />
2:00* When is Low Ejection Fraction an Indication for<br />
Anticoagulation?<br />
Susan E. Ammon, San Fransisco, CA<br />
2:15* Anticoagulation for Continuous Flow Ventricular Assist<br />
Devices<br />
Mary Patricia Massicotte, Edmonton, AB, Canada<br />
2:30* Bleeding with Ventricular Assist Devices<br />
Jeffrey J. Teuteberg, Pittsburgh, PA<br />
2:45* What is the Incidence <strong>of</strong> Heparin-Induced<br />
Thrombocytopenia?<br />
Samuel Z. Goldhaber, Boston, MA<br />
3:00* Home INR Monitoring<br />
Melissa A. Mikelson, Marshfield, WI<br />
2:00 Cell-Based Therapy (Vascular Progenitor Cells)<br />
Douglas W. Losordo, Chicago, IL<br />
2:15 Bone Marrow Stem Cells to Repair the Damaged <strong>Heart</strong><br />
Robert D. Simari, Rochester, MN<br />
2:30 The SCIPIO Trial (Cardiac Progenitor Cells)<br />
Roberto Bolli, Louisville, KY<br />
2:45 Stem Cells: Next Generation <strong>of</strong> Mesenchymal Cells<br />
Joshua M. Hare, Miami, FL<br />
3:00 Assessing the Efficacy <strong>of</strong> Stem Cell Therapy in Clinical<br />
Trials<br />
Scott D. Solomon, Boston, MA<br />
3:15 Panel Discussion<br />
TuesdAY<br />
3:15* Early Lessons with Dabigatran<br />
Michael D. Ezekowitz, Wynnewood, PA<br />
Learning Objective: Discuss the current status <strong>of</strong> stem cell<br />
therapy for cardiovascular disease.<br />
*12 minute presentation, 3 minute audience discussion<br />
Learning Objective: Describe circumstances in which<br />
anticoagulation is called for in patients with heart failure and<br />
the options available.<br />
3:30 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
3:30 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Halls C and D<br />
104<br />
105
Sept. 20<br />
Tuesday<br />
PM<br />
DEBATES<br />
Tuesday, September 20<br />
4:00-5:30 PM<br />
Ballrooms A-B<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
4:00-5:30 PM<br />
Room 306<br />
Sept. 20<br />
Tuesday<br />
PM<br />
Moderators: Lynne Warner Stevenson, Boston, MA<br />
James B. Young, Cleveland, OH<br />
Status with Novel Proteins and Metabolic<br />
Markers in Characterizing <strong>Heart</strong> <strong>Failure</strong><br />
TuesdAY<br />
DEBATE: How Do You Vote: The Weekly <strong>Meeting</strong><br />
4:00 A 71 Year-Old Man with <strong>Heart</strong> <strong>Failure</strong><br />
James B. Young, Cleveland, OH<br />
4:09 Why He Should Have a <strong>Heart</strong> Transplant<br />
Sharon A. Hunt, Stanford, CA<br />
4:16 Why He Should Receive an LVAD<br />
Leslie W. Miller, Tampa, FL<br />
4:23 Why He Should Have Palliative Care<br />
Heather J. Ross, Toronto, ON, Canada<br />
4:30 Panel Discussion: What if?<br />
Sharon A. Hunt, Stanford, CA<br />
Leslie W. Miller, Tampa, FL<br />
Michael G. Petty, Minneapolis, MN<br />
Heather J. Ross, Toronto, ON, Canada<br />
Ben Sun, Minneapolis, MN<br />
DEBATE: Risk Stratification Is an Intervention<br />
4:45 Protagonist: Christopher M. O’Connor, Durham, NC<br />
5:00 Antagonist: Milton Packer, Dallas, TX<br />
5:15 Questions from moderators<br />
Learning Objective: Outline considerations influencing<br />
selection <strong>of</strong> therapies in advanced heart failure and the<br />
arguments for and against risk stratification.<br />
Moderators: Wilson S. Colucci, Boston, MA<br />
Pothur R. Srinivas, Bethesda, MD<br />
4:00* The Proteome as the Key Determinant <strong>of</strong> Phenotype in<br />
Cardiovascular Health and Disease<br />
Joseph Loscalzo, Boston, MA<br />
4:18* K (ATP): Channel-Dependent Metaboproteome<br />
Decoded: Systems Approaches to <strong>Heart</strong> <strong>Failure</strong><br />
Prediction, Diagnosis, and Therapy<br />
Andre Terzic, Rochester, MN<br />
4:36* Novel Metabolomic Defects in <strong>Heart</strong> <strong>Failure</strong><br />
Catherine E. Costello, Boston, MA<br />
4:54* New Protein Markers in Acute Myocardial Infarction<br />
Robert E. Gerszten, Boston, MA<br />
5:12* The Cardiac Organellar Proteoms Atlas<br />
(COPa Library): A Protein Knowledgebase for<br />
Cardiovascular Medicine<br />
Peipei Ping, Los Angeles, CA<br />
*15 minute presentation, 3 minute audience discussion<br />
Learning Objective: Discuss the role <strong>of</strong> novel proteins and<br />
metabolic markers in heart failure and their implications for<br />
research and therapy.<br />
TuesdAY<br />
5:30 Poster Session and Reception<br />
Exhibit Halls C and D<br />
Presenters at their Posters 5:45-6:45 PM<br />
Refreshments and Hors d’oeuvres served<br />
106<br />
5:30 Poster Session and Reception<br />
Exhibit Halls C and D<br />
Presenters at their Posters 5:45-6:45 PM<br />
Refreshments and Hors d’oeuvres served<br />
107
Sept. 20<br />
Tuesday<br />
PM<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
4:00-5:30 PM<br />
Room 302<br />
SYMPOSIUM<br />
Tuesday, September 20<br />
4:00-5:30 PM<br />
Room 304<br />
Sept. 20<br />
Tuesday<br />
PM<br />
Paradox on the Right<br />
Oxidative Stress and Uric Acid<br />
TuesdAY<br />
Moderators: Teresa De Marco, San Francisco, CA<br />
Michael A. Mathier, Pittsburgh, PA<br />
4:00* Role <strong>of</strong> the Right Ventricle in Exercise Limitation<br />
Gregory D. Lewis, Boston, MA<br />
4:15* Pulmonary Hypertension from Increased Forward vs.<br />
Increased Backward Flow<br />
Anne Marie Valente, Boston, MA<br />
4:30* Pulmonary Versus Arterial Vascular Loading<br />
Ryan J. Tedford, Baltimore, MD<br />
4:45* The Right Ventricle as Victim <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong><br />
Preserved EF<br />
Aaron B. Waxman, Boston, MA<br />
5:00* Pulmonary Hypertension in Potential Transplant<br />
Candidates<br />
Richard J. Rodeheffer, Rochester, MN<br />
5:15* When Does Mechanical Support Need to be<br />
Biventricular?<br />
Robert L. Kormos, Pittsburgh, PA<br />
*12 minute presentation, 3 minute audience discussion<br />
Learning Objective: Discuss the importance <strong>of</strong> the right<br />
ventricle in the progression <strong>of</strong> heart failure and the selection<br />
<strong>of</strong> therapies.<br />
Moderators: Inder S. Anand, Minneapolis, MN<br />
Horng H. Chen, Rochester, MN<br />
4:00* Why Do We Worry About Oxidative Stress in <strong>Heart</strong><br />
<strong>Failure</strong>?<br />
Joshua M. Hare, Miami, FL<br />
4:18* Mitochondrial ROS and Arrhythmias<br />
Samuel C. Dudley, Chicago, IL<br />
4:36* NADPH and CHF<br />
Junichi Sadoshima, Newark, NJ<br />
4:54* Treatment <strong>of</strong> Gout Exacerbations in <strong>Heart</strong> <strong>Failure</strong><br />
Brian F. Mandell, Cleveland, OH<br />
5:12* Should Therapy Be Guided by Uric Acid Levels?<br />
Michael M. Givertz, Boston, MA<br />
*15 minute presentation, 3 minute audience discussion<br />
Learning Objective: Describe the role <strong>of</strong> oxidative stress and<br />
potential interventions to reduce it for patients with heart<br />
failure and identify recommended clinical responses.<br />
TuesdAY<br />
5:30 Poster Session and Reception<br />
Exhibit Halls C and D<br />
Presenters at their Posters 5:45-6:45 PM<br />
Refreshments and Hors d’oeuvres served<br />
108<br />
5:30 Poster Session and Reception<br />
Exhibit Halls C and D<br />
Presenters at their Posters 5:45-6:45 PM<br />
Refreshments and Hors d’oeuvres served<br />
109
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Cardiovascular Physiology<br />
Posters<br />
Cardiovascular Physiology<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
036 Non-Invasive Hemodynamic Assessment Using<br />
Photoplethysmography (PPG) for CRT Optimization<br />
Wenbo Hou 1 , Sturt P. Rosenberg 1 , Steve Koh 1 , John W.<br />
Poore 1 , Jeffery D. Snell 1 , Michael Yang 1 , Nirav Dalal 1 , Gene<br />
A. Bornzin 1 ; 1 Cardiac Rhythm Management Division, St Jude<br />
Medical, Sylmar, CA<br />
037 Renal Tubule Is the Critical Site in Patients with<br />
Idiopathic Dilated Cardiomyopathy Showing<br />
Microalbuminuria<br />
Masahiro Ito 1 , Makoto Tomita 1 , Yukako Ohno 1 , Hiroaki Obata 1 ,<br />
Makoto Kodama 1 , Yoshifusa Aizawa 1 ; 1 First Department <strong>of</strong><br />
Internal Medicine, Niigata University School <strong>of</strong> Medicine,<br />
Niigata, Japan<br />
038 M-Atrial Natriuretic Peptide and Nitroglycerin in<br />
a Model <strong>of</strong> Acute Hypertensive <strong>Heart</strong> <strong>Failure</strong>: A<br />
Comparison <strong>of</strong> Two cGMP Therapeutics<br />
Paul M. McKie 1 , Tomoko Ichiki 1 , S. Jeson Sangaralingham 1 ,<br />
Alessandro Cataliotti 1 , Horng H. Chen 1 , John C. Burnett, Jr. 1 ;<br />
1<br />
Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN<br />
039 Ranolazine Prevents <strong>Heart</strong> <strong>Failure</strong> with Preserved<br />
Ejection Fraction; Diastolic Dysfunction and Left<br />
Ventricular Hypertrophy in a Hypertensive Murine<br />
Model<br />
R. Valadri 1 , R. Gadesam 2 , A. Onwuanyi 2 , M.T. Fan 1 , H. Bloom 1 ;<br />
1<br />
Cardio, Emory SM, ATL; 2 Cardio, Morehouse SM, ATL<br />
040 Early Experimental Chronic Kidney Disease Activates<br />
Myocardial Apoptotic Genes and Leads to Early<br />
Myocardial Fibrosis<br />
Fernando L. Martin 1 , Brenda K. Huntley 1 , Gerald E. Harders 1 ,<br />
S. Jeson Sangaralingham 1 , Tomoko Ichiki 1 , Paul M. McKie 1 ,<br />
Alessandro Cataliotti 1 , Josef Korinek 1 , Horng H. Chen 1 , John C.<br />
Burnett 1 ; 1 Cardiovascular Diseases, Mayo Clinic, Rochester, MN<br />
041 Role <strong>of</strong> Caveolae in Shear Stress-Induced Endothelium-<br />
Dependent Vasodilation in Isolated Mouse Coronary<br />
Arteries<br />
Hon-Chi Lee 1 , Qiang Chai 1 ; 1 Internal Medicine/Cardiovascular<br />
Diseases, Mayo Clinic, Rochester, MN<br />
042 Calcium/ Calmodulin Dependent Kinase Type II<br />
(CaMKIIδ) Phosphorylation <strong>of</strong> the Cardiac Ryanodine<br />
Receptor Is Crucial for the Development <strong>of</strong> <strong>Heart</strong><br />
<strong>Failure</strong><br />
Jonathan L. Respress 1 , Ralph J. van Oort 1 , Angela C. de<br />
Almeida 1 , Na Li 1 , Natale Rolim 2 , Ulrik Wisl<strong>of</strong>f 2 , Xander H.T.<br />
Wehrens 1 ; 1 Molecular Physiology and Biophysics, Baylor<br />
College <strong>of</strong> Medicine, Houston, TX; 2 Circulation and Medical<br />
Imaging, Norwegian University <strong>of</strong> Science and Technology,<br />
Trondheim, Norway<br />
043 Speckle Tracking Echo Derived Measures <strong>of</strong> Left<br />
Ventricular Contraction Have Better Correlation with<br />
Functional Status Than Does Ejection Fraction<br />
John W. Petersen 1 ; 1 Cardiovascular Disease, University <strong>of</strong><br />
Florida, Gainesville, FL<br />
044 Ventricular-Vascular Coupling at Rest and with Exercise<br />
Predicts <strong>Heart</strong> <strong>Failure</strong> in Coronary Artery Disease<br />
Rakesh K. Mishra 1 , Mary A. Whooley 1 , Nelson B. Schiller 1 ;<br />
1<br />
Medicine, University <strong>of</strong> California, San Francisco, CA<br />
045 The Difference in Radial Strain Pattern <strong>of</strong> Contractility<br />
<strong>of</strong> the Right Ventricular Free Wall Versus the Septum by<br />
Speckle Tracking<br />
Mujeeb A. Sheikh 1 , Steven R. Bruhl 1 , Samer Khouri 1 ;<br />
1<br />
Department <strong>of</strong> Cardiology, University <strong>of</strong> Toledo (UT), Toledo,<br />
OH<br />
046 Lean Mass as an Indicator <strong>of</strong> Muscle Strength in<br />
Patients with <strong>Heart</strong> <strong>Failure</strong><br />
A. Zavin 1 , K. Allsup 1 , D.R. Gagnon 6,7 , R. Arena 4 , J. Joseph 1,2 , A.<br />
Lazzari 1,3 , P.C. Schulze 5 , S. Lecker 2 , S. Davis 1 , D.E. Forman 1,2 ;<br />
1<br />
VA Boston Healthcare System, Boston; 2 Harvard Medical<br />
School, Boston, MA; 3 Boston University School <strong>of</strong> Medicine,<br />
Boston, MA; 4 University <strong>of</strong> New Mexico, Albuquerque,<br />
NM; 5 Columbia University Medical Center, New York, NY;<br />
6<br />
Boston University SPH, Boston, MA; 7 VA Cooperative Studies<br />
Program, Boston, MA<br />
047 Blunted Vital Sign Changes during Exercise Can Help<br />
Identify or Exclude Severe Impairment<br />
Michael C. Tjandrawidjaja 1 , Lynne W. Stevenson 1 , Jennifer Ho 1 ,<br />
Garrick Stewart 1 , Daniel E. Forman 1 ; 1 Cardiovascular Division,<br />
Brigham and Women’s Hospital, Boston, MA<br />
048 Which Drug Is the Best for Pulmonary Hypertension<br />
Reversibility Testing?<br />
Maya Guglin 1 , Shabnam Mehra 2 , Thomas Mason 2 ; 1 Cardiology,<br />
University <strong>of</strong> South Florida, Tampa, FL; 2 Statistics and<br />
Epidemiology, University <strong>of</strong> South Florida, Tampa, FL<br />
tuesdAY<br />
110<br />
111
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Cardiovascular Physiology<br />
Posters<br />
Cardiovascular Physiology<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
049 Discordance between Aortic Augmentation Index and<br />
Hemodynamic Measurements in Patients with Acute<br />
Decompensated <strong>Heart</strong> <strong>Failure</strong> Receiving Intensive<br />
Medical Therapy<br />
Maria M. Patarroyo 1 , Yi Lu 2 , Mohammad Rafey 3 , W.H. Wilson<br />
Tang 2 ; 1 Internal Medicine, Cleveland Clinic Foundation,<br />
Cleveland, OH; 2 Cardiovascular Medicine, Cleveland Clinic<br />
Foundation, Cleveland, OH; 3 Nephrology and Hypertension,<br />
Cleveland Clinic Foundation, Cleveland, OH<br />
050 Electrophysiological Properties <strong>of</strong> the Infarcted Rodent<br />
Myocardium<br />
Elisabeth Steadman 1 , Joao Ferreira-Martins 1 , Sergio Signore 1 ,<br />
Justin A. Korn 1 , Fumihiro Sanada 1 , Hanqiao Zheng 1 , Francesco<br />
Cappetta 1 , Toru Hosoda 1 , Claudia Fiorini 1 , Annarosa Leri 1 , Piero<br />
Anversa 1 , Jan Kajstura 1 , Marcello Rota 1 ; 1 Anesthesia Medicine,<br />
Brigham Women’s Hospital-Harvard Medical School, Boston,<br />
MA<br />
051 Right Ventricle Glucose Metabolism and Pressure<br />
Overload in Patients with Pulmonary Arterial<br />
Hypertension<br />
Peter R. Mit<strong>of</strong>f 1 , Ian Burwash 1 , Rob J. deKemp 1 , May Aung 1 ,<br />
George Chandy 1 , Duncan J. Stewart 1 , Ross A. Davies 1 , Carolyn<br />
Pugliese 1 , Jean DaSilva 1 , Rob Beanlands 1 , Lisa M. Mielniczuk 1 ;<br />
1<br />
Cardiology, University <strong>of</strong> Ottawa <strong>Heart</strong> Institute, Ottawa, ON,<br />
Canada<br />
052 Pulmonary Hypertension as a Function <strong>of</strong> Diastolic<br />
Grade in Patients with Left <strong>Heart</strong> <strong>Failure</strong> Is a Predictor<br />
<strong>of</strong> Right <strong>Heart</strong> Function and Can Be Used To Optimize<br />
Timing <strong>of</strong> LVAD Therapy<br />
Daniel Zakhary 1 , Eyad Alhaj 1 , Robert Berkowitz 1 ; 1 <strong>Heart</strong> <strong>Failure</strong><br />
and Pulmonary Hypertension Program <strong>of</strong> the <strong>Heart</strong> and Vascular<br />
Hospital, Hackensack University Medical Center, Hackensack,<br />
NJ<br />
053 Association between Arterial Load and Left Ventricular<br />
Rotation in <strong>Heart</strong> <strong>Failure</strong> with Preserved Ejection<br />
Fraction<br />
Holly S. Norman 1 , Gary F. Mitchell 2 , Nancy K. Sweitzer 1 ;<br />
1<br />
Medicine, University <strong>of</strong> Wisconsin-Madison, Madison, WI;<br />
2<br />
Cardiovascular Engineering, Inc, Norwood, MA<br />
054 Do Asymptomatic Chronic Kidney Disease Patients<br />
without Primary Cardiac Disease Have Diminished<br />
Cardiac Reserve?<br />
Shanmugakumar Chinnappa 1 , Meguid El Nahas 2 , Andrew<br />
Mooney 1 , Lip-Bun Tan 1 ; 1 Leeds Teaching Hospitals NHS Trust,<br />
Leeds, United Kingdom; 2 Sheffield Teaching Hospitals NHS<br />
Foundation Trust, Sheffield, United Kingdom<br />
055 Strength and Aerobic Capacities Both Contribute to<br />
Functional Decline in <strong>Heart</strong> <strong>Failure</strong><br />
K. Allsup 1 , A. Zavin 1 , J. Joseph 1,2 , R. Arena 4 , P. Vokonas 1,3 , S.<br />
Lecker 1,2 , L. Lazzari 1,3 , P.C. Schulze 5 , D.E. Forman 1,2 ; 1 VA Boston<br />
Healthcare System, Boston, MA; 2 Harvard Medical School,<br />
Boston, MA; 3 Boston University School <strong>of</strong> Medicine, Boston,<br />
MA; 4 University <strong>of</strong> New Mexico, Albuquerque, NM; 5 Columbia<br />
University Medical Center, New York, NY<br />
Cardiovascular Structure<br />
061 Diastolic Dysfunction in Patients with End-Stage Liver<br />
Disease Is Associated with Development <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong><br />
Early after Liver Transplantation<br />
Taylor F. Dowsley 1 , David B. Bayne 1 , Alan N. Langnas 2 ,<br />
Ioana Dumitru 1 , John R. Windle 1 , Thomas R. Porter 1 , Eugenia<br />
Raichlin 1 ; 1 Cardiology, University <strong>of</strong> Nebraska Medical Center,<br />
Omaha, NE; 2 Section <strong>of</strong> Transplantation, Department <strong>of</strong> Surgery,<br />
University <strong>of</strong> Nebraska Medical Center, Omaha, NE<br />
062 Risk Stratification and Serious Ventricular Arrhythmias:<br />
The Importance <strong>of</strong> Left Ventricular Hypertrophic<br />
Remodeling in Patients with Depressed Ejection Fraction<br />
Timothy S. Draper, Jr. 1 , Jonathan S. Silver 1 , William H. Gaasch 1 ;<br />
1<br />
Cardiovascular Medicine, Lahey Clinic, Burlington, MA<br />
063 Right Ventricular Diastolic Parameter Changes and<br />
Correlation with Pulmonary Pressure Severity<br />
Jayme Rock-Willoughby 1 , Steven Bruhl 1 , Mujeeb Sheikh 1 ,<br />
Samer Khouri; 1 University <strong>of</strong> Toledo Medical Center, Toledo,<br />
OH<br />
064 Endoplasmic Reticulum Stress Is a Mechanism <strong>of</strong> Self-<br />
Progression in Congestive <strong>Heart</strong> <strong>Failure</strong><br />
Paul J. Mather 1 , Holly Stewart 1 , John L. Farber 2 ; 1 Cardiology,<br />
Thomas Jefferson University Hospital, Philadelphia, PA;<br />
2<br />
Pathology, Thomas Jefferson University Hospital, Philadelphia,<br />
PA<br />
065 Prognostic Utility <strong>of</strong> Left Atrial Volume Index in Older<br />
Patients with <strong>Heart</strong> <strong>Failure</strong> and Moderate or Severe<br />
Mitral Regurgitation<br />
Justin S. Sadhu 1 , Majesh Makan 1 , Michael W. Rich 1 ;<br />
1<br />
Cardiovascular Division, Washington University School <strong>of</strong><br />
Medicine in St. Louis, St. Louis, MO<br />
tuesdAY<br />
112<br />
113
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Neurohormones/Cytokines<br />
Posters<br />
Neurohormones/Cytokines<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
083 Comparison <strong>of</strong> Rest and Peak Exercise Exhaled Nitric<br />
Oxide in Determining Underlying Pulmonary Vascular<br />
Dysfunction in <strong>Heart</strong> <strong>Failure</strong><br />
Andres Schuster 1 , Allen G. Borowski 1 , Akanksha Thakur 2 , W.H.<br />
Wilson Tang 1 ; 1 Department <strong>of</strong> Cardiovascular Medicine, <strong>Heart</strong><br />
and Vascular Institute, Cleveland Clinic Foundation, Cleveland,<br />
OH; 2 Case Western Reserve School <strong>of</strong> Medicine, Case Western<br />
Reserve University, Cleveland, OH<br />
084 Fms-Like Tyrosine Kinase 3 Protects Cardiomyocytes<br />
Against Oxidative Stress-Induced Apoptosis<br />
Otmar Pfister 1,2 , Vera Lorenz 1 , Stephanie P. Hauselmann 1 , Katrin<br />
Buhler 1 , Aleksandra Wodnar-Filipowicz 1 , Gabriela M. Kuster 1,2 ;<br />
1<br />
Department <strong>of</strong> Biomedicine, University Hospital, Basel,<br />
Switzerland; 2 Division <strong>of</strong> Cardiology, University Hospital,<br />
Basel, Switzerland<br />
085 Systemic Asymmetric Dimethylarginine Levels Identify<br />
Chronic Systolic <strong>Heart</strong> <strong>Failure</strong> Patients with Diminished<br />
Exercise Capacity and Impaired Peripheral Vascular<br />
Reactivity<br />
Andres Schuster 1 , Akanksha Thakur 2 , Allen G. Borowski 1 , W.H.<br />
Wilson Tang 1 ; 1 Department <strong>of</strong> Cardiovascular Medicine, <strong>Heart</strong><br />
and Vascular Institute, Cleveland Clinic Foundation, Cleveland,<br />
OH; 2 Case Western Reserve School <strong>of</strong> Medicine, Case Western<br />
Reserve University, Cleveland, OH<br />
086 Serum Arylesterase Activity Levels Provide Stronger<br />
Prognostic Value Than Serum Paraoxonase Activity<br />
Levels in Patients with <strong>Heart</strong> <strong>Failure</strong><br />
Zhili Shao 1 , Yuping Wu 2 , Yi Lu 1 , Stanley L. Hazen 1 , W.H.<br />
Wilson Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Cleveland<br />
State University, Cleveland, OH<br />
087 Diminished Endothelial Progenitor Cells Were<br />
Associated with Endothelial Dysfunction in Patients<br />
with Pulmonary Hypertension Secondary to Left <strong>Heart</strong><br />
Disease<br />
Yenal Harper 1 , Kewal Asosingh 1 , Cotleur Anne 1 , Serpil C.<br />
Erzurum 1 , W.H. Wilson Tang 1 ; 1 Cleveland Clinic Foundation,<br />
Cleveland, OH<br />
088 Protein Carbamylation in Chronic Systolic <strong>Heart</strong><br />
<strong>Failure</strong>: Relation with Renal Insufficiency and Adverse<br />
Long-Term Clinical Outcomes<br />
Kevin Shrestha 1 , Zeneng Wang 1 , Allen G. Borowski 1 , Richard<br />
W. Troughton 2 , Allan L. Klein 1 , Stanley L. Hazen 1 , W.H. Wilson<br />
Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Christchurch School<br />
<strong>of</strong> Medicine and Health Sciences, Christchurch, New Zealand<br />
089 Elevated Urinary Neopterin Levels Are Associated with<br />
Cardiac and Functional Impairment in Patients with<br />
Chronic Systolic <strong>Heart</strong> <strong>Failure</strong><br />
Zhili Shao 1 , Renliang Zhang 1 , Allen G. Borowski 1 , Akanksha<br />
Thakur 2 , W.H. Wilson Tang 1 ; 1 Cleveland Clinic, Cleveland, OH;<br />
2<br />
Case Western Reserve University, Cleveland, OH<br />
090 Gut-Flora-Dependent Phosphatidylcholine Metabolites<br />
Predict Adverse Clinical Outcomes in Chronic Systolic<br />
<strong>Heart</strong> <strong>Failure</strong><br />
Kevin Shrestha 1 , Zeneng Wang 1 , Allen G. Borowski 1 , Richard<br />
W. Troughton 2 , Allan L. Klein 1 , Stanley L. Hazen 1 , W.H. Wilson<br />
Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Christchurch School<br />
<strong>of</strong> Medicine and Health Sciences, Christchurch, New Zealand<br />
091 Do Cytokines and Biomarkers Play a Role on Cognitive<br />
Impairment in <strong>Heart</strong> <strong>Failure</strong>?<br />
Ponrathi R. Athilingam 1 , Leway Chen 2 ; 1 University <strong>of</strong> South<br />
Florida, Tampa, FL; 2 University <strong>of</strong> Rochester, Rochester, NY<br />
092 High Sensitivity C-Reactive Protein Predicts Carvedilol-<br />
Induced Improvement <strong>of</strong> Left Ventricular Systolic<br />
Function in Patients with <strong>Heart</strong> <strong>Failure</strong><br />
Jadwiga M. Nessler 1 , Bohdan J. Nessler 1 , Mariusz Kitlinski 2 ,<br />
Ole Melander 2 , Artur Fedorowski 2 ; 1 Dpt <strong>of</strong> Coronary <strong>Heart</strong><br />
Disease, Institute <strong>of</strong> Cardiology, Medical School <strong>of</strong> Jagiellonian<br />
University, Cracow, Poland; 2 Dpt <strong>of</strong> Cardiology, Skane<br />
University Hospital, Malmoe, Sweden<br />
093 Adrenergic-Mediated Suppression <strong>of</strong> Monocyte<br />
Proinflammatory Cytokine Production Is Reduced in<br />
Acute <strong>Heart</strong> <strong>Failure</strong><br />
Tien M.H. Ng 1 , Brian J. Kim 1 , Jennifer I. Park 1 , Stan G. Louie 1 ,<br />
Uri Elkayam 1 ; 1 School <strong>of</strong> Pharmacy and Keck School <strong>of</strong><br />
Medicine, University <strong>of</strong> Southern California, Los Angeles, CA<br />
094 IL-17 RA PLAD-Ig Reduces Cardiac Fibrosis in<br />
Experimental Autoimmune Myocarditis Rats<br />
Wei Liu, Weimin Li, Ning Yang, Yunyan Song; Cardiology, The<br />
First Affiliated Hospital <strong>of</strong> Harbin Medical University, Harbin,<br />
Heilongjiang, China<br />
095 Plasma Galectin-3 in Patients with <strong>Heart</strong> <strong>Failure</strong>:<br />
Relationship to Clinical Status, Pathophysiology <strong>of</strong> <strong>Heart</strong><br />
<strong>Failure</strong>, and Renal Function<br />
Deepa M. Gopal 1 , Maya Kommineni 1 , Nir Ayalon 1 , Christian<br />
Koelbl 1 , Rivka Ayalon 1 , Andreia Biolo 1 , Laura M. Dember 1 ,<br />
Jill Downing 1 , Deborah A. Siwik 1 , Chang-seng Liang 1 , Wilson<br />
S. Colucci 1 ; 1 Cardiovascular Medicine Section, Department <strong>of</strong><br />
Medicine, and the Myocardial Biology Unit, Boston University<br />
Medical Center, Boston, MA<br />
tuesdAY<br />
114<br />
115
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Neurohormones/Cytokines<br />
Posters<br />
Molecular Biology and Genetics<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
096 Systemic and Urinary Neutrophil Gelatinase-Associated<br />
Lipocalin (NGAL) Levels Reflect Different Aspects<br />
<strong>of</strong> Renal Impairment in Acute Decompensated <strong>Heart</strong><br />
<strong>Failure</strong><br />
Kevin Shrestha 1 , Dhssraj Singh 1 , Matthias Dupont 1 , W.H. Wilson<br />
Tang 1 ; 1 Cleveland Clinic, Cleveland, OH<br />
097 Prediction <strong>of</strong> Future Cardiovascular Risk by Detecting<br />
Subclinical Myocardial Necrosis in Stable Patients with<br />
Diabetes Mellitus<br />
Earl B. Britt, Jr. 1 , Yuping Wu 2 , Stanley L. Hazen 1 , W.H. Wilson<br />
Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Cleveland State<br />
University, Cleveland, OH<br />
098 Elevated Plasma Nitrate Levels Are Associated with<br />
Decompensated <strong>Heart</strong> <strong>Failure</strong> and with Oral Nitrate<br />
Therapy in Chronic <strong>Heart</strong> <strong>Failure</strong><br />
Zhili Shao 1 , Allison Janocha 1 , Allen G. Borowski 1 , Serpil C.<br />
Erzurum 1 , W.H. Wilson Tang 1 ; 1 Cleveland Clinic, Cleveland, OH<br />
Molecular Biology and Genetics<br />
107 DNA Variants in NOS3 Are Associated with Improved<br />
Small Artery Elasticity and Decreased Systolic Blood<br />
Pressure in Asymptomatic Individuals<br />
Jennifer L. Hall 1 , Natalia Florez 1 , Marj Carlson 1 , Sara Saul 1 ,<br />
Mark Lawson 2 , Aaron Mackey 2 , Joao Lima 3 , Jay Cohn 1 ,<br />
Stephen S. Rich 2 , Wei Zhong 1 , Gregory Grandits 1 , Daniel<br />
A. Duprez 1 ; 1 Cardiology, Medicine, Lillehei <strong>Heart</strong> Institute,<br />
University <strong>of</strong> Minnesota, Minneapolis, MN; 2 Center for Public<br />
Health Genomics, University <strong>of</strong> Virginia, Charlottesville, VA;<br />
3<br />
Medicine, Johns Hopkins University, Baltimore, MD<br />
108 Oxidative Modification <strong>of</strong> the Extracellular Domain<br />
Decreases β1-Integrin Avidity and Interferes with<br />
Outside-In Signaling and Cell Survival<br />
Stephanie P. Hauselmann 1 , Vera Lorenz 1 , Otmar Pfister 1,2 ,<br />
Gabriela M. Kuster 1,2 ; 1 Department <strong>of</strong> Biomedicine, University<br />
Hospital, Basel, Switzerland; 2 Division <strong>of</strong> Cardiology,<br />
University Hospital, Basel, Switzerland<br />
109 Right Ventricular <strong>Failure</strong> in Patients Requiring<br />
Mechanical Circulatory Assistance Is Associated with<br />
Elevated miR-15b Expression<br />
Alexander G. Moore 1 , Marc Simon 2 , Bonnie Lemster 2 , John<br />
Gorcsan 2 , Charles McTiernan 2 , Ravi Ramani 2 ; 1 University<br />
<strong>of</strong> Pittsburgh School <strong>of</strong> Medicine, Pittsburgh, PA; 2 UPMC<br />
Cardiovascular Institute, Pittsburgh, PA<br />
110 Right Ventricular Metabolic Imaging in Experimental<br />
Pulmonary Artery Hypertension<br />
Lisa M. Mielniczuk 1 , Stephanie Thorn 1 , Jennifer J. Renaud 1 , Ran<br />
Klein 1 , Jean DaSilva 1 , Robert J. deKemp 1 , Rob A. Beanlands 1 ,<br />
Duncan J. Stewart 1 ; 1 Cardiology, University <strong>of</strong> Ottawa <strong>Heart</strong><br />
Institute, Ottawa, ON, Canada<br />
111 Evidence <strong>of</strong> Anti-Cardiac Antibody Deposition in End-<br />
Stage Failing Myocardium: A Potential Contributor to<br />
Disease Progression<br />
Alejandro Trevino 1 , Jose H. Flores-Arredondo 1 , Roberto<br />
Barrios 1 , Keith A. Youker 1 , Andrea M. Cordero-Reyes 1 , Jerry<br />
D. Estep 1 , Carlos M. Orrego 1 , Guillermo Torre-Amione 1,2 ; 1 The<br />
Methodist DeBakey <strong>Heart</strong> Vascular Center, The Methodist<br />
Hospital, Houston, TX; 2 Instituto de Cardiología y Medicina<br />
Vascular, Hospital San José Tec de Monterrey, Monterery,<br />
Nuevo Leon, Mexico<br />
112 Cardiac Fibrosis Induced by Angiotensin II Is Dependent<br />
on a Radiation Sensitive or Bone Marrow Derived Cell<br />
Jose H. Flores-Arredondo 1 , Andrea M. Cordero-Reyes 1 ,<br />
Alejandro Trevino 1 , Keith A. Youker 1 , Carlos M. Orrego 1 , Jerry<br />
D. Estep 1 , Guillermo Torre-Amione 1,2 ; 1 The Methodist DeBakey<br />
<strong>Heart</strong> Vascular Center, The Methodist Hospital, Houston, TX;<br />
2<br />
Instituto de Cardiología y Medicina Vascular, Hospital San José<br />
Tec de Monterrey, Monterrey, Nuevo Leon, Mexico<br />
113 Transcriptional Pr<strong>of</strong>iles <strong>of</strong> Ventricular Ectopy on<br />
β-Blocker Therapy<br />
Andreas Brieke 1 , David P. Kao 1 , Ronald Zolty 2 , Edward M.<br />
Gilbert 3 , Alastair D. Robertson 1 , Michael R. Bristow 1 , Brian<br />
D. Lowes 1 ; 1 Cardiology, University <strong>of</strong> Colorado School <strong>of</strong><br />
Medicine, Aurora, CO; 2 Montefiore Medical Center, Bronx, NY;<br />
3<br />
University <strong>of</strong> Utah HSC, Salt Lake City, UT<br />
114 Novel Findings <strong>of</strong> Upregulated Neutrophil Gelatinase-<br />
Associated Lipocalin (NGAL) in Myocytes <strong>of</strong> Advanced<br />
<strong>Heart</strong> <strong>Failure</strong> Patients<br />
Cara Statz 1 , Mridula Rai 1,2 , Aleksandra Ras 1 , Jacqueline Imse 1 ,<br />
Faisal Zaeem 1 , Roja Mulamalla 1 , Jonathan Hammond 1 , Detlef<br />
Wencker 1 ; 1 <strong>Heart</strong> <strong>Failure</strong> and Transplant Center, Hartford<br />
Hospital, Hartford, CT; 2 University <strong>of</strong> Connecticut Health<br />
Center, Farmington, CT<br />
tuesdAY<br />
116<br />
117
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Surgery, Transplantation, Devices<br />
Posters<br />
Surgery, Transplantation, Devices<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
138 Treatment <strong>of</strong> Functional Mitral Regurgitation by<br />
Percutaneous Annuloplasty Results in Durable Clinical<br />
Efficacy through 18 Months<br />
David G. Reuter 1 , Michael Haude 2 , Tomasz Siminiak 3 , Jerzy<br />
Sadowski 4 , Janusz Lipiecki 5 , Jean Fajadet 6 , Uta C. Hoppe 7 ;<br />
1<br />
Cardiology, Seattle Childrens Hosp and Cardiac Dimensions,<br />
Kirkland, WA; 2 Stadtische Kliniken Neuss Lukaskrankenhaus,<br />
Neuss, Germany; 3 Poznan University, Poznan, Poland; 4 John<br />
Paul II Hospital, Krakow, Poland; 5 Univeristy Hospital,<br />
Clermont Ferrand, France; 6 La Clinique Pasteur, Toulouse,<br />
France; 7 Cologne University, Cologne, Germany<br />
139 Effect <strong>of</strong> QRS Morphology on Clinical Event Reduction<br />
with Cardiac Resynchronization Therapy: Meta-Analysis<br />
<strong>of</strong> Randomized Controlled Trials<br />
Josephine C. Chou 1 , Ilke Sipahi 1 , Marshall Hyden 1 , Daniel I.<br />
Simon 1 , James C. Fang 1 ; 1 Harrington-McLaughlin <strong>Heart</strong> and<br />
Vascular Institute, University Hospitals Case Medical Center,<br />
Cleveland, OH<br />
140 <strong>Heart</strong> <strong>Failure</strong> Diagnostic Parameters and Symptoms:<br />
Observations from the ALTITUDE Study<br />
John P. Boehmer 1 , John D. Day 2 , Francis R. Gilliam 3 , Paul A.<br />
Heidenreich 4 , David L. Hayes 5 , Kristine Roy 6 , Songtao Jiang 6 ,<br />
Leslie A. Saxon 7 ; 1 Penn State, Hershey, PA; 2 Intermountain<br />
Medical Ctr, Salt Lake City, UT; 3 Cardiology Assoc <strong>of</strong> NE<br />
Arkansas, Jonesboro, AR; 4 VA Palo Alto Health Care System,<br />
Palo Alto, CA; 5 Mayo Clinic, Rochester, MN; 6 Boston<br />
<strong>Scientific</strong>, Natick, MA; 7 USC, Los Angeles, CA<br />
141 Virtual Cross-Match in Orthotopic <strong>Heart</strong> Transplant: A<br />
Blessing or a Curse?<br />
Roja Mulamalla 1 , Jason Gluck 1 , Joseph Radojevic 1 , Detlef<br />
Wencker 1 , Todd Alberghini 1 , Michael Rewiniski 1 ; 1 <strong>Heart</strong> <strong>Failure</strong><br />
Transplant, University <strong>of</strong> Connecticut-Hartford Hospital,<br />
Hartford, CT<br />
142 Continuous Flow Left Ventricular Assist Device Support<br />
as a Bridge to Decision in Patients with End-Stage <strong>Heart</strong><br />
<strong>Failure</strong> Complicated by Pulmonary Hypertension<br />
Toshikazu D. Tanaka 1 , Robert L. Kormos 2 , Basar Sareyyupoglu 2 ,<br />
Ravi Ramani 1 , Jeffrey J. Teuteberg 1 , Michael A. Mathier 1 ,<br />
Dennis M. McNamara 1 , Marc A. Simon 1 ; 1 Cardiovascular<br />
Institute, University <strong>of</strong> Pittsburgh, Pittsburgh, PA; 2 Artificial<br />
<strong>Heart</strong> Program, University <strong>of</strong> Pittsburgh, Pittsburgh, PA<br />
143 Elderly Patients with Advanced <strong>Heart</strong> <strong>Failure</strong> and Atrial<br />
Fibrillation Benefit from Cardiac Tissue Ablation at the<br />
Time <strong>of</strong> Structural <strong>Heart</strong> Repair<br />
Mark A. Groh 1 , Ben I. Groh 1 , Oliver A. Binns 1 , Alan<br />
M. Johnson 1 , Stephen W. Ely 1 , Gerard L. Champsaur 2 ;<br />
1<br />
Cardiovascular Surgery, Asheville <strong>Heart</strong>, Asheville, NC;<br />
2<br />
Clinical Research, Mission Hospitals, Asheville, NC<br />
144 A Robust Cardiac MRI Assessment for the<br />
Characterization <strong>of</strong> an Ovine Ischemic Cardiomyopathy<br />
Model Creation Protocol Demonstrates Rapid <strong>Heart</strong><br />
<strong>Failure</strong> Progression with Minimized Mortality<br />
Anthony S. Fargnoli 1 , Michael G. Katz 1 , Kevin Koomalsingh 1 ,<br />
Louella Pritchette 1 , James J. Pilla 1 , Charles R. Bridges 1 ;<br />
1<br />
Cardiovascular Surgery, University <strong>of</strong> Pennsylvania,<br />
Philadelphia, PA<br />
145 Cardiac Amyloidosis: Screening Criteria for <strong>Heart</strong><br />
Transplantation and New Strategies for Post-Transplant<br />
Therapy<br />
Brandon C. Varr 1 , Michaela Liedtke 2 , Sally Arai 3 , Richard<br />
A. Lafayette 4 , Stanley L. Schrier 2 , Ronald M. Witteles 5 ;<br />
1<br />
Department <strong>of</strong> Internal Medicine, Stanford University School<br />
<strong>of</strong> Medicine, Stanford, CA; 2 Division <strong>of</strong> Hematology, Stanford<br />
University School <strong>of</strong> Medicine, Stanford, CA; 3 Division <strong>of</strong><br />
Blood and Marrow Transplantation, Stanford University School<br />
<strong>of</strong> Medicine, Stanford, CA; 4 Division <strong>of</strong> Nephrology, Stanford<br />
University School <strong>of</strong> Medicine, Stanford, CA; 5 Division <strong>of</strong><br />
Cardiovascular Medicine, Stanford University School <strong>of</strong><br />
Medicine, Stanford, CA<br />
146 Outcomes <strong>of</strong> Patients with Acute Right Ventricular<br />
<strong>Failure</strong> in the Era <strong>of</strong> Mechanical Circulatory Support<br />
Margot K. Davis 1 , Jennifer Higgins 1 , Annemarie Kaan 2 , Andrew<br />
Ignaszewski 1 , Anson Cheung 1 ; 1 University <strong>of</strong> British Columbia,<br />
Vancouver, BC, Canada; 2 St. Paul’s Hospital, Vancouver, BC,<br />
Canada<br />
147 Can Right Ventricular <strong>Failure</strong> Associated with LVAD<br />
Insertion Be Avoided?<br />
Robert M. Adamson 1 , Sam Baradarian 1 , Joseph Chammas 1 ,<br />
Vanja Norman 1 , Brian Jaski 2 , Peter Hoagland 2 , Suzanne<br />
Chilcott 3 , Marcia Stahovich 3 , Lesli Hazard 3 , Vicki McCalmont 3 ,<br />
Kristi Ortiz 3 , Walter P. Dembitsky 1 ; 1 Cardiothoracic Surgery,<br />
Sharp Memorial Hospital, San Diego, CA; 2 Cardiology, Sharp<br />
Memorial Hospital, San Diego, CA; 3 Nursing, Sharp Memorial<br />
Hospital, San Diego, CA<br />
tuesdAY<br />
118<br />
119
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Surgery, Transplantation, Devices<br />
Posters<br />
Surgery, Transplantation, Devices<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
148 Transthoracic Echocardiography <strong>of</strong> the <strong>Heart</strong>Ware Left<br />
Ventricular Assist Device<br />
Nishant R. Shah 1,2 , Cihan Cevik 1,2 , Antonieta Hernandez 1 , Igor D.<br />
Gregoric 1 , O.H. Frazier 1,2 , Raymond F. Stainback 1,2 ; 1 Texas <strong>Heart</strong><br />
Institute at St. Luke’s Episcopal Hospital, Houston, TX; 2 Baylor<br />
College <strong>of</strong> Medicine, Houston, TX<br />
149 Reduced Serum Albumin Concentration before <strong>Heart</strong><br />
Transplantation Predicts Poor Post-Transplant Prognosis<br />
Tomoko S. Kato 1 , Faisal H. Cheema 1 , Jonathan Yang 2 , Hiroo<br />
Takayama 2 , Yoshifumi Naka 2 , Maryjane Farr 1 , Donna Mancini 1 ,<br />
P. Christian Schulze 1 ; 1 Department <strong>of</strong> Medicine, Division <strong>of</strong><br />
Cardiology, Columbia University Medical Center, New York,<br />
NY; 2 Department <strong>of</strong> Surgery, Division <strong>of</strong> Cardiothoracic<br />
Surgery, Columbia University Medical Center, New York, NY<br />
150 Psychological and Cognitive Pr<strong>of</strong>iles <strong>of</strong> Advanced <strong>Heart</strong><br />
<strong>Failure</strong> Surgical Intervention Candidates<br />
Rebecca A. Stout 1 , Moises Gaviria 1 , Sunil Pauwaa 1 , Geetha<br />
Bhat 1 ; 1 Advocate Christ Medical Center, Oak Lawn, IL<br />
151 Impairment <strong>of</strong> Myocardial Endocannabinoid Signaling<br />
and Depletion <strong>of</strong> the Endogenous Ligands Anandamide<br />
and Arachidonoylglycerol in Patients with Advanced<br />
<strong>Heart</strong> <strong>Failure</strong><br />
Ruiping Ji 1 , Aalap Chokshi 1 , Faisal Cheema 2 , Tuba Khawaja 1 ,<br />
Raffay Khan 1 , Shuiqing Yu 1 , Hiroo Takayama 2 , Yoshifumi<br />
Naka 2 , Hongfeng Jiang 1 , Donna Mancini 1 , P. Christian<br />
Schulze 1 ; 1 Cardiology, Columbia University, New York, NY;<br />
2<br />
Cardiothoracic Surgery, Columbia University, New York, NY<br />
152 AV Delay Optimization in CRT Based on LV dP/dtmax<br />
and Fick Cardiac Output<br />
Stuart P. Rosenberg 1 , Steve Koh 1 , Wenbo Hou 1 , John W. Poore 1 ,<br />
Jeffery D. Snell 1 , Nirav Dalal 1 , Gene A. Bornzin 1 ; 1 Cardiac<br />
Rhythm Management Division, Research, St. Jude Medical,<br />
Sylmar, CA<br />
153 Comparison <strong>of</strong> <strong>Heart</strong> Sound Index from Accelerometer<br />
and Microphone for Hemodynamic Optimization <strong>of</strong> CRT<br />
Steve Koh 1 , Wenbo Hou 1 , Stuart P. Rosenberg 1 , Jeffery D.<br />
Snell 1 , John W. Poore 1 , Nirav Dalal 1 , Gene A. Bornzin 1 ; 1 St. Jude<br />
Medical Cardiac Rhythm Management Division, Sylmar, CA<br />
154 Correction <strong>of</strong> Diastolic Dyssynchrony by Cardiac<br />
Resynchronization Therapy Improves <strong>Heart</strong> <strong>Failure</strong> Via<br />
Acceleration <strong>of</strong> Global Diastolic Filling<br />
Takeshi Yamamoto 1 , Miyuki Ando 1 , Masunori Matsuzaki 1 ;<br />
1<br />
Department <strong>of</strong> Medicine and Clinical Science, Yamaguchi<br />
University Graduate School <strong>of</strong> Medicine, Ube, Japan<br />
155 Changes in Hemoglobin Associated with Different<br />
Unloading Conditions in Patient Supported with<br />
Continuous Flow Left Ventricular Assist Devices<br />
Omar Wever Pinzon 1 , Abdulfattah Saidi 1 , Stavros Drakos 1 ,<br />
Edward Gilbert 1 , Craig Selzman 1 , Rami Alharethi 2 , Deborah<br />
Budge 2 , Bruce Reid 2 , Abdallah Kfoury 2 , Josef Stehlik 1 , Feras<br />
Bader 1 ; 1 University <strong>of</strong> Utah Health Sciences Center, Salt Lake<br />
City, UT; 2 Intermountain Medical Center, Salt Lake City, UT<br />
156 Aquapheresis Can Be Safely Applied for Volume<br />
Overload in Patients with Left-Ventricular Assist Device<br />
Peter M. Eckman 1 , Douglas Horstmansh<strong>of</strong> 2 , Megan Wroblewski 1 ;<br />
1<br />
Department <strong>of</strong> Medicine, Cardiovascular Division, University<br />
<strong>of</strong> Minnesota, Minneapolis, MN; 2 INTEGRIS Advanced Cardiac<br />
Care, Oklahoma City, OK<br />
157 Left Ventricular Assist Device Implantation Is<br />
an Effective Therapy for Decreasing Pulmonary<br />
Hypertension and Reducing <strong>Heart</strong> Transplant Allograft<br />
Right Ventricular Strain<br />
Pavan Atluri 1 , Brant W. Ullery 1 , John W. MacArthur 1 , Ashwin<br />
Murthy 1 , William Hiesinger 1 , Mary Lou O’Hara 1 , Kimberly<br />
Breuer 1 , Mariell Jessup 2 , Michael A. Acker 1 , J. Eduardo<br />
Rame 2 , Kenneth B. Marguiles 2 , Y. Joseph Woo 1 ; 1 Division<br />
<strong>of</strong> Cardiovascular Surgery, University <strong>of</strong> Pennsylvania,<br />
Philadelphia, PA; 2 Division <strong>of</strong> Cardiovascular Medicine,<br />
University <strong>of</strong> Pennsylvania, Philadelphia, PA<br />
158 Effect <strong>of</strong> Alemtuzumab on Gene Expression Pr<strong>of</strong>ile <strong>of</strong><br />
Mononuclear Cells Score in Cardiac Transplant Patients<br />
Aarti A. Patel 1 , Renzo Y. Loyaga-Rendon 2 , Si Pham 3 , Sandra<br />
Chaparro 1 ; 1 Internal Medicine, University <strong>of</strong> Miami/Jackson<br />
Memorial Hospital, Miami, FL; 2 Cardiology, University <strong>of</strong><br />
Miami, Miami, FL; 3 Cardiothoracic Surgery, University <strong>of</strong><br />
Miami, Miami, FL<br />
159 Successful Initiation <strong>of</strong> a Mechanical Circulatory<br />
Support Program in a Non-Transplant Institution<br />
Barbara Lee-Grasso 1 , Audrey C. Kleet 1 , Nancy L. Bonnet 1 ,<br />
James P. Slater 1 ; 1 <strong>Heart</strong> Success Program, Morristown Memorial<br />
Hospital, Morristown, NJ<br />
160 Can Optimal LVAD Speed Be Determined by Body<br />
Surface Area and Pulsatile Index<br />
Mubashir Ahmed 1 , Kulpreet Barn 1 , William Posligua 1 , Farshad<br />
Raissi 1 , Raymond Stainback 1 , Howard O. Frazier 1 , MacArthur A.<br />
Elayda 1 , Reynolds M. Delgado 1 ; 1 <strong>Heart</strong> <strong>Failure</strong> and Transplant,<br />
Texas <strong>Heart</strong> Institute/St Luke’s Episcopal Hospital, Houston, TX<br />
tuesdAY<br />
120<br />
121
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Surgery, Transplantation, Devices<br />
Posters<br />
Electrophysiology/Arrhythmias<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
161 Immediate Post-Transplant Hyperglycemia and the Risk<br />
<strong>of</strong> <strong>Heart</strong> Allograft Rejection<br />
James Fleming, Mohamed Ahmed, David Lanfear; <strong>Heart</strong> and<br />
Vascular Institute, Henry Ford Hospital, Detroit, MI<br />
Electrophysiology/Arrhythmias<br />
171 Requests for ICD and Pacemaker Deactivation:<br />
Characteristics <strong>of</strong> Affected Patients and Outcomes<br />
Tracy L. Webster 1 , Lillian C. Buchhalter 1 , Abigale L. Ottenberg 1 ,<br />
Keith M. Swetz 1 , Paul S. Mueller 1 ; 1 Mayo Clinic, Rochester, MN<br />
172 Impact <strong>of</strong> B-Type Natruretic Peptide and Renal<br />
Function on Mortality in Patients with Atrial Fibrillation<br />
Receiving Cardiac Resynchronization Therapy<br />
Clay A. Cauthen 1 , John Rickard 1 , Bruce L. Wilk<strong>of</strong>f 1 , W.H.<br />
Wilson Tang 1 ; 1 Department <strong>of</strong> Cardiovascular Medicine,<br />
Cleveland Clinic Foundation, Cleveland, OH<br />
173 Calcium Mobilization Via IP3 Receptors Alters<br />
Electrical, Calcium Cycling and Contractile Properties<br />
<strong>of</strong> Human and Rodent Cardiomyocytes<br />
Sergio Signore 1 , Joao Ferreira-Martins 1 , Elisabeth Steadman 1 ,<br />
Justin A. Korn 1 , Polina Goihberg 1 , Yingnan A. Bai 1 , Fumihiro<br />
Sanada 1 , Hanqiao Zheng 1 , Claudia Fiorini 1 , Federica del Monte 2 ,<br />
Barbara Ogorek 1 , Francesco Cappetta 1 , Domenico D’Amario 1 ,<br />
Toru Hosoda 1 , Annarosa Leri 1 , Piero Anversa 1 , Jan Kajstura 1 ,<br />
Marcello Rota 1 ; 1 Anesthesia Medicine, Brigham Women’s<br />
Hospital-Harvard Medical School, Boston, MA; 2 Beth Israel<br />
Deaconess Medical Ctr, Boston, MA<br />
174 Withdrawn<br />
175 The Effects <strong>of</strong> Cardiac Resynchronization Therapy on<br />
Chronotropic Incompetence in Patients Intolerant <strong>of</strong><br />
Beta Antagonist Therapy. Data from the DECREASE<br />
HF Trial<br />
Michael A. Samara 1 , Masaomi Kimura 1 , Lillian Batizy 2 , Donald<br />
L. Hopper 3 , Bruce Wilk<strong>of</strong>f 1 ; 1 Department <strong>of</strong> Cardiovascular<br />
Medicine; <strong>Heart</strong> and Vascular Institute, Cleveland Clinic,<br />
Cleveland, OH; 2 Department <strong>of</strong> Quantitative Health Sciences,<br />
Cleveland Clinic, Cleveland, OH; 3 Boston <strong>Scientific</strong><br />
Corporation, Natick, MA<br />
176 Protecting Tako-Tsubo Patients from Sudden Death: Are<br />
Wearable Defibrillators the Answer?<br />
Jo Ann M. Glad 1 , Nicole R. Bianco 1 , Chingping Wan 1 , Steven J.<br />
Szymkiewicz 1 ; 1 Medical Affairs, Zoll, Pittsburgh, PA<br />
177 Mortality Benefit <strong>of</strong> Statins in Patients with Atrial<br />
Fibrillation<br />
Jason N. Salamon 1 , Jeremy Mazurek 1 , Muhammad R. Sardar 1 ,<br />
Ronald Zolty 1 ; 1 Cardiology, Montefiore Medical Center, Bronx,<br />
NY<br />
178 Electro-Mechanical Remodeling and Survival after<br />
Cardiac Resynchronization Therapy<br />
Jawad Kiani 1 , Sunil Kumar Agarwal 1 , Swapna Kamireddy 1 , Evan<br />
Adelstein 1 , Samir Saba 1 ; 1 University <strong>of</strong> Pittsburgh, Pittsburgh,<br />
PA<br />
Clinical Trials<br />
188 The Prognosis Investigation in Patients with Chronic<br />
<strong>Heart</strong> <strong>Failure</strong> and Pericardial Effusion<br />
Shengbo Yu 1 , Qingyan Zhao 1 , He Huang 1 , Hongying Cui 1 , Mu<br />
Qin 1 , Congxin Huang 1 ; 1 Cardiovascular Research Institute <strong>of</strong><br />
Wuhan University, Renmin Hospital <strong>of</strong> Wuhan University,<br />
Wuhan, China<br />
189 Role <strong>of</strong> Lung Impedance Monitoring in the Outpatient<br />
Clinic for Predicting and Preventing <strong>of</strong> Hospitalizations<br />
Patients with Chronic <strong>Heart</strong> <strong>Failure</strong><br />
Michael Shochat 1 , Avraham Shotan 1 , Aya Asif 1 , Yaniv Levy 1 ,<br />
Ilia Shochat 1 , Iris Dahan 1 , David Blonheim 1 , Simcha Meisel 1 ;<br />
1<br />
Cardiology, Hillel Yaffe, Hadera, Israel<br />
190 Design <strong>of</strong> the Investigations in Pregnancy Associated<br />
Cardiomyopathy (IPAC) Trial: A Multicenter<br />
Investigation <strong>of</strong> Immune Pathogenesis and Myocardial<br />
Recovery in Peripartum Cardiomyopathy<br />
Dennis M. McNamara 1 , Uri Elkayam 2 , Leslie T. Cooper 3 , Jessica<br />
Pisarcik 1 , John Gorcsan 1 , Erik B. Schelbert 1 , Charles McTiernan 1 ,<br />
James D. Fett 4 , For the IPAC Investigators; 1 Cardiovascular<br />
Institute, University <strong>of</strong> Pittsburgh Medical Center, Pittsburgh,<br />
PA; 2 University <strong>of</strong> Southern California, Los Angeles, CA;<br />
3<br />
Mayo Clinic Foundation, Rochester, MN; 4 Peripartum<br />
Cardiomyopathy Consultant, Seattle, WA<br />
191 The Relationship between Red Cell Distribution Width<br />
with Clinical Characteristics: Analysis Based on 16681<br />
Chronic Systolic <strong>Heart</strong> <strong>Failure</strong> Patients with Different<br />
Causation<br />
Shengbo Yu 1 , Qingyan Zhao 1 , He Huang 1 , Hongying Cui 1 , Mu<br />
Qin 1 , Congxin Huang 1 ; 1 Renmin Hospital <strong>of</strong> Wuhan University,<br />
Wuhan, China<br />
tuesdAY<br />
122<br />
123
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Clinical Trials<br />
Posters<br />
Cardiovascular Pharmacology<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
192 Intervention Research for <strong>Heart</strong> <strong>Failure</strong> Patients and<br />
Caregivers in Hospice – Is It Even Feasible?<br />
Cheryl H. Zambroski 1 , Chris Garrison 1 , Harleah G. Buck 2 , Susan<br />
C. McMillan 1 ; 1 Nursing, University <strong>of</strong> South Florida, Tampa,<br />
FL; 2 Nursing, Pennsylvannia State University, University Park,<br />
PA<br />
193 International Differences in Acute <strong>Heart</strong> <strong>Failure</strong> (AHF)<br />
Patients: Insight from the PROTECT Trial<br />
M. Fiuzat 1 , B. Massie 2 , K. Chiswell 1 , M. Givertz 3 , B. Davison 4 ,<br />
G. Cotter 4 , J. Cleland 5 , H. Dittrich 6 , G. Mansoor 6 , P. Ponikowski 7 ,<br />
A. Voors 8 , J.R. Teerlink 2 , R. Mentz 1 , M. Metra 9 , C. O’Connor 1 ;<br />
1<br />
Duke Univ, Durham, NC; 2 SFVAMC; 3 Brigham Womens;<br />
4<br />
Momentum; 5 Univ <strong>of</strong> Hull, United Kingdom; 6 Merck;<br />
7<br />
Med. Univ, Wroclaw, Poland; 8 Univ Med. Ctr, Groningen,<br />
Netherlands; 9 Univ <strong>of</strong> Brescia, Brescia, Italy<br />
194 The Prognostic Value <strong>of</strong> Right Ventricular End-Diastolic<br />
Diameter in Patients with Chronic Systolic <strong>Heart</strong> <strong>Failure</strong><br />
Shengbo Yu 1 , Qingyan Zhao 1 , He Huang 1 , Hongying Cui 1 , Mu<br />
Qin 1 , Congxin Huang 1 ; 1 Renmin Hospital <strong>of</strong> Wuhan University,<br />
Wuhan, China<br />
195 Impairment <strong>of</strong> Muscle Fiber Recruitment and Decreased<br />
Total Muscle Work Capacity during Isokinetic Exercise<br />
in Patients with Advanced <strong>Heart</strong> <strong>Failure</strong><br />
Meaghan L. Jones 1 , Aalap Chokshi 1 , J. Elias Collado 1 , Aimee<br />
Layton 1 , Hilary F. Armstrong 1 , Daniel E. Forman 2 , Matthew<br />
Bartels 1 , Donna Mancini 1 , P. Christian Schulze 1 ; 1 Cardiology,<br />
Columbia University, New York, NY; 2 Cardiology, VA Boston<br />
Health Care System, Boston, MA<br />
196 Is Radial Strain by 2D Speckle Tracking Ready for<br />
Prime Time in Multicenter Echocardiographic Study <strong>of</strong><br />
<strong>Heart</strong> <strong>Failure</strong> Patients?<br />
Salima Qamruddin 1 , Reza Rafie 1 , Kyungmoo Ryu 2 , Allen J.<br />
Keel 2 , Tasneem Z. Naqvi 1 ; 1 Non Invasive Lab, Division <strong>of</strong><br />
Cardiology, Department <strong>of</strong> Medicine, University <strong>of</strong> Southern<br />
California, Los Angeles, CA; 2 Research Division, St. Jude<br />
Medical, Inc., Sylmar, CA<br />
197 The Clinical Efficacy <strong>of</strong> CRT-D in Japanese <strong>Heart</strong><br />
<strong>Failure</strong> Patients. Comparison <strong>of</strong> MOMIJI (MIRACLE-<br />
ICD Outcome Measured in Japanese Indication) Study<br />
and MIRACLE ICD<br />
Shin-ichi Momomura 1 , Kaoru Sugi 2 , Tomoyuki Tejima 3 ,<br />
Hiroyuki Tsutsui 4 , For the MOMIJI Study Investigators;<br />
1<br />
Cardiovascular Medicine, Jichi Medical University Saitama<br />
Meducal Center, Saitama, Japan; 2 Toho University Ohashi<br />
Medical Center, Tokyo, Japan; 3 Medtronic Japan, Tokyo, Japan;<br />
4<br />
Hokkaido University Graduate School <strong>of</strong> Medicine, Sapporo,<br />
Japan<br />
206 Clenbuterol + C-CSF Administration Improves Left<br />
Ventricular Function through Stem/Progenitor Cell<br />
Mobilization in Rats with <strong>Heart</strong> <strong>Failure</strong><br />
Toshikazu D. Tanaka 1 , Jordan J. Lancaster 1 , Elizabeth Juneman 1 ,<br />
Sarah Arnce 1 , Nicholle M. Johnson 1 , Maribeth Stansifer 1 ,<br />
Howard Byrne 1 , Grace Gorman 1 , Joseph J. Bahl 1 , Steven<br />
Goldman 1 ; 1 Cardiology, Southern Arizona VA Health Care<br />
System, Tucson, AZ<br />
207 Optimal <strong>Heart</strong> <strong>Failure</strong> Management in the Outpatient<br />
Setting: Assessing Treatment by Provider Type<br />
Megan E. Cevasco 1 , Katherine M. Sullivan 1 , Mark E. Dunlap 1 ;<br />
1<br />
MetroHealth Campus <strong>of</strong> Case Western Reserve University,<br />
Cleveland, OH<br />
208 Pro-Fibrotic Role <strong>of</strong> the A2B Adenosine Receptor in<br />
Human Cardiac Fibroblasts<br />
Hongyan Zhong 1 , Luiz Belardinelli 1 , Dewan Zeng 1 ; 1 Gilead<br />
Sciences, Inc., Palo Alto, CA<br />
209 Antiviral Activity <strong>of</strong> Water Soluble Coxsackievirus B3<br />
3C Protease Inhibitor<br />
Eun-Seok Jeon 1 , Soo-Hyeon Yun 1 , Jin-Oh Choi 1 , Eun-Seon<br />
Ju 1 , Yong-Chul Kim 2 ; 1 Cardiology, Sungkyunkwan University<br />
School <strong>of</strong> Medicine, Seoul, Republic <strong>of</strong> Korea; 2 School <strong>of</strong><br />
Life Science, Gwangju Institute <strong>of</strong> Science and Technology,<br />
Gwangju, Republic <strong>of</strong> Korea<br />
210 Use <strong>of</strong> Fish Oil in Systolic <strong>Heart</strong> <strong>Failure</strong> (SHF): A<br />
Retrospective Mortality Analysis<br />
Zia Rab 1 , Wajeeha Saeed 2 , Jason Salamon 2 , Muhammad<br />
R. Sardar 2 , Ronald Zolty 2 ; 1 Internal Medicine, Montefiore<br />
Medical Center, Bronx, NY; 2 Cardiology/CHF and Transplant,<br />
Montefiore Medical Center, Bronx, NY<br />
211 Use <strong>of</strong> Carpeptide in Patients Admitted with Acutely<br />
Decompensated <strong>Heart</strong> <strong>Failure</strong> in Japan<br />
Yoshihisa Morita 1 , Shun Kohsaka 2 , Yutaka Endo 2 , Kazuki<br />
Oshima 2 , Tsutomu Yoshikawa 2 , Keiichi Fukuda 2 ; 1 Department <strong>of</strong><br />
Anesthesiology and Critical Care, Teikyo University, School <strong>of</strong><br />
Medicine, Itabashi, Tokyo, Japan; 2 Department <strong>of</strong> Cardiology,<br />
Keio University, School <strong>of</strong> Medicine, Shinjuku, Tokyo, Japan<br />
212 Clinical Experience with Low-Dose Continuous Infusion<br />
Furosemide in Acute <strong>Heart</strong> <strong>Failure</strong>: Assessment <strong>of</strong><br />
Efficacy and Safety<br />
Tien M.H. Ng 1 , Shenche Hshieh 1 , Cynthia Y. Chan 1 , Uri<br />
Elkayam 1 ; 1 School <strong>of</strong> Pharmacy and Keck School <strong>of</strong> Medicine,<br />
University <strong>of</strong> Southern California, Los Angeles, CA<br />
tuesdAY<br />
124<br />
125
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Cardiovascular Pharmacology<br />
Posters<br />
Epidemiology/Prevention<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
213 Affect <strong>of</strong> Warfarin on Pulmonary Arterial Hypertension<br />
(PAH) Mortality: Facts Have Changed?<br />
Wajeeha Saeed 1 , Nidhish Tiwari 2 , Jason Salamon 1 , Muhammad<br />
R. Sardar 1 , Zia Rab 1 , Ronald Zolty 1 ; 1 Cardiology/CHF and<br />
Transplant, Montefiore Medical Center, Bronx, NY; 2 Internal<br />
Medicine, Jacobi Medical Center, Bronx, NY<br />
Epidemiology/Prevention<br />
221 Genotype and Phenotypic Characteristics <strong>of</strong> Persons<br />
with Cardiac Amyloidosis from the Multinational<br />
Transthyretin Amyloidosis Outcomes Survey (THAOS)<br />
Registry<br />
Kumar Dharmarajan 1 , Say Salomon 1 , Stephen Helmke 1 , Sergio<br />
Tereyua 1 , Claudio Rapezzi 2 , Rodney Falk 3 , Mathew S. Maurer 1 ;<br />
1<br />
Clinical Cardiovascular Research Lab for the Elderly, Columbia<br />
University, New York, NY; 2 Harvard Vanguard Medical<br />
Associates, Boston, MA; 3 University <strong>of</strong> Bologna, Bologna, Italy<br />
222 <strong>Heart</strong> <strong>Failure</strong> Patients with Lower Socioeconomic Status<br />
Generate Lower Charges<br />
Billy G. Chacko 1 , Tej K. Atluri 1 , Hamza Rana 1 , Syed U.<br />
Naqvi 1 , Pavel Levy 1 , Kimberley J. Hansen 2 ; 1 Vascular and<br />
Endovascular Surgery, Section on Vascular Medicine, Wake<br />
Forest Baptist Medical Center, Winston-Salem, NC; 2 Vascular<br />
and Endovascular Surgery, Wake Forest Baptist Medical Center,<br />
Winston-Salem, NC<br />
223 Ethnicity and <strong>Heart</strong> <strong>Failure</strong> and Their Epidemiological<br />
Pr<strong>of</strong>ile and Outcomes in a Multi-Ethnic Asian Cohort in<br />
Singapore<br />
Kui Toh Gerard Leong 1 , Yan Cao 2 , Michelle Tan 2 , Ping Ping<br />
Goh 1 ; 1 Cardiology, Changi General Hospital, Singapore,<br />
Singapore; 2 Case Management, Changi General Hospital,<br />
Singapore, Singapore<br />
224 Systolic Dysfunction Predicts 30 Day <strong>Heart</strong> <strong>Failure</strong><br />
Specific Readmission in US Academic Medical Centers<br />
and All-Cause Readmission in Academic Safety Net<br />
Hospitals<br />
Edward F. Gibbons 1 , Ellen Robinson 1 , Paula Minton-Foltz 1 ,<br />
J. Richard Goss 1 ; 1 Departments <strong>of</strong> Cardiology, Quality<br />
Improvement, Patient Care Services, and Medicine, University<br />
<strong>of</strong> Washington School <strong>of</strong> Medicine, Harborview Medical Center,<br />
Seattle, WA<br />
226 The Actual Utilization and the Reasons for Donor <strong>Heart</strong><br />
Unacceptability in Korean <strong>Heart</strong> Transplantation<br />
Myung-jin Cha 1 , Hae-Young Lee 1 , Hyun-Jai Cho 1 , Kee-Bong<br />
Kim 1 , Byung-Hee Oh 1 ; 1 Seoul National University Hospital,<br />
Seoul, Korea<br />
227 Navigating the Cultural Geography <strong>of</strong> an Indigenous<br />
Community’s Attitude toward Genetic Research Is<br />
Dependant upon a History <strong>of</strong> Fostered Trust<br />
May Vawer 1 , Ann E. Leonard 1 , Patsy Kaina 2 , Beth Blackburn 1 ,<br />
Malia Young 1 , Todd B. Seto 1 ; 1 The Queen’s Medical Center,<br />
Honolulu, HI; 2 Rural Community, Kahului, HI<br />
Outcomes<br />
255 Early Enalapril Therapy on Long-Term Mortality in<br />
Patients with Asymptomatic Left Ventricular Systolic<br />
Dysfunction: A 22-Year Follow-Up <strong>of</strong> SOLVD in Belgium<br />
Philip Jong 2 , Sylvie A. Ahn 1 , Michel F. Rousseau 1 ; 1 Division <strong>of</strong><br />
Cardiology, University <strong>of</strong> Louvain, Brussels, Belgium; 2 Division<br />
<strong>of</strong> Cardiology, University <strong>of</strong> Toronto, Toronto, ON, Canada<br />
256 Is B-Type Natriuretic Peptide Predictive <strong>of</strong> Outcomes in<br />
Non-<strong>Heart</strong> <strong>Failure</strong> Patients with Differing Body Mass?<br />
K. Rasmusson 1 , R. Alharethi, B. Horne, T. Bair, K. Brunisholz,<br />
D. Budge, J. Nixon, J. Connolly, A. Kfoury; 1 <strong>Heart</strong> <strong>Failure</strong><br />
Prevention and Treatment Program, Intermountain Medical<br />
Center, <strong>Heart</strong> and Lung Institute, Salt Lake City, UT<br />
257 Canadian <strong>Heart</strong> <strong>Failure</strong> Patient and Caregiver Emotions<br />
Karen I. Harkness 1,2,3 , Estrellita Estrella-Holder 3,4 , Annemarie<br />
Kaaan 3,5 , Heather M. Arthur 1,2 , Robert S. McKelvie 1,2 ; 1 Faculty <strong>of</strong><br />
Health Sciences, McMaster University, Hamilton, ON, Canada;<br />
2<br />
Hamilton Health Sciences, Hamilton, ON, Canada; 3 Canadian<br />
<strong>Heart</strong> <strong>Failure</strong> Network, London, ON, Canada; 4 Cardiac Sciences<br />
Program <strong>Heart</strong> <strong>Failure</strong> Clinic, Y3 Bergen Cardiac Centre,<br />
Winnipeg, MB, Canada; 5 Vancouver Coastal <strong>Heart</strong> <strong>Failure</strong><br />
Strategy, St Paul’s Hospital, Vancouver, BC, Canada<br />
258 ICD Implantation May Increase <strong>Heart</strong> <strong>Failure</strong><br />
Admissions in Patients with Left Ventricular Systolic<br />
Dysfunction Who Demonstrate Reverse Remodeling<br />
Pradeep K. Bhat 1 , Ottorino Costantini 1 ; 1 <strong>Heart</strong> and Vascular<br />
Center, MetroHealth Campus, Case Western Reserve University,<br />
Cleveland, OH<br />
tuesdAY<br />
225 Broken <strong>Heart</strong>, That’s Right<br />
Deepakraj Gajanana, Prasanna Sugathan, Jeffrey Veluz;<br />
Department <strong>of</strong> Cardiology, St Luke’s Hospital and Health<br />
Network, Bethlehem, PA<br />
126<br />
127
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Outcomes<br />
Posters<br />
Outcomes<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
259 Seattle <strong>Heart</strong> <strong>Failure</strong> Model Scores Significantly Predict<br />
Medical Resource Use and Costs in HF-ACTION<br />
Shelby D. Reed 1 , Yanhong Li 1 , Stephen J. Ellis 1 , David J.<br />
Whellan 2 , Kevin A. Schulman 1 , Christopher M. O’Connor 1 ,<br />
Wayne C. Levy 3 ; 1 Duke Clinical Research Institute, Durham,<br />
NC; 2 Jefferson Medical College, Philadelphia, PA; 3 University<br />
<strong>of</strong> Washington, Seattle, WA<br />
260 Longitudinal Investigation <strong>of</strong> Patient Centric Outcomes:<br />
Comparisons between CRT-D vs. ICD Patients<br />
Brian Ramza 1 , Samuel F. Sears 2 , Christina Murray 3 , John House 1 ,<br />
Paul Kennedy 1 , Rose Thompson 1 , Michelle M. Fedewa 4 ; 1 St.<br />
Luke’s Hospital, Kansas City, KS; 2 East Carolina, Greenville,<br />
NC; 3 Oklahoma University Health Sciences Ctr, Oklahoma City,<br />
OK; 4 Medtronic, Inc., Fridley, MN<br />
261 One-Year Survival Post-ICD Implantation: Another<br />
Indicator <strong>of</strong> Appropriate Candidate Selection<br />
Kismet Rasmusson 1 , Roberta James 1 , Rami Alharethi 1 , Deborah<br />
Budge 1 , Kim Brunisholz 1 , Jenny Connolly 1 , Joe Tuinei 1 , Dylan<br />
Nelson 1 , Colleen Roberts 1 , Abdallah Kfoury 1 ; 1 <strong>Heart</strong> <strong>Failure</strong><br />
Prevention and Treatment Program, Intermountain Medical<br />
Center, Salt Lake City, UT<br />
262 Quality <strong>of</strong> Life and Family Function Are Poorest When<br />
Both Patients with <strong>Heart</strong> <strong>Failure</strong> and Their Caregivers<br />
Depressed<br />
Misook L. Chung 1 , Debra K. Moser 1 , Susan K. Frazier 1 , Terry A.<br />
Lennie 1 ; 1 Nursing, University <strong>of</strong> Kentucky, Lexington, KY<br />
263 Clinical Characteristics and Outcomes <strong>of</strong> Patients with<br />
Ischemic Cardiomyopathy (ICM) and Angina: Findings<br />
from the Duke Cardiovascular Database<br />
R.J. Mentz 1 , M. Fiuzat 1 , L. Shaw 1 , S. Borges-Neto 1 , H.R.<br />
Phillips 1 , M. Gheorghiade 2 , C.M. O’Connor 1 ; 1 DCRI, Duke Univ,<br />
Durham, NC; 2 Northwestern Univ, Chicago, IL<br />
264 Effect <strong>of</strong> Spironolactone on 30 Day Readmission Rates<br />
in Patients with <strong>Heart</strong> <strong>Failure</strong> Following Ultrafiltration<br />
Therapy<br />
Mahesh Aradhya 1 , Deepakraj Gajanana 1 , Santh V.S.<br />
Silpershetty 1 , Hyma Vani Polimera 1 , Ellen Amedeo 2 , Prasanna<br />
Sugathan 2 ; 1 Internal Medicine, St Luke’s Hospital, Bethlehem,<br />
PA; 2 Cardiology, St Luke’s Hospital, Bethlehem, PA<br />
265 Do Comorbidity Scores Compare with or Improve the<br />
Performance <strong>of</strong> the Seattle <strong>Heart</strong> <strong>Failure</strong> Model in<br />
Predicting Outcomes?<br />
Omar F. Abouezzeddine 1 , Sultan A. Mirzoyev 1 , Wayne C.<br />
Levy 2 , Margaret M. Redfield 1 ; 1 Mayo Clinic, Rochester, MN;<br />
2<br />
University <strong>of</strong> Washington, Seattle, WA<br />
266 Hypoalbuminemia Is an Independent Predictor <strong>of</strong> Long<br />
Term Mortality in Patients with <strong>Heart</strong> <strong>Failure</strong> with<br />
Preserved Ejection Fraction (HFpEF)<br />
Muhammad R. Sardar 1 , Zia Rab 1 , Jason N. Salamon 1 , Wajeeha<br />
Saeed 1 , Ronald Zolty 1 ; 1 Cardiology/CHF and Transplant,<br />
Montefiore Medical Center, Bronx, NY<br />
267 Prognostic Value <strong>of</strong> Serial Clinical, Laboratory and<br />
Ecocardiographic Tests in Ambulatory Patients with<br />
Chronic <strong>Heart</strong> <strong>Failure</strong><br />
Carlo Lombardi 1 , Alessandra Manerba 1 , Enrico Vizzardi 1 ,<br />
Giovanni Cuminetti 1 , Silvia Bugatti 1 , Valentina Carubelli 1 ,<br />
Valentina Lazzarini 1 , Savina Nodari 1 , Marco Metra 1 , Livio Dei<br />
Cas 1 ; 1 Cardiology, University <strong>of</strong> Brescia, Brescia, Italy<br />
268 Optimal Low-Density Lipoprotein Levels in Patients<br />
with Acutely Decompensated <strong>Heart</strong> <strong>Failure</strong><br />
Mark R. Kahn 1 , Arzhang Fallahi 1 , Greg Serrao 1 , Gabriel<br />
Wagman 1 , Timothy J. Vittorio 1 ; 1 Zena and Michael A. Wiener<br />
Cardiovascular Institute, Mount Sinai Medical Center, New<br />
York, NY<br />
269 Prognostic Scoring in Patients Requiring BIVAD as a<br />
Bridge to Cardiac Transplantation<br />
Richard K. Cheng 1 , Chi-Hong Tseng 2 , Richard Shemin 3 ,<br />
W. Robb MacLellan 1 ; 1 Cardiology, UCLA, Los Angeles,<br />
CA; 2 General Internal Medicine, UCLA, Los Angeles, CA;<br />
3<br />
Cardiothoracic Surgery, UCLA, Los Angeles, CA<br />
270 Successful Facilitation <strong>of</strong> the Save 5 Million Lives<br />
Campaign at VA VISNs (Regions): CHF QUERI<br />
Anju Sahay 1 , Paul A. Heidenreich 1 ; 1 CHF QUERI, Dept <strong>of</strong><br />
Veterans Affairs, Palo Alto, CA<br />
271 Performance <strong>of</strong> Generic Health Related Quality <strong>of</strong> Life<br />
Instruments in <strong>Heart</strong> <strong>Failure</strong> Clinics<br />
Andrew J. Henn 1 , Steven Tally 2 , Robert M. Kaplan 3 , Dennis<br />
Fryback 1 , Theodore G. Ganiats 2 , Nancy K. Sweitzer 1 ; 1 University<br />
<strong>of</strong> Wisconsin School <strong>of</strong> Medicine and Public Health, Madison,<br />
WI; 2 University <strong>of</strong> California - San Diego, San Diego, CA;<br />
3<br />
Department <strong>of</strong> Health Services, UCLA School <strong>of</strong> Public Health,<br />
Los Angeles, CA<br />
272 Changing Clinical Pr<strong>of</strong>iles and Timing <strong>of</strong> Enrollment in<br />
Acute <strong>Heart</strong> <strong>Failure</strong> Syndromes Clinical Trials<br />
Sean Collins 1 , Alan Storrow 2 , Karen Miller 2 , Sue Roll 1 , Greg<br />
Fermann 1 , Peter Pang 3 , Mihai Gheorghiade 3 , Chris Lindsell 1 ,<br />
Douglas Sawyer 2 , Neal Weintraub 1 ; 1 Emergency Medicine,<br />
University <strong>of</strong> Cincinnati, Cincinnati, OH; 2 Emergency Medicine,<br />
Vanderbilt, Nashville, TN; 3 Emergency Medicine, Northwestern<br />
University, Chicago, IL<br />
tuesdAY<br />
128<br />
129
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Outcomes<br />
Posters<br />
Outcomes<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
273 Variation in Right <strong>Heart</strong> Catheterization Use for Patients<br />
Hospitalized with <strong>Heart</strong> <strong>Failure</strong><br />
Richard K. Cheng 1 , Haiyong Xu 2 , Carol Mangione 2 , Jose<br />
Escarce 2 , Michael Ong 2 ; 1 Cardiology, UCLA Medical Center,<br />
Los Angeles, CA; 2 General Internal Medicine, UCLA Medical<br />
Center, Los Angeles, CA<br />
274 Association <strong>of</strong> Soluble ST2, an Emerging Biomarker <strong>of</strong><br />
<strong>Heart</strong> <strong>Failure</strong>, with Peripartum Cardiomyopathy<br />
Kismet Rasmusson 1 , Benjamin Horne 1 , Kim Brunisholz 1 , James<br />
Januzzi 2 , Rami Alharethi 1 , Deborah Budge 1 , Oxana Galenko 1 ,<br />
Josef Stehlik 3 , John Carlquist 1 , Jenny Connollly 1 , Stacey<br />
Frampton 1 , Stephanie Moore 2 , Abdallah Kfoury 1 ; 1 <strong>Heart</strong> <strong>Failure</strong><br />
Prevention and Treatment Program, Intermountain Medical<br />
Center, Salt Lake City, UT; 2 <strong>Heart</strong> <strong>Failure</strong> and Transplant,<br />
Massachusetts General Hospital, Boston, MA; 3 <strong>Heart</strong> <strong>Failure</strong><br />
and Transplant, University <strong>of</strong> Utah, Salt Lake City, UT<br />
275 Type II Diabetes Is Associated with Sleep Continuity,<br />
Variability in Wake Time, and Excess Daytime Sleepiness<br />
in Patients with Stable <strong>Heart</strong> <strong>Failure</strong><br />
Nancy S. Redeker 1 , Sangchoon Jeon 1 ; 1 School <strong>of</strong> Nursing, Yale<br />
University, New Haven, CT<br />
276 Symptom Recognition and Decision To Seek Care by<br />
Both Chronic <strong>Heart</strong> <strong>Failure</strong> Patients and Their Family<br />
Caregivers/Significant Others Prior to Hospitalization<br />
Jill R. Quinn 1 , Leway Chen 2 , Judy Brasch 1 , Joyce A. Smith 1 ,<br />
Rebecca Tucker 1 , Ding-Geng Chen 1 ; 1 School <strong>of</strong> Nursing,<br />
University <strong>of</strong> Rochester, Rochester, NY; 2 School <strong>of</strong> Medicine<br />
and Dentistry, University <strong>of</strong> Rochester, Rochester, NY<br />
277 Sex Differences in the Obesity Paradox <strong>of</strong> Systolic <strong>Heart</strong><br />
<strong>Failure</strong>?<br />
Adrienne L. Clark 1 , Tamara B. Horwich 2 ; 1 David Geffen<br />
School <strong>of</strong> Medicine, University <strong>of</strong> California, Los Angeles,<br />
Los Angeles, CA; 2 Ahmanson-UCLA Cardiomyopathy Center,<br />
University <strong>of</strong> California, Los Angeles, Los Angeles, CA<br />
278 Prognostic Importance <strong>of</strong> Serial Evaluation <strong>of</strong> Blood<br />
Urea Nitrogen in Ambulatory Patients with Chronic<br />
Systolic <strong>Heart</strong> <strong>Failure</strong> and Preserved Renal Function<br />
Clay A. Cauthen 1 , Matthew Tong 2 , Yuping Wu 3 , Anil Jain 4 ,<br />
W.H. Wilson Tang 1 ; 1 Department <strong>of</strong> Cardiovascular Medicine,<br />
Cleveland Clinic Foundation, Cleveland, OH; 2 Department<br />
<strong>of</strong> Internal Medicine, Kettering Medical Center, Kettering,<br />
OH; 3 Department <strong>of</strong> Mathematics, Cleveland State University,<br />
Cleveland, OH; 4 Division <strong>of</strong> Information Technology, Cleveland<br />
Clinic Foundation, Cleveland, OH<br />
279 Predictors <strong>of</strong> 30-Day Hospital Readmissions in Patients<br />
with <strong>Heart</strong> <strong>Failure</strong> (HF)<br />
Manreet Kanwar 1 , Daniel Spinuzzi 2 , Diane Vido 1 , Raymond<br />
Benza 1 , Srinivas Murali 1 , George Sokos 1 ; 1 Cardiology, Allegheny<br />
General Hospital, Pittsburgh, PA; 2 Internal Medicine, Allegheny<br />
General Hospital, Pittsburgh, PA<br />
280 Clinical Characteristics and Outcomes for Hospitalized<br />
<strong>Heart</strong> <strong>Failure</strong> (HF) Patients with Chronic Obstructive<br />
Pulmonary Disease (COPD): Findings from OPTIMIZE-<br />
HF<br />
R.J. Mentz 1 , M. Fiuzat 1 , D. Wojdyla 1 , K. Chiswell 1 , K. Pieper 1 ,<br />
M. Gheorghiade 2 , G.C. Fonarow 3 , C.M. O’Connor 1 ; 1 Duke<br />
Univ, Durham, NC; 2 Northwestern Univ, Chicago, IL; 3 UCLA<br />
Medical Center, Los Angeles, CA<br />
281 Long-Term Follow-Up <strong>of</strong> Stem Cell Therapy after Acute<br />
Myocardial Infarction<br />
Suzana A. Alves 1 , Sabrina B. Pereira 1 , Rose Frajtag 1 , Rodrigo<br />
C. Moreira 1 , Andre L.S. Souza 1 , Andrea Haddad 1 , Fabio Tuche 1 ,<br />
Karla Menezes 1 , Radovan Borojevic 2 , Hans F. Dohmann 1 ;<br />
1<br />
Procardíaco Hospital, Rio de Janeiro, Brazil; 2 Federal<br />
University <strong>of</strong> Rio de Janeiro, Rio de Janeiro, Brazil<br />
Clinical Care/Management Strategies<br />
319 Do Advanced Practice Nurses Conform to <strong>Heart</strong> <strong>Failure</strong><br />
Therapies at the Same Rate as Team-Based Physicians?<br />
Nancy M. Albert 1 , Maureen O’Malley 1 , Benjamin Nutter 1 ,<br />
Randall Starling 1 ; 1 Cleveland Clinic Foundation, Cleveland, OH<br />
320 Exercise Induced Pulmonary Hypertension:<br />
Comparison <strong>of</strong> Stress Echocardiography to Right <strong>Heart</strong><br />
Catheterization<br />
Karthik Gujja 1 , Deepika Misra 1 , Christine Roncari 1 , Roxana<br />
Sulica 1 ; 1 Cardiology, Beth Israel Medical Center, New York, NY<br />
321 Complex Telemonitoring or a Simple Telephone Call,<br />
Which Is More Effective in Post-Discharge <strong>Heart</strong> <strong>Failure</strong><br />
(HF) Management?<br />
Robyn A. Clark 1 , Sally C. Inglis 2 , Finlay A. McAllister 3 ,<br />
Simon Stewart 4 , John G.F. Cleland 5 , Cochrane <strong>Heart</strong> Group 5 ;<br />
1<br />
Queensland University <strong>of</strong> Technology, Brisbane, Australia;<br />
2<br />
University <strong>of</strong> Technology, Sydney, Australia; 3 University<br />
<strong>of</strong> Alberta, Alberta, Canada; 4 Baker IDI <strong>Heart</strong> and Diabetes<br />
Institute, Melbourne, Australia; 5 Castle Hill Hospital, Hull,<br />
United Kingdom<br />
tuesdAY<br />
130<br />
131
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Clinical Care/Management Strategies<br />
Posters<br />
Clinical Care/Management Strategies<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
322 Hyponatremia in Hospitalized <strong>Heart</strong> <strong>Failure</strong> Patients:<br />
Interim Data from an Observational, Prospective, Multi-<br />
Center, Global Hyponatremia Registry<br />
Jun Chiong 1 , Paul Hauptman 2 , Sonnie Kim 3 ; 1 Loma Linda<br />
University Medical Center, Loma Linda, CA; 2 Saint Louis<br />
University School <strong>of</strong> Medicine, Saint Louis, MO; 3 Otsuka<br />
<strong>America</strong> Pharmaceutical, Inc., Princeton, NJ<br />
323 Pilot Study <strong>of</strong> a Hospital-to-Home Program To Reduce<br />
<strong>Heart</strong> <strong>Failure</strong> Readmissions Led by <strong>Heart</strong> <strong>Failure</strong> Nurse<br />
Practitioners<br />
Aileen Sauris 1 , Carol Flavell 1 , Joanne Weintraub 1 , Michelle<br />
Young 1 , Parakash Pratibhu 1 , Michael Givertz 1 , Neal Lakdawala 1 ,<br />
Eldrin Lewis 1 , Gilbert Mudge 1 , Anju Nohria 1 , Lynne Stevenson 1 ,<br />
Akshay Desai 1 ; 1 Cardiovascular Division, Brigham and Women’s<br />
Hospital, Boston, MA<br />
324 NT proBNP Can Predict the Cardiovascular Events in<br />
Patients with Dilated Cardiomyopathy Which Is the<br />
First Manifestation <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong><br />
Eun-Young Kim 1 , Jin-Oh Choi 1 , Soo-Hyeon Yun 1 , Eun-Seon Ju<br />
Ju 1 , Eun-Seok Jeon 1 ; 1 Cardiology, Sungkyunkwan University<br />
School <strong>of</strong> Medicine, Seoul, Republic <strong>of</strong> Korea<br />
325 The Association <strong>of</strong> Sodium Intake and Objective and<br />
Subjective Indicators <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong> Severity<br />
Kristie M. Harris 1 , Andrew J. Wawrzyniak 1 , Jennifer M.<br />
Marshall 2 , Sarah M. Godoy 1 , Joanne P. Marshall 2 , Shawn W.<br />
Robinson 2 , David S. Krantz 1 , Stephen S. Gottlieb 2 ; 1 Medical <br />
Clinical Psychology, Uniformed Services University, Bethesda,<br />
MD; 2 Medicine, University <strong>of</strong> Maryland, Baltimore, MD<br />
326 Early Detection <strong>of</strong> Left Ventricular Dysfunction in<br />
Asymptomatic Type 2 Diabetic Patients<br />
Angelina Stevanovic 1 , Mirjana Krotin 2 , Milica Dekleva 3 , Nevena<br />
Paunovic 1 , Snezana Trajic 4 ; 1 Cardiology Department, Railway<br />
Health Care Institute, Belgrade, Serbia; 2 Cardiology Department,<br />
University Clinical Center “Bezanijska Kosa”, Belgrade, Serbia;<br />
3<br />
Cardiology Department, University Clinical Center Zvezdara,<br />
Belgrade, Serbia; 4 Cardiology Department, Institute for<br />
Cardiovascular Dedinje, Belgrade, Serbia<br />
327 Technetium Pyrophosphate SPECT Imaging for<br />
Non-Invasive Identification <strong>of</strong> Transthyretin Cardiac<br />
Amyloidosis<br />
Mathew S. Maurer 1 , Farhana Latif 1 , Sabahat Bokhari 1 ;<br />
1<br />
Cardiology, Columbia University Medical Center, New York,<br />
NY<br />
328 What Type <strong>of</strong> Social Support Do <strong>Heart</strong> <strong>Failure</strong> Patients<br />
Need?<br />
Seongkum Heo 1 , Debra K. Moser 2 , Terry A. Lennie 2 ; 1 College<br />
<strong>of</strong> Nursing, University <strong>of</strong> Arkansas for Medical Science,<br />
Little Rock, AR; 2 College <strong>of</strong> Nursing, University <strong>of</strong> Kentucky,<br />
Lexington, KY<br />
329 Factors Related to Self-Care Behavior among<br />
Outpatients with <strong>Heart</strong> <strong>Failure</strong> in Korea<br />
Jong Sun Ok 1 , Heejung Choi 2 , Kyu Hyung Ryu 1 , Sung Hea<br />
Kim 1 , Min-Seok Kim 3 , Jin-Oh Choi 4 ; 1 Cardiovascular Center,<br />
KonKuk University Medical Center, Seoul, Republic <strong>of</strong> Korea;<br />
2<br />
Nursing, Konkuk Univeristy, Chungju, Republic <strong>of</strong> Korea;<br />
3<br />
Cardiovascular Center, Asan Medical Center, Seoul, Republic<br />
<strong>of</strong> Korea; 4 Division <strong>of</strong> Cardiology, Samsung Medical Center,<br />
Seoul, Republic <strong>of</strong> Korea<br />
330 Frequency <strong>of</strong> Improvement in Ventricular Function<br />
Allows Many Patients To Defer Defibrillator<br />
Implantation<br />
Bethany A. Austin 1 , Nicole R. Bianco 2 , Steven J. Szymkiewicz 2 ,<br />
Sanjeev Aggarwal 1 , Andrew C. Kao 1 ; 1 Saint Luke’s Mid-<strong>America</strong><br />
<strong>Heart</strong> and Vascular Institute, Saint Luke’s Hospital, Kansas City,<br />
MO; 2 Zoll Corporation, Pittsburgh, PA<br />
331 Teach-Back Is an Effective Strategy for Educating Older<br />
<strong>Heart</strong> <strong>Failure</strong> Patients<br />
Jill Howie-Esquivel 1 , Matthew White 1 , Maureen Carroll 2 , Eileen<br />
Brinker 2 ; 1 Physiological Nursing, University <strong>of</strong> California, San<br />
Francisco, CA; 2 Cardiovascular Service Line, University <strong>of</strong><br />
California, San Francisco, CA<br />
332 Clinic-Based Systematic Optimization Algorithm To<br />
Improve Rate <strong>of</strong> Response to Cardiac Resynchronization<br />
Therapy<br />
Keith Miller 1 , Andrew D. Merliss 1 , Rhonda Olmsted 1 , Vinay<br />
Thohan 2 , William Sauer 3 , Duy Nguyen 3 , Keith Bruce 4 , Gregg<br />
Yamada 5 , Michelle M. Fedewa 6 , Jason Brown 6 , Jeff Torrey 6 ;<br />
1<br />
Bryan LGH Hospital, Lincoln, NE; 2 Wake Forest University<br />
Health Sciences, Winston-Salem, NC; 3 University <strong>of</strong> Colorado,<br />
Denver, CO; 4 Chattanooga <strong>Heart</strong> Institute, Chattanooga, TN;<br />
5<br />
Pacific Cardiology, Honolulu, HI; 6 Medtronic, Inc., Fridley,<br />
MN<br />
333 Improving <strong>Heart</strong> <strong>Failure</strong> Symptom Assessment<br />
Congruence through a Perspective-Taking Intervention:<br />
A Pilot Study<br />
Christina Quinn 1 , Sandra B. Dunbar 2 , Melinda Higgins 2 ;<br />
1<br />
Division <strong>of</strong> Nursing, Gordon College, Barnesville, GA; 2 Nell<br />
Hodgson Woodruff School <strong>of</strong> Nursing, Emory University,<br />
Atlanta, GA<br />
tuesdAY<br />
132<br />
133
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Clinical Care/Management Strategies<br />
Posters<br />
Clinical Care/Management Strategies<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
334 Prevalence and Clinical Features <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong><br />
with Preserved Ejection Fraction in a Veterans<br />
Administration Medical Center<br />
Edlira Maska 1 , Tamarah Jungklaus 2 , Samantha Malloy 2 ,<br />
Shawn Anderson 2 , Timothy Cleeton 2 , Juan Aranda 1,2 , Richard<br />
Sch<strong>of</strong>ield 1,2 ; 1 University <strong>of</strong> Florida College <strong>of</strong> Medicine,<br />
Gainesville, FL; 2 Department <strong>of</strong> Veterans Affairs Medical<br />
Center, Gainesville, FL<br />
335 Suffering and Spiritual Transformation in <strong>Heart</strong> <strong>Failure</strong><br />
Melissa Dyo 1 , Cheryl Westlake 1 ; 1 Nursing, Azusa Pacific<br />
University, Azusa, CA<br />
336 Utilizing Cardiac Magnetic Resonance Imaging to<br />
Prognosticate for Peripartum Cardiomyopathy<br />
Jacob A. Misenheimer 1 , Andrew Lenneman 2 , William S.<br />
Bradham 2 , Julie B. Damp 2 ; 1 Internal Medicine, Vanderbilt<br />
University Medical Center, Nashville, TN; 2 Cardiology,<br />
Vanderbilt <strong>Heart</strong> and Vascular Institute, Nashville, TN<br />
337 Left Ventricular Non-Compaction Often Masquerades as<br />
a Dilated Cardiomyopathy: Implications for Prognosis<br />
and Treatment<br />
Elizabeth A. Langlois 1 , Frank W. Smart 1 ; 1 Cardiovascular<br />
Medicine, Morristown Memorial Hospital, Morristown, NJ<br />
338 The Lack <strong>of</strong> a Standardized <strong>Heart</strong> <strong>Failure</strong> Assessment<br />
Leads to Under Dosing Diuretics in the Emergency<br />
Department<br />
Frank W. Smart 1 , Elizabeth A. Langlois 1 , Frank Manole 1 ,<br />
Jacqueline Fearon-Clarke 1 , Steve Sheris 2 ; 1 Cardiovascular<br />
Medicine, Morristown Memorial Hospital, Morristown, NJ;<br />
2<br />
Medicine, Overlook Hospital, Summit, NJ<br />
339 Validating the Physical Exam: Using Orthopnea To<br />
Assess Inpatient Diuresis and Time to Readmission<br />
Shaline D. Rao 1 , Stacey Rotman 1 , Stuart D. Russell 1 ;<br />
1<br />
Department <strong>of</strong> Cardiology, Johns Hopkins Hospital, Baltimore,<br />
MD<br />
340 Physiologic Sensor Response to Activity Level in the<br />
MultiSENSE Study<br />
John P. Boehmer 1 , Yi Zhang 2 , Kenneth C. Beck 2 , Robert J.<br />
Sweeny 2 ; 1 <strong>Heart</strong> Vascular Institute, The Penn State College <strong>of</strong><br />
Medicine, Hershey, PA; 2 Boston <strong>Scientific</strong> CRV, Minneapolis,<br />
MN<br />
341 Cardiac Resynchronization Therapy, Pre Implantation<br />
Cardiac Magnetic Resonance Imaging and Long Term<br />
Mortality<br />
Maria E. Tettamanti 1 , Ana Revilla Orodea 1 , Roman Arnold 1 ,<br />
Javier Lopez Diaz 1 , Luis de la Fuente Galan 1 , Itziar Gomez<br />
Salvador 1 , Jose A. San Roman Calvar 1 ; 1 Cardiology, <strong>Heart</strong><br />
<strong>Failure</strong> and Cardiac Transplantation Section, Hospital Clinico<br />
Universitario de Valladolid, Valladolid, Spain<br />
342 Survival Benefit <strong>of</strong> Beta-Blockers in Patients with <strong>Heart</strong><br />
<strong>Failure</strong> and Hyperbilirubinemia<br />
Christopher Labos 1 , Viviane Nguyen 1 , Nadia Giannetti 1 , Thao<br />
Huynh 1 ; 1 Department <strong>of</strong> Cardiology, McGill University Health<br />
Centre, Montreal, QC, Canada<br />
343 The Metabolic Pr<strong>of</strong>ile and Global Cardiovascular Risk<br />
in a Cohort <strong>of</strong> Chronic <strong>Heart</strong> <strong>Failure</strong> Outpatients<br />
Wolney A. Martins 2 , Lucia B. Oliveira 1 , Luciana N. Barros 1 ,<br />
Rosiane S.F. Abreu 1 , Gelsomina A.M. Pereira 1 , Maria A.R.<br />
Manhaes 1 , Paulo J.P. Camandaroba 1 , Sergio F. Sgaraglia 1 , Marli<br />
G. Oliveira 1 , Eugenio P. Campos 1 , Monica M.P. Quintao 1 ,<br />
Ana C.D. Cavalcanti 2 , Evandro T. Mesquita 2 ; 1 <strong>Heart</strong> <strong>Failure</strong><br />
Clinic (CLIC), HCTCO, Serra dos Órgãos University Center,<br />
Teresópolis, RJ, Brazil; 2 Fluminense Federal University, Niterói,<br />
RJ, Brazil<br />
344 <strong>Heart</strong> <strong>Failure</strong> Patients with Diabetes Have Higher<br />
Incidence <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong> Hospitalization and<br />
Rehospitalization<br />
Vinod Sharma 1 , Jodi Koehler 1 , David J. Whellan 2 ; 1 New<br />
Therapies and Diagnostics, Medtronic Inc., Minneapolis, MN;<br />
2<br />
Jefferson University Hospitals, Philadelphia, PA<br />
345 Sodium Polystyrene Sulfonate for Secondary Prevention<br />
<strong>of</strong> Hyperkalemia in Patients with Chronic Kidney and<br />
<strong>Heart</strong> Diseases on Renin-Angiotensin-Aldosterone<br />
System Blockade Therapy<br />
Gil Chernin 1 , Amir Gal-Oz 1 , Idit F. Schwartz 1 , Doron Schwartz 1 ,<br />
Donald S. Silverberg 1 ; 1 Nephrology Department, Tel Aviv<br />
Medical Center, Tel Aviv, Israel<br />
346 Changes <strong>of</strong> Left Ventricular Function Assessed by 2D<br />
and Doppler Echocardiography in Patients Receiving<br />
Tratsuzumab Therapy<br />
Sun Hwa Lee 1 , Won Ho Kim 1 , Jae Ki Ko 1 , Yun Ji Park 1 , Lae<br />
Young Jung 1 , Min Ju Song 1 , Hae Eun Yun 1 ; 1 Cardiology,<br />
Chonbuk National University Medical School, Jeonju, Korea<br />
tuesdAY<br />
134<br />
135
Sept. 20<br />
Tuesday<br />
Posters<br />
Posters<br />
Clinical Care/Management Strategies<br />
Posters<br />
Clinical Care/Management Strategies<br />
Sept. 20<br />
Tuesday<br />
Posters<br />
tuesdAY<br />
347 Evaluation <strong>of</strong> an Educational Intervention, Utilizing<br />
Simulation and a Teach Back (TB) Method, To Increase<br />
Nurses’ Knowledge and Retention <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong> (HF)<br />
Self-Management (SM) Principles<br />
Sarah Frewin 1 , Tara Mahramus 1 , Lyne Chamberlain 2 , Debra<br />
Wilson 3 , Daleen Penoyer 4 , Mary Lou Sole 4 ; 1 Cardiology, Orlando<br />
Health: ORMC, Orlando, FL; 2 Cardiology, Orlando Health: Dr.<br />
P. Phillips, Orlando, FL; 3 Home Health, Orlando Health: Visiting<br />
Nurses Association, Orlando, FL; 4 Nursing Research, Orlando<br />
Health, Orlando, FL<br />
348 Diabetes and <strong>Heart</strong> <strong>Failure</strong>: Does the Type <strong>of</strong> Anti-<br />
Diabetic Therapy Matter?<br />
Lazaros A. Nikolaidis 1 , Swetang Shah 1 , Laurie Russell 1 , Alfred<br />
A. Bove 1 ; 1 Cardiology, Temple University School <strong>of</strong> Medicine,<br />
Philadelphia, PA<br />
349 Improved Survival with <strong>Heart</strong>Mate II Left Ventricular<br />
Assist Device for Acute Cardiogenic Shock<br />
Susan Lien 1 , Ryan C. Nelson 1 , Scott McNitt 1 , H. Todd Massey 1 ,<br />
Jeffrey D. Alexis 1 , Leway Chen 1 , Eugene Storozynsky 1 , Michael<br />
W. Fong 2 ; 1 Cardiology Division, Cardiac Surgery Division,<br />
University <strong>of</strong> Rochester Medical Center, Rochester, NY;<br />
2<br />
Cardiology Division, University <strong>of</strong> Southern California, Los<br />
Angeles, CA<br />
350 Electronic Identifiers Accurately Identify Inpatient<br />
<strong>Heart</strong> <strong>Failure</strong> Admissions<br />
Carrie Geisberg 1 , Connie Lewis 1 , Starmer Jack 1 , Zachary<br />
Cox 1 , DiSalvo Thomas 1 , Douglas Sawyer 1 , Daniel Lenihan 1 ;<br />
1<br />
Cardiovascular Medicine, Vanderbilt University, Nashville, TN<br />
353 Specialized <strong>Heart</strong> <strong>Failure</strong> Outpatient Clinics: What<br />
Staff Are Required, What Is Their Workload, and Can<br />
These Data Facilitate the Planning <strong>of</strong> New <strong>Heart</strong> <strong>Failure</strong><br />
Clinics?<br />
Malcolm Arnold, Anne Marie Kaan, Jonathan Howlett, Andrew<br />
Ignaszewski, Marie-Helene LeBlanc, Liu Peter, Haddad<br />
Hassam, Miroslav Rajda, Shelley Zieroth, Michael Chan;<br />
London Health Sciences Center, London, Canada; St Paul’s<br />
Hospital, Vancouver, Canada; Foothills Hospital, Calgary,<br />
Canada; St Paul’s Hospital, Vancouver, Canada; Institute de<br />
Cardiologie de Quebec, Quebec City, Canada; University Health<br />
Network, Toronto, Canada; Ottawa <strong>Heart</strong> Institute, Ottawa,<br />
Canada; Halifax Infirmary, Halifax, Canada; St Boniface<br />
Hospital, Winnipeg, Canada; Royal Alexandra Hospital,<br />
Edmonton, Canada<br />
354 Early Ultrafiltration May Reduce Length <strong>of</strong> Hospital<br />
Stay for Decompensated <strong>Heart</strong> <strong>Failure</strong><br />
Santh V.S. Silparshetty 1 , Hyma V. Polimera 1 , Mahesh Aradhya 1 ,<br />
Deepakraj Gajanana 1 , Ellen Amedeo 2 , Prasanna Sugathan 2 ;<br />
1<br />
Internal Medicine, Saint Luke’s Hospital and Health Network,<br />
Bethlehem, PA; 2 Cardiology, Saint Luke’s Hospital and Health<br />
Network, Bethlehem, PA<br />
355 Prevalence and Clinical Correlates <strong>of</strong><br />
Hemoconcentration during Hospitalization for Acute<br />
Decompensated <strong>Heart</strong> <strong>Failure</strong><br />
Carlos Davila 1 , Alex Reyentovich 1 , Stuart D. Katz 1 ; 1 Leon H.<br />
Charney Division <strong>of</strong> Cardiology, New York University Langone<br />
Medical Center, New York, NY<br />
tuesdAY<br />
351 Pilot Program To Improve Self Management <strong>of</strong> Patients<br />
with <strong>Heart</strong> <strong>Failure</strong> by Redesigning Care Coordination<br />
Jessica Shaw 1 , Dan O’Neal 2 , Frances Zarella 3 , Kris Siddharthan 2 ,<br />
Britta Neugaard 1 ; 1 Quality Management, James A Haley VA,<br />
Tampa, FL; 2 Research Service, James A Haley VA, Tampa, FL;<br />
3<br />
Nursing Service, James A Haley VA, Tampa, FL<br />
352 An Evaluation <strong>of</strong> Pharmacist-Led <strong>Heart</strong> <strong>Failure</strong> Clinic in<br />
Tan Tock Seng Hospital<br />
Kai Xin Ong 1 , Hwei Khien Lee 1 , Daniel Yeo 2 ; 1 Outpatient<br />
Pharmacy, Tan Tock Seng Hospital, Singapore, Singapore;<br />
2<br />
Cardiology, Tan Tock Seng Hospital, Singapore, Singapore<br />
136<br />
137
Sept. 21<br />
Wednesday<br />
AM<br />
CLINICAL FUNDAMENTALS<br />
Wednesday, September 21<br />
7:00-8:15 AM<br />
Room 306<br />
GUIDELINE SESSION<br />
Wednesday, September 21<br />
8:30-10:00 AM<br />
Ballroom A<br />
Sept. 21<br />
Wednesday<br />
AM<br />
WEDNESDAY<br />
Clinical Fundamentals: Atrial and Ventricular<br />
Arrhythmias/Troubleshooting CRT/ICD/<br />
Mechanical Circulatory Support<br />
Moderators: Denise D. Barnard, San Diego, CA<br />
Ravi V. Shah, Boston, MA<br />
7:00 Indications and Pr<strong>of</strong>iles for Implantable Circulatory<br />
Support Devices<br />
Garrick C. Stewart, Boston, MA<br />
7:10 Outcomes and Adverse Events with Continuous Flow<br />
Devices<br />
Robert L. Kormos, Pittsburgh, PA<br />
7:25 Atrial Fibrillation with all EF: Prevalence and Approach<br />
Gregory F. Michaud, Boston, MA<br />
7:35 After the First Shock, and After Many<br />
Roy M. John, Boston, MA<br />
7:45 Rhythm Device Programming 101<br />
Jagmeet P. Singh, Boston, MA<br />
8:00 Questions and Answers<br />
Faculty<br />
Learning Objective: Describe the use <strong>of</strong> implantable devices<br />
in the treatment <strong>of</strong> patients with heart failure.<br />
Guideline Updates 2011: What’s Current,<br />
Controversial, and Coming Next<br />
Moderators: Michael M. Givertz, Boston, MA<br />
Randall C. Starling, Cleveland, OH<br />
8:30 Use <strong>of</strong> Aldosterone Antagonists in <strong>Heart</strong> <strong>Failure</strong><br />
Justin A. Ezekowitz, Edmonton, AB, Canada<br />
8:45 Panel Discussion<br />
Kirkwood F. Adams, Jr., Chapel Hill, NC<br />
JoAnn Lindenfeld, Denver, CO<br />
Wendy Gattis Stough, Cary, NC<br />
8:52 Use <strong>of</strong> CRT in Mild, Moderate, and Severe <strong>Heart</strong> <strong>Failure</strong><br />
Adrian F. Hernandez, Durham, NC<br />
9:07 Panel Discussion<br />
Kirkwood F. Adams, Jr., Chapel Hill, NC<br />
JoAnn Lindenfeld, Denver, CO<br />
Wendy Gattis Stough, Cary, NC<br />
9:14 Use <strong>of</strong> LVADs in <strong>Heart</strong> <strong>Failure</strong><br />
Joseph G. Rogers, Durham, NC<br />
9:29 Panel Discussion<br />
Kirkwood F. Adams, Jr., Chapel Hill, NC<br />
JoAnn Lindenfeld, Denver, CO<br />
Wendy Gattis Stough, Cary, NC<br />
9:36 Acute Decompensated <strong>Heart</strong> <strong>Failure</strong> Therapy<br />
John R. Teerlink, San Francisco, CA<br />
9:51 Panel Discussion<br />
Kirkwood F. Adams, Jr., Chapel Hill, NC<br />
JoAnn Lindenfeld, Denver, CO<br />
Wendy Gattis Stough, Cary, NC<br />
Learning Objective: Describe updates to guideline<br />
recommendations for the treatment <strong>of</strong> patients with heart<br />
failure.<br />
WEDNESDAY<br />
8:15 HFSA <strong>Annual</strong> Business <strong>Meeting</strong><br />
Room 311<br />
8:15 HFSA <strong>Annual</strong> Business <strong>Meeting</strong><br />
Room 311<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in 3rd floor foyer area<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in 3rd floor foyer area<br />
138<br />
139
Sept. 21<br />
Wednesday<br />
AM<br />
SYMPOSIUM<br />
Wednesday, September 21<br />
8:30-10:00 AM<br />
Room 302<br />
SYMPOSIUM<br />
Wednesday, September 21<br />
8:30-10:00 AM<br />
Room 304<br />
Sept. 21<br />
Wednesday<br />
AM<br />
WEDNESDAY<br />
What to Evaluate After the Office Visit: To<br />
Diagnose, Predict or Guide?<br />
Moderators: Stefan D. Anker, Berlin, Germany<br />
Marc A. Silver, Oak Lawn, IL<br />
8:30* Biomarkers for Diagnostic and Risk Stratification<br />
Barry H. Greenberg, San Diego, CA<br />
8:45* Indications for Magnetic Resonance Imaging for<br />
Diagnosis and Follow-Up<br />
Raymond Y. Kwong, Boston, MA<br />
9:00* Are Biomarkers Useful as Targets to Titrate Therapy?<br />
Inder S. Anand, Minneapolis, MN<br />
9:15* Quality <strong>of</strong> Life Assessments: Routine or Investigational?<br />
Debra K. Moser, Lexington, KY<br />
9:30* Exercise Testing: Who and When?<br />
Donna M. Mancini, New York, NY<br />
9:45* When Should You Look For Reverse Remodeling and<br />
What if You Find It?<br />
Marvin A. Konstam, Boston, MA<br />
*12 minute presentation, 3 minute audience discussion<br />
Learning Objective: Outline evaluation and prognostic<br />
options for patients diagnosed with heart failure and the<br />
circumstances in which they are recommended.<br />
The Supported Circulation<br />
Moderators: Mariell L. Jessup, Philadelphia, PA<br />
Ben Sun, Minneapolis, MN<br />
8:30 Supporting the Less Sick: Approved or Investigational?<br />
Joseph G. Rogers, Durham, NC<br />
8:40 Questions and Answers<br />
8:45 Needs for RVAD: None, Temporary or Permanent?<br />
Mark S. Slaughter, Louisville, KY<br />
8:55 Questions and Answers<br />
9:00 Organ Function Before and After VAD<br />
Katherine Lietz, Maywood, IL<br />
9:10 Questions and Answers<br />
9:15 Prevalence and Impact <strong>of</strong> Aortic Regurgitation<br />
Jennifer Cowger, Ann Arbor, MI<br />
9:25 Questions and Answers<br />
9:30 Function and Quality <strong>of</strong> Life with Current Devices<br />
Kathleen L. Grady, Chicago, IL<br />
9:40 Questions and Answers<br />
9:45 What Are Optimal Continuous Pressures and Flows?<br />
Mandeep R. Mehra, Baltimore, MD<br />
9:55 Questions and Answers<br />
Learning Objective: Describe the use <strong>of</strong> mechanical<br />
circulatory support in patients with heart failure.<br />
WEDNESDAY<br />
8:15 HFSA <strong>Annual</strong> Business <strong>Meeting</strong><br />
Room 311<br />
8:15 HFSA <strong>Annual</strong> Business <strong>Meeting</strong><br />
Room 311<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in 3rd floor foyer area<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in 3rd floor foyer area<br />
140<br />
141
Sept. 21<br />
Wednesday<br />
AM<br />
SYMPOSIUM<br />
Wednesday, September 21<br />
8:30-10:00 AM<br />
Room 311<br />
SYMPOSIUM<br />
Wednesday, September 21<br />
10:30 AM-NOON<br />
Room 302<br />
Sept. 21<br />
Wednesday<br />
AM<br />
Cancer Chemotherapy and Cardiotoxicity<br />
How Will Therapy Change This Year?<br />
Moderators: Daniel J. Lenihan, Nashville, TN<br />
Douglas B. Sawyer, Nashville, TN<br />
Moderators: Eugene Braunwald, Boston, MA<br />
Barry M. Massie, San Francisco, CA<br />
8:30 Long-Term Cancer Care and Cardiomyopathies<br />
Thomas Force, Philadelphia, PA<br />
10:30 Major Drug Trials That Could Change Practice<br />
John R. Teerlink, San Francisco, CA<br />
WEDNESDAY<br />
8:50 Detecting and Reporting Cardiotoxicity:<br />
Does the End Justify the Means?<br />
Ronald M. Witteles, Stanford, CA<br />
9:00 Studies in Cancer Therapy Cardiotoxicity:<br />
What Can We Learn from Chronic <strong>Heart</strong> <strong>Failure</strong>?<br />
Bonnie Ky, Philadelphia, PA<br />
9:10 The Cardio-Oncology Population<br />
Anju Nohria, Boston, MA<br />
9:20 Cardiotoxicity and Cardiac Repair: Role <strong>of</strong> Neureregulin<br />
Carrie A. Geisberg, Nashville, TN<br />
9:30 Is Chemotherapy Creating a Stage B Population that<br />
Needs Treatment?<br />
Jean-Bernard Durand, Houston, TX<br />
9:40 Panel Discussion<br />
10:42 Major Device Studies<br />
Mandeep R. Mehra, Baltimore, MD<br />
10:54 Real World Data on <strong>Heart</strong> <strong>Failure</strong> Management<br />
Barbara J. Riegel, Philadelphia, PA<br />
11:06 Any Subpopulations That Merit Change in Therapy?<br />
Clyde W. Yancy, Chicago, IL<br />
11:18 New Quality-<strong>of</strong>-Life Data<br />
Eldrin F. Lewis, Boston, MA<br />
11:30 Panel Discussion: How Do You Treat Patients Differently<br />
Than Last Year?<br />
Faculty<br />
Learning Objective: Discuss recent research and its potential<br />
impact on the treatment <strong>of</strong> heart failure.<br />
WEDNESDAY<br />
Learning Objective: Describe the impact <strong>of</strong><br />
chemotherapeutic agents on heart failure and recommended<br />
management options.<br />
8:15 HFSA <strong>Annual</strong> Business <strong>Meeting</strong><br />
Room 311<br />
10:00 C<strong>of</strong>fee Break<br />
Refreshments served in 3rd floor foyer area<br />
142<br />
143
Sept. 21<br />
Wednesday<br />
AM<br />
SYMPOSIUM<br />
Wednesday, September 21<br />
10:30 AM-NOON<br />
Room 304<br />
SYMPOSIUM<br />
Wednesday, September 21<br />
10:30 AM-NOON<br />
Room 306<br />
Sept. 21<br />
Wednesday<br />
AM<br />
WEDNESDAY<br />
Making Decisions with Level <strong>of</strong> Evidence C<br />
Moderators: J. Thomas Heywood, La Jolla, CA<br />
Corrine Y. Jurgens, Stony Brook, NY<br />
10:30* How Do You Initiate Aldosterone Antagonists<br />
in Someone on ACEI/ARB, Diuretics, and K+<br />
Replacement?<br />
Akshay M. Desai, Boston, MA<br />
10:45* Fluid Restriction - Essential or Water Torture?<br />
Nancy M. Albert, Cleveland, OH<br />
11:00* When Do You Decrease Beta Blockers in a Patient Who<br />
Still Feels Tired After Six Months?<br />
W.H. Wilson Tang, Cleveland, OH<br />
11:15* When Is It Time to Introduce Palliative Care?<br />
Harleah G. Buck, University Park, PA<br />
11:30* End-<strong>of</strong>-Life Symptoms and Therapies<br />
Carol Flavell, Boston, MA<br />
11:45* Whom Do You Send Home on Intravenous Inotropic<br />
Therapy?<br />
Randall C. Starling, Cleveland, OH<br />
*10 minute presentation, 5 minute audience discussion<br />
Learning Objective: Describe clinical recommendations<br />
in difficult clinical circumstances in the treatment <strong>of</strong> heart<br />
failure.<br />
Hope for <strong>Heart</strong> <strong>Failure</strong> with Preserved Ejection<br />
Fraction<br />
Moderators: James C. Fang, Cleveland, OH<br />
William C. Little, Winston-Salem, NC<br />
10:30* Why Are <strong>Heart</strong> <strong>Failure</strong> Patients with Preserved Ejection<br />
Fraction Short <strong>of</strong> Breath?<br />
Barry A. Borlaug, Rochester, MN<br />
10:45* A Disease <strong>of</strong> Diastole?<br />
William C. Little, Winston-Salem, NC<br />
11:00* Co-Morbidities in <strong>Heart</strong> <strong>Failure</strong> with Preserved Ejection<br />
Fraction as Alternate Targets for “Therapy”<br />
Flora Sam, Boston, MA<br />
11:15* Clinical Trials in <strong>Heart</strong> <strong>Failure</strong> with Preserved Ejection<br />
Fraction: Can We Learn From <strong>Failure</strong>?<br />
Nancy K. Sweitzer, Madison, WI<br />
11:30* Is It All About Fluid?<br />
Stuart D. Katz, New York, NY<br />
11:45* Is It Time to Relax?<br />
Gregory D. Lewis, Boston, MA<br />
*12 minute presentation, 3 minute audience discussion<br />
Learning Objective: Describe current knowledge about<br />
heart failure with preserved ejection fraction and identify<br />
treatment strategies.<br />
WEDNESDAY<br />
144<br />
145
Thank you for coming –<br />
see you next year!<br />
16th <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
September 9 – 12, 2012<br />
Washington State Convention and Trade Center<br />
Seattle, WA<br />
147<br />
www.hfsa.org
Monday, September 19<br />
10:00 AM-4:00 PM<br />
Exhibit Hall C<br />
Hands-on Workshop<br />
Mechanical Circulatory Support (MCS)<br />
Hands-on Workshop<br />
10:00-11:00 AM Case Study Presentations<br />
11:15-11:45 AM <strong>Heart</strong>Mate II Patient Exam<br />
NOON-1:30 PM<br />
Case Study Presentations<br />
1:45-2:15 PM <strong>Heart</strong>Mate II Patient Exam<br />
2:30-4:00 PM Case Study Presentations<br />
This non-CME workshop is designed to provide practical information<br />
and hands-on experience for participants who may care for patients<br />
being supported by the <strong>Heart</strong>Mate II® (Left Ventricular Assist System)<br />
LVAS and optional CentriMag® RVAS. The topics for presentation<br />
and discussion are related to routine care and problem resolution in<br />
VAD-supported patients. Specific topics include:<br />
Tuesday, September 20<br />
12:30-1:45 PM<br />
Exhibit Hall D<br />
Product Theater<br />
Understanding Hyponatremia: Treating Beyond the<br />
Primary Diagnosis<br />
John B. O’Connell, MD<br />
Executive Director<br />
<strong>Heart</strong> <strong>Failure</strong> Program<br />
<strong>Heart</strong> and Vascular Institute<br />
St. Joseph’s Hospital<br />
Atlanta, Georgia<br />
Program Description: This non-CME actaivity is an overview <strong>of</strong><br />
hyponatremia and the management <strong>of</strong> patients presenting with<br />
hyponatremia in the hospital setting.<br />
Sponsored by Otsuka <strong>America</strong> Pharmaceutials, Inc.<br />
1. Selection <strong>of</strong> patients for VAD support<br />
2. Common early postoperative problems (patient and device)<br />
3. Routine outpatient exam; patient review and device<br />
interrogation<br />
4. Echocardiography for diagnosing specific problems and<br />
assessing recovery<br />
5. Making changes to the VAD systems (operating parameters<br />
and equipment)<br />
6. Troubleshooting problems with device and patient (case<br />
presentations)<br />
Expert cardiologists, nurses and Thoratec clinical support staff will<br />
be available throughout the workshop to give presentations and for<br />
discussion. Case studies will be used for presenting problem-solving<br />
information. Patients currently supported by the <strong>Heart</strong>Mate II LVAS<br />
will be available for discussion with participants.<br />
The main focus <strong>of</strong> presentations and discussions will be the use <strong>of</strong> the<br />
<strong>Heart</strong>Mate II LVAS. GoGear® System Components for the <strong>Heart</strong>Mate<br />
II will be available for hands-on learning and discussion. Working<br />
<strong>Heart</strong>Mate II and CentriMag pumps attached to mock loops will be<br />
available to simulate operation. A simulated outpatient clinic visit with<br />
a <strong>Heart</strong>Mate II patient will also be conducted.<br />
The schedule <strong>of</strong> events will be posted onsite. No preregistration is<br />
necessary. However, participants must be registered for the HFSA<br />
<strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong>.<br />
Sponsored by Thoratec Corporation<br />
148 149
EXHIBIT FLOOR PLAN<br />
HFSA Exhibitor Booth #<br />
ABIOMED . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2724<br />
Alere . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2721<br />
<strong>America</strong>n Association <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong> Nurses . . . . . . . . . . .Booth #2920<br />
<strong>America</strong>n Express OPEN . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2926<br />
<strong>America</strong>n <strong>Heart</strong> Association . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2918<br />
Aton Pharma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2726<br />
COFFEE STATION<br />
2926<br />
2924<br />
2922<br />
2920<br />
2918<br />
2916<br />
2914<br />
2912<br />
2910<br />
2906<br />
BG Medicine, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2511<br />
PRODUCT<br />
THEATER<br />
2530<br />
LAPTOP<br />
LOUNGE<br />
2830<br />
2925<br />
2826<br />
COFFEE<br />
STATION<br />
2825<br />
2726<br />
EMAIL<br />
STATION<br />
2923<br />
2824<br />
2823<br />
2724<br />
2721<br />
2622<br />
2426<br />
2821<br />
2722<br />
2719<br />
2620<br />
2522<br />
COFFEE<br />
STATION<br />
2818 2917<br />
2617<br />
2518<br />
2815<br />
2716<br />
COFFEE<br />
STATION<br />
2813<br />
2714<br />
2613<br />
2514<br />
2812 2911<br />
2511<br />
2412<br />
2626<br />
2705<br />
2506<br />
2406<br />
ENTRANCE TO<br />
EXHIBIT HALL<br />
REGISTRATION<br />
REGISTRATION<br />
CME<br />
Boston <strong>Scientific</strong> Corporation . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2821<br />
BTG International Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2823<br />
CardiacAssist, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2925<br />
Cytokinetics, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2705<br />
Daxor Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2620<br />
Elsevier Publishing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2910<br />
Gambro UF Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2917<br />
GeneDX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2617<br />
Gilead Sciences, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2514<br />
Gilead Sciences, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2613<br />
<strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong> . . . . . . . . . . . . . . . . . . . . . .Booth #2906<br />
<strong>Heart</strong> Institute Diagnostic Laboratory . . . . . . . . . . . . . . . . . .Booth #2922<br />
CLINICAL TRIAL ROW<br />
HFSA Laptop Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth # 2830<br />
HFSA E-mail Retrieval Stations . . . . . . . . . . . . . . . . . . . . . . .Booth #2522<br />
<strong>Heart</strong>Ware, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2716<br />
Home Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2924<br />
Infinite Therapeutics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2825<br />
Janssen Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2506<br />
WORKSHOP<br />
LabCorp . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2824<br />
Lippincott Williams & Wilkins - WRH . . . . . . . . . . . . . . . . .Booth #2714<br />
Medtronic, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2626<br />
Millar Instruments, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2813<br />
POSTER SESSIONS<br />
COFFEE STATION<br />
Miller Pharmacal Group, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2622<br />
NeuMeDx . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2518<br />
NitroMed, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2923<br />
Otsuka <strong>America</strong> Pharmaceutical, Inc. . . . . . . . . . . . . . . . . . . .Booth #2406<br />
Otsuka <strong>America</strong> Pharmaceutical, Inc. . . . . . . . . . . . . . . . . . . .Booth #2426<br />
Oxford University Press . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2719<br />
St. Jude Medical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2818<br />
Shape Medical Systems, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2911<br />
SynCardia Systems, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2826<br />
The Joint Commission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2912<br />
The Methodist JC Walter Jr Transplant Center . . . . . . . . . . . .Booth #2914<br />
Thoratec Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2815<br />
Vasomedical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2722<br />
Wiley-Blackwell . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2916<br />
XDx, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2412<br />
ZOLL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2812<br />
150<br />
151
Clinical Trial Row<br />
EXHIBITORS<br />
Amgen Inc.<br />
B1<br />
ATOMIC-HF<br />
Acute Treatment with Omecamtiv Mecarbil to<br />
Increase Contractility in Acute <strong>Heart</strong> <strong>Failure</strong><br />
ABIOMED.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2724<br />
22 Cherry Hill Drive<br />
Danvers, MA 01923<br />
Website: www.abiomed.com<br />
BioControl Medical LTD<br />
B2<br />
INOVATE-HF<br />
INcrease Of VAgal Tone in <strong>Heart</strong> <strong>Failure</strong><br />
Gambro UF Solutions, Inc.<br />
B3<br />
AVOID-HF<br />
Aquapheresis Versus Intravenous Diuretics and<br />
Hospitalizations for <strong>Heart</strong> <strong>Failure</strong><br />
Medtronic CRDM<br />
B4<br />
aCRT<br />
Adaptive Cardiac Resynchronization Therapy Study<br />
B5<br />
BLOCK HF<br />
Biventricular Versus Right Ventricular Pacing in<br />
<strong>Heart</strong> <strong>Failure</strong> Patients with Atrioventricular Block<br />
B6<br />
PainFree SST<br />
Study to Evaluate System Safety and Clinical<br />
Performances <strong>of</strong> the Protecta ICD Plus CRT-<br />
Defibrillator<br />
Medtronic CRDM (University <strong>of</strong> Calgary)<br />
B7<br />
REFINE-ICD<br />
Efficacy <strong>of</strong> Implantable Defibrillator Therapy After<br />
a Myocardial Infarction<br />
Medtronic CRDM<br />
B8<br />
Medtronic Product Performance Platform<br />
B9<br />
Medtronic Feasibility Research Program<br />
Pfizer<br />
B10<br />
THAOS<br />
Transthyretin-Associated Amyloidosis Outcomes<br />
Survey<br />
Abiomed, Inc. is a leading provider <strong>of</strong> breakthrough heart support<br />
technologies enabling safer revascularization, heart muscle recovery<br />
and cost-effective patient care.<br />
Alere.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2721<br />
2 Research Way<br />
Princeton, NJ 08540<br />
Website: www.alere.com<br />
Alere enables individuals to take charge <strong>of</strong> improving their health and<br />
quality <strong>of</strong> life by developing new capabilities in near-patient diagnosis<br />
and monitoring. Alere <strong>of</strong>fers a suite <strong>of</strong> leading CLIA waived and<br />
moderately complex near-patient tests, including the Triage® MeterPro,<br />
which test quantitative BNP, CK-MB, D-Dimer, Myoglobin, Troponin I.<br />
<strong>America</strong>n Association <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong> Nurses.. . . . . . . . . . . . . 2920<br />
15000 Commerce Parkway<br />
Suite C<br />
Mount Laurel, NJ 08054<br />
Website: www.aahfn.org<br />
The <strong>America</strong>n Association <strong>of</strong> <strong>Heart</strong> <strong>Failure</strong> Nurses (AAHFN) is a<br />
specialty organization dedicated to advancing nursing education,<br />
clinical practice and research to improve heart failure patient<br />
outcomes. We serve as the interface for sharing ideas, translating<br />
research findings into practice and setting priorities for the future.<br />
<strong>America</strong>n Express OPEN .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2926<br />
200 Vessey St<br />
New York, NY 10281<br />
Website: www.<strong>America</strong>nExpress.com/OPEN<br />
<strong>America</strong>n Express OPEN consists <strong>of</strong> small business cash flow<br />
management tools along with products focusing on small business<br />
purchasing needs which assist business owners with managing their<br />
bottom line. Our award winning line <strong>of</strong> charge cards provide travel<br />
benefits, purchasing power, management tools, warranties, insurances,<br />
assurances, and protections.<br />
152<br />
153
EXHIBITORS<br />
EXHIBITORS<br />
<strong>America</strong>n <strong>Heart</strong> Association.. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2918<br />
7272 Greenville Avenue<br />
Dallas, TX 75231<br />
Website: www.heart.org/quality<br />
The <strong>America</strong>n <strong>Heart</strong> Association/<strong>America</strong>n Stroke Association <strong>of</strong>fers<br />
a complete portfolio <strong>of</strong> quality improvement programs dedicated to<br />
bettering patient care through guideline adherence. The programs<br />
address improving quality <strong>of</strong> patient care for patients <strong>of</strong> heart disease<br />
and stroke from primary prevention all the way through outpatient care.<br />
BTG International Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2823<br />
300 Barr Harbor Drive, Suite 800<br />
West Consho Hocken, PA 19428<br />
Website: www.btgplc.com<br />
BTG is an international specialist healthcare company, developing<br />
and commercializing products targeting critical care, cancer and other<br />
disorders. BTG’s products, CroFab® Crotalidae Polyvalent Immune<br />
Fab (Ovine) and DigiFab® Digoxin Immune Fab (Ovine) are FDAapproved<br />
and marketed in the United States.<br />
Aton Pharma.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2726<br />
7545 Irvine Center Drive<br />
Suite 100<br />
Irvine, CA 92618<br />
Website: www.valeant.com<br />
Aton Pharma, Inc., a division <strong>of</strong> Valeant Pharmaceuticals North<br />
<strong>America</strong>, is a specialty pharmaceutical company that is committed to<br />
improving medical outcomes and enhancing quality <strong>of</strong> life for patients<br />
worldwide by facilitating and expanding the availability <strong>of</strong> medically<br />
essential products and therapies, and ensuring accessibility to these<br />
vital treatments.<br />
BG Medicine, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2511<br />
610 N. Lincoln Street<br />
Waltham, MA 02451<br />
Website: www.bg-medicine.com<br />
BG Medicine (NASDAQ:BGMD) is a life sciences company focused<br />
on the discovery, development, and commercialization <strong>of</strong> novel<br />
diagnostics to improve patient outcomes and contain healthcare<br />
costs. BG Medicine’s galectin-3 blood test identifies patients with<br />
an inherently progressive form <strong>of</strong> heart failure resulting from<br />
fibrogenesis.<br />
Boston <strong>Scientific</strong> Corporation. . . . . . . . . . . . . . . . . . . . . . . . . . . 2821<br />
4100 Hamline Avenue North<br />
St. Paul, MN 55112<br />
Website: www.bostonscientific.com<br />
Boston <strong>Scientific</strong> is a worldwide developer, manufacturer, and<br />
marketer <strong>of</strong> medical devices whose products are used in a broad<br />
range <strong>of</strong> interventional medical specialties. With approximately<br />
25,000 employees and annual revenue <strong>of</strong> more than $8 billion, Boston<br />
<strong>Scientific</strong> is the world’s largest medical device company dedicated to<br />
less-invasive therapies.<br />
CardiacAssist, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2925<br />
240 Alpha Drive<br />
Pittsburgh, PA 15238<br />
Website: www.cardiacassist.com<br />
CardiacAssist’s Tandem <strong>Heart</strong>® System delivers extracorporeal<br />
circulatory support. System can provide up to 5.0 L/min <strong>of</strong> circulatory<br />
support when deployed percutaneously and up to 8.0 L/min <strong>of</strong> support<br />
with direct surgical cannulation.<br />
Cytokinetics, Inc. .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2705<br />
280 E Grand Ave<br />
South San Francisco, CA 94080<br />
Website: www.cytokinetics.com<br />
Cytokinetics, Inc. is a biopharmaceutical company focused on<br />
the discovery, development and commercialization <strong>of</strong> novel small<br />
molecule drugs that specifically target the cytoskeleton. Cytokinetics’<br />
heart failure program is focused towards small molecule activators<br />
<strong>of</strong> cardiac myosin, the cytoskeletal motor protein in cardiac muscle<br />
responsible for cardiac contraction.<br />
Daxor Corporation .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2620<br />
350 Fifth Avenue<br />
Suite 7120<br />
New York, NY 10118<br />
Website: www.daxor.com<br />
Daxor Corporation’s BVA-100® Blood Volume Analyzer is a<br />
semi-automated instrument patented for direct measurement <strong>of</strong><br />
blood volume, red cell and plasma volume. The system utilizes<br />
the Volumex® injection kit for a multi-sample blood volume.<br />
Measurement <strong>of</strong> blood volume is applicable for hypertension, CHF,<br />
transfusion, ICU/CCU, anemia, orthostatic hypotension and syncope.<br />
154<br />
155
Elsevier Publishing .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2910<br />
1600 JFK Blvd., Suite 1800<br />
Philadelphia, PA 19103<br />
Website: www.elsevier.com<br />
EXHIBITORS<br />
ELSEVIER, proud publisher <strong>of</strong> the Journal <strong>of</strong> Cardiac <strong>Failure</strong>,<br />
<strong>of</strong>ficial journal <strong>of</strong> the HFSA. Come view the latest issue <strong>of</strong> the Journal<br />
and browse our books such as the NEW Braunwald’s Textbook <strong>of</strong><br />
<strong>Heart</strong> Disease, Mann’s <strong>Heart</strong> <strong>Failure</strong> Textbook, <strong>Heart</strong> <strong>Failure</strong> Clinics,<br />
and many other new and exciting periodicals and online solutions in<br />
the field <strong>of</strong> cardiology.<br />
Gilead Sciences, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2613<br />
333 Lakeside Drive<br />
Foster City, CA 94404<br />
Website: www.gilead.com<br />
EXHIBITORS<br />
Gilead Sciences is a biopharmaceutical company that discovers,<br />
develops and commercializes innovative therapeutics in areas <strong>of</strong><br />
unmet medical need. The company’s mission is to advance the<br />
care <strong>of</strong> patients suffering from life-threatening diseases worldwide.<br />
Headquartered in Foster City, California, Gilead has operations in<br />
North <strong>America</strong>, Europe and Australia.<br />
Gambro UF Solutions .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2917<br />
7601 Northland Drive<br />
Suite 170<br />
Brooklyn Park, MN 55428<br />
Website: www.gambro.com<br />
Gambro UF Solutions <strong>of</strong>fers a proven way to manage patients<br />
suffering from fluid overload. Aquapheresis therapy with the Aquadex<br />
FlexFlow is evidence-based, guideline recommended, and guaranteed.<br />
Visit www.Gambro.com for more information.<br />
<strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong>.. . . . . . . . . . . . . . . . . . . . . . . . 2906<br />
Court International, Suite 240 South<br />
2550 University Avenue West<br />
St. Paul, MN 55114<br />
Website: www.hfsa.org<br />
The <strong>Society</strong> welcomes you to our <strong>15th</strong> <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong>. We<br />
hope you enjoy your stay in Boston and look forward to seeing you<br />
at the 16th <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong>, September 9-12, 2012, Seattle,<br />
WA. Please visit our booth for more information about the <strong>Society</strong>.<br />
GeneDx.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2617<br />
207 Perry Parkway<br />
Gaithersburg, MD 20877<br />
Website: www.GeneDx.com<br />
GeneDx <strong>of</strong>fers testing for more than 350 rare Mendelian disorders,<br />
using DNA sequencing and deletion/duplication analysis <strong>of</strong> the<br />
associated gene(s). GeneDx also <strong>of</strong>fers genetic testing services for<br />
inherited cardiac disorders such as Hypertrophic cardiomyopathy,<br />
Dilated cardiomyopathy and Arrhythmias. Our services include<br />
mutation analysis, carrier testing, prenatal diagnosis, and mutation<br />
confirmations.<br />
<strong>Heart</strong> Institute Diagnostic Laboratory. . . . . . . . . . . . . . . . . . . . 2922<br />
Cincinnati Children’s Hospital Medical Center<br />
3333 Burnet Avenue<br />
Cincinnati, OH 45227<br />
Website: www.cincinnatichildrens.org<br />
The <strong>Heart</strong> Institute Diagnostic Lab at Cincinnati Children’s Hospital<br />
Medical Center specializes in sequencing <strong>of</strong> genes associated with<br />
cardiovascular disease and molecular analysis <strong>of</strong> viruses known<br />
to cause myocarditis. The lab draws upon the expert analysis and<br />
consultation services <strong>of</strong> the <strong>Heart</strong> Institute’s cardiologists, cardiacfocused<br />
geneticists and dedicated genetic counselors.<br />
Gilead Sciences, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2514<br />
333 Lakeside Drive<br />
Foster City, CA 94404<br />
Website: www.gilead.com<br />
Gilead Sciences is a biopharmaceutical company that discovers,<br />
develops and commercializes innovative therapeutics in areas <strong>of</strong><br />
unmet medical need. The company’s mission is to advance the<br />
care <strong>of</strong> patients suffering from life-threatening diseases worldwide.<br />
Headquartered in Foster City, California, Gilead has operations in<br />
North <strong>America</strong>, Europe and Australia.<br />
HFSA Laptop Lounge.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2830<br />
HFSA E-mail Retrieval Stations.. . . . . . . . . . . . . . . . . . . . . . . . . 2522<br />
During exhibit hours, this booth will have computers available for<br />
attendees to retrieve their e-mail.<br />
156<br />
157
<strong>Heart</strong>Ware, Inc .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2716<br />
205 Newbury Street<br />
Framingham, MA 01701<br />
Website: www.heartware.com<br />
<strong>Heart</strong>Ware, Inc. is developing a family <strong>of</strong> implantable mechanical<br />
circulatory support systems for the treatment <strong>of</strong> advanced heart<br />
failure. <strong>Heart</strong>Ware’s lead device, the <strong>Heart</strong>Ware® Ventricular Assist<br />
System, incorporates state-<strong>of</strong>-the-art peripherals and features the<br />
only full-output pump designed to be implanted less invasively in the<br />
pericardial space. The <strong>Heart</strong>Ware® System is commercially available<br />
in Europe and is the subject <strong>of</strong> a 150-patient US IDE trial.<br />
Home Solutions .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2924<br />
1601 New Road, #100<br />
Northfield, NJ 08225<br />
Website: www.infusioncare.com<br />
EXHIBITORS<br />
Home Solutions is one <strong>of</strong> the largest independent home infusion<br />
providers in the country that specializes in cardiac therapies. With full<br />
service locations in the Northeast and Mid-Atlantic regions, Home<br />
Solutions recently launched InfuLink®, a patient driven/clinician<br />
focused web-monitoring tool dedicated to sharing vital information<br />
about a patient’s care while receiving service.<br />
Infinite Therapeutics.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2825<br />
68 Route 125<br />
Kingston, NH 03848<br />
Website: www.infinitetherapeutics.com<br />
The cardiovascular benefits <strong>of</strong> Massage Therapy & Inversion Massage<br />
Therapy have been well documented in the medical community<br />
<strong>of</strong> years. The ADA / <strong>America</strong>n Diabetes Association are a strong<br />
proponent <strong>of</strong> massage therapy for the significant cardiovascular<br />
circulation benefits it yields. Many practitioners today are prescribing<br />
massage therapy strictly for the cardiovascular benefits.<br />
Janssen Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . 2506<br />
1000 Route 202<br />
Raritan, NJ 08869<br />
Website: www.janssenpharmaceuticalsinc.com<br />
Janssen Pharmaceuticals, Inc., a pharmaceutical company <strong>of</strong> Johnson &<br />
Johnson, provides medicines for an array <strong>of</strong> health concerns in several<br />
therapeutic areas, including: attention deficit hyperactivity disorder (ADHD),<br />
general medicine (acid reflux disease, infectious diseases), mental health<br />
(bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy,<br />
migraine prevention and treatment), pain management, and women’s health.<br />
158<br />
LabCorp.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2824<br />
531 S. Spring Street, 3rd Floor<br />
Burlington, NC 27523<br />
LabCorp provides leading-edge tests and services through a national<br />
network <strong>of</strong> primary clinical and specialized laboratories to support<br />
cardiovascular disease prevention, diagnosis and management.<br />
Services include traditional lipids; lipoproteins; markers <strong>of</strong><br />
inflammation, acute ischemia and heart failure; genetic tests for<br />
inherited diseases and conditions; genetic counseling and ambulatory<br />
electrocardiography.<br />
Lippincott Williams & Wilkins – WRH.. . . . . . . . . . . . . . . . . . . 2714<br />
Two Commerce Square<br />
2001 Market Street<br />
Philadelphia, PA 19103<br />
Website: www.wolterskluwer.com<br />
Lippincott Williams & Wilkins, a Wolters Kluwer Health company<br />
is a leading international publisher <strong>of</strong> medical books, journals, and<br />
electronic media. We proudly <strong>of</strong>fer specialized publications and<br />
s<strong>of</strong>tware for physicians, nurses, students and clinicians. Please visit<br />
our booth to browse our comprehensive product line.<br />
Medtronic, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2626<br />
710 Medtronic Parkway<br />
Minneapolis, MN 55432<br />
Website: www.medtronic.com<br />
At Medtronic (www.medtronic.com), we’re committed to Innovating<br />
for life by pushing the boundaries <strong>of</strong> medical technology and actually<br />
changing the way the world treats and manages heart failure. Visit<br />
booth #2626 to see how our newest products and therapies are solving<br />
unmet needs by diagnosing, monitoring, and treating patients.<br />
Millar Instruments, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2813<br />
6001-A Gulf Freeway<br />
Houston, TX 77023<br />
Website: www.millar.com<br />
EXHIBITORS<br />
Millar manufactures a complete line <strong>of</strong> Mikro-Tip pressure and<br />
pressure-volume catheters for evaluation <strong>of</strong> cardiac function. Our<br />
catheters range from 8F down to 1F, with single to multiple sensors.<br />
Additionally, Millar <strong>of</strong>fers the Mikro-Cath disposable pressure<br />
catheter. This single-use, sterile catheter delivers a high-fidelity signal<br />
for everyday cath lab use.<br />
159
Miller Pharmacal Group, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . 2622<br />
350 Randy Road, Suite 2<br />
Carol Stream, IL 60188<br />
Website: www.millerpharmacal.com<br />
“MG PLUS PROTEIN” (TM) supplies 133 mg <strong>of</strong> elemental<br />
magnesium in an easy to swallow tablet. It is well-tolerated and does<br />
not cause the GI disturbances common with magnesium oxide, even in<br />
high doses commonly required for patients on tacrolimus or diuretics.<br />
“MG PLUS PROTEIN”, inexpensive and well-tolerated.<br />
NeuMeDx.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2518<br />
2014 Ford Road, Unit G<br />
Bristol, PA 19007<br />
Website: www.neumedx.com<br />
NeuMeDx presents the PhysioFlow NICO monitor; beneficial in<br />
assisting clinicians in optimizing stroke volume, usage for EGDT and<br />
fluid management. It is noninvasive, user independent and can receive<br />
data in less than five minutes. Used everywhere from the ER to the<br />
ICU for the critically ill or in your <strong>of</strong>fice!<br />
NitroMed, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2923<br />
6000 Fairview Road<br />
Suite 610<br />
Charlotte, NC 28210<br />
Website: www.nitromed.com<br />
BiDil is a fixed dose combination <strong>of</strong> hydralazine and isosorbide<br />
dinitrate that’s approved for use in self proclaimed black patients<br />
with heart failure. It’s been shown to reduce mortality by 43% and<br />
risk <strong>of</strong> first hospitalization by 39% when added onto standard <strong>of</strong> care<br />
including ACE inhibitors and beta blockers.<br />
Otsuka <strong>America</strong> Pharmaceutical, Inc. . . . . . . . . . . . . . . . . . . . . 2406<br />
1 University Square Drive<br />
Suite 500<br />
Princeton, NJ 08540<br />
Website: www.otsuka-us.com<br />
EXHIBITORS<br />
Otsuka is hard at work investigating potential new treatments, with<br />
numerous compounds in various stages <strong>of</strong> development to treat<br />
disorders <strong>of</strong> the cardiovascular, gastrointestinal, respiratory, renal, and<br />
central nervous systems, and to treat cancer and ophthalmic disorders.<br />
Our goal is to create new products for better health worldwide. For<br />
information, please visit www.otsuka-us.com.<br />
Otsuka <strong>America</strong> Pharmaceutical, Inc. . . . . . . . . . . . . . . . . . . . . 2426<br />
1 University Square Drive<br />
Suite 500<br />
Princeton, NJ 08540<br />
Website: www.otsuka-us.com<br />
Otsuka is hard at work investigating potential new treatments, with<br />
numerous compounds in various stages <strong>of</strong> development to treat<br />
disorders <strong>of</strong> the cardiovascular, gastrointestinal, respiratory, renal, and<br />
central nervous systems, and to treat cancer and ophthalmic disorders.<br />
Our goal is to create new products for better health worldwide. For<br />
information, please visit www.otsuka-us.com.<br />
Oxford University Press .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2719<br />
2001 Evans Road<br />
Cary, NC 27513<br />
Website: www.oup.com<br />
Oxford University Press publishes some <strong>of</strong> the most respected medical<br />
and scientific books and journals in the world, including The ESC<br />
Textbook <strong>of</strong> Cardiovascular Medicine, and European Journal <strong>of</strong> <strong>Heart</strong><br />
<strong>Failure</strong>, the <strong>of</strong>ficial international journal <strong>of</strong> the European <strong>Society</strong> <strong>of</strong><br />
Cardiology. Visit www.oup.com for more information.<br />
St. Jude Medical. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2818<br />
6400 Bee Cave Road<br />
Bldg 2, Suite 100<br />
Austin, TX 78746<br />
Website: www.sjm.com<br />
EXHIBITORS<br />
St. Jude Medical develops medical technology designed to put more<br />
control into the hands <strong>of</strong> those who treat cardiac, neurological and<br />
chronic pain patients worldwide. The company is dedicated to advancing<br />
the practice <strong>of</strong> medicine by reducing risk wherever possible and<br />
contributing to successful patient outcomes. Learn more at sjm.com.<br />
Shape Medical Systems, Inc. .. . . . . . . . . . . . . . . . . . . . . . . . . . . 2911<br />
5000 Township Parkway<br />
St. Paul, MN 55110<br />
Website: www.shapemedsystems.com<br />
Shape Medical Systems provides predictive modeling to improve<br />
the detection and therapeutic outcome assessment <strong>of</strong> heart and lung<br />
disease. Technology assesses cardiopulmonary function, defines the<br />
probable source <strong>of</strong> heart or lung limitations, quantifies prognosis,<br />
predicts future risk, provides recommendations regarding future<br />
treatment and monitors the ongoing clinical response to therapy.<br />
160<br />
161
SynCardia Systems, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2826<br />
1992 E. Silverlake Rd.<br />
Tucson, AZ 85713<br />
Website: www.syncardia.com<br />
EXHIBITORS<br />
The SynCardia temporary Total Artificial <strong>Heart</strong> (TAH-t) is the world’s<br />
only FDA, Health Canada and CE approved Total Artificial <strong>Heart</strong>. It<br />
is approved as a bridge to transplant for patients dying from end-stage<br />
biventricular failure. Visit our booth for updates on the Freedom<br />
portable driver and more.<br />
The Joint Commission.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2912<br />
One Renaissance Blvd<br />
Oakbrook Terrace, IL 60181<br />
Website: www.jointcommission.org<br />
The Joint Commission’s advanced certification for heart failure uses<br />
Get With The Guidelines heart failure measures as the clinical practice<br />
requirement. Advanced certification for heart failure provides a<br />
comprehensive evaluation <strong>of</strong> this patient population. Certification <strong>of</strong><br />
your heart failure program demonstrates excellence in fostering better<br />
outcomes.<br />
Vasomedical.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2722<br />
180 Linden Avenue<br />
Westbury, NY 11590<br />
Website: www.vasomedical.com<br />
Vasomedical EECP® therapy systems are the only non-invasive<br />
external counterpulsation therapy devices proven safe and effective<br />
in angina and heart failure clinical trials published in peer reviewed<br />
medical journals. EECP® therapy is FDA cleared and Medicare<br />
approved. Vasomedical also features Holter monitors (including the<br />
unique combined 3-channel ECG Holter and ABP recorder) and EZ<br />
patient management products.<br />
Wiley-Blackwell.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2916<br />
350 Main Street<br />
Malden, MA 02148<br />
Website: www.wiley.com<br />
EXHIBITORS<br />
Wiley-Blackwell is the international scientific, technical, medical and<br />
scholarly publishing business <strong>of</strong> John Wiley & Sons, with strengths<br />
in every major academic and pr<strong>of</strong>essional field and partnerships with<br />
many <strong>of</strong> the world’s leading societies.<br />
The Methodist JC Walter Jr Transplant Center.. . . . . . . . . . . . 2914<br />
6550 Fannin, Suite 1200<br />
Houston, TX 77030<br />
Website: www.tmhs.org<br />
Since 1963 Methodist has been a pioneer in thoracic transplantation<br />
and assist devices. In 2010, we completed 362 total transplants,<br />
making Methodist the largest transplant center in Texas and the<br />
region. Methodist is number one in the nation for combined heart/lung<br />
transplants and became the first center in Texas to <strong>of</strong>fer total artificial<br />
heart procedures.<br />
Thoratec Corporation.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2815<br />
6035 Stoneridge Drive<br />
Pleasanton, CA 94588<br />
Website: www.thoratec.com<br />
Thoratec Corporation is a world leader in therapies to address<br />
advanced-stage heart failure. The company’s products include the<br />
<strong>Heart</strong>Mate® LVAS and Thoratec® VAD (Ventricular Assist Device)<br />
with more than 18,000 devices implanted in patients suffering from<br />
heart failure. For more information, visit the company’s web site at<br />
http://www.thoratec.com.<br />
XDx, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2412<br />
3260 Bayshore Blvd.<br />
Brisbane, CA 94005<br />
Website: www.xdx.com<br />
XDx is a molecular diagnostics company focused on the discovery,<br />
development and commercialization <strong>of</strong> gene expression testing in the<br />
areas <strong>of</strong> transplant medicine and autoimmunity. XDx has one marketed<br />
product, AlloMap® Molecular Expression Testing, a non-invasive gene<br />
expression test that aids in the management <strong>of</strong> heart transplant patients.<br />
ZOLL .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2812<br />
121 Gamma Road<br />
Pittsburgh, PA 15238<br />
Website: www.zoll.com<br />
The ZOLL® LifeVest® wearable defibrillator protects patients at<br />
risk <strong>of</strong> sudden cardiac arrest, during a patient’s changing condition<br />
and when permanent SCA risk has not been established. The LifeVest<br />
provides patients constant monitoring, immediate protection, and<br />
peace <strong>of</strong> mind.<br />
162 163
AUTHOR INDEX<br />
<strong>15th</strong> <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
<strong>Heart</strong> <strong>Failure</strong> <strong>Society</strong> <strong>of</strong> <strong>America</strong><br />
“P” preceding number indicates a poster<br />
Aaronson, Keith D. 33<br />
Aban, Inmaculada<br />
P205<br />
Abdellatif, Maha 42<br />
Abouezzeddine, Omar F.<br />
P236, P265<br />
Abraham, William T.<br />
36, 97, P126, P132, P299<br />
Abreu, Rosiane S.F.<br />
P343<br />
Acker, Michael A.<br />
P157<br />
Adams, Jr., Kirkwood F. 96, 139<br />
Adams, Volker<br />
P020<br />
Adamson, Philip B.<br />
P299<br />
Adamson, Robert M.<br />
P119, P147<br />
Adelstein, Evan<br />
P178<br />
Adourian, Aram S.<br />
45, P294, P297<br />
Agarwal, Sunil Kumar<br />
P178<br />
Aggarwal, Sanjeev<br />
P330<br />
Aguilar, David<br />
P293<br />
Ahmed, Ali<br />
P205<br />
Ahmed, Mohamed<br />
P161, P310<br />
Ahmed, Mubashir<br />
P160<br />
Ahmet, Ismayil<br />
P202<br />
Ahn, Sylvie A.<br />
101, P078, P079, P255<br />
Aizawa, Yoshifusa<br />
P037<br />
Akashi, Hirokazu<br />
55, P130<br />
Al-Khatib, Sana M. 49<br />
Alberghini, Todd<br />
P141<br />
Albert, Nancy M.<br />
102, 144, P319<br />
Aleong, Ryan G.<br />
P168<br />
Alexis, Jeffrey D.<br />
P349<br />
Alhaj, Eyad<br />
P052<br />
Alharethi, R.<br />
P256<br />
Alharethi, Rami 44, P060, P155, P235, P249,<br />
P261, P274<br />
Ali, Shah R.<br />
P099<br />
Allen, Larry A. 30, 48<br />
Allman, Richard<br />
P205<br />
Allsup, K.<br />
P024, P046, P055<br />
Almond, Christopher S.<br />
44, P229<br />
Alves, Suzana A.<br />
P281<br />
Amedeo, Ellen<br />
P264, P354<br />
Ameenuddin, Syed<br />
45, P068<br />
Amin, Alpesh<br />
P228, P243<br />
Ammon, Susan E. 104<br />
Anand, Inder S. 109, 140<br />
Anderson, Jeffrey L.<br />
P106<br />
164<br />
AUTHOR INDEX<br />
Anderson, Mark E. 51<br />
Anderson, Shawn<br />
P334<br />
Ando, Miyuki<br />
P154<br />
Andrade, Wolney<br />
P102<br />
Andriulli, John<br />
P162, P301<br />
Andriulli, John A.<br />
P163<br />
Anjan, Venkatesh<br />
P298<br />
Anker, Stefan D.<br />
49, 91, 140, P020, P029<br />
Anna, Kiran<br />
P215<br />
Anne, Cotleur<br />
P087<br />
Anstrom, Kevin J. 52<br />
Anversa, Piero<br />
56, 92, P050, P173<br />
Anyanwu, Anelechi C.<br />
44, P122, P127<br />
Aoyagi, Toshinori 56<br />
Arabia, Francisco A.<br />
P128<br />
Aradhya, Mahesh<br />
P264, P354<br />
Arai, Sally<br />
P145<br />
Aranda, Juan<br />
P334<br />
Ardehali, Reza<br />
P099<br />
Arena, R.<br />
P024, P046, P055<br />
Arenja, N.<br />
P069<br />
Armstrong, Hilary F.<br />
P195<br />
Armstrong, Paul W. 52<br />
Arnce, Sarah<br />
P206<br />
Arnold, J. Malcolm O. 48<br />
Arnold, Malcolm<br />
P353<br />
Arnold, Roman<br />
P341<br />
Arora, Tarun<br />
P205<br />
Arthur, Heather M.<br />
P257<br />
Ashley, Kimberly<br />
44, P122, P127<br />
Asif, Aya<br />
P181, P189, P317<br />
Asirvatham, Samuel J.<br />
P248<br />
Asosingh, Kewal<br />
P087<br />
Ather, Sameer<br />
P101, P293<br />
Atherton, John J.<br />
P230<br />
Athilingam, Ponrathi R.<br />
P034, P091<br />
Atluri, Pavan<br />
P157<br />
Atluri, Tej K.<br />
P222<br />
Attig, Stacie M.<br />
P128<br />
Aukrust, Pal<br />
45, P294<br />
Aung, May<br />
P051<br />
Austin, Bethany A.<br />
P330<br />
Awad, Adiveh<br />
P077<br />
Ayalon, Nir<br />
P095<br />
Ayalon, Rivka<br />
P095<br />
Azad, Nahid<br />
P291<br />
Bachtel, Carol S.<br />
P128<br />
Bader, Feras<br />
P060, P155<br />
Bahl, Joseph J.<br />
P120, P206<br />
165
AUTHOR INDEX<br />
Bai, Yingnan A.<br />
P173<br />
Bair, T.<br />
P256<br />
Balla, Cristina 56<br />
Balling, Kyle D.<br />
44, P235<br />
Balshaw, Robert<br />
P137<br />
Bang, Claudia<br />
P020<br />
Bank, Alan J.<br />
P170<br />
Baradarian, Sam<br />
P119, P147<br />
Barajas, Justine<br />
P303<br />
Barajas, Linda<br />
P303<br />
Barker, Diane<br />
P023<br />
Barn, Kulpreet<br />
P160<br />
Barnard, Denise<br />
45, P289<br />
Barnard, Denise D. 138<br />
Barrett-Connor, Elizabeth<br />
P074<br />
Barrios, Roberto<br />
P111<br />
Barros, Luciana N.<br />
P343<br />
Bart, Bradley A. 47<br />
Bartels, Matthew<br />
P195<br />
Basraon, Jagroop<br />
P121<br />
Batizy, Lillian<br />
P175<br />
Battiprolua, Pavan K. 56<br />
Baumann, Matthew<br />
P292<br />
Baumer, Dorothy<br />
P228, P243<br />
Baumgarten, Anna<br />
P020<br />
Bayne, David B.<br />
P061<br />
Beanlands, Rob<br />
P051<br />
Beanlands, Rob A.<br />
P110<br />
Beck, Kenneth C.<br />
P340<br />
Belardinelli, Luiz<br />
P208<br />
Belk, Kathy<br />
P228, P243<br />
Bellavia, Diego<br />
45, P067<br />
Bennett, Alexandra A.<br />
P300<br />
Bennett-Gittens, Raquel L.<br />
P187<br />
Benton, Casey R.<br />
P127<br />
Benza, Raymond<br />
P279<br />
Berkowitz, Robert<br />
P052<br />
Bers, Donald M. 98<br />
Bhardwaj, Anju<br />
P303<br />
Bhat, Geetha<br />
P150<br />
Bhat, Pradeep K.<br />
P258<br />
Bhatia, Vivek<br />
P125<br />
Bianco, Nicole R.<br />
P166, P176, P330<br />
Binns, Oliver A.<br />
P143<br />
Biolo, Andreia<br />
P095<br />
Birks, Emma J. 40<br />
Blackburn, Beth<br />
P214, P227<br />
Blackwell, Minnie P.<br />
P308<br />
Blaxall, Burns C. 56<br />
166<br />
AUTHOR INDEX<br />
Blecker, Saul<br />
P217<br />
Blomdhaim, David<br />
P317<br />
Blomqvist, Andreas<br />
P179<br />
Blondheim, David<br />
P181<br />
Blonheim, David<br />
P189<br />
Bloom, H.<br />
P039<br />
Boehmer, John P.<br />
35, P140, P247, P340<br />
Boerrigter, Guido<br />
P027, P070, P200, P204<br />
Boilson, Barry A.<br />
P116<br />
Bokhari, Sabahat<br />
P327<br />
Bolli, Roberto 105<br />
Bolwell, Gregory J.<br />
P292<br />
Bonde, Pramod<br />
P136<br />
Bonnet, Nancy L.<br />
P159<br />
Bonow, Robert O.<br />
P298<br />
Borges-Neto, S.<br />
P263<br />
Borges-Neto, Salvador<br />
P251<br />
Borlaug, Barry A.<br />
145, P184<br />
Bornzin, Gene A.<br />
P036, P152, P153<br />
Borojevic, Radovan<br />
P281<br />
Borowski, Allen G. 101, P019, P076, P083, P085,<br />
P088, P089, P090, P098<br />
Bourgoun, Mikhail<br />
P183<br />
Bove, Alfred A.<br />
P348<br />
Bozkurt, Biykem<br />
P101, P293<br />
Bradham, William S.<br />
P336<br />
Branch, Ashley C.<br />
P167<br />
Brasch, Judy<br />
P276<br />
Braunwald, Eugene<br />
52, 143, P081<br />
Breidthardt, T.<br />
P069<br />
Brennan, Simarta<br />
P295<br />
Breuer, Kimberly<br />
P157<br />
Bridges, Charles R.<br />
P144<br />
Brieke, Andreas<br />
P113<br />
Briggs, Patricia E.<br />
P253<br />
Brinker, Eileen<br />
P331<br />
Brinkley, Douglas M.<br />
P239<br />
Bristow, Michael R.<br />
51, P113<br />
Britt, Jr., Earl B.<br />
P072, P097<br />
Britton, Nancy<br />
P030<br />
Brook, Robert D. 55<br />
Brooke, Kelly L.<br />
P169, P248<br />
Brown, Jason<br />
P332<br />
Brown, Patricia<br />
P103<br />
Brozovich, Frank C. 55<br />
Bruce, Keith<br />
P332<br />
Bruck, S.<br />
P129<br />
Bruckner, Brian<br />
P186<br />
Bruhl, Steven<br />
P063<br />
167
AUTHOR INDEX<br />
Bruhl, Steven R.<br />
P045<br />
Brunisholz, K.<br />
P256<br />
Brunisholz, Kim<br />
P249, P261, P274<br />
Brunisholz, Kimberly D.<br />
44, P106, P235<br />
Buchhalter, Lillian C.<br />
102, P171<br />
Buck, Harleah G.<br />
144, P192<br />
Budge, D.<br />
P256<br />
Budge, Deborah 44, P060, P155, P235, P249,<br />
P261, P274<br />
Bufe, Alexander<br />
P070<br />
Bugatti, Silvia<br />
P267<br />
Buhler, Katrin<br />
101, P084<br />
Bull, David A.<br />
P186<br />
Burgess, Pamela R.<br />
P017<br />
Burke, Michael A.<br />
P298<br />
Burnett, John C.<br />
P040, P067<br />
Burnett, Jr., John C. 45, 47, 52, 55, P027, P038,<br />
P057, P068, P070, P104, P116,<br />
P200, P204<br />
Burns, Kevin V.<br />
P170<br />
Burwash, Ian<br />
P051<br />
Bustami, Rami<br />
P295<br />
Butler, Javed<br />
30, P187<br />
Buxton, Alfred E. 41<br />
Byrne, Howard<br />
P206<br />
Califf, Robert M. 52<br />
Calvin, Andrew D.<br />
P059<br />
Camandaroba, Paulo J.P.<br />
P343<br />
Campbell, Patricia<br />
P115, P183<br />
Campos, Eugenio P.<br />
P343<br />
Cannone, Valentina<br />
P027<br />
Canter, Charles E.<br />
44, P229<br />
Cao, Dian J. 56<br />
Cao, Yan<br />
P223<br />
Cappetta, Francesco<br />
56, P050, P173<br />
Cappola, Thomas P.<br />
44, P066, P314<br />
Carlquist, John<br />
P106, P274<br />
Carlson, Marj<br />
P107<br />
Carroll, Maureen<br />
P331<br />
Carson, Peter E. 48<br />
Carubelli, Valentina<br />
P267<br />
Castriani, Anna Isotta<br />
P315<br />
Cataliotti, Alessandro 45, P027, P038, P040, P067,<br />
P200<br />
Cauthen, Clay A.<br />
P165, P172, P278<br />
Cavalcanti, Ana C.D.<br />
P343<br />
Cevasco, Megan E.<br />
P207<br />
Cevik, Cihan<br />
P148<br />
Cha, Myung-jin<br />
P226<br />
168<br />
AUTHOR INDEX<br />
Cha, Yong-Mei<br />
P169, P248<br />
Chacko, Billy G.<br />
P222<br />
Chai, Qiang<br />
P041<br />
Chamberlain, Lyne<br />
P347<br />
Chambers, Susan V.<br />
P031<br />
Chammas, Joseph<br />
P119, P147<br />
Champsaur, Gerard L.<br />
P143<br />
Chan, Cynthia Y.<br />
P212<br />
Chan, Michael<br />
P353<br />
Chan, Wandy<br />
P179<br />
Chan, Wenyaw<br />
P293<br />
Chandra, Ramesh<br />
P237<br />
Chandy, George<br />
P051<br />
Chang, Patricia<br />
P217<br />
Channah, Soheni<br />
P028<br />
Chaparro, Sandra<br />
P158<br />
Chareonthaitawee, Panithaya<br />
P169<br />
Charles, Chris<br />
P318<br />
Charonko, John J.<br />
P017<br />
Cheema, Faisal<br />
55, P151<br />
Cheema, Faisal H.<br />
P130, P149<br />
Chen, Ding-Geng<br />
P276<br />
Chen, Horng H. 45, 109, P038, P040, P057,<br />
P058, P068, P116<br />
Chen, Jennifer<br />
P314<br />
Chen, Leway<br />
P091, P276, P349<br />
Chen, Virginia<br />
P137<br />
Cheng, Che Ping<br />
P199<br />
Cheng, Heng-Jie<br />
P199<br />
Cheng, Richard K.<br />
P254, P269, P273<br />
Chermont, Sergio<br />
P102<br />
Chernin, Gil<br />
P345<br />
Cheung, Anson<br />
P146<br />
Cheung, Rebecca<br />
P252<br />
Chew, Michael 55<br />
Chia, Shaw Yang<br />
P218<br />
Chilcott, Suzanne<br />
P147<br />
Chin, John 87<br />
Chinnappa, Shanmugakumar<br />
P023, P054<br />
Chiong, Jun<br />
P252, P322<br />
Chiswell, K.<br />
P193, P245, P280<br />
Cho, Hyun-Jai<br />
P226<br />
Choi, Heejung<br />
P329<br />
Choi, Jin-Oh<br />
P071, P209, P324, P329<br />
Chokshi, Aalap<br />
55, P117, P130, P151, P195<br />
Chopra, Deepak 37<br />
Chou, Josephine C.<br />
102, P139<br />
Chruscinski, Andrzej<br />
P123<br />
Chung, Misook L.<br />
P262<br />
169
AUTHOR INDEX<br />
Clark, Adrienne L.<br />
P277<br />
Clark, Robyn A.<br />
102, P288, P321<br />
Clark, William<br />
P134<br />
Cleeland, Charles<br />
P316<br />
Cleeton, Timothy<br />
P334<br />
Cleland, J.<br />
P193, P245<br />
Cleland, John G.F.<br />
102, P288, P321<br />
Clopton, Paul<br />
55, P074, P185, P219, P302<br />
Coca, Steven G.<br />
P314<br />
Cochrane <strong>Heart</strong> Group<br />
P321<br />
Cohen Freue, Gabriela<br />
P137<br />
Cohn, Jay<br />
P107<br />
Cohn, Jay N. 52, 103<br />
Colecraft, Henry M. 98<br />
Collado, J. Elias<br />
P195<br />
Collins, Sean<br />
P272<br />
Colombo, Paolo C.<br />
P124<br />
Colucci, Wilson S.<br />
89, 107, P095<br />
Condorelli, Gianluigi 42<br />
Connollly, Jenny<br />
P274<br />
Connolly, J.<br />
P256<br />
Connolly, Jenny<br />
P249, P261<br />
Contarato, Luiza<br />
P102<br />
Cooper, Christopher<br />
P216<br />
Cooper, Leslie T.<br />
P190<br />
Corcoran, Kevin M.<br />
P299<br />
Cordero-Reyes, Andrea 56<br />
Cordero-Reyes, Andrea M.<br />
P111, P112<br />
Costantini, Ottorino<br />
P258<br />
Costanza, Maria Rosa<br />
P132<br />
Costanzo, Maria Rosa<br />
33, 86, P299<br />
Costello, Catherine E. 107<br />
Costello, Elizabeth C.<br />
P070, P200<br />
Cotter, G.<br />
P193, P245<br />
Cowart, Pam A.<br />
P299<br />
Cowger, Jennifer 141<br />
Cowger, Jennifer A.<br />
44, P118<br />
Cox, Scott<br />
P030<br />
Cox, Zachary<br />
P306, P350<br />
Cox, Zachary L.<br />
P296<br />
Coyle, Laura A. 33<br />
Cristian, Maiandi<br />
P315<br />
Crook, Martin<br />
P103<br />
Crozier, Ian<br />
P179<br />
Cui, Hongying<br />
P188, P191, P194<br />
Cuminetti, Giovanni<br />
P267, P315<br />
Cunningham, Brittany L.<br />
P296<br />
Curl, Kevin<br />
P313<br />
Dahan, Iris<br />
P181, P189, P317<br />
170<br />
AUTHOR INDEX<br />
Dalal, Nirav<br />
P036, P152, P153<br />
Dallesandro, David<br />
P125<br />
Daly, Richard<br />
P116<br />
D’Amario, Domenico<br />
P173<br />
Damp, Julie B.<br />
P336<br />
Dandamudi, Sanjay<br />
P058<br />
Daniels, Lori 55<br />
Daniels, Lori B.<br />
P074<br />
DaSilva, Jean<br />
P051, P110<br />
Daubert, James P. 41, 97<br />
Davidson, Patricia M.<br />
P300<br />
Davies, Ross A.<br />
P051<br />
Davila, Carlos<br />
P355<br />
Davis, Margot K.<br />
P146<br />
Davis, S.<br />
P024, P046<br />
Davison, B.<br />
P193, P245<br />
Day, John D.<br />
P140, P247<br />
de Almeida, Angela C.<br />
P042<br />
de Boer, Rudolf A.<br />
45, P294, P297<br />
de Couto, Ge<strong>of</strong>frey<br />
P016<br />
de la Fuente Galan, Luis<br />
P341<br />
De Marco, Teresa 108<br />
Deedwania, Prakash C. 48<br />
deFilippi, Christopher<br />
P297<br />
Dei Cas, Livio<br />
P267<br />
Deitelzweig, Steven<br />
P228, P243<br />
deKemp, Rob J.<br />
P051<br />
deKemp, Robert J.<br />
P110<br />
Dekleva, Milica<br />
P326<br />
del Monte, Federica<br />
56, 98, P173<br />
del Rio, Carlos L.<br />
P126<br />
Delgado, Reynolds M.<br />
P160<br />
Dember, Laura M.<br />
P095<br />
Dembitsky, Walter P.<br />
P119, P147<br />
Demmer, Ryan T.<br />
P124<br />
DeN<strong>of</strong>rio, David 48<br />
Desai, Akshay<br />
P323<br />
Desai, Akshay M. 30, 94, 144<br />
Desvigne-Nickens, Patrice 52<br />
Deswal, Anita<br />
P293<br />
Dev, Sandesh<br />
P308<br />
DeValeria, Patrick A.<br />
P128<br />
Dhaliwal, Amandeep<br />
P293<br />
Dharmarajan, Kumar<br />
101, P221<br />
Di Carli, Marcelo F.<br />
P115<br />
Dickey, Amy<br />
P080<br />
Dickson, Victoria V. 39, 54<br />
Dickstein, Kenneth 52<br />
DiSalvo, Thomas<br />
P296, P306<br />
171
AUTHOR INDEX<br />
DiSomma, Salvatore<br />
P082<br />
Dispenzieri, Angela<br />
P304<br />
Dittrich, H.<br />
P193<br />
Dittrich, H.C.<br />
P245<br />
Doering, Lynn V. 39<br />
Dohmann, Hans F.<br />
P281<br />
Domanski, Michael J.<br />
44, P122, P127<br />
Dorn, II, Gerald W. 32<br />
Douglas, Sawyer<br />
P080<br />
Dowling, R.<br />
P129<br />
Downing, Jill<br />
P095<br />
Dowsley, Taylor F.<br />
P061<br />
Dracup, Kathleen 54<br />
Drakos, Stavros<br />
P155<br />
Drakos, Stavros G.<br />
P060<br />
Draper, Jr., Timothy S.<br />
P062<br />
Drazner, Mark H. 30<br />
Drew, Laura A. 52<br />
Drexler, B.<br />
P069<br />
Drukker, Micha<br />
P099<br />
Dudley, Samuel C. 109<br />
Dumitru, Ioana<br />
P061, P135<br />
Dunbar, Sandra B.<br />
54, P333<br />
Dunlap, Mark<br />
P282<br />
Dunlap, Mark E.<br />
P207, P215, P250<br />
Dupont, Matthias<br />
P072, P077, P096<br />
Dupree, Carla<br />
P217<br />
Duprez, Daniel A.<br />
P107<br />
Durand, Jean-Bernard 142<br />
Dweik, Raed A. 55<br />
Dyo, Melissa<br />
P335<br />
East, Cara<br />
P186<br />
Eckman, Peter<br />
P121<br />
Eckman, Peter M.<br />
P156<br />
Edwards, Brooks S.<br />
P116<br />
Edwards, Pauline<br />
P125<br />
Eigler, Neal<br />
P318<br />
El Nahas, Meguid<br />
P054<br />
El Shahawy, Mahfouz<br />
P220<br />
Elayda, MacArthur A.<br />
P160<br />
Elkayam, Uri<br />
P093, P190, P212<br />
Ellenbogen, Kenneth A. 30<br />
Elliot, Tonya 100<br />
Ellis, Stephen J.<br />
P259<br />
Ely, Stephen W.<br />
P143<br />
Endo, Yutaka<br />
P211<br />
Entcheva, Miglena<br />
P220<br />
Epstein, Andrew E. 97<br />
Epstein, Jonathan A. 32<br />
172<br />
AUTHOR INDEX<br />
Erdmann, Erland 52<br />
Erzurum, Serpil C.<br />
P087, P098<br />
Escarce, Jose<br />
P273<br />
Estep, Jerry D.<br />
56, P111, P112<br />
Estrella-Holder, Estrellita<br />
P257<br />
Ezekowitz, Justin A. 55, 139<br />
Ezekowitz, Michael D. 104<br />
Fadol, Anecita P.<br />
P316<br />
Fajadet, Jean<br />
101, P138<br />
Fakorede, Foluso<br />
P313<br />
Falk, Rodney<br />
101, P180, P221<br />
Fallahi, Arzhang<br />
P268<br />
Fan, M.T.<br />
P039<br />
Fang, James C.<br />
44, 94, 102, 145, P066, P139<br />
Farber, John L.<br />
P064<br />
Fard, Arrash<br />
P219<br />
Fargnoli, Anthony S.<br />
P144<br />
Farr, MaryJane<br />
P130, P149<br />
Fearon-Clarke, Jacqueline<br />
P295, P338<br />
Fedewa, Michelle M.<br />
P260, P332<br />
Fedorowski, Artur<br />
P092<br />
Fedson, Savitri<br />
P180<br />
Feldman, Arthur M. 101<br />
Felker, G. Michael<br />
46, P308, P081<br />
Felker, G.M.<br />
P022<br />
Felker, Mike<br />
P187<br />
Fermann, Greg<br />
P272<br />
Fermin, David R.<br />
P116<br />
Ferrari, Roberto 52<br />
Ferreira-Martins, Joao<br />
56, P050, P173<br />
Fett, James D.<br />
P190<br />
Fields, Anjali V.<br />
P031<br />
Fiessinger, Lori<br />
P311<br />
Filippatos, Gerasimos 52<br />
Fiorini, Claudia<br />
56, P050, P173<br />
Firek, Anthony 54<br />
Firek, Chistopher J. 54<br />
Fiuzat, M.<br />
P193, P245, P263, P280<br />
Fiuzat, Mona<br />
P251<br />
Flannery, Margaret<br />
P124<br />
Flattery, Maureen<br />
P134<br />
Flavell, Carol<br />
144, P323<br />
Fleming, James<br />
P161<br />
Floras, John S. 96<br />
Flores-Arredondo, Jose 56<br />
Flores-Arredondo, Jose H.<br />
P111, P112<br />
Florez, Natalia<br />
P107<br />
Flynn, Rachel<br />
44, P122, P127<br />
Fonarow, G.C.<br />
P280<br />
173
AUTHOR INDEX<br />
Fonarow, Gregg<br />
P205<br />
Fonarow, Gregg C. 34, 46<br />
Fong, Michael W.<br />
P349<br />
Force, Thomas<br />
142, P029<br />
Forfia, Paul R.<br />
31, P031<br />
Forman, D.E.<br />
P024, P046, P055<br />
Forman, Daniel 55<br />
Forman, Daniel E.<br />
P047, P117, P195<br />
Forrest, Michael<br />
P103<br />
Fotuhi, Majid 37<br />
Fowler, Michael B. 100, 103<br />
Frajtag, Rose<br />
P281<br />
Frampton, Stacey<br />
P274<br />
Francis, Gary S. 43<br />
Frank, Dana L.<br />
P292<br />
Frantz, Robert P. 31<br />
Frazier, Howard O.<br />
P160<br />
Frazier, O.H.<br />
P148<br />
Frazier, Susan K.<br />
P262<br />
Freehardt, Darla<br />
P080<br />
French, Benjamin<br />
44, P066<br />
Frewin, Sarah<br />
P347<br />
Frivold, Geir<br />
45, P289<br />
Fryback, Dennis<br />
P271<br />
Fukuda, Keiichi<br />
P211<br />
Gaasch, William H.<br />
P062<br />
Gadesam, R.<br />
P039<br />
Gage, Ryan M.<br />
P170<br />
Gagnon, D.R.<br />
P024, P046<br />
Gajanana, Deepakraj<br />
P225, P264, P354<br />
Galenko, Oxana<br />
P106, P274<br />
Gal-Oz, Amir<br />
P345<br />
Ganiats, Theodore G.<br />
P271<br />
Gao, Erhe<br />
P018<br />
Gao, Sheng<br />
P103<br />
Garan, Hasan 41, 97<br />
Garcia, Mario J.<br />
P032<br />
Garrison, Chris<br />
P192<br />
Gaspard, Dany<br />
P313<br />
Gauvreau, Kimberlee<br />
P229<br />
Gaviria, Moises<br />
P150<br />
Geisberg, Carrie<br />
P080, P350<br />
Geisberg, Carrie A. 142<br />
Geltman, Edward M.<br />
P239<br />
Gennivois, Daniel 52<br />
Gerszten, Robert E. 107<br />
Ghali, Jalal K. 46<br />
Gheorghiade, M.<br />
52, 88, P263, P280, P315<br />
Gheorghiade, Mihai<br />
P272, P298<br />
174<br />
AUTHOR INDEX<br />
Gholami, Parisa<br />
P240<br />
Giannetti, Nadia<br />
P342<br />
Gianni, Davide 56<br />
Gibbons, Edward F.<br />
P224<br />
Gibson, Douglas N.<br />
P028<br />
Gilbert, Cameron<br />
P033<br />
Gilbert, Edward<br />
P060, P155<br />
Gilbert, Edward M.<br />
P113<br />
Gilbert, Michele N. 91<br />
Gillette, Thomas G. 56<br />
Gilliam, F.R.<br />
P247<br />
Gilliam, Francis R.<br />
P140<br />
Ginn, Greg L.<br />
P299<br />
Ginwalla, Mahazarin<br />
P282<br />
Giridharan, G.<br />
P129<br />
Givertz, M.<br />
P193<br />
Givertz, M.M.<br />
P245<br />
Givertz, Michael<br />
P323<br />
Givertz, Michael M.<br />
109, 139, P115<br />
Glad, Jo Ann M.<br />
P176<br />
Glockner, James F.<br />
P058<br />
Gluck, Jason<br />
P141<br />
Gluck, Jason A.<br />
44, P287<br />
Godoy, Sarah M.<br />
P325<br />
Goh, Ping Ping<br />
P223<br />
Goihberg, Eduward 56<br />
Goihberg, Polina<br />
P173<br />
Goldberg, Lee R.<br />
39, 44, P066<br />
Goldberg, Ythan<br />
P032<br />
Goldenberg, Ilan<br />
P183<br />
Goldhaber, Joshua I. 89, 98<br />
Goldhaber, Samuel Z. 104<br />
Goldman, Steven<br />
42, P120, P203, P206<br />
Goldsmith, Steven R. 46<br />
Goldspink, David<br />
P023<br />
Goldstein, Daniel<br />
P125<br />
Goldstein, Nathan E. 43<br />
Gomez Salvador, Itziar<br />
P341<br />
Gong, Y.T.<br />
P201<br />
Gong, Z.H.<br />
P286<br />
Gonzalez, Jaime 54<br />
Gopal, Deepa M.<br />
P095<br />
Gopalan, Radha S.<br />
P128<br />
Gorcsan, John<br />
35, P109, P190<br />
Gorman, Grace<br />
P206<br />
Goss, J. Richard<br />
P224<br />
Gottlieb, Stephen S.<br />
89, 103, P325<br />
Grady, Kathleen L. 141<br />
Grandits, Gregory<br />
P107<br />
175
AUTHOR INDEX<br />
Gratz, E.<br />
P129<br />
Green, Jennifer<br />
P242<br />
Greenberg, Barry<br />
P289<br />
Greenberg, Barry H. 34, 45, 140<br />
Greenwald, Jeffrey L. 88<br />
Gregoric, Igor D.<br />
P148<br />
Griffin, Leslie<br />
P115<br />
Grill, Diane E.<br />
P073<br />
Grogan, Donna<br />
P180<br />
Groh, Ben I.<br />
P143<br />
Groh, Mark A.<br />
P143<br />
Gruson, Damien<br />
P078, P079<br />
Grzesiak, Aleksandra<br />
P029<br />
Guavreau, Kimberlee<br />
44, P229<br />
Guglin, Maya<br />
P026, P048, P234, P290<br />
Guglin, Maya E.<br />
44, P118<br />
Guidetti, Federica<br />
P315<br />
Gujja, Karthik<br />
101, P320<br />
Gullestad, Lars<br />
45, P294<br />
Gunter, Staci<br />
P106<br />
Guo, Yu<br />
P294, P297<br />
Gupta, Deepak<br />
P298<br />
Gutfinger, Dan<br />
P318<br />
Haddad, Andrea<br />
P281<br />
Haghika, Arash<br />
P029<br />
Haglund, Nicholas<br />
P135<br />
Hajjar, Roger J. 40<br />
Hall, Jennifer L.<br />
P107<br />
Hamilton, Michele A. 100<br />
Hamlin, Robert L.<br />
P126<br />
Hamman, Baron L.<br />
52, P186<br />
Hammond, Elizabeth<br />
P060<br />
Hammond, Jonathan<br />
P105, P114<br />
Hansen, Kimberley J.<br />
P222<br />
Harders, Gerald E.<br />
P040<br />
Harding, Tina M. 52<br />
Hare, Joshua M. 105, 109<br />
Haring, Bernhard 56<br />
Harkness, Karen I.<br />
P257<br />
Harper, Yenal<br />
P087<br />
Harris, Collette R.<br />
P117<br />
Harris, Kristie M.<br />
P325<br />
Harton, Suzanne<br />
P134<br />
Hasin, Tal<br />
P116<br />
Hassam, Haddad<br />
P353<br />
Hasselblad, Vic 52<br />
Hatakeyama, Akiko<br />
P307<br />
Hatano, Masaru<br />
P307<br />
Haude, Michael<br />
101, P138<br />
176<br />
AUTHOR INDEX<br />
Haunschild, Carolyn<br />
P302<br />
Hauptman, Paul<br />
P322<br />
Hauptman, Paul J. 97<br />
Hauselmann, Stephanie P.<br />
101, P084, P108<br />
Hawkins, Lee Ann 54<br />
Hayashi, Yacki<br />
P124<br />
Hayes, David L.<br />
P140, P247, P248<br />
Haywood, Christopher S.<br />
P230<br />
Hazard, Lesli<br />
P147<br />
Hazen, Stanley L. P072, P075, P086, P088, P090,<br />
P097, P100<br />
Heath, Russell R.<br />
P168<br />
Heidenreich, Paul A. 52, P140, P168, P240, P246,<br />
P247, P270<br />
Heimann, Mark<br />
P030<br />
Heinisch, C.<br />
P069<br />
Heizer, Gretchen M. 52<br />
Helmke, Stephen<br />
101, P221<br />
Henn, Andrew J.<br />
P271<br />
Heo, Seongkum<br />
54, P328<br />
Hernandez, A.F.<br />
P022<br />
Hernandez, Adrian F.<br />
48, 52, 139, P187, P230<br />
Hernandez, Antonieta<br />
P148<br />
Herre, John M.<br />
P167<br />
Hershberger, Ray E. 99<br />
Hess, Michael L.<br />
P134<br />
Hesselson, Aaron<br />
P025<br />
Hettrick, Douglas<br />
P163<br />
Hettrick, Douglas A.<br />
P162<br />
Hetzer, Roland<br />
P020<br />
Heublein, Denise M.<br />
P027, P070<br />
Heximer, Scott<br />
P016<br />
Heywood, J. Thomas<br />
54, 96, 144, P163, P301<br />
Heywood, James T.<br />
P028<br />
Hiesinger, William<br />
P157<br />
Higgins, Jennifer<br />
P146<br />
Higgins, Melinda<br />
P333<br />
Hilfiker-Kleiner, Denise<br />
P029<br />
Hill, Joseph A. 42, 56<br />
Ho, Carolyn Yung 99<br />
Ho, Jennifer<br />
P047<br />
Hoagland, Peter<br />
P119, P147<br />
Hodge, David O.<br />
P058<br />
Hoek, Maarten<br />
P103<br />
Hollander, Zsuzsanna<br />
P137<br />
Hong, Namki<br />
P238, P244<br />
Hong, Sung Jin<br />
P238<br />
Hoppe, Uta C.<br />
101, P138<br />
Hopper, Donald L.<br />
P175<br />
177
AUTHOR INDEX<br />
Horne, B.<br />
P256<br />
Horne, Benjamin<br />
P249, P274<br />
Horne, Benjamin D.<br />
44, P106, P235<br />
Horstmansh<strong>of</strong>, Douglas<br />
P156<br />
Horwich, Tamara B.<br />
P277<br />
Hosoda, Toru<br />
56, P050, P173<br />
Hou, Wenbo<br />
P036, P152, P153<br />
House, John<br />
P260<br />
Houser, Steven R. 32, 103<br />
Howe, Alexandra 54<br />
Howie-Esquivel, Jill<br />
P331<br />
Howlett, Jonathan<br />
P353<br />
Howlett, Jonathan G. 30, 52<br />
Hshieh, Shenche<br />
P212<br />
Huang, Congxin<br />
P188, P191, P194<br />
Huang, He<br />
P188, P191, P194<br />
Huang, Tsuey-Yuan 54<br />
Huiskes, Bonita L. 54<br />
Hummel, Scott L.<br />
45, 55, P233<br />
Hunt, Sharon A. 106<br />
Hunter, Claire 39<br />
Huntley, Brenda K.<br />
55, P027, P040, P104<br />
Hurwitz, Shelley<br />
P285<br />
Huynh, Thao<br />
P342<br />
Hwang, Shiow-Li 54<br />
Hyden, Marshall<br />
102, P139<br />
Ichiki, Tomoko 55, P038, P040, P057, P104,<br />
P116<br />
Ide-Iwata, Noriko 56<br />
Ignaszewski, Andrew<br />
P137, P146, P353<br />
Ikeda, Yasuhiro<br />
45, P067<br />
Iliadis, Elias<br />
P313<br />
Imse, Jacqueline<br />
P114<br />
Inglis, Sally C.<br />
102, P288, P321<br />
Inouye, Brendan T. 56<br />
IPAC Investigators<br />
P190<br />
Iqbal, Navaid<br />
55, P219<br />
Irwin, Dennis 86<br />
Isaac, Debra L.<br />
P305<br />
Ito, Masahiro<br />
P037<br />
Ivanhoe, Russell J.<br />
P132<br />
Jack, Brian 91<br />
Jack, Starmer<br />
P350<br />
Jacoby, Meni<br />
P126<br />
Jaffe, Allan S.<br />
P073<br />
Jain, Anil<br />
P278<br />
James, Jeanne<br />
P021<br />
James, Roberta<br />
44, P235, P261<br />
Jang, Yangsoo<br />
P238, P244<br />
178<br />
AUTHOR INDEX<br />
Janocha, Allison<br />
P098<br />
Januzzi, James<br />
P274<br />
Januzzi, James L.<br />
P297, P303<br />
Januzzi, Jr., James L. 47<br />
Jaroszewski, Dawn E.<br />
P128<br />
Jaski, Brian<br />
45, P119, P147, P289<br />
Javaheri, Shahrokh 36<br />
Jensen, Kurt<br />
P249<br />
Jeon, Eun-Seok<br />
P071, P209, P324<br />
Jeon, Sangchoon<br />
P275<br />
Jessup, Mariell<br />
44, P066, P157<br />
Jessup, Mariell L. 35, 90, 141<br />
Ji, Ruiping<br />
P131, P151<br />
Jiang, Hongfeng<br />
P131, P151<br />
Jiang, Songtao<br />
P140<br />
John, Ranjit<br />
P121<br />
John, Roy M. 94, 138<br />
Johnson, Alan M.<br />
P143<br />
Johnson, Allen D.<br />
P028<br />
Johnson, Frances L.<br />
44, P118<br />
Johnson, James<br />
P162<br />
Johnson, Jeremy<br />
P282<br />
Johnson, Nicholle M.<br />
P120, P206<br />
Jones, Meaghan 55<br />
Jones, Meaghan L.<br />
P195<br />
Jong, Philip<br />
101, P255<br />
Jorde, Ulrich 55<br />
Jorde, Ulrich P.<br />
P124<br />
Joseph, J.<br />
P024, P046, P055<br />
Joseph, Jacob 30<br />
Joyce, Lyle<br />
P116<br />
Joynt, Karen E. 48<br />
Ju, Eun-Seon<br />
P209<br />
Ju, Eun-Seon Ju<br />
P324<br />
Judge, Daniel<br />
P180<br />
Juneman, Elizabeth<br />
P120, P203, P206<br />
Jung, Lae Young<br />
P284, P346<br />
Jungklaus, Tamarah<br />
P334<br />
Jurgens, Corrine Y. 103, 144<br />
Kaaan, Annemarie<br />
P257<br />
Kaan, Anne Marie<br />
P353<br />
Kaan, Annemarie<br />
P146<br />
Kadakia, Hemal H.<br />
P028<br />
Kahn, Mark R.<br />
P268<br />
Kaina, Patsy<br />
P227<br />
Kajstura, Jan<br />
56, 105, P050, P173<br />
Kalya, Anantharam V.<br />
P128<br />
Kamdar, Forum<br />
P121<br />
Kamireddy, Swapna<br />
P178<br />
179
AUTHOR INDEX<br />
Kang, Seok-Min<br />
P238, P244<br />
Kanwar, Manreet<br />
P279<br />
Kao, Andrew C.<br />
P330<br />
Kao, David P.<br />
P113<br />
Kaplan, Robert M.<br />
P271<br />
Karadolian, Sevan S.<br />
P310<br />
Karl, Justin A.<br />
P032<br />
Karpawich, Peter P.<br />
P164<br />
Kaschina, Elena<br />
P029<br />
Kashner, T. Michael 54<br />
Kasirajan, Vigneshwar<br />
P134<br />
Kasper, Diane L.<br />
P128<br />
Katlaps, Gundars J.<br />
P134<br />
Kato, Naoko<br />
P307<br />
Kato, Tomoko 55<br />
Kato, Tomoko S.<br />
P130, P149<br />
Katz, David F.<br />
P168<br />
Katz, Michael G.<br />
P144<br />
Katz, Stuart 54, 145<br />
Katz, Stuart D.<br />
P355<br />
Kazatsker, Mark<br />
P181<br />
Keel, Allen J.<br />
P196<br />
Kennedy, Paul<br />
P260<br />
Keown, Paul<br />
P137<br />
Keren, Gad<br />
P126<br />
Ketelslegers, Jean-Marie<br />
P078, P079<br />
Kfoury, A.<br />
P256<br />
Kfoury, Abdallah<br />
P155, P249, P261, P274<br />
Kfoury, Abdallah G.<br />
44, P060, P235<br />
Khan, Farman<br />
P060<br />
Khan, Imran<br />
P215<br />
Khan, Raffay<br />
55, P131, P151<br />
Khan, Raffay S.<br />
P117<br />
Khan, Tariq<br />
P028<br />
Khawaja, Tuba<br />
55, P130, P131, P151<br />
Khorshid, Lamees<br />
P292<br />
Khouri, Samer<br />
P045, P063, P216<br />
Kiani, Jawad<br />
P178<br />
Kiffer, Jerome<br />
P292<br />
Kilgore, Meredith<br />
P205<br />
Kilian, Shirley 54<br />
Kim, Antony Y.<br />
P242<br />
Kim, Brian J.<br />
P093<br />
Kim, Eun-Young<br />
P324<br />
Kim, Han-na<br />
P303<br />
Kim, Henry E.<br />
P310<br />
Kim, Jae-Joong<br />
P071<br />
Kim, Jieun<br />
P311<br />
Kim, Kee-Bong<br />
P226<br />
180<br />
AUTHOR INDEX<br />
Kim, Min-Seok<br />
P329<br />
Kim, Sonnie<br />
P322<br />
Kim, Soo-Young<br />
P244<br />
Kim, Sung Hea<br />
P329<br />
Kim, Won Ho<br />
P284, P346<br />
Kim, Yong-Chul<br />
P209<br />
Kimmel, Stephen E.<br />
P314<br />
Kimura, Masaomi<br />
P175<br />
Kinugawa, Koichiro<br />
P307<br />
Kirkpatrick, James N. 33, 87<br />
Kishore, Raj 92<br />
Kitlinski, Mariusz<br />
P092<br />
Kittleson, Michelle M.<br />
44, 90, P118<br />
Kleet, Audrey C.<br />
P159<br />
Klein, Allan L.<br />
P019, P088, P090<br />
Klein, Ran<br />
P110<br />
Klevan, Linette R.<br />
P167<br />
Knight, J. David 52<br />
Ko, Jae Ki<br />
P284, P346<br />
Kobashigawa, Jon A. 90<br />
Koch, Walter J.<br />
51, P018<br />
Kocovic, Dusan Z.<br />
P030<br />
Kodama, Makoto<br />
P037<br />
Koehler, Jodi<br />
P344<br />
Koelbl, Christian<br />
P095<br />
Koelling, Todd M.<br />
30, 45, P233<br />
Koenig, S.<br />
P129<br />
Koh, Steve<br />
P036, P152, P153<br />
Kohsaka, Shun<br />
P211<br />
Komajda, Michel 52<br />
Kommineni, Maya<br />
P095<br />
Kommuri, Naga V.A.<br />
45, P233<br />
Kono, Alan T. 94<br />
Konstam, Marvin A. 34, 140<br />
Koomalsingh, Kevin<br />
P144<br />
Koplan, Bruce A. 43<br />
Korinek, Josef<br />
P040<br />
Kormos, Robert<br />
P136<br />
Kormos, Robert L.<br />
86, 108, 138, P142<br />
Korn, Justin A.<br />
56, P050, P173<br />
Koulisis, Nicole 56<br />
Kovach, Cynthia<br />
P077<br />
Kowey, Peter R. 98<br />
Kranias, Evangalia G.<br />
51, P021<br />
Krantz, David S.<br />
P325<br />
Kraus, William E.<br />
P250<br />
Krotin, Mirjana<br />
P326<br />
Kubo, Spencer H.<br />
P170<br />
Kucharska-Newton, Anna<br />
P217<br />
181
AUTHOR INDEX<br />
Kumagai, Yumiko<br />
P307<br />
Kusakari, Yuichiro 56<br />
Kushwaha, Sudhir S.<br />
P116<br />
Kuster, Gabriela M.<br />
101, P084, P108<br />
Kwok, Bernard<br />
P218<br />
Kwong, Raymond Y. 100, 140<br />
Ky, Bonnie<br />
44, 142, P066<br />
Labos, Christopher<br />
P342<br />
Lafayette, Richard A.<br />
P145<br />
Lakatta, Edward G.<br />
89, P202<br />
Lakdawala, Neal<br />
43, 99, P323<br />
Lal, Hind<br />
P029<br />
Lam, Carolyn<br />
P218<br />
Lancaster, Jordan J.<br />
P120, P203, P206<br />
Landzberg, Michael J. 31<br />
Lanfear, David<br />
89, P161<br />
Lanfear, David E.<br />
45, P198<br />
Langlois, Elizabeth A.<br />
P337, P338<br />
Langnas, Alan N.<br />
P061<br />
Lanier, Gregg<br />
P124<br />
Lankford, Brenda<br />
P187<br />
Lanza, Louis A.<br />
P128<br />
Lapp, Harald<br />
P070<br />
Lark, Michael W.<br />
P204<br />
Larson, Douglas F.<br />
P056<br />
Larue, Catherine<br />
P070<br />
Latif, Farhana<br />
P327<br />
Lattouf, Omar M.<br />
P186<br />
Law, Catherine<br />
P234<br />
Lawson, Mark<br />
P107<br />
Layton, Aimee<br />
P195<br />
Lazzari, A.<br />
P024, P046<br />
Lazzari, L.<br />
P055<br />
Lazzarini, Valentina<br />
P267<br />
LeBlanc, Marie-Helene<br />
P353<br />
Lecker, S.<br />
P024, P046, P055<br />
Lederer, C.<br />
P129<br />
Lederer, Melissa<br />
P135<br />
Lee, Christopher S.<br />
P242<br />
Lee, Hae-Young<br />
P226<br />
Lee, Hon-Chi<br />
P041<br />
Lee, Hwei Khien<br />
P352<br />
Lee, Kerry L.<br />
P187<br />
Lee, Kyoung Suk 54<br />
Lee, Sang Hoon<br />
P071<br />
Lee, Sun Hwa<br />
P284, P346<br />
Lee-Grasso, Barbara<br />
P159<br />
Leier, Carl V. 44<br />
Lemay, Genevieve<br />
P291<br />
182<br />
AUTHOR INDEX<br />
Lemster, Bonnie<br />
P109<br />
Lenihan, Daniel<br />
P350<br />
Lenihan, Daniel J. 142<br />
Lenneman, Andrew<br />
P336<br />
Lennie, Terry A.<br />
47, 54, P262, P328<br />
Leonard, Ann E.<br />
P214, P227<br />
Leong, Kui Toh Gerard<br />
P223<br />
Leri, Annarosa<br />
56, 92, P050, P173<br />
Lerman, Amir<br />
P070<br />
Lerman, Bruce B. 88<br />
Leszczynski, Karen<br />
45, P198<br />
Levy, Gary<br />
P123<br />
Levy, Pavel<br />
P222<br />
Levy, Philip D. 52<br />
Levy, Wayne<br />
P121<br />
Levy, Wayne C.<br />
44, P066, P236, P259, P265<br />
Levy, Yaniv<br />
P181, P189<br />
LeWinter, Martin M.<br />
103, P081<br />
Lewis, Connie<br />
P350<br />
Lewis, Eldrin<br />
P323<br />
Lewis, Eldrin F. 143<br />
Lewis, Gregory D. 108, 145<br />
Lewis, Nigel<br />
P023<br />
Li, Dean Y.<br />
P060<br />
Li, Jun<br />
P103<br />
Li, Na<br />
P042, P101<br />
Li, W.M.<br />
P201, P286<br />
Li, Weimin<br />
P094<br />
Li, Y.<br />
P201, P286<br />
Li, Yanhong<br />
P250, P259<br />
Liang, Chang-seng<br />
P095<br />
Liang, Li<br />
P230<br />
Liao, Ronglih 92, 105<br />
Libby, Peter 90<br />
Liebenstein, Michael<br />
P292<br />
Liedtke, Michaela<br />
P145<br />
Lien, Susan<br />
P349<br />
Lietz, Katherine 141<br />
Lima, Joao<br />
P107<br />
Lim-Shon, Jongsung<br />
P123<br />
Lin, David<br />
P137<br />
Lin, Jay<br />
P228, P243<br />
Lindenfeld, JoAnn 39, 139<br />
Lindsell, Chris<br />
P272<br />
Link, Mark S. 97<br />
Lipiecki, Janusz<br />
101, P138<br />
Little, William C.<br />
52, 145, P017<br />
Liu, Peter<br />
P016<br />
Liu, Peter P. 44<br />
183
AUTHOR INDEX<br />
Liu, Wei<br />
P094<br />
Livio, Dei Cas<br />
P315<br />
Lombardi, Carlo<br />
P267, P315<br />
London, Barry 41, 98<br />
Lopes, Renato D.<br />
P230<br />
Lopez Diaz, Javier<br />
P341<br />
Lorenz, Vera<br />
101, P084, P108<br />
Loscalzo, Joseph 107<br />
Losordo, Douglas W. 105<br />
Louie, Stan G.<br />
P093<br />
Love, Thomas<br />
P205<br />
Lowe, Timothy<br />
P228, P243<br />
Lowes, Brian D.<br />
P113<br />
Loyaga-Rendon, Renzo Y.<br />
P158<br />
Lu, Yi<br />
P049, P075, P086<br />
Lundbye, Justin<br />
P287<br />
Lymperopoulos, Anastasios<br />
P018<br />
Macabasco-O’Connell, Aurelia P283<br />
MacArthur, John W.<br />
P157<br />
Machado, Christian<br />
P182<br />
Macheret, Fima<br />
P070<br />
Mack, Joan<br />
P135<br />
Mackey, Aaron<br />
P107<br />
MacLellan, W. Robb<br />
P254, P269<br />
Magrini, Laura<br />
P082<br />
Mahramus, Tara<br />
P347<br />
Maisel, Alan<br />
55, P185, P219<br />
Maisel, Alan S.<br />
45, P074, P082, P289, P302<br />
Maggioni, Aldo 52<br />
Makan, Majesh<br />
P065<br />
Malinowski, Marcin 52<br />
Malloy, Samantha<br />
P334<br />
Mancini, Donna 55, P117, P130, P131, P149,<br />
P151, P195<br />
Mancini, Donna M.<br />
140, P124<br />
Mandell, Brian F. 109<br />
Manerba, Alessandra<br />
P267<br />
Mangiafico, Sarah<br />
45, P067, P200<br />
Mangion, Judy R.<br />
P285<br />
Mangione, Carol<br />
P273<br />
Manhaes, Maria A.R.<br />
P343<br />
Mankad, Anit K.<br />
P134<br />
Mann, Douglas L. 40<br />
Manole, Frank<br />
P338<br />
Mansoor, G.<br />
P193, P245<br />
Marais, John<br />
45, P289<br />
Marco, Metra<br />
P315<br />
Marguiles, Kenneth B.<br />
92, P157<br />
Marian, Ali J. 32<br />
184<br />
AUTHOR INDEX<br />
Mark, Daniel 52<br />
Markham, Bruce<br />
P203<br />
Markowitz, Steven M.<br />
P162<br />
Maroo, Anjli P.<br />
P077<br />
Marshall, Jennifer M.<br />
P325<br />
Marshall, Joanne P.<br />
P325<br />
Martin, Fernando<br />
P070<br />
Martin, Fernando L.<br />
45, P040, P057, P067<br />
Martin, Tony 33<br />
Martins, Wolney A.<br />
P343<br />
Maska, Edlira<br />
P334<br />
Mason, Thomas<br />
P048<br />
Masoudi, Frederick A. 46, 88<br />
Massey, H. Todd<br />
P349<br />
Massicotte, Mary Patricia 104<br />
Massie, B.<br />
P193<br />
Massie, B.M.<br />
P245<br />
Massie, Barry M.<br />
37, 49, 52, 143, P168<br />
Mather, Paul J.<br />
90, P064<br />
Mathier, Michael A.<br />
108, P142<br />
Matsui, Takashi 56<br />
Matsuzaki, Masunori<br />
P154<br />
Mau, Marjorie K.<br />
P214<br />
Maurer, Mathew S.<br />
101, P221, P327<br />
Maurer, Matthew<br />
P180<br />
Maybaum, Simon<br />
103, P125<br />
Mazurek, Jeremy<br />
P177, P232, P309<br />
McAlister, Finlay A.<br />
P288<br />
McAllister, Finlay A.<br />
102, P321<br />
McCalmont, Vicki<br />
P147<br />
McCarthy, Margaret M. 54<br />
McCauley, Brian D.<br />
P314<br />
McCauley, Kathleen M. 91<br />
McCauley, Mark D.<br />
P101, P293<br />
McConnell, Patrick I.<br />
P126<br />
McKee, Michael G.<br />
P292<br />
McKelvie, Robert S.<br />
P257<br />
McKie, Paul M.<br />
55, P038, P040, P057<br />
McLachlan, Andrew M.<br />
P300<br />
McManus, Bruce M.<br />
P137<br />
McMaster, Robert W.<br />
P137<br />
McMillan, Susan C.<br />
P192<br />
McMurray, John JV 52<br />
McNally, Elizabeth M. 99<br />
McNamara, Dennis M.<br />
43, P142, P190<br />
McNitt, Scott<br />
P183, P349<br />
McNulty, Steven E.<br />
P081, P187<br />
McTiernan, Charles<br />
P109, P190<br />
Mebazaa, Alexandre 52<br />
185
AUTHOR INDEX<br />
Medin, Jeffrey<br />
P016<br />
Mehra, Mandeep R. 30, 141, 143<br />
Mehra, Shabnam<br />
P048<br />
Meisel, Simcha<br />
P181, P189, P317<br />
Melander, Ole<br />
P092<br />
Melton, Iain<br />
P179, P318<br />
Mendez, Adriana<br />
P283<br />
Mendoza, Tito<br />
P316<br />
Menezes, Karla<br />
P281<br />
Mentz, R.<br />
P193<br />
Mentz, R.J.<br />
P022, P245, P263, P280<br />
Merliss, Andrew D.<br />
P332<br />
Merveil-Ceneus, Betty<br />
P295<br />
Mesquita, Evandro T.<br />
P102, P343<br />
Metra, M.<br />
P193, P245<br />
Metra, Marco<br />
P267<br />
Meyer, Rudolf<br />
P020<br />
Michaud, Gregory F. 41, 138<br />
Mielniczuk, Lisa M.<br />
P051, P110<br />
Mikelson, Melissa A. 104<br />
Miller, Clayton<br />
P301<br />
Miller, Clayton T.<br />
P163<br />
Miller, Dylan<br />
P060<br />
Miller, Karen<br />
P272<br />
Miller, Keith<br />
P332<br />
Miller, Leslie W. 106<br />
Miller, Wayne L.<br />
P073<br />
Minton-Foltz, Paula<br />
P224<br />
Mirzoyev, Sultan A.<br />
P236, P265<br />
Misenheimer, Jacob A.<br />
P336<br />
Mishra, Rakesh K.<br />
P044<br />
Misra, Deepika<br />
101, P320<br />
Misselwitz, Frank 88<br />
Mitchell, Gary F.<br />
P053<br />
Mit<strong>of</strong>f, Peter R.<br />
P051<br />
Miura, Chikako<br />
P307<br />
Mochly-Rosen, Daria 51<br />
Mohammed, Asim A.<br />
P303<br />
Moldovan, Nicanor Ilie 40<br />
Molkentin, Jeffery D. 42, 51<br />
MOMIJI Study Investigators<br />
P197<br />
Momomura, Shin-ichi<br />
P197<br />
Montesino, Rosmery<br />
P295<br />
Mooney, Andrew<br />
P054<br />
Moore, Alexander G.<br />
P109<br />
Moore, Hans J.<br />
P162<br />
Moore, Stephanie<br />
P274<br />
Moore, Stephanie A.<br />
87, P303<br />
Moravec, Christine S.<br />
P292<br />
186<br />
AUTHOR INDEX<br />
Moreira, Rodrigo C.<br />
P281<br />
Morgan, Eric E.<br />
P216<br />
Morita, Yoshihisa<br />
P211<br />
Morris, Rohinton J. 94, 105<br />
Moser, Debra K.<br />
43, 54, 140, P262, P328<br />
Mosley, Thomas<br />
P217<br />
Moss, Arthur J.<br />
P183<br />
Moss, Noah<br />
P231<br />
Mountis, Maria M.<br />
44, P118<br />
Movsesian, Matthew A. 103<br />
Mudge, Gilbert<br />
P323<br />
Mueller, C.<br />
P069<br />
Mueller, Paul S.<br />
101, P171<br />
Muir, Melody<br />
P025<br />
Mujib, Marjan<br />
P205<br />
Mulamalla, Roja<br />
44, P105, P114, P141, P287<br />
Munger, Mark A. 39<br />
Muntendam, Pieter<br />
45, P294, P297<br />
Murali, Srinivas<br />
P279<br />
Murphy, Jennifer<br />
P124<br />
Murray, Christina<br />
P260<br />
Murthy, Ashwin<br />
P157<br />
Nadella, Neelima<br />
P310<br />
Nagai, Ryozo<br />
P307<br />
Nagaraju, Lakshmi<br />
P164<br />
Nagayama, Masayoshi<br />
P307<br />
Naik, Ajay 52<br />
Nair, Ajith P.<br />
44, P122, P127<br />
Naka, Yoshifumi 55, P117, P124, P130, P149,<br />
P151<br />
Nakayama, Etsuko<br />
P307<br />
Naqvi, Syed U.<br />
P222<br />
Naqvi, Tasneem Z.<br />
P196, P312<br />
Nelson, Dylan<br />
P261<br />
Nelson, Dylan P.<br />
44, P235<br />
Nelson, Ryan C.<br />
P349<br />
Nessler, Bohdan J.<br />
P092<br />
Nessler, Jadwiga M.<br />
P092<br />
Neugaard, Britta<br />
P351<br />
Ng, Raymond T.<br />
P137<br />
Ng, Tien M.H.<br />
P093, P212<br />
Nguyen, Duy<br />
P332<br />
Nguyen, Duy T.<br />
P168<br />
Nguyen, Hugh 55<br />
Nguyen, Viviane<br />
P342<br />
Niazi, Tariq<br />
P203<br />
Niebel, Cassie L.<br />
P017<br />
Nieminen, Markku 52<br />
Nikolaidis, Lazaros A.<br />
P348<br />
187
AUTHOR INDEX<br />
Nitzan, Yaacov<br />
P126<br />
Nixon, J.<br />
P256<br />
Nobrega, Antonio Claudio L.<br />
P102<br />
Nodari, Savina<br />
P267<br />
Nohria, Anju<br />
142, P323<br />
Noonan, Thomas E. 100<br />
Noren, Kjell<br />
P179<br />
Norman, Holly S.<br />
P053<br />
Norman, Vanja<br />
P147<br />
Norman, Vanjah<br />
P119<br />
Noveanu, M.<br />
P069<br />
Nowack, Christina 52<br />
Nucci, Cecelia<br />
P125<br />
Nutter, Benjamin<br />
101, P319<br />
O’Bara, Lynn<br />
P105<br />
Obata, Hiroaki<br />
P037<br />
O’Brien, Erin<br />
P025<br />
Ocampo, Norela<br />
P252<br />
O’Connell, John B.<br />
86, P298<br />
O’Connor, C.<br />
P193<br />
O’Connor, C.M.<br />
P022, P245, P263, P280<br />
O’Connor, Christopher M.<br />
52, 106, P251, P259, P308<br />
Oduwole, Adefisayo<br />
P187<br />
Oehler, Elise A.<br />
45, P068<br />
Ofili, Elizabeth O.<br />
P187<br />
Ogorek, Barbara<br />
56, P173<br />
Oh, Byung-Hee<br />
P226<br />
Oh, Jaewon<br />
P238, P244<br />
O’Hara, Mary Lou<br />
P157<br />
Ohara, Takahiro<br />
P017<br />
Ohno, Yukako<br />
P037<br />
Ohtani, Tomohito<br />
P081<br />
Ok, Jong Sun<br />
P329<br />
Oliva, Nancy L.<br />
P240<br />
Oliveira, Lucia B.<br />
P343<br />
Oliveira, Marli G.<br />
P343<br />
Olmsted, Rhonda<br />
P332<br />
Olson, Lyle J.<br />
P059<br />
O’Malley, Maureen<br />
101, P319<br />
O’Neal, Dan<br />
P351<br />
Ong, Kai Xin<br />
P352<br />
Ong, Michael<br />
P273<br />
Onwuanyi, A.<br />
P039<br />
Onwuanyi, Anekwe<br />
P187<br />
Orlanes, Khristine<br />
P124<br />
Orrego, Carlos M.<br />
56, P111, P112<br />
Ortiz, Kristi<br />
P147<br />
Oshima, Kazuki<br />
P211<br />
Ottenberg, Abigale L.<br />
101, P171<br />
188<br />
AUTHOR INDEX<br />
Packer, Milton 31, 106<br />
Packman, Jeff<br />
P180<br />
Page, II, Robert Lee 39<br />
Pagnanelli, Robert<br />
P251<br />
Pajaro, Octavio E.<br />
P128<br />
Panahi, Samin<br />
P106<br />
Pang, Peter<br />
P272<br />
Pang, Peter S. 88<br />
Pano, Arian<br />
P180<br />
Park, Jennifer I.<br />
P093<br />
Park, Myung H. 96<br />
Park, Soon J.<br />
55, P116<br />
Park, Sungha<br />
P238, P244<br />
Park, Sung-Ji<br />
P071<br />
Park, Yun Ji<br />
P284, P346<br />
Parker, John D.<br />
P033<br />
Partington, Sara L.<br />
P285<br />
Pasala, Tilak<br />
P282<br />
Paschke, Kelly M. 55<br />
Patarroyo, Maria M.<br />
P049, P241<br />
Patel, Aarti A.<br />
P158<br />
Patel, Amit N.<br />
P186<br />
Patel, Ankitkumar K.<br />
P313<br />
Patel, Ayan R. 100<br />
Patel, C.<br />
P022<br />
Patel, Chetan B.<br />
44, P118<br />
Patel, Parag<br />
44, P118<br />
Patel, Snehal R.<br />
P125<br />
Patterson, J. Herbert 94<br />
Paul, Sara C. 39<br />
Paulson, James F.<br />
P167<br />
Paunovic, Nevena<br />
P326<br />
Pauwaa, Sunil<br />
P150<br />
Pawar, Pushkar P.<br />
P205<br />
Peacock, W. Frank<br />
P311<br />
Pedraza, Adriana<br />
P126<br />
PEERLESS HF Investigators<br />
P132<br />
Pelligrini, Cara N.<br />
P168<br />
Pellikka, Patricia A.<br />
P304<br />
Penoyer, Daleen<br />
P347<br />
Pereira, Gelsomina A.M.<br />
P343<br />
Pereira, Naveen L.<br />
P304<br />
Pereira, Sabrina B.<br />
P102, P281<br />
Perez, Elena V. 54<br />
Peter, Liu<br />
P353<br />
Petersen, John W.<br />
P043<br />
Peterson, Brett J.<br />
P182<br />
Petty, Michael G. 33, 106<br />
Pfeffer, Marc A.<br />
55, P115, P183<br />
189
AUTHOR INDEX<br />
Pfister, Otmar<br />
101, P084, P108<br />
Pham, Si<br />
P158<br />
Phelps, Mary A.<br />
P073<br />
Phillips, H.R.<br />
P263<br />
Piano, Mariann R. 54<br />
Piccini, Jonathan P.<br />
P230<br />
Pieper, K.<br />
P280<br />
Piercey, Gary E.<br />
44, P229<br />
Pignone, Michael<br />
P283<br />
Pilla, James J.<br />
P144<br />
Piña, Ileana L. 50, 57<br />
Ping, Peipei 107<br />
Pinney, Sean P.<br />
44, P122, P127<br />
Pisarcik, Jessica<br />
P190<br />
Pointer, Lauren<br />
P168<br />
Polimera, Hyma V.<br />
P354<br />
Polimera, Hyma Vani<br />
P264<br />
Ponikowski, P.<br />
P193, P245<br />
Ponikowski, Piotr 49<br />
Poore, John W.<br />
P036, P152, P153<br />
Popat, Jesal<br />
P026, P290<br />
Popovtzer, Baruch<br />
P232, P309<br />
Porter, Thomas R.<br />
P061<br />
Posligua, William<br />
P160<br />
Potocki, M.<br />
P069<br />
Pratibhu, Parakash<br />
P323<br />
Pregla, Reinhard<br />
P020<br />
Pressler, Susan J. 54<br />
Pritchett, Allison M.<br />
P293<br />
Pritchette, Louella<br />
P144<br />
Pu, Min<br />
P017<br />
Pugliese, Carolyn<br />
P051<br />
Puig, Oscar<br />
P103<br />
Purevjav, Enkhsaikhan<br />
P021<br />
Qamruddin, Salima<br />
P196, P312<br />
Qin, Mu<br />
P188, P191, P194<br />
Qu, Fujian<br />
P318<br />
Quinn, Christina<br />
P333<br />
Quinn, Jill R.<br />
P276<br />
Quintao, Monica<br />
P102<br />
Quintao, Monica M.P.<br />
P343<br />
Quinzani, Filippo<br />
P315<br />
Quyyumi, Arshed<br />
P180<br />
Rab, Zia<br />
P210, P213, P266<br />
Rademaker, Miriam<br />
P318<br />
Rader, Florian<br />
P282<br />
Radford, Martha J. 46<br />
Radojevic, Joseph<br />
44, P141, P287<br />
Rafey, Mohammad<br />
P049<br />
190<br />
AUTHOR INDEX<br />
Rafferty, Kathryn M.<br />
P021<br />
Rafie, Reza<br />
P196, P312<br />
Rahn, Jennifer<br />
P105<br />
Rai, Mridula<br />
P105, P114<br />
Raichlin, Eugenia<br />
P061, P135<br />
Raina, Amresh<br />
P031<br />
Raissi, Farshad<br />
P160<br />
Rajda, Miroslav<br />
52, P353<br />
Ramani, Ravi<br />
P109, P142<br />
Ramasubbu, Kumudha<br />
P293<br />
Rame, J. Eduardo<br />
44, P118, P157<br />
Ramza, Brian<br />
P260<br />
Rana, Hamza<br />
P222<br />
Rankin, Gena 52<br />
Rao, Shaline D.<br />
P339<br />
Rao, Vivek<br />
P123<br />
Rapezzi, Claudio<br />
101, P221<br />
Ras, Aleksandra<br />
P105, P114<br />
Rasmusson, K.<br />
P256<br />
Rasmusson, Kismet<br />
P249, P261, P274<br />
Rasmusson, Kismet D.<br />
44, 87, 94, P235<br />
Rathman, Lisa D.<br />
91, P235<br />
Rayburn, Barry K.<br />
P132<br />
Redeker, Nancy S.<br />
P275<br />
Redfield, Margaret M.<br />
46, P081, P236, P265<br />
Redwine, Laura<br />
P219<br />
Reed, Shelby D.<br />
P250, P259<br />
Rehman, Shafiq U.<br />
P303<br />
Reid, Bruce<br />
P155<br />
Reigle, Juanita 43<br />
Renaud, Jennifer J.<br />
P110<br />
Rengo, Giuseppe<br />
P018<br />
Respress, Jonathan L.<br />
P042<br />
Reuter, David G.<br />
101, P138<br />
Revelo, Monica P.<br />
P060<br />
Revilla Orodea, Ana<br />
P341<br />
Rewiniski, Michael<br />
P141<br />
Reyentovich, Alex<br />
P355<br />
Reyes-S<strong>of</strong>fer, Gissette<br />
P117<br />
Ribeiro, Georgina S.<br />
P102<br />
Rich, Michael W.<br />
46, P065<br />
Rich, Stephen S.<br />
P107<br />
Rickard, John<br />
P165, P172<br />
Riegel, Barbara J. 37, 39, 103, 143<br />
Rivero, Abel<br />
P026<br />
Roberts, Colleen<br />
P261<br />
Robertson, Alastair D.<br />
P113<br />
Robinson, Ellen<br />
P224<br />
Robinson, Shawn W.<br />
P325<br />
191
AUTHOR INDEX<br />
Rock-Willoughby, Jayme<br />
P063<br />
Rodeheffer, Richard J. 108<br />
Rogers, J.G.<br />
P022<br />
Rogers, Joseph G.<br />
139, 141, P308<br />
Rolim, Natale<br />
P042<br />
Roll, Sue<br />
P272<br />
Roncari, Christine<br />
101, P320<br />
Rosa, Maria Luiza G.<br />
P102<br />
Rosenbaum, Andrew<br />
P121<br />
Rosenberg, Stuart P.<br />
P036, P152, P153<br />
Rosenblum, Hannah R. 55<br />
Rosenfeld, Anne<br />
P242<br />
Rosenzweig, Anthony 56<br />
Ross, Heather<br />
P123<br />
Ross, Heather J. 106<br />
Rota, Marcello<br />
56, P050, P173<br />
Rotman, Stacey<br />
P339<br />
Rousseau, Michel F.<br />
101, P078, P079, P255<br />
Roy, Kristine<br />
P140<br />
Roy, Sophie<br />
P103<br />
Russell, Laurie<br />
P348<br />
Russell, Stuart D.<br />
30, 86, 96, P339<br />
Ryu, Kyu Hyung<br />
P329<br />
Ryu, Kyungmoo<br />
P025, P196<br />
Saad, Walid<br />
P313<br />
Saba, Samir<br />
P178<br />
Sabbah, Hani N.<br />
40, 45, P198<br />
Sabir, Sajjad<br />
P313<br />
Sadhu, Justin S.<br />
P065<br />
Sadoshima, Junichi 109<br />
Sadowski, Jerzy<br />
101, P138<br />
Saeed, Wajeeha<br />
P210, P213, P266<br />
Saffitz, Jeffrey E. 99<br />
Sahay, Anju<br />
P240, P246, P270<br />
Sahni, Sheila<br />
44, P122<br />
Saidi, Abdulfattah<br />
P155<br />
Sakaguchi, Scott<br />
P182<br />
Salamon, Jason<br />
P210, P213<br />
Salamon, Jason N.<br />
P177, P232, P266, P309<br />
Saleh, Laith<br />
P203<br />
Salomon, Say<br />
101, P221<br />
Sam, Flora 145<br />
Samara, Michael A.<br />
55, P100, P175<br />
Sample, Alanson<br />
P136<br />
Samsa, Gregory<br />
P250<br />
Samuels, Martin A. 37<br />
San Roman Calvar, Jose A.<br />
P341<br />
Sanada, Fumihiro<br />
56, P050, P173<br />
Sandoval, M.<br />
P129<br />
192<br />
AUTHOR INDEX<br />
Sangaralingham, S. Jeson<br />
55, P038, P040, P057<br />
Sanil, Yamuna<br />
P164<br />
Sardar, Muhammad<br />
P232, P309<br />
Sardar, Muhammad R.<br />
P177, P210, P213, P266<br />
Sareyyupoglu, Basar<br />
P142<br />
Sauer, William<br />
P332<br />
Sauer, William H.<br />
P168<br />
Saul, Sara<br />
P107<br />
Sauris, Aileen<br />
P323<br />
Savina, Nodari<br />
P315<br />
Sawyer, Douglas<br />
P272, P350<br />
Sawyer, Douglas B. 142<br />
Saxon, Leslie A.<br />
P140, P247<br />
Sayer, Gabriel<br />
P127<br />
Sayer, Gabriel T.<br />
44, P122<br />
Scarcipino, Mario<br />
P077<br />
Schaefer, Kristen G. 43<br />
Schelbert, Erik B.<br />
P190<br />
Schiller, Nelson B.<br />
P044<br />
Schipper, Judith 54<br />
Schirger, John A.<br />
P116<br />
Schocken, Douglas D. 39, 103<br />
Sch<strong>of</strong>ield, Richard<br />
P334<br />
Schott, Gerilynn M. 43<br />
Schrier, Stanley L.<br />
P145<br />
Schuller, Joseph<br />
P168<br />
Schulman, Kevin A.<br />
P250, P259<br />
Schulze, P. Christian 55, P117, P130, P131, P149,<br />
P151, P195<br />
Schulze, P.C.<br />
P024, P046, P055<br />
Schuster, Andres<br />
101, P076, P083, P085<br />
Schwartz, Doron<br />
P345<br />
Schwartz, Idit F.<br />
P345<br />
Scott, Robert L.<br />
P128<br />
Sears, Samuel F.<br />
P260<br />
Seidman, Christine E. 32<br />
Selzman, Craig<br />
P060, P155<br />
Semigran, Marc J. 50, 57<br />
Semler, Herbert J.<br />
P184<br />
Serrao, Greg<br />
P268<br />
Seth, Milan<br />
P247<br />
Seto, Todd B.<br />
P214, P227<br />
Seymour, E. Mitchell 55<br />
Sgaraglia, Sergio F.<br />
P343<br />
Shah, Kevin S.<br />
P082<br />
Shah, Keyur B.<br />
P134<br />
Shah, Monica R. 88<br />
Shah, Nishant R.<br />
P148<br />
Shah, Pankil<br />
P316<br />
193
AUTHOR INDEX<br />
Shah, Ravi V. 138<br />
Shah, Riddhi<br />
P318<br />
Shah, Sanjiv J.<br />
P298<br />
Shah, Swetang<br />
P348<br />
Shao, Zhili P019, P075, P076, P086, P089,<br />
P098<br />
Sharma, Vinod<br />
P162, P344<br />
Shaw, Jessica<br />
P351<br />
Shaw, L.<br />
P263<br />
Shaw, Linda K.<br />
P251<br />
Shea, Julie B. 43<br />
Sheikh, Mujeeb<br />
P063, P216<br />
Sheikh, Mujeeb A.<br />
P045<br />
Shemin, Richard<br />
P254, P269<br />
Sheris, Steve<br />
P338<br />
Sheris, Steven<br />
P295<br />
Sherwood, L.<br />
P129<br />
Sheth, Samar S. 55<br />
Shi, J.<br />
P201, P286<br />
Shiga, Taro<br />
P307<br />
Shinn, Julie A. 90<br />
Shirger, John A. 55<br />
Shirolkar, Shailesh C.<br />
P308<br />
Shochat, Ilia<br />
P181, P189, P317<br />
Shochat, Michael<br />
P181, P189, P317<br />
Shotan, Avraham<br />
P181, P189, P317<br />
Shrestha, Kevin<br />
P019, P088, P090, P096<br />
Siddharthan, Kris<br />
P351<br />
Signore, Sergio<br />
56, P050, P173<br />
Silparshetty, Santh V.S.<br />
P354<br />
Silpershetty, Santh V.S.<br />
P264<br />
Silver, Jonathan S.<br />
P062<br />
Silver, Marc A. 140<br />
Silverberg, Donald S.<br />
P345<br />
Silvet, Helme 54<br />
Sim, Ling Ling<br />
P218<br />
Simari, Robert D. 105<br />
Simbaqueba, Cesar A.<br />
P241<br />
Siminiak, Tomasz<br />
101, P138<br />
Simon, Daniel I.<br />
102, P139<br />
Simon, Marc<br />
P109<br />
Simon, Marc A.<br />
P142<br />
Simons, Grant<br />
P182<br />
Singh, Dhssraj<br />
P096<br />
Singh, Harinder R.<br />
P164<br />
Singh, Jagmeet P. 35, 138<br />
Singh, T.P.<br />
44, P229<br />
Siou, Jeff<br />
P318<br />
Sipahi, Ilke<br />
102, P139<br />
194<br />
AUTHOR INDEX<br />
Siwik, Deborah A.<br />
P095<br />
Skali, Hicham<br />
P115<br />
Slater, James P.<br />
P159<br />
Slaughter, M.<br />
P129<br />
Slaughter, Mark S. 141<br />
Slawsky, Mara T. 30<br />
Slusser, Joshua P.<br />
P058<br />
Small, Roy<br />
P163<br />
Small, Roy S.<br />
P301<br />
Smart, Frank W.<br />
P337, P338<br />
Smedira, Nicholas G.<br />
P186<br />
Smith, Andrew L. 97<br />
Smith, Colleen<br />
P115<br />
Smith, Holly M.<br />
P080<br />
Smith, Joshua<br />
P136<br />
Smith, Joyce A.<br />
P276<br />
Smith, Michael R.<br />
P028<br />
Smith, Peter K. 52<br />
Snell, Jeffery D.<br />
P036, P152, P153<br />
Snider, J.<br />
P069<br />
Sobotka, Paul A. 47<br />
Socrates, T.<br />
P069<br />
Soergel, David G.<br />
P204<br />
Sokos, George<br />
P279<br />
Sole, Mary Lou<br />
P347<br />
Solomon, Scott D.<br />
40, 105, P115, P183<br />
Somers, Virend K.<br />
36, P059<br />
Song, Min Ju<br />
P284, P346<br />
Song, Yunyan<br />
P094<br />
Souza, Andre L.S.<br />
P281<br />
Spanier, G.<br />
P129<br />
Spence, P.<br />
P129<br />
Spevack, Daniel<br />
P032, P237<br />
Spinuzzi, Daniel<br />
P279<br />
Springer, Jochen<br />
P020, P029<br />
Srinivas, Pothur R. 107<br />
Stahovich, Marcia<br />
P147<br />
Stainback, Raymond<br />
P160<br />
Stainback, Raymond F.<br />
P148<br />
Stanford, William<br />
P016<br />
Stansifer, Maribeth<br />
P206<br />
Stanton, Marshall S. 88<br />
Starling, Randall<br />
P241, P319<br />
Starling, Randall C.<br />
52, 102, 139, 144, P292<br />
Statz, Cara<br />
P105, P114<br />
Steadman, Elisabeth<br />
56, P050, P173<br />
Stearns, Sally<br />
P217<br />
Stehlik, Josef<br />
90, P060, P155, P249, P274<br />
Steidley, D. Eric<br />
P128<br />
195
AUTHOR INDEX<br />
Stein, Kenneth M. 88<br />
Stein, Murray<br />
P219<br />
Stevanovic, Angelina<br />
P326<br />
Stevens, Susanna R.<br />
P308<br />
Stevenson, Lynne<br />
P323<br />
Stevenson, Lynne W.<br />
44, P047, P118<br />
Stevenson, Lynne Warner 37, 101, 106<br />
Stevenson, William G. 41, 97<br />
Stewart, Duncan J.<br />
P051, P110<br />
Stewart, Garrick<br />
P047<br />
Stewart, Garrick C.<br />
45, 138, P118<br />
Stewart, Holly<br />
P064<br />
Stewart, Kelley C.<br />
P017<br />
Stewart, Simon<br />
102, P288, P321<br />
Stoll, Scott T.<br />
P128<br />
Storozynsky, Eugene<br />
P349<br />
Storrow, Alan<br />
P272<br />
Stough, Wendy Gattis 139<br />
Stout, Rebecca A.<br />
P150<br />
Struck, Joachim<br />
P073<br />
Struthers, Christine<br />
P291<br />
Suarez, J.<br />
P022<br />
Suarez, Jorge<br />
P230<br />
Subramanian, Khaushik 56<br />
Sugathan, Prasanna<br />
P225, P264, P354<br />
Sugi, Kaoru<br />
P197<br />
Sulica, Roxana<br />
101, P320<br />
Sullivan, Dorothy<br />
P303<br />
Sullivan, Katherine M.<br />
P207<br />
Sumiyoshi, Tetsuya<br />
P307<br />
Sun, Benjamin 106, 141<br />
Suresh, Rahul<br />
P304<br />
Sussman, Mark A. 40, 101<br />
Swedberg, Karl 49, 52, 89<br />
Sweeney, Michael O.<br />
P182<br />
Sweeny, Robert J.<br />
P340<br />
Sweitzer, Nancy K.<br />
44, 145, P053, P066, P271<br />
Swetz, Keith M.<br />
101, P171<br />
Szymkiewicz, Steven J.<br />
P166, P176, P330<br />
Takayama, Hiroo<br />
55, P124, P130, P149, P151<br />
Takeuchi, Madoka<br />
P183<br />
Talan, Mark I.<br />
P202<br />
Talati, Asha<br />
P311<br />
Tally, Steven<br />
P271<br />
Tan, Lip-Bun<br />
P023, P054<br />
Tan, Michelle<br />
P223<br />
Tanaka, Toshikazu D.<br />
P142, P206<br />
Tang, Daniel G.<br />
P134<br />
196<br />
AUTHOR INDEX<br />
Tang, W.H. Wilson 47, 55, 101, 144, , P019, P049,<br />
P075, P076, P083, P085, P086,<br />
P087, P088, P089, P090, P096,<br />
P097, P098, P100, P165, P172,<br />
P241, P278, P292, P301<br />
Tang, Wilson<br />
P163<br />
Tang, Wilson W.H.<br />
P072, P077<br />
Taub, Pam<br />
55, P219<br />
Taylor, David O.<br />
49, 87, 90, P241<br />
Tedford, Ryan J. 108<br />
Teerlink , John R. 139, 143<br />
Teerlink, J.R.<br />
P245, P193<br />
Te-Frey, Rosie<br />
P124<br />
Tejima, Tomoyuki<br />
P197<br />
Tereyua, Sergio<br />
101, P221<br />
Terzic, Andre 92, 107<br />
Testani, Jeffrey M.<br />
47, P314<br />
Tettamanti, Maria E.<br />
P341<br />
Teuteberg, Jeffrey J.<br />
44, 104, P118, P142<br />
Thai, Hoang<br />
P203<br />
Thakur, Akanksha<br />
101, P076, P083, P085, P089<br />
Thohan, Vinay<br />
P332<br />
Thomas, DiSalvo<br />
P350<br />
Thompson, Rose<br />
P260<br />
Thompson, Shelley L.<br />
P308<br />
Thorn, Stephanie<br />
P110<br />
Thum, Thomas<br />
P020<br />
Tiwari, Nidhish<br />
P213<br />
Tjandrawidjaja, Michael C.<br />
P047<br />
Tomassoni, Gery F.<br />
P025<br />
Tomita, Makoto<br />
P037<br />
Tompkins, L.<br />
P129<br />
Tong, Deborah<br />
P300<br />
Tong, Matthew<br />
P278<br />
Tonne, Jason M.<br />
45, P067<br />
Topilsky, Yan<br />
P116<br />
Torre-Amione, Guillermo<br />
56, P111, P112<br />
Torrey, Jeff<br />
P332<br />
Towbin, Jeffrey A.<br />
99, P021<br />
Trajic, Snezana<br />
P326<br />
Trevino, Alejandro<br />
56, P111, P112<br />
Troughton, Richard<br />
P179, P318<br />
Troughton, Richard W.<br />
P019, P088, P090<br />
Tsai, Ming-Feng 54<br />
Tschirner, Anika<br />
P020, P029<br />
Tseng, Chi-hong<br />
P254<br />
Tseng, Chi-Hong<br />
P269<br />
Tsutsui, Hiroyuki<br />
P197<br />
Tuche, Fabio<br />
P281<br />
197
AUTHOR INDEX<br />
Tucker, Rebecca<br />
P276<br />
Tuinei, Joe<br />
P261<br />
Tuinei, Joseph M.<br />
44, P235<br />
Tuy, Tertius<br />
P311<br />
Uber, Patricia A. 96<br />
Udelson, James E. 34, 43, 47, 100<br />
Udlis, Kimberly A.<br />
P133<br />
Ueland, Thor<br />
45, P294<br />
Ueyama, Yukie<br />
P126<br />
Ullery, Brant W.<br />
P157<br />
Uriel, Nir<br />
P124<br />
Valadri, R.<br />
P039<br />
Valdez, Riccardo<br />
P128<br />
Valente, Anne Marie 108<br />
van der Walt, Christelle<br />
P059<br />
van Oort, Ralph J.<br />
P042<br />
van Rooij, Eva 42<br />
van Veldhuisen, Dirk J.<br />
45, 49, P294, P297<br />
Vargas, Bernardo<br />
P295<br />
Vargas, Pedro<br />
P126<br />
Varosy, Paul D.<br />
P168<br />
Varr, Brandon C.<br />
P145<br />
Vatterott, Daniel B.<br />
P170<br />
Vawer, May<br />
P214, P227<br />
Velazquez, Eric J. 52<br />
Veloso, Monica W.<br />
P102<br />
Veluz, Jeffrey<br />
P225<br />
Ventura, Hector O. 96<br />
Verbalis, Joseph G. 34<br />
Verheye, Stefan<br />
P126<br />
Verma, Divya Ratan<br />
P060<br />
Vido, Diane<br />
P279<br />
Villacorta, Humberto<br />
P102<br />
Vishneski, Susan R.<br />
P167<br />
Vittorio, Timothy J.<br />
P268<br />
Vizzardi, Enrico<br />
P267<br />
Vlachos, Pavlos P.<br />
P017<br />
Vokonas, P.<br />
P055<br />
Volpe, Massimo 56<br />
von Haehling, Stefan<br />
P029<br />
Vongooru, Haree<br />
P121<br />
Voors, A.<br />
P193<br />
Voors, A.A.<br />
P245<br />
Wagman, Gabriel<br />
P268<br />
Walsh, Mary N. 91, 100<br />
Wan, Chingping<br />
P176<br />
Wang, Da-Zhi 42<br />
Wang, Tiannan<br />
P101<br />
Wang, Yibin 51<br />
198<br />
AUTHOR INDEX<br />
Wang, Zeneng<br />
P088, P090<br />
Warren, S.<br />
P129<br />
Wasilewski, Jaroslaw 52<br />
Waters, Benjamin<br />
P136<br />
Watson, Ronald R.<br />
P056<br />
Wawrzyniak, Andrew J.<br />
P325<br />
Waxman, Aaron B. 108<br />
Webster, Tracy A.<br />
P248<br />
Webster, Tracy L.<br />
102, P169, P171<br />
Weder, Alan B. 55<br />
Wehrens, Xander<br />
P101<br />
Wehrens, Xander H.T.<br />
98, P042, P293<br />
Weintraub, Andrew R. 91<br />
Weintraub, Joanne<br />
P323<br />
Weintraub, Neal<br />
P272<br />
Weissman, Irvig L.<br />
P099<br />
Wells, Joanna M. 55<br />
Wencker, Detlef<br />
44, P105, P114, P141, P287<br />
Westlake, Cheryl<br />
P335<br />
Wever Pinzon, Omar<br />
P155<br />
Whellan, David J.<br />
87, 91, P250, P259, P344<br />
White, Brenda<br />
P080<br />
White, Matthew<br />
P331<br />
White-Williams, Connie L. 87<br />
Whooley, Mary A.<br />
P044<br />
Wilk<strong>of</strong>f, Bruce<br />
P175<br />
Wilk<strong>of</strong>f, Bruce L.<br />
P165, P172<br />
Williams, Celeste<br />
P310<br />
Williams, Janice<br />
P217<br />
Wilson, Debra<br />
P347<br />
Wilson-McManus, Janet<br />
P137<br />
Windle, John<br />
P135<br />
Windle, John R.<br />
P061<br />
Wisl<strong>of</strong>f, Ulrik<br />
P042<br />
Wiste, Heather<br />
P248<br />
Witteles, Ronald M.<br />
103, 142, P145<br />
Wodnar-Filipowicz, Aleksandra 101, P084<br />
Wojdyla, D.<br />
P245, P280<br />
Wolf, Kelly 33<br />
Wolf, Matthew J. 32<br />
Won, Hoyoun<br />
P238, P244<br />
Wong, Shirley<br />
P252<br />
Woo, Y. Joseph<br />
P157<br />
Wroblewski, Megan<br />
P156<br />
Wu, Alan H.B.<br />
44, P066<br />
Wu, Yuping<br />
P072, P075, P086, P097, P278<br />
Xiao, Chunyang 56<br />
Xu, Haiyong<br />
P273<br />
Xu, Yi-Zhou<br />
P169<br />
199
AUTHOR INDEX<br />
Xue, Yang<br />
55, P185, P219, P302<br />
Yadav, Rakesh 52<br />
Yamada, Gregg<br />
P332<br />
Yamamoto, Takeshi<br />
P154<br />
Yancy, Clyde W. 86, 143<br />
Yang, B.F.<br />
P286<br />
Yang, Fang<br />
P182<br />
Yang, James<br />
45, P198<br />
Yang, Jonathan<br />
P130, P149<br />
Yang, Michael<br />
P036<br />
Yang, N.<br />
P201<br />
Yang, Ning<br />
P094<br />
Yao, Atsushi<br />
P307<br />
Yedlapati, Neeraja<br />
P032<br />
Yeo, Daniel<br />
P352<br />
Yoshikawa, Tsutomu<br />
P211<br />
Youker, Keith A.<br />
56, P111, P112<br />
Young, Courtney A.<br />
P305<br />
Young, James B.<br />
106, P292<br />
Young, Malia<br />
P227<br />
Young, Michelle<br />
P323<br />
Yu, Shengbo<br />
P188, P191, P194<br />
Yu, Shuiqing<br />
P117, P131, P151<br />
Yun, Hae Eun<br />
P284, P346<br />
Yun, Soo-Hyeon<br />
P209, P324<br />
Zaeem, Faisal<br />
P105, P114<br />
Zakhary, Daniel<br />
P052<br />
Zambroski, Cheryl H.<br />
P192<br />
Zampini, Giorgio<br />
P082<br />
Zareba, Wojciech<br />
P183<br />
Zarella, Frances<br />
P351<br />
Zavin, A.<br />
P024, P046, P055<br />
Zaw, Ma Wai Wai<br />
P218<br />
Zeldenrust, Steven<br />
P180<br />
Zelin, Kathleen<br />
P164<br />
Zeng, Dewan<br />
P208<br />
Zhang, Renliang<br />
P089<br />
Zhang, Yan<br />
P205<br />
Zhang, Yi<br />
P340<br />
Zhao, Qingyan<br />
P188, P191, P194<br />
Zhao, Wang V. 56<br />
Zheng, Hanqiao<br />
56, P050, P173<br />
Zhong, Hongyan<br />
P208<br />
Zhong, Wei<br />
P107<br />
Zhou, Peng<br />
P199<br />
Zhou, Xiaoyan<br />
P103<br />
Zibadi, Sherma<br />
P056<br />
Zielke, Sayeh<br />
P305<br />
Zieroth, Shelley<br />
P353<br />
200<br />
AUTHOR INDEX<br />
Zile, Michael<br />
P250<br />
Zile, Michael R. 56<br />
Zolty, Ronald P113, P177, P210, P213, P231,<br />
P232, P266, P309<br />
201
Hynes AUTHOR Convention INDEXCenter<br />
Second Level<br />
hynes AUTHOR convention INDEXcenter<br />
Third Level<br />
201<br />
207<br />
REGISTRATION<br />
CME<br />
208 209<br />
202 203 204 205<br />
Entrance<br />
REGISTRATION<br />
202<br />
203
HFSA DATES TO REMEMBER<br />
October 21-23, 2011<br />
The Practical Management <strong>of</strong> HF:<br />
From Prevention to Advanced Disease<br />
Chicago, IL<br />
April 9, 2012 (Monday)<br />
Abstract Deadline<br />
16th HFSA <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
September 9-12 , 2012<br />
HFSA <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
Seattle, WA<br />
Advanced HF/Transplant Cardiology Certification<br />
• May 1, 2012<br />
ABIM Exam Registration Deadline<br />
• September 29-30, 2012<br />
HFSA Board Review<br />
Minneapolis, MN<br />
• October 23, 2012<br />
ABIM Certifying Exam
16th <strong>Annual</strong> <strong>Scientific</strong> <strong>Meeting</strong><br />
September 9 – 12, 2012<br />
Washington State Convention and Trade Center<br />
Seattle, WA<br />
Abstract Deadline: April 9, 2012<br />
www.hfsa.org